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Abstract 
 
The stage of ‘matching’, commonly described as ‘donor selection’ or ‘donor 
allocation’, is an integral stage in the egg donation process and refers to the selection 
of a particular donor for a particular recipient for the purpose of reproduction. Despite 
the model of clinic-mediated matching being an ‘institutionalised practice’ in the UK 
much of the literature on egg donation has taken this stage for granted. This study set 
out to explore the organisation of matching in egg donation in two fertility clinics in 
South East England. Ethnographic fieldwork was conducted over two years and 
involved observations, in-depth interviews with clinicians and recipients and the 
collation of matching statistics. Theoretical frameworks of (bio)medicalisation, 
stratification and racialisation were utilised to understand the matching process, with a 
particular emphasis on their application in the UK regulated context of egg donation. 
In this study ‘matching’ was taken to be a process rather than a single practice of 
selection, enabling insight into how different sets of aims, activities, decisions, 
trajectories, roles, tools, constraints, perceptions and interactions at different stages of 
the matching process combine to result in particular outcomes. Situated within the 
wider regulatory context of the UK and the immediate clinical contexts in which 
research took place this study showed how donor-recipient matching in egg donation 
simultaneously (bio)medicalised, stratified and racialised reproduction in novel and 
nuanced ways, particularly through practices of ‘racial matching’ and ‘transracial 
matching’. Concepts of ‘kinship risk, ‘marked whiteness’ and ‘strategic 
rationalisation’ were employed to understand the perceptions and practices of 
clinicians and recipients in the matching process. 
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Chapter 1: Introduction 
1.1 Introduction 
This study set out to explore the organisation of donor-recipient matching in egg 
donation in the UK. The stage of ‘matching’ (i.e. donor selection) is an integral stage 
in egg donation and refers to the pairing of a particular donor and a particular 
recipient for the purpose of reproduction. Despite the model of clinic-mediated 
matching being an ‘institutionalised practice’ in the UK (Haimes, 1992) much of the 
literature on egg donation has until recently paid little attention to this process. As 
such, researchers have only alluded to matching as part of wider studies on gamete 
donation, in contexts of donor selection by recipients themselves or in neo-liberal 
contexts with little regulation and a relatively high supply of donors, or have explored 
recipients’ selection of donors outside of the clinical context.  
Researchers who have explored matching in any-depth have predominantly focused 
on the construction of resemblance between recipients and donors and on recipients’ 
preference for desirable differences. These researchers have theorised matching as a 
kinship practice, a consumer practice and, relatedly, as a 'biomedicalized' practice. 
Studies that have given the topic of matching some primacy, have predominantly 
taken place in international and transnational contexts of egg donation. These contexts 
were often associated with having low regulation, a highly commercialised 
environment and a high supply of donors. For example, egg donation agencies, which 
exist specifically to recruit donors, are commonplace in neo-liberal contexts of egg 
donation, such as the USA. Indeed, studies on transnational contexts of reproduction 
have reported that individuals travelled abroad to escape the regulatory context of 
their home counties, and its implications, such as long waiting lists for egg donors 
(Bergmann, 2011; Culley et al., 2011; Hudson et al., 2016). 
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This has significant implications for the study of matching in the UK context, which 
is characterised by is a high level of state regulation, a relative shortage of donors and 
long recipient waiting lists for egg donors. Whilst UK policy on matching in gamete 
donation has changed over time, there has nonetheless remained an inherent 
assumption in policy that it is clinicians, not recipients, who will select donors. It is 
important, therefore, to account for the constraints of the UK context, in particular the 
regulatory framework, a shortage of egg donors, and the particular roles, experiences 
and negotiations of clinicians and recipients, in understanding how matching is 
organised and undertaken in the UK context of egg donation. The current research 
explores these facets 
 
1.2 Background to the ‘Research Problem’ 
1.2.1 Egg Donation and Matching  
Egg donation is a type of fertility treatment that comes under the umbrella Assisted 
Reproductive Technologies (ARTs). Egg donation refers to the process by which one 
group of women, egg donors, donate their reproductive gametes to enable another 
group of women, recipients, to conceive and raise a child. More recently, recipients of 
donor eggs have included single and gay men. Typically, a donor’s eggs are fertilised 
by the partner of a recipient, with the intention that the recipient becomes pregnant 
from the transfer of embryo(s) created using the donor eggs and becomes the mother 
of any child conceived. Unlike sperm donation, egg donation is predicated upon the 
clinical context and requires high, rather than low, technological intervention. Egg 
donation can be undertaken using a ‘known donor’, where a recipient recruits their 
own donor, or, more typically, using an ‘anonymous donor’. The use of an 
anonymous egg donor, which is the focus of this study, necessitates the need for a 
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recipient to be paired with a donor. Donor-recipient matching refers to this pairing of 
a particular egg donor with a particular recipient. 
Matching is significant for several reasons. Firstly, matching determines the types of 
families that are reproduced through egg donation, not merely the types of children 
and parents that are reproduced (Thompson, 2005). Secondly, matching determines 
recipients’ access to treatment and reproduction even after they have gained access to 
the clinic, i.e. by virtue of their access to donors (a necessary precondition of 
treatment). Finally, matching is significant because it is implicated with the daily 
reinforcement and reproduction of ‘race’, inequalities and medical power.  
 
1.2.2 Overview of the Matching literature 
Matching has often been looked at peripherally in studies on gamete donation, which 
have often focused on other aspects of the egg donation process. Existing literature 
has predominantly focused on areas such as recipients willingness to disclose to their 
child (Readings et al., 2011; Murray and Golombok, 2003; Greenfeld and Klock, 
2004; MacDougall et al., 2007), the experiences and socio-psychological functioning 
of donor-conceived parents and children (Brewaeys et al., 1997; Golombok et al., 
1999; Murray et al., 2006; MacDougall et al., 2007) and constructions of relatedness 
in the absence of a bio-genetic tie (Strathern, 1992a, 1992b, 1992c; Ragoné, 1994; 
Franklin, 1995; Hayden, 1995; Carsten, 2004; Becker et al., 2005; Konrad, 2005; 
Mamo, 2005; Thompson, 2005; Hargreaves, 2006; Harrington et al., 2008; Lesnik-
Oberstein, 2008). 
A pervading theme in the literature on ARTs has been on barriers to recipients’ access 
to treatment, and reproduction, by virtue of their ability to access the clinic (Corea et 
al., 1985; Steinberg, 1997; Roberts, 1999; Malin, 2003; Culley et al., 2009). However, 
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few studies have explored recipients’ access to treatment after they enter the clinic, by 
virtue of their access to egg donors. Despite the diverse range of ethnographies that 
took place in the UK over the 1980s and 1990s (Stanworth, 1987; McNeil, 1990; 
Stacey, 1992; Strathern, 1992a, 1992b, 1992c; Edwards et al., 1993; Franklin, 1997; 
Franklin and Ragoné, 1998), few addressed the topic of matching in egg donation 
(Price, 1997; Konrad, 2005).  
Studies that have explored the role of clinicians in the matching process have 
predominantly been undertaken outside of the UK context of gamete donation 
(Almeling, 2007; Costa, 2007; Szkupinski-Quiroga, 2007; Kroløkke, 2014; Ariza, 
2015; Bergmann, 2015; Deomampo, 2016; Homanen, 2018). An increasing literature 
has also focused on the secondary analysis of egg and sperm donor profiles (Schmidt 
and Moore, 1998; Baum, 2001; Kroløkke, 2009; Mamo, 2010; Daniels and Heidt-
Forsythe, 2012). 
Studies exploring clinicians’ views of matching in egg donation in the UK have also 
been sparse. These studies have predominantly reported variability in clinicians’ 
perceptions and practices of ‘ethnic matching’ but some coherence in their reluctance 
to ‘transracially’ match donors and recipients. This includes studies utilising 
quantitative surveys (Birdsall and Edwards, 1996; Murray and Golombok, 2000; 
Human Fertilisation and Embryology Authority, 2005b) and qualitative methods 
(Price, 1997; Konrad, 2005; Campbell, 2007; Klotz, 2014).  
Studies on matching have typically focused on recipients’ preferences for egg donor 
characteristics, often outside of the clinical context. Some studies have used 
quantitative methods (Klock et al., 1994; Lindheim and Sauer, 1998; Lindheim et al., 
2000; Broderick and Walker, 2001). The majority of qualitative studies on matching 
have been undertaken in transnational and international contexts of egg donation, 
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including India, Mexico, USA, Israel, Romania, Spain, Finland, Czech Republic and 
Thailand, which had low regulation and a high supply of donors (Nahman, 2006; 
Whitakker and Speier, 2010; Becker, 2000; Fogg-Davis, 2001; Almeling, 2007; 
Szkupinski-Quiroga, 2007; Bergmann, 2011, 2015; Daniels and Heidt-Forsythe, 2012; 
Kroløkke 2014; Deomampo, 2016, Schurr, 2016; Homanen, 2018).  
Qualitative studies exploring recipients’ preferences for egg donor characteristics and 
information about donors in the UK have been few and far between (Ahuja et al., 
1997; Konrad, 2005; Stuart-Smith et al., 2012; Braverman and Frith, 2014; Hudson 
and Culley, 2014; Klotz, 2014; Zadeh et al., 2016a). Recipients’ selection of sperm 
donors has received more in-depth theoretical attention, particularly in contexts of 
heterosexual, lesbian and single parent reproduction (Hayden, 1995; Jones, 2005; 
Nordqvist, 2010; Mamo, 2010). The majority of researchers exploring matching have 
theorised recipients’ selection of donors as a kinship practice (Becker, 2000; Becker 
et al, 2005; Jones, 2005; Konrad, 2005; Mamo, 2005, 2007; Thompson, 2005; 
Nordqvist, 2010; Klotz, 2014; Bonaccorso, 2009; Strathern, 1992a, 1992c).  
Using a kinship studies framework, these scholars have generally sought to explore to 
what extent matching practices reinforce or challenge a normative ideology of the 
nuclear family and how recipients, in the absence of a biogenetic tie with their child, 
construct kinship relatedness. These studies have highlighted the normative 
importance of matching for resemblance and the strategies that recipients used to 
foreground or minimise different aspects of genetics, nature, culture, ‘ethnicity’, race, 
relatedness and resemblance in order to do, and display, kinship (Hayden, 1995; 
Becker et al., 2005; Konrad, 2005; Mamo, 2005; Thompson, 2005; Hargreaves, 2006, 
Harrington et al., 2008; Cadoret, 2009; Nordqvist, 2010).  
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In the literature, there has also been a significant emphasis also on matching as a 
consumer practice. Here, researchers have argued that recipients are consumers who 
seek to enhance the characteristics of their child by selecting, and often paying for, 
donors according to their ideal-type preferences, fertility providers are depicted are 
predominantly commercial businesses which sell donors to recipients and ‘broker’ 
egg donors, and donors are described ‘vendors’ who sell their eggs in return for 
money, thus commodifying reproduction and kinship (Becker, 2000; Sharp, 2001; 
Almeling, 2007; Mamo, 2010). 
Some researchers have argued that rather than seek to ‘match’ their own 
characteristics, recipients selected donors with characteristics which were ‘different’, 
and perceived as ‘better’, than their own characteristics, as a way of “enhancing” their 
“family qualities” (Birenbaum-Carmeli and Carmeli, 2002; Mamo; 2005; Nahman, 
2006; Nordqvist, 2010; Deomampo, 2016). In this respect, researchers have argued 
that matching is a consumer practice, where recipients select donors with 
characteristics which mirror dominant “cultural understandings of physical and 
cultural power” as a way of increasing the ‘social health and well-being’ of their child 
(Mamo, 2005). Situating matching as both a consumer practice and a kinship practice, 
Mamo (2005) has argued that lesbian couples selection of sperm donors in the US 
constitutes a “biomedicalization of kinship”. Like scholars exploring matching as a 
kinship practice and as a consumer practice, Mamo (2005) argued that the recipients 
negotiate nature and culture in complex, co-constitutive ways (Strathern, 1992b; 
Hayden, 1995; Franklin, 1997; Becker, 2000; Thompson, 2005; Mamo, 2005). 
The relatively large literature on matching in transnational contexts of egg donation 
often touch upon the ‘push’ and ‘pull’ factors which have led recipients to travel 
abroad for egg donation. Scholars of this literature highlight the constraints in 
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recipients’ home countries which led to them go abroad, including availability of 
donors and waiting times for treatment (Bergmann, 2015; Hudson and Culley, 2011).  
A key theme in this literature has been the stratification of reproduction through the 
reproduction of whiteness, where recipients travel to countries that they associate with 
having desirable donors, or rather desirably white donors, and clinics specifically 
recruit such donors to meet this demand (Nahman, 2006, 2011; Whitakker and Speier, 
2010; Cooper and Waldby, 2014; Kroløkke, 2014; Bergmann, 2015; Deomampo, 
2015; Schurr, 2016; Homanen, 2018). Scholars have revealed how reproduction is 
stratified through ‘racial’, ethnic, class and geographical lines, whereby recipients of 
donor eggs are often white women from wealthy countries whereas those providing 
donor eggs are often women from low-income backgrounds (Whitakker and Speier, 
2010) and sometimes minority ethnic women (Deomampo, 2016).  
The above studies have typically explored the movement of recipients from highly 
regulated contexts of ARTs to less regulated, commercialised, countries. However, 
few studies in the UK have explored how recipients have navigated the constraints of 
the UK clinical context when having treatment in the UK, rather than the impact of 
these constraints on seeking treatment abroad. This lack of attention, to matching as a 
medicalised practice, is surprising. 
 
1.2.3 Rationale for this Study  
Regulation around Matching 
In the UK, egg donation is organised around a regulatory framework. The macro 
organisation of matching in the UK sits in between matching framework extremes. In 
the USA and India, for example, matching is organised around the free-market 
(Becker, 2000; Thompson, 2005; Almeling, 2007; Deomampo, 2016). In Spain and 
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Finland, there is legislation specifying that clinicians have a mandatory duty to match 
the ‘ethnicity’ and physical characteristics of donors and recipients (Kroløkke, 2014; 
Bergmann, 2015; Homanen, 2018). Although there has been no specific legislation 
pertaining to matching in the UK, the regulation of matching has taken place through 
policy, the nature of which has changed over time.  
Changes in Policy 
Between 1990 and 2006, the Human Fertilisation and Embryology Authority (HFEA) 
specified that clinicians must match donors and recipients by CMV status, ‘physical 
characteristics’ and ‘ethnicity’, and prohibit recipients from choosing a donor of a 
different ‘ethnicity’ to themselves (HFEA, 2003). Between 2007-2014, there was a 
period of policy absence on matching in which matching was left entirely to 
clinicians' discretion (HFEA, 2007). From 2014 to the present day HFEA guidance 
stipulates that clinicians are no longer required to ‘ethnically match’ donors and 
recipients and that, if recipients are willing, clinicians can offer them a donor of a 
different ‘ethnicity’ (HFEA, 2014a).  
The qualitative studies and commentaries on the HFEA ‘ethnic matching’ policy 
predominantly took place before 2007, when prescriptive HFEA policy on matching 
was in place (Millns, 1995; Culley, 2005; Campbell, 2007; Wade, 2007). However, no 
one has yet fully explored the implications of the removal of this policy for the 
organisation of matching and for the perceptions, experiences and practices of 
clinicians and recipients within the matching process. Neither has there been 
sufficient analysis of the implications of matching policy for clinical autonomy, for 
recipient agency and for the reproduction of families. This study was undertaken 
during the period of HFEA policy absence on matching, in which matching was left to 
clinical discretion. 
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The Wider Context 
The predominant model of donor allocation in egg donation and the framing of 
‘ethnic matching’ in egg donation are particularly topical because of their resonance 
with other areas of healthcare and reproduction, such as organ donation and adoption, 
particularly in relation to the semantics of supply and demand and the role of ‘race’ 
and ‘ethnicity’. In organ donation, the ‘ethnic matching’ of donors and recipients has 
had important implications for Black and Minority Ethic (BME) patients. Despite 
having a relatively higher need for donor organs, the practice ‘ethnic matching’ and a 
shortage of BME organ donors has meant that BME recipients typically wait longer to 
be matched with a donor (Higgins and Fishman, 2006; Malek et al., 2011).  
In the field of adoption, the topic of ‘ethnic matching’ has also been subject to much 
debate (Charles et al., 1992; Gaber and Aldridge, 1994; Rushton and Minnis, 1997; 
Kirton, 2000; Patel, 2007; Ridley et al., 2010). Here too, BME children are reported 
as being overrepresented in the care system and wait longer for an adoptive match 
than their white counterparts. This disadvantage has been perpetuated by a shortage of 
BME adopters and by regulation stipulating the ‘ethnic matching’ of adopters and 
adoptees. The implication for BME children, that they remain in the care system 
rather than be placed with a white adoptive couple, has led to reconsideration of 
‘ethnic matching’ as in the best interests of the chid. 
Debates about ‘ethnic matching’ in adoption have centred on legislative welfare of the 
child concerns and have been implicated in wider political and socio-historical 
debates about ‘race’, ethnicity, the state and reproduction (Kirton, 2000). Unlike in 
the context of organ donation, where racialised ethnicity has been used as a marker 
for genetic attributes and genetic comparability (Kierans and Cooper, 2013), debates 
about ‘race’/ethnicity in adoption have centred on ethnicity as a cultural attribute and 
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cultural compatibility (Kirton, 2000). In both of these contexts, the racialisation of 
matching and the cultural production of the ‘ethnic donor’ (Kierans and Cooper, 
2012) have led to a professional and cultural discourse of BME communities being 
‘selfish’, ‘ignorant’ and needing to be ‘educated’ (Rozon-Solomon and Burrows, 
1999; Callender and Miles, 2010), in addition to stratifying BME individuals access to 
resources. 
The ‘ethnic matching’ of donors and recipients in UK egg donation resonates with the 
issues outlined above for organ donation and adoption. Here too, the imposition of 
‘ethnicity’ as a matching criterion, particularly in the context of a shortage of BME 
donors, has been criticised for restricting BME recipients’ access to the majority of 
(white) donors, and to treatment (Millns, 1995; Culley, 2005; Campbell, 2007), and 
for embodying a sense of social engineering / eugenics in the racialised reproduction 
of families (Roberts, 1999; Campbell, 2007; Fogg-Davis, 2001; Szkupinski-Quiroga, 
2007). Here too, ‘ethnic matching’ is framed as a welfare of the child concern in 
policy and clinical discourse (Culley, 2005; Campbell, 2007; Wade, 2007), except 
here, unlike in adoption, ‘ethnicity’ is conceptualised as a racialised characteristic, i.e. 
as a proxy for phenotype and a genetically inheritable attribute.  
The geneticisation (Lippman, 1991) of ‘race’ in this way is particularly alarming 
given the fact that ‘race’ is a socio-political construct which has been discredited as 
having an scientific or genetic basis (Lewontin, 1992; Omi and Winant, 1994; 
Bradby, 1995; Hall, 2000; M’Charek, 2008), the history of state intervention into 
‘race’ and reproduction (Stoler, 1995; Roberts, 1999) and the use of ‘racial’ categories 
as mechanisms of othering, oppression, discrimination (Ahmad and Sheldon, 1992; 
Omi, 1997; Karlsen and Nazroo, 2006; Wade, 2010; Omi and Winant, 1994; Du Bois, 
1994). Policies and practices of ‘ethnic matching’ in reproduction are particularly 
contentious at the current time, where the sharp rise in mixed ethnicity families is 
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challenging traditional pre-conceptualisations about ‘race’ and reproduction and 
assumptions about kinship and resemblance (Patel, 2009; Aspinall and Song, 2013). 
The Research Focus  
Given differences between the context in which matching takes place, the existing 
theoretical frameworks used to understand matching in egg and sperm donation 
cannot be simply transposed onto the UK context. Little is known empirically about 
how matching is organised and undertaken in the UK context of egg donation, in 
which matching has typically been left to clinical discretion. Scholars have called for 
researchers to explore the UK context of matching in egg donation further, 
highlighting the need to explore how clinicians classify donors’ characteristics and 
allocate donors to recipients (Culley, 2005; Hudson, 2015) and how the clinical 
context impacts recipients’ preferences for donor characteristics (Braverman and Frith 
2014; Zadeh et al., 2016a). 
Given the paucity of research studies on matching in the UK, and the often peripheral 
attention given to matching in studies on gamete donation, the aim of this study was 
to put matching at the centre of research, i.e. the central focus. Understanding how 
matching takes place in the context of UK egg donation will also enable insight into 
to what extent current theorisations of matching hold in the UK context and/or which 
other concepts might be drawn upon to understand the peculiarities of matching in the 
UK context. Contrary to common depictions in the literature, which frame matching 
as a practice (of donor selection or donor allocation), for the purposes of this study 
matching is defined as a process which can be broken down into 6 interdependent 
stages.  
These comprise: (1) Classification of donor characteristics (2) Classification of 
recipient characteristics and recipient preferences for donor characteristics (3) 
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Management of the recipient waiting list (4) Allocation of donors to recipients by 
clinicians (5) Offering of donors to recipients by clinicians (6) Recipients’ acceptance 
or refusal of offered donor(s).  
Research Questions and Methodology  
Based on the review of literature outlined above (and fieldwork) the aim of this 
research was to explore how donor-recipient matching in egg donation is organised in 
2 UK fertility clinics. This involves exploring 4 sub-questions, which will frame the 
empirical chapters (5-8) of this thesis: 
 How do clinicians classify donors and recipients into categories? 
 How do clinicians allocate donors to recipients? 
 How do recipients express and negotiate their preferences in the 
context of the clinic? 
 How do recipients negotiate accepting/declining donors they are 
matched with? 
 
This study employs frameworks of (bio)medicalisation, stratification and racialisation 
to understand the organisation of matching in the UK and the perceptions, practices 
and experiences of clinicians and recipients within this. This will include exploring 
the extent to which matching is medicalised compared to common depictions of 
matching as commercialised and how reproduction and (bio)medicalisation are 
stratified through matching. In doing so, my aim is to show how a theorised 
understanding of matching requires consideration of local context and critical 
examination and reflective application of the theoretical concepts employed to explain 
matching elsewhere.  
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The methodology employed is significant to the aims of this study. Because of the 
nature of matching as a backstage activity (Goffman, 1959) and a clinic-mediated 
activity (Price, 1997; Konrad, 2005; Klotz, 2014) an ethnographic approach was 
considered to be the most appropriate method for understanding the organisation of 
matching and the roles of clinicians and recipients within the matching process. 
Understanding how matching is organised and practised in the UK context of egg 
donation can have significant implications for policy makers, clinicians, donors, 
recipients and donor-conceived persons, and reproduction and society more generally.  
 
1.3 Personal Motivation 
 I chose the topic of matching in egg donation because I thought it was intellectually 
exciting. The year before starting this PhD I had just finished an MSc in Medial 
Sociology, which introduced me to concepts of and debates within ‘medicalisation’, 
‘race’ and ethnicity, healthcare inequalities, the social construction of health and 
illness, the organisation of healthcare, reproductive technologies, medical power and 
patient agency, all of which I found invigorating. A friend and I were talking about 
transracial matching in adoption before I chose to study matching, and ‘ethnic 
matching’, in egg donation. He asked me, ‘Why is it so wrong for a black woman to 
adopt a white baby but okay for a white woman to adopt a black baby?’ 
I was confused, and slightly uncomfortable. Something in what he said that rang true 
with me, but I wanted to pretend that I didn’t understand the question. I started talking 
about the semantics of the ‘supply’ of adopters vs. the ‘demand’ by adoptees. I think 
that feeling of confusion, and discomfort, has been one of the motivators for choosing 
this topic. The topic of ‘matching’ in family building seemed to reveal some of the 
complexities underlying traditional notions of ‘race’ and reproduction, and the role of 
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the state, the medical profession, the market and individual agency within this. I had 
originally planned to compare ‘ethnic matching’ in reproduction across gamete 
donation and adoption. However, I soon came to realise that this topic appeared to 
make up two, if not three, separate theses.  
As I started to explore the topic of matching in the literature I realised that hardly any 
studies had focused on matching in the UK context of gamete donation compared 
with adoption, and so I decided that this would be an interesting and novel area to 
explore. Upon further exploration, I decided to focus on egg donation, rather than 
sperm donation, predominantly because of the lack of literature on the former and 
because of the differential organisation of egg donation and sperm donation in most 
fertility clinics at the time (e.g. many clinics had ‘outsourced’ sperm donation so that 
recipients chose their own sperm donor from a provider in Denmark or the USA).  
Until 2006, there was a policy in the UK which specified that gamete donors and 
recipients should be ‘ethnically matched’ by fertility providers. I was intrigued. Why 
should the state determine the types of families that could be reproduced through 
gamete donation, and what did this policy say about wider societal values? What was 
the role of the medical profession within this? What did recipients of donor gametes 
think about clinicians choosing a donor them? And how did we find ourselves in a 
situation where the state was not only biologising ‘ethnicity’ but seeking to reproduce 
racial hierarchies through reproduction, again? 
This policy was removed in 2006, but having been introduced to the topic, I could not 
help but see ‘ethnic matching’ in reproduction everywhere, e.g. in the literature and in 
advertisements for fertility treatments, on dating websites, and even when walking 
through the street and contemplating what makes me assume that particular 
individuals that I saw together were related (aside from their interactions). Although 
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my interest was initially sparked by ‘ethnic matching’ in egg donation, the paucity of 
empirical work on matching led me to broaden this scope to explore the organisation 
of matching in UK egg donation more generally. I felt that this was the gap that 
needed to be addressed.  
 
1.4 Structure of Thesis  
This thesis aims to provide an in-depth, ethnographic, exploration of the organisation 
of matching in the UK clinical context of egg donation, a topic that has received little 
empirical attention in the UK to date and which has not been the focus of 
ethnographic inquiry. The thesis is presented in 8 chapters, including the current 
introduction to the thesis.  
Chapter 2 reviews the relevant literature relating to matching and the main theoretical 
concepts drawn upon in this study, providing the theoretical background to important 
concepts and to the generation of the research questions for this thesis. This will 
explore theoretical frameworks of medicalisation, biomedicalisation, racialisation and 
stratification and how these have been applied to reproduction through ARTs. Chapter 
3 outlines the methodological approach of ethnography as it was employed for this 
study, including the methods of data collection, sampling, recruitment and data 
analysis. Chapter 4 explored the wider regulatory context and immediate clinical 
context of matching and outlines the stages comprising matching as a process; this 
chapter provides the background context for the empirical chapters to follow. 
Chapters 5-8 present the empirical findings of this study.  
Chapter 5 presents clinicians’ formal, informal and implicit classification of donors 
and recipients into different categories for the purpose of donor allocation, including 
donors’ and recipients’ ‘ethnicity’, physical and social characteristics, recipients’ 
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preferences for donor characteristics and recipients’ practices of accepting and 
declining donors. Chapter 6 looks at how clinicians allocated donors to recipients and 
the factors that shaped their decision-making. Chapter 7 explores recipients’ 
preferences for donor characteristics within the context of the clinic and the types of 
donors they were willing, and unwilling, to accept as well as their preference for 
donor information. Chapter 8 focuses on recipients’ practices of declining and 
accepting donors that they were matched with, including how recipients negotiated 
the constraints of the clinical context.  
 Chapter 9 presents the conclusions of this study in relation to the research questions. 
This chapter brings together the key findings of the study and the key contributions it 
makes. In it, recommendations are made for policy, practice and future research and 
the limitations of the study are discussed.   
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Chapter 2: Literature Review  
 
2.1 Introduction 
This chapter discusses the literature framing this study. The first part of this literature 
review focuses on the theoretical frameworks of medicalisation and biomedicalisation 
as applied broadly to healthcare and the concept of racialisation. Attention will then 
be given to relevant theorisations of reproduction in relation to Assisted Reproductive 
Technologies (ARTs) including: stratified reproduction, the (bio)medicalisation of 
reproduction, commodification of reproduction, technologisation of reproduction, 
stigma and infertility and the accomplishment of kinship through the clinic. Focus 
will then be paid to the existing literature on donor-recipient matching in gamete 
donation and how the gaps in this research shaped the research questions for this 
study.  
 
2.2 Overarching Theoretical Frameworks 
2.2.1 Medicalisation Theory 
A key interest guiding medical sociologists until the late 1980s was the origins, 
persistence and social consequences of medical autonomy (Gabe et al., 2004). The 
concept of “medicalization” was framed by Zola (1972) to theorise the extension of 
medical jurisdiction, authority, and practices into increasingly broader areas of 
people's lives.  
‘Medicalisation’ refers to a process where everyday life events become defined and 
treated as medical problems, requiring medical intervention (Conrad, 2007: 4). 
Medicalisation has traditionally been associated with the expansion and reification of 
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medical jurisdiction, dominance and control over behaviour and events which were 
perceived as being ‘undesirable’, ‘pathological’ or ‘deviant’ (Zola, 1972; Illich, 1977; 
Conrad and Schneider, 1992a), such as alcoholism and obesity (Salant and Santry, 
2006), as well as ‘normal’ and ‘natural’ events, such as pregnancy, childbirth (Oakley, 
1984; Petchesky, 1987; Davis-Floyd, 1993), and more recently, infertility and 
reproduction (Becker, 1992; Whiteford and Gonzalez, 1995; Franklin and Ragoné, 
1998; Teman, 2003; Greil et al., 2011; Bell, 2016). 
The notion of medicine as an agent of social control was first developed by Parsons 
(1951) through his conceptualisation of the “sick role”, where an individual enters a 
period of socially sanctioned deviance which is defined and policed by the medical 
profession. According to this functionalistic conceptualisation, clinicians have 
legitimate sanctioned authority as knowledgeable, honest and financially disinterested 
parties and patients have ascribed rights and obligations, part of which is to seek and 
follow medical advice. According to Conrad and Schneider (1980b), medicalisation 
can happen at three distinct levels: the conceptual level (defining a problem as 
medical), the institutional level (where medical intuitions adopt a medical approach to 
a problem) and the interactional level (where treatment is sought and a problem is 
defined/approached as medical). 
According to Conrad (2007), medicalisation became the dominant institution of social 
control, surpassing the role of the church, the family and the state, through its ability 
to re-define certain categories of ‘deviant’ and ‘natural’ behaviour as being a medical 
problem rather than a moral problem. This entailed a re-conceptualisation of certain 
individuals who were regarded as deviant from being ‘bad’ to being ‘sick’ (Conrad 
and Schneider, 1980a). The main focus in the medicalisation literature has been on the 
roles (and dominance) of the medical profession and on the role of the lay population 
in bringing about medicalisation (Ballard and Elston, 2005: 236), in which emphasis 
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has traditionally been given to the high degree of professional authority, autonomy 
and dominance enjoyed by the medical profession in society (Zola, 1972; Freidson, 
1970; Conrad, 2007), with some earlier theorists emphasising the medical imperialism 
underlying medicalisation (Illich, 1975). In contrast, the role of patients in the 
medicalisation thesis has traditionally been depicted as that of ‘passive’ ‘docile’ and 
‘vulnerable’ patients, who lose control over what happens to their own body, are 
subject to assessment, diagnosis and treatment, all of which they are expected to 
unquestioningly comply with (Lupton, 1997).  
The medicalisation thesis has been criticised on a number of levels. Feminist critiques 
of medicalisation have highlighted its patriarchal nature, where it is women who are 
especially vulnerable to the process of medicalisation and men who exercise them 
(Steinberg, 1997; Conrad, 2007). The relationship between the medical profession and 
the state has also been theorised in relation medical autonomy, where state regulation 
of medicine can at once can sanction clinicians’ autonomy and dominance 
(MacDonald, 1995; Moran, 1999; Johnson, 1982; Salter, 2004; Freidson, 1970) and 
constrain it (Freidson, 1970; Larkin, 1993). Since the 1990s, attention in the 
sociological literature has turned to wider changes which have challenged the medical 
profession’s deep-seated position of power and changed the nature of the patient role 
(Gabe et al., 2004). 
These critiques argue that modernity, the era through which medicalisation was 
theorised, has been superseded by different social orders, including 
postmodernity/late modernity, neo-liberalism, individualisation and risk society 
(Giddens, 1990; Beck, 1994; Ballard and Elson, 2005). As such, some scholars argue 
that the concept of medicalisation is no longer suited to the current era and should be 
abandoned (Rose, 2007) and replaced with concepts more able to explain these wider 
frameworks, such as “Pharmaceuticalization” (Abraham, 2010) or 
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“Biomedicalization” (Clarke et al., 2010). Of these, the concept of ‘biomedicalisation’ 
is most suited to understanding ARTs, which have been posited as epitomising 
biomedicalisation (ibid), and provides a useful synthesis of the concepts and changes 
to medicalisation theory which are relevant for this thesis. The UK-English spelling of 
these theories (i.e. the use of “s” rather than “z”) has explicitly been chosen to denote 
the importance of considering how they might be applied to the UK context as well as 
being a preferred grammatical choice.  
 
2.2.2 “Biomedicalization” Theory 
According to Clarke et al. (2003), the increasing use of ‘technoscientific’ innovations 
and the commodification of healthcare more generally have not only been co-
constitutive of medicine but have led to the transformation of the very nature of 
medicine, or biomedicine, itself. As such, they argue that medicalisation theory is 
unable to capture the nuanced power dynamics and complex ways in which 
individuals, as agents of power, engage with biotechnologies and in which the market 
shapes relations and practices of healthcare. Instead, Clarke et al. put forward the term 
“Biomedicalization”, which they argue is more suited to explaining some of issues 
previously encompassed under the umbrella of the medicalisation thesis. According to 
Clarke et al. (2003), biomedicalisation refers to: 
“The increasingly complex, multi-sited, multidirectional process of 
medicalization, extended through and reconstituted through new social forms 
of highly technoscientific biomedicine” (Clarke et al., 2003: 161)  
 
Biomedicine, Clarke et al. argue, has been reorganised “not only from the top down or 
the bottom up but from the inside out” (2003; 162, original emphasis). They argue that 
biomedicalisation is “mutually constituted” and “manifest” through five interactive 
33 
 
processes which began in the mid-1980s. These comprise: (1) the politico-economy of 
biomedicine, (2) a focus on health (rather than illness) and the elaboration of risk and 
self-surveillance biomedicines, (3) the increasingly (co-constitutive) technological 
and scientific nature of biomedicine, (4) transformations in the production, 
management, distribution and consumption of biomedical knowledges and 
information, and (5) the transformation of bodies and the production of new 
individual and collective techno scientific identities (rather than medical labels).  
Echoing wider critiques of the medicalisation thesis (Haug, 1973, McKinlay and 
Arches, 1985; Rose, 2007) Clarke et al., (2010) argue that the above processes have 
led to a transformation of the ‘patient’ role and to a decline of medical autonomy and 
dominance (Busfield, 2017). They argue that the main driver for medicalisation is no 
longer the medical profession, something which has been generally agreed upon by 
scholars of medicalisation (Conrad, 2005; Busfield, 2017; Ballard and Elston, 2005), 
and that the above processes, which have curbed the expansion of medical 
jurisdiction, and even retracted it (Clarke et al., 2010). 
A central tenant of the thesis is that there has been a shift in focus away from the 
treatment of disease and illness towards the commodification of health and well-being 
and that as part of this shift there has been a transfer of the medical profession’s 
dominance to multiple sources of agency through an increase towards ‘technologies 
of the self’ and governmentality (Foucault, 1988; Rose, 1996, Turner, 1997; Clarke et 
al., 2003: 162). Thus, health becomes both a commodity and moral obligation ‘to be 
fulfilled through improved access to knowledge, self-surveillance, risk assessment, 
the treatment of risk, and the consumption of appropriate biomedical goods and 
services’ (Clarke et al., 2010: 162). Clarke et al., (2003) argue that in the 
‘biomedicalized’ era there is no longer need to pathologise the body for medical 
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intervention; rather one always has to manage being ‘at risk’ through self-surveillance 
and governmentality.  
According to Clarke et al., (2003) risk and self-surveillance mutually construct each 
other. Thus individuals are ‘always at risk’ to some degree (Giddens, 1990; Beck, 
1992; Lupton, 1999) or occupy the role of the “worried well”, where risk, rather than 
merely illness, becomes the object of intervention and treatment. Thus it is impossible 
not to be “at risk” as the rhetoric of ‘biomedical governmentality’ means that 
individuals feel compelled to inscribe themselves with technoscientific identities 
which give them access to previously unavailable identities, e.g. infertile women 
becoming mothers (Clarke et al., 2010: 64). According to Roth (2010: 471) risk has 
become a ‘proxy for moral discourse’, where the use of risk assessment techniques by 
governments, which identify people as ‘at risk’, serve as a justification for bringing 
people under social control.  
Clarke et al., (2010) argue that whilst health becomes more biomedicalised through 
risk, self-surveillance and routine screening it simultaneously becomes “less 
medicalized”, which they define as a shift in responsibility from the medical 
profession to the individual. This echoes the view of other scholars who argue that an 
increase in self-surveillance and care can constitute de-medicalisation at an 
interactional level (Ballard and Elston, 2005). One of the most potentially fruitful 
concepts in the biomedicalisation thesis is that of “stratified biomedicalization” 
(Clarke et al., 2010). According to Clarke et al. (2003: 170) the concept “stratified 
biomedicalization” refers to the persisting “cooptative and exclusionary tendencies” 
of medicalisation which: 
“Become increasingly complex, and new modes of stratification are also 
produced- not just based on inability to pay […] Thus, Even as biomedical 
technologies extend their reach into ever more spaces, many people are 
completely bypassed, others impacted unevenly” (Clarke et al., 2003: 170).  
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Thus, new modes of inequalities are produced and old ones are reinforced. Clarke et 
al., (2010) seek to incorporate the uneven, heterogeneous and multidirectional nature 
and effects of biomedicalisation, through which wider societal inequalities are 
reproduced in the field of biomedicine according to familiar divisions of ‘race’, class, 
gender and other ‘sites of inequality’. Pertinent here are the two framings of 
stratification that Clarke et al. (2010) incorporate and elaborate on in their formulation 
of stratified biomedicalisation; Ehrenreich and Ehrenreich’s (1978) ‘critical 
elucidation’ of the dual tendencies of medicalisation as ‘cooptative’ and ‘exclusionary 
disciplining’ and Ginsburg and Rapp (1995b) framing of “stratified reproduction” 
(which will be elaborated on further below).  
Whilst cooptive medicalisation refers to the traditional use of medicalisation and has 
predominantly included middle/upper class white women, exclusionary/disciplinary 
medicalisation refers to the ways in which medicine erect barriers to access and 
targets particular segments of the population for particular types of biomedicalisation, 
and have been prevalent with BME and poorer women (Clarke et al., 2010; Shim 
2010; Bell, 2016). The main focus of stratified biomedicalisation in Clarke et al.’s 
(2010) framing of the concept has been on individuals’ access to healthcare, and 
ARTs, which are “imposed, made accessible, and/or promoted differentially to 
different populations and groups”, predominantly based on ability to pay (Clarke et al. 
2003: 181).  
Thus, stratified biomedicalisation is closely linked to the commodification of health. 
Other ‘dividing practices’ drawn up by the authors include ‘risky’ or ‘good’ genetics, 
‘deserving’ and ‘compliant’ behaviours and valued demographics (e.g. income and 
insurance). The reproduction of wider inequalities is at the heart of stratified 
biomedicalisation. According to Clarke et al. (2010: 21) inequalities “dwell in the 
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very structures and processes of biomedicalization […] Thus biomedicalization 
carries within itself the ideological, social, and cultural infrastructures that support 
and maintain racial and class inequalities”.  
Criticisms of Biomedicalisation Theory 
“Biomedicalisation theory” has itself been subject to numerous critiques. This 
includes criticisms regarding the overlap of phenomena across biomedicalisation and 
medicalisation (Conrad, 2013), the era to which the recent thesis lays claim (Busfield, 
2017), the broad theoretical framework used to describe biomedicine (Williams et al., 
2012) and about the consumer and rational agency accorded to patients (May 2007; 
Ballard and Elston, 2005). Conrad (2005) has argued that the rise of consumerism and 
biotechnologies are part of an “important shift in the engines that drive 
medicalization”, and not apart from medicalisation.  
Conrad (2005) too acknowledges that the medical profession now has an 
insubordinate role in the expansion of medicalisation but argues that de-
medicalisation only occurs when a problem is no longer defined in medical terms and 
medical treatment is no longer deemed appropriate (Conrad, 1992). Thus Conrad 
(1992) and others have argued that medicalisation and medical dominance are not 
synonymous (Ballard and Elston, 2005: 233). More recently scholars have argued that 
the concept of medicalisation still has value but that the thesis of the 1970s is more 
complex, ambiguous and contested; they argue that we need to consider the contexts 
of that are conducive to medicalisation, or not, and the different forms of 
medicalisation, as well as the roles of the ‘active patient’ and ‘medical dominance’ 
(Busfield, 2017; Ballard and Elston, 2005).  
As highlighted by Herzig (2015: 83), “the concept of “stratified biomedicalization” on 
its own does not offer much in terms of delineating the processes of mechanisms of 
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stratification”. Missing in biomedicalisation theory are understandings of how ‘race’ 
and ethnicity interact with biomedicalisation, as acknowledged by Clarke et al., 
(2010). Despite Clarke et al., (2010) contention that stratified biomedicalisation goes 
beyond ability to pay and involves ‘new modes of stratification’ they offer few 
examples outside of the commercialised context of ARTs to develop this. To these 
criticisms I would add that one needs to consider the extent to which the wider neo-
liberal framework of healthcare in the USA is applicable to other contexts of 
biomedicine where there is a different healthcare system and political-economic 
context (Larkin, 1993; Moran, 1999; Gabe et al. 2004).  
Although biomedicalisation theory provides some useful concepts and an insightful 
synthesis of changes to (bio)medicine in recent decades, I agree with recent scholars 
who argue that it does not necessarily constitute a separate theory in and of itself 
(Conrad, 2005; Busfield, 2017; Ballard and Elston, 2005). Following Bell and Figert 
(2015), I will use the pre-fix the term ‘bio’ in brackets, where relevant, when using 
the theory to denote these limitations.  
 
2.2.3 Racialisation 
‘Race’ is a socio-political construct that refers to the grouping of people based on 
perceived phenotypical variation and which is assumed to be grounded in 
biology/genetics (Jenkins, 2008) but can also incorporate cultural differences as part 
of the ‘natural’ differences between ‘races’ (Wade, 1995). Historically, ‘race’ and 
‘racial categories’ have been used to differentiate between people as a mechanism for 
legitimating systems of slavery, colonialism and eugenics (Du Bois, 1994; Stoler, 
1995; Malik, 1996; Rex, 1988; Karlsen and Nazroo, 2006; Omi and Winant, 1994). 
Bluemenbach’s ‘racial’ classification in the late 1700s has shaped modern day 
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conceptualisations of ‘race’ and ethnicity, in which he distinguished between 5 
different ‘races’ of human being: Caucasian, Mongolian, Ethiopian, American and 
Malay.  
In the 1950s, following historic and then recent atrocities based on racist 
conceptualisations, social and biological scientists demonstrated that ‘race’ does not 
exist, in scientific terms at least, by showing that there is more genetic variation 
between individuals in ‘racial’ groups than variation within ‘racial’ groups (Lewontin, 
1972; Ahmad, 1993; Omi and Winant, 1994; Bradby, 1995; Wade, 1995; Back and 
Solomos, 2000; Hall, 2000; M’Charek, 2008). 
Whilst there is general consensus amongst scholars that “race” is a social construct 
and does not have a biological reality (Hall, 2000), hence the common use of inverted 
commas around the term, there is also acknowledgement that the term has a legal, 
social, political and historical reality with important material, social, economic and 
political consequences (Wallman, 1988; Omi and Winant, 1994; Guillaumin, 1999; 
Appiah, 2000; Gunaratnam, 2003; Szkupinski-Quiroga, 2007). Thus scholars 
generally agree that the use of terms such as ‘racialisation’ and ‘racism’ but are more 
ambiguous about to what extent to retrain the concept of ‘race’ (Miles, 1989; Omi and 
Winant, 1994; Gilroy, 2000a, 2005b; Hall, 2000).  
The term “ethnicity” emerged in sociological writings in the 1960s (Furseth and 
Repstad 2006) was introduced to draw attention away from racialised ideas of 
immutable differences and external categorisation based on phenotypical differences 
(Chapman, 1993; Nazroo, 1997). “Ethnicity” depicts collective identities with a 
shared history or culture, common geographical origin (nationalism), common 
language, religion or set of experiences and emphasises the flexible and self-defining 
nature of classification (Bulmer, 1986; Wallman, 1986; Omi and Winant, 1994; 
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Bradby, 1995; Smaje 1996; Aspinall, 1997; Furseth and Repstad 2006). There is also 
debate around these elements of ‘ethnicity’ and what they mean, and whether to 
include physical appearance as a marker of ethnicity (Modood et al., 1997).  
Despite ‘ethnicity’ existing to rectify the earlier misgivings of ‘race’, in practice, it is 
commonly conflated with ‘race’ (Wallman, 1988; Smaje, 1996; Hall, 2000) or used as 
a euphemism for ‘race’ (Gilroy, 2000b). Indeed, the term ‘race’ has remained in 
general use, policy, popular discourse and healthcare. There is also recognition that 
ethnic categories are generally deemed to be a poor proxy for understanding the 
complexities of human variation and instead provide the basis on which particular 
groups become racialised. Racialisation is a social and political process through which 
groups of people with shared migratory, ancestral histories, skin colour, shared 
languages and in some cases, religions, become ‘marked’ as a racial group which is 
assumed to share a biological basis (Miles, 1989). According to Miles (1989:75) 
racialisation refers to ‘those instances where social relations between people have 
been structured by the signification of human biological characteristics in such a way 
as to define and construct differentiated social collectivities’.  
In healthcare, the main focus of the literature has been on patterns of ethnic 
inequalities in health and access to healthcare (Bhopal, 1990, 2007; Ahmad, 1992; 
Bradby, 1995; Smaje, 1995; Modood et al., 1997; Nazroo, 1997, 1998; Nazroo and 
Williams, 2006; Clarke et al., 2010; Shim, 2010) and the relationship between class 
and ethnicity has been highlighted to varying degrees (Rex, 1988; Miles, 1989; 
Nazroo, 1998; Gilroy, 2000). Attention has also been given to healthcare 
professionals’ meaning and use of ‘racial’ and ethnic terminology and measures for 
operationalising ethnicity (Sheldon and Parker, 1992; Aspinall, 2005; Karlsen and 
Nazroo, 2006). The collection and use of ‘ethnic’ statistics and data is a contentious 
and contested terrain, including debates about the advantages and disadvantages of 
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ethnic data collection, the purpose of collection, how categories of identification are 
created and operationalised and the subsequent utility and interpretation of ethnic 
statistics (Sillitoe and White 1992; Bulmer 1986; Aspinall 1997).  
More recently scholars explored the ways in which ‘race’ has become reinvigorated 
through developments in genetic technologies, including the Human Genome Project 
and personalised genetic medicine through which sophisticated technologies are being 
employed based on old classificatory regimes (Collins, 1999; Duster, 1990; 2005; 
Rabinow and Rose, 2006; M’Charek, 2008).  
In this study the term ‘racial matching’ rather than ‘ethnic matching’ has been chosen 
because it most accurately reflected the meaning of participants’ accounts. It would 
have been inauthentic to use ‘ethnic matching’ in inverted commas to relay the 
ambiguity surrounding its use as ethnicity clearly was not the subject of clinicians’ 
discourses and practices. The term ‘racial matching’ was also chosen because it was 
consistent with the terminology used to describe its antithesis- ‘transracial matching’. 
However, in recognising that ‘race’ does not in fact exist as a scientific construct 
‘race’ and ‘racial’ terminology is kept in inverted commas.  
Below, I will discuss how reproduction how been theorised in relation to ARTs, 
particularly in the context of the theoretical frameworks and concepts outlined above.  
 
2.3 Theorising Reproduction  
2.3.1 Stratified Reproduction Theory  
The concept of ‘stratified reproduction’ emerged with a focus on globalised and 
transnational contexts of reproduction. The term was originally coined by Shellee 
Colen in the 1980s from her analysis of the relationship between West Indian migrant 
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women working as childcare workers for white employers in New York (Colen, 
1986). Ginsburg and Rapp (1995b) elaborated Colen’s (1986) concept of ‘stratified 
reproduction’ in their jointly edited book which explored how women in different 
societies varied in their experiences of genetic reproduction and child care. Unlike 
Colen’s (1986) original use of the term, which referred specifically to ‘social 
reproduction’ (i.e. nurturing) Ginsburg and Rapp (1995b) expanded the concept to 
include bio-genetic reproduction, in addition to social reproduction. 
Like Colen (1986, 1995), Ginsburg and Rapp (1995b: 313) advocate the need to 
explore how seemingly distinct power relations and contexts (e.g. policy, cultural, 
economic) shape local reproductive practices. According to Ginsburg and Rapp’s 
definition (1995b: 3) definition, which has subsequently been used by a range of 
scholars in a range of reproductive contexts, stratified reproduction refers to: 
“The power relations by which some categories of people are empowered to 
nurture and reproduce, while others are disempowered . . . [and] 
arrangements by which some reproductive futures are valued while others are 
despised”  
 
The prime focus of stratified reproduction has traditionally been on conceptive 
technologies, such as sterilisation, abortion and birth control (Greil et al., 2011). 
However, in recent years scholars have applied the concept to Assisted Reproductive 
Technologies (ARTs) and on women’s stratified access to ARTs based on wider 
divisions of class, ethnicity and sexuality (Mamo, 2007; Culley and Hudson, 2009b; 
Inhorn et al., 2009; Greil et al., 2011; Bell, 2016), particularly in cases of 
‘transnational’ and ‘cross-border’ fertility treatment (Kahn, 2000; Nahman, 2006; 
Twine, 2015). Thus the concept has predominantly been explored within highly 
commercialised contexts of reproduction where intending parents from wealthy 
countries travelled to less wealthy countries to access fertility treatment, often leaving 
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their home countries to escape regulatory constraints (Bergmann, 2011; Culley et al., 
2011; Hudson et al., 2016).  
The stratification of reproduction is also evident within academic studies on infertility 
and ARTs, where most studies on ARTs have focused on the experiences of white 
middle class women, in what Culley et al., (2009: 2) have referred to as a ‘research 
lacuna’. This has led to a large literature on the ‘reproduction of whiteness’ (Roberts, 
1999; Szkupinski-Quiroga, 2007; Cooper and Waldby, 2014; Kroløkke, 2014; 
Deomampo, 2015; Schurr, 2016; Homanen, 2018).  
ARTs have been posited in the literature as a “prime example” of both stratified 
reproduction (Ginsburg and Rapp, 1995b; Inhorn and Fakih, 2006; Inhorn and 
Birenbaum-Carmeli, 2008) and stratified (bio)medicalisation (Clarke et al., 2010). As 
the majority of ARTs are privately funded, access is largely restricted to those who 
can pay, although other barriers may also impede access (Roberts, 1999; Culley et al., 
2004; Culley and Hudson, 2009b; Greil et al., 2011; Armstrong and Plowden, 2012). 
On the one hand, ARTs have generally been made available to white wealthy women, 
whose reproduction is ultimately valued and empowered (Inhorn, 2003; Bell, 2016). 
On the other hand, poor and BME women, who are reported as having a higher 
prevalence of infertility, are unable to access ARTs or are typically subject to 
particular types of co-optive medicalisation intended to restrict their fertility and 
therefore have their reproduction ‘despised’ and disempowered (Roberts, 1999; 
Inhorn, 2003; Inhorn and Fakih, 2006; Inhorn and Birenbaum-Carmeli, 2008; Culley 
et al., 2004; Culley et al. 2009; Inhorn et al., 2009; Greil et al., 2011; Bell, 2016). 
Women from BME and lower social class backgrounds are more likely to receive 
medical attention that impedes fertility (like sterilisation and compulsory 
contraception) and less likely to receive medical interventions which facilitate fertility 
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(like ARTs), patterns which reflect wider social values about deserving and 
undeserving mothers (Riessman, 1983; Stoler, 1995; Roberts, 1997; McCormack, 
2005; Greil et al., 2011; Inhorn and Fakih, 2006; Inhorn et al., 2009). Thus, as pointed 
out by Cussins (1998: 73, now Thompson), women are stratified into two groups: 
“those for whom contraception is available if only they’d use it and those for whom 
there are infertility treatments”. According to Roberts (1999: 253-254) the disparity 
between white and black women’s access to ARTs in the US “stem from a complex 
interplay of financial barriers, cultural preferences, and more deliberate professional 
manipulation” and are “an extension of their more general marginalization from the 
health care system” (Culley et al., 2009).  
Scholars argue that ‘stratified reproduction’ and ‘a eugenic logic’ (Inhorn and Fakih, 
2006) mean that infertility has been seen as a ‘non-issue’ for low income and black 
women, who have been stereotyped as “hyper-fertile” by the white medical profession 
and consequently ‘steered away’ from the use of such technologies or discouraged in 
other ways (Roberts, 1999; Culley et al., 2004 Inhorn and Fakih, 2006; Inhorn et al., 
2009). In the UK, structural, linguistic and cultural barriers have also been 
emphasised over individualistic contributions to such inequalities (such as individual 
cultural preferences and professional manipulation), and the pervasiveness of racism 
has been a dominant aspect of these barriers (Culley et al., 2009).  
 
2.3.2 The (Bio)Medicalisation of Reproduction  
Early theorising and research on the medicalisation of reproduction was championed 
by feminist scholars, who saw patriarchy as a key force behind the medicalisation of 
women’s health. This added an additional dimension of power in medical 
technologies, between those who invent and use them vs. those upon whom they are 
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used, particularly in relation to gender (Spallone, 1989). Women are especially 
vulnerable to the process of medicalisation (Steinberg, 1997; Gabe et al., 2004; 
Conrad, 2007) where the focus of technological and medical control has not merely 
been on reproductive bodies but on women’s bodies (McNeil 1990) and where the 
majority of scientists and doctors are nearly always men (Corea et al., 1985; Spallone, 
1989, Burfoot, 1990; Steinberg, 1990).  
Much of the earlier work on the medicalisation of reproduction focused on the 
medicalisation of pregnancy and childbirth (Oakley, 1984; Petchesky, 1987; Davis-
Floyd, 1993) which provided the “gateway” into work on the ‘medicalisation of 
infertility’ and scholarship on ARTs (McNeil, 1990: Annandale and Clark, 1996; 
Gabe et al., 2004; Conrad, 2007). Before the advent of In Vitro Fertilisation (IVF), 
female infertility, or involuntary childlessness, was traditionally defined as a natural 
and social condition, with a social solution, i.e. adoption (Pfeffer, 1993; Szkupinski-
Quiroga, 2007). However, the successful development of IVF technology, which also 
enabled egg donation, meant that infertility could be ‘treated’, or circumvented, to 
enable otherwise infertile women access to reproduction. This meant that female 
infertility came to be re-defined as a medical problem, with a medical solution.  
In emphasising an increase in ‘technologies of the self’ and governmentality (in the 
Foucauldian sense of the medical gaze and disciplining bodies), Clarke et al. (2010) 
argue that infertile women may feel obligated to use ARTs as a means of accessing 
the desired identity of motherhood, which is itself informed by wider social norms 
and expectations surrounding women and motherhood, i.e. the ‘motherhood mandate’ 
(Russo, 1976). This echoes earlier feminist critiques of ARTs which argued that in a 
context within which motherhood is defined as a natural role for all women (Russo, 
1976), childlessness, whether by choice or not, is seen as deviating from this norm 
and stigmatised (Raymond, 1993; Franklin, 1997). In this context, the 
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(bio)medicalisation of infertility has meant that women feel “compelled to try” to 
reproduce through ARTs (Franklin, 1997; Becker, 2000; Clarke et al., 2010).  
Radical feminists opposing the use of ARTs argued that these technologies 
depersonalise and objectify women, turning them into mere body parts (i.e. womb, 
eggs, hormones) and baby making machines (Corea et al., 1985; Raymond, 1993) 
through procedures controlled by men which are intended to monitor, control and 
manipulate aspects of women’s reproductive bodies (Spallone, 1989). Echoing 
feminist critiques of the medicalisation of childbirth these scholars argue that ARTs 
have not enhanced women’s reproductive rights but diminished them, turning women 
from agents of their own reproduction to passive patients whose definitions and 
meanings of their own experiences are overcome by doctors medical definitions and 
discourses (McNeil, 1990; Steinberg, 1990; Pfeffer, 1993). However, such critiques 
have not been without their own criticisms (Riessman, 1983; Petchesky, 1987; Davis-
Floyd 1993; Annandale and Clark, 1996). 
The subjective role of clinicians as gatekeepers and decision-makers in determining 
access to infertility services has been the subject of much attention and criticisms 
(Rose, 1987; Millns, 1995; Price, 1997; Steinberg, 1997; Roberts, 1999; Szkupinski-
Quiroga, 2007; Hudson and Culley, 2014). According to Price (1990: 152): “The IVF 
procedure raises fundamental ethical questions about the control of human 
reproduction and the grounds for limiting clinical freedom. IVF clinicians and their 
scientific colleagues cannot legitimately claim any special skills to make ethical and 
social decisions”.  
The gate-keeping role of clinicians in accepting or refusing women as recipients can 
be seen a mechanism for stratification of reproduction, whereby those with socially or 
genetically desirable characteristics are encouraged to procreate whereas those who 
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are deemed socially or biologically ‘undesirable’ tend to be excluded from the 
reproductive process, e.g. people who use drugs, those with a criminal history, 
alcoholics, those with genetic disorders (Steinberg, 1990; Robertson, 1991; Roberts, 
1999; HFEA, 2003; Mamo, 2005; Almeling, 2007; Szkupinski-Quiroga, 2007; Apel, 
2008).  
Thus, whilst explicit in the notion of medicalisation is that medical professionals 
exercise control over the means of reproduction also implicit in such control is the 
desire towards an ideology of normalisation (Conrad, 2005), specifically in relation to 
notions of the ideal-type white nuclear heterosexual family (Steinberg, 1997; 
Campbell, 2007). In other words, the medicalisation of reproduction is concerned with 
what is normal and pathological, and what is considered normal within the infertility 
clinic is supported and confirmed by what is considered natural and socially 
acceptable in society more generally (Spallone, 1989; Steinberg, 1997; Atkinson et 
al., 2001; Thompson, 2005). As highlighted by Atkinson et al., (2001:9): “what health 
professionals’ identify as a family, and what counts as knowledge about families (or 
any one particular family) is socially defined and legitimated”. Therefore, 
reproduction is not only medicalised but is structurally normalised so that it develops 
according to the ideology of the traditional nuclear family (Franklin, 1990).  
As highlighted by Franklin (1990: 1) what appears to be at stake therefore “is more 
than helping couples to biologically procreate, it is the necessity for the social and 
cultural reproduction of specific constructions of parenthood and procreation on 
which traditional family values and conventional sexual arrangement are predicated”. 
Studies have found that clinicians judgments about who is a ‘deserving patient’ 
(Doyal, 1987) or even a ‘deserving parent’ (Malin, 2003) are based on their own 
‘idiosyncratic values and personal principles’ (Pennings, 2001) and according to their 
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own perceptions of patients’ relationships, age, sexuality, ethnicity and class (Haimes, 
1992; Price, 1997; Steinberg, 1997; Roberts, 1999; Malin, 2003).  
In particular, scholars have drawn attention to Section 13(5) of The Human 
Fertilisation and Embryology Act (1990) which mandates that clinicians take into 
account welfare of the child considerations before providing intending parents with 
treatment (explored further in Chapter 4) as an illustration of clinicians’ expanding 
medical jurisdiction (Steinberg, 1990; Millns, 1995; Steinberg, 1997; Malin, 2001, 
Campbell, 2007).  
Section 13(5) has been seen as a prime example of medicalisation in which clinicians 
have a state-sanctioned role as reproductive gatekeepers (Campbell, 2007; 
Szkupinski-Quiroga, 2007), although Lee et al. (2014) have argued that this 
gatekeeping capacity has more of a reality in law than in practice. From their study 
with 66 fertility clinic staff (including medical and non-medical professionals) Lee et 
al. (2014) found that clinicians took a “light touch” approach to the application of 
their duty to consider the welfare of the child which was more a ‘box-ticking’ and 
symbolic exercise than judgement of family forms. Instead, they drew attention to the 
role of other non-medical professionals in taking into account the welfare of the child, 
i.e. counsellors, and concluded that that medicalization is a “blunt tool” for 
understanding the complex realities of service provision (Lee et al., 2014: 513). 
However, like other authors who have focused on legislated welfare of the child 
considerations Lee et al., (2014) did not specifically question clinicians about 
matching (Blyth, 1995; Daniels et al., 2016).  
Thus the main focus in the literature has been on the role of clinicians as gatekeepers 
to social and genetic parenthood by virtue of their role in determining whether 
patients can access treatment (Steinberg, 1997; Mamo, 2005). Less attention however 
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has been paid to clinicians’ role in determining patients’ access to treatment by virtue 
of their access to egg donors (Millns, 1995; Pennings, 2000). Drawing on historical 
connections between eugenics and medicine and the role of medicine in controlling 
women’s reproduction along racial, sexual and class grounds (Spallone, 1989) radical 
feminists have argued that the ARTs follow similar patterns of prejudice (Petchesky, 
1987; Stanworth, 1987; Spallone, 1989; Steinberg, 1997). Such stratifications are also 
reflected in Ehrenreich and Ehrenreich’s (1978) conceptualisation of the dual 
tendencies of medicalisation as ‘cooptative’ and ‘exclusionary’. 
The (bio)medicalisation of reproduction through ARTs has thus contributed to the 
‘stratification of reproduction’, whereby some categories of people are encouraged to 
reproduce whilst others are disempowered and discouraged from reproduction (Colen, 
1986), and where “inequalities of class, race and gender are reinforced and intensified 
through stratified systems of reproduction” (Ginsburg and Rapp, 1995b: 98). In 
addition to medicalisation, concepts of ‘commercialisation’ and ‘technologisation’ are 
central to the (bio)medicalisation thesis and have also been theorised in relation to 
their impact on reproduction.  
 
2.3.3 Commodification of Reproduction 
The emergence of fertility treatment within a ‘for-profit’ healthcare industry has been 
central to the development of ARTs in most countries (Mamo, 2010). The majority of 
fertility treatments are privately funded across the world (with some exceptions, such 
as in Israel), making egg donation an inherently commercialised practice. Whilst the 
commodification of healthcare and medicine more generally has shown medicine and 
health to be a consumer good, particularly in the USA (Conrad, 2005), the 
commodification of reproduction in particular raises specific ethical concerns because 
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it involves the creation of life (Strathern, 1992b), although some argue that we should 
reflexively lay such concerns about the commodification of reproduction to bed (Spar, 
2006).  
The commodification of reproduction assumes that reproduction (and the people and 
gametes involved) can be acquired and marketed in the same way as other 
commodities and consumer goods. Within this context, some sociologists have argued 
that donors, their characteristics, their gametes, and children conceived through 
gamete donation have become commodified through the use of ARTs (Overall, 1987; 
Stanworth, 1987; Pfeffer, 1993; Sharp, 2001; Duster, 2006; Almeling, 2007). This has 
particularly been the case in unregulated contexts of egg donation, where donors can 
be paid uncapped amounts for their donation and recipients can pay hundreds of 
thousands of dollars for treatment (Almeling, 2007; Glennon, 2012).  
One of the central debates in literature on gamete donation has been whether the 
‘donation’ of gametes amounts to their exchange as an altruistic gift or a commodity 
(Strathern, 1992b; Tober, 2001; Konrad, 2005; Thompson, 2005). Some researchers 
have argued that true altruism cannot exist in gamete donation, where the notion of 
altruism itself is used by gamete agencies and fertility providers as a “secondary 
commodity” in order to imbue it with higher emotional, moral and economic value 
(Tober, 2001: 157; Almeling, 2007). 
Whilst the predominant concerns of earlier feminists were centred on the 
transformation of women from being agents of their own reproductive capacities to 
patients in the reproductive process the enormous growth of the fertility industry has 
re-focused attention to the role of women as consumers. According to McNeil (1990), 
the language of consumerism has infused the language of choice in ARTs to such a 
degree that the idea of women’s choice has now become a ‘consumer idiom’ 
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(Strathern, 1992b) where women’s reproductive freedom and rights have been 
translated into consumer rights and choices (McNeil, 1990; Davis-Floyd, 1993).  
 
2.3.4 Technologisation of Reproduction  
Whilst the medicalisation of reproduction has fundamentally re-defined the 
reproductive process through the expansion of medical jurisdiction and social control, 
this expansion has only been made possible by the use of technologies, or 
biotechnologies (McNeil, 1990; Conrad and Schneider, 1992b; Conrad, 2013). That 
is, ARTs involve “the interventions of the natural sciences and the biotechnology 
industry brought to medicine” (Spallone, 1989: 178), and it is these aspects of science 
and technology which have received attention from sociological and Science and 
Technology Studies and feminist scholars of ARTs. 
The tension between ‘natural reproduction’ and ‘assisted reproduction’ has been 
central to discussions about the use of technologies in reproductive processes 
(Franklin, 1990) and has typically been framed in terms of a ‘woman-centred’ natural 
approach versus the technological, artificial and consumerist nature of ARTs 
(Burfoot, 1990; David-Floyd, 1992). According to this dualistic view “what was once 
regarded as natural- that is, reproducing babies – is now the work of culture, of 
human-made technologies” (Finkler, 2000: 40; Strathern, 1992c).  
Since the mid-1980s/early 1990s scholars began to shift their analytic focus from 
gender to the field of science and technology (Franklin, 1997; Thompson, 2005; 
Mamo, 2010) and explore how individuals transformed, accepted or rejected 
‘technological scripts’ for their own purposes and at how they understood ‘meaning as 
conjoined with materiality’ (MacKenzie and Wajcman, 1985; Haraway, 1991; 
Rabinow, 2005; Thompson, 2005; Mamo, 2007). These scholars have rejected the 
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natural-technological dichotomy, arguing that these two domains are co-constitutive, 
rather than separate and oppositional (Haraway, 1991 Rabinow, 1992; Strathern, 
1992b; Franklin, 1997; Wade, 2007). Based on the idea of nature and biotechnology 
as co-constitutive, a number of researchers have looked at the implications of this 
mergence and the ways in which science and technology have enabled the emergence 
of new group and individual identities (Haraway, 1991; Rabinow, 1992; Clarke et al., 
2003) and new types of relationships (Strathern, 1992b; Franklin, 1997; Mamo, 2005; 
Thompson, 2005).  
The rise of genetic technologies have had particular implications for reproduction and 
the ‘geneticisation thesis’, which contends that increasingly “most disorders, 
behaviours and physiological variations [are] defined, at least in part, as genetic in 
origin” (Lippman, 1991: 19; Haraway, 1991; Rabinow, 1992; Rapp, 1999; Thompson, 
2005; Mamo, 2007; Wajcman, 2009). For example, researchers exploring the impact 
of ARTs on kinship and the family have drawn on such conceptualisations to 
understand recipients’ constructions of relatedness, as will be outlined further below. 
 
2.3.5 Stigma and Infertility 
The concept of stigma has predominantly been developed through the work of Erving 
Goffman. A stigma refers to a socially ascribed label which deviates from the ‘norm’, 
is discrediting, and which reduces the bearer "from a whole and usual person to a 
tainted, discounted one" (Goffman 1963: 3). Goffman outlined 3 forms of stigma: 
“abominations of the body” (physical ‘deformities’), “blemishes of individual 
character” (e.g. homosexuality, unemployment) and “tribal stigma” (stigmatised 
attributes which are transmitted through family lineage, e.g. ‘race’, nation, religion).  
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Drawing on social interactionist perspectives of labelling theory Goffman maintained 
that stigmatisation is about social perceptions and social relationships rather 
something inherent in an attribute or person. In this context, the ‘normal’ and the 
‘stigmatised’ can be seen as perspectives rather than people who occupy these 
categories (Goffman, 1963: 163-4). Goffman argued that a stigma is a ‘special 
discrepancy’ between a person’s ‘virtual identity’ (normative assumptions about how 
people should be) and a person’s ‘actual social identity’ (the actual qualities they 
possess). That is, a stigma is a ‘spoiled identity’ which deviates from the norm. When 
this discrepancy is immediately obvious and visible then a person is ‘discredited’ and 
has little control over the disclosure of their stigmatised attribute(s), e.g. a physical 
deformity. When this discrepancy is present but not immediately apparent then a 
person is ‘discreditable’ e.g. a mental illness.  
Stigma thus refers to the ‘marking’ (a taint or blemish) of individuals and groups 
based on stereotypes about them. A person’s stigmatised characteristic(s) can be 
conceptualised as a person’s ‘Master Status’ (Hughes, 1945) which overrides all other 
identity categories associated with individuals (Becker, 1963). Goffman (1963) also 
used the term ‘courtesy stigma’ to refer to “normal” individuals who associate with 
stigmatised individuals and share the ‘taint’ of their stigma by association. Others 
have developed this concept into terms such as ‘associative stigma’ and ‘stigma by 
association’ (Neuberg et al. 1994; Goldstein and Johnson, 1997). 
Studies which have explored women’s experiences of infertility have highlighted the 
negative disruption of infertility on women’s lives, well-being and identity, including 
feelings of stigma, vulnerability, worthlessness, grief, depression, isolation, guilt, loss 
of control, marital stress, life course disruption and their experience of infertility as a 
spoiled identity (Franklin, 1997; Becker 2000; Ulrich and Weatherall, 2000; Inhorn, 
2003; Allan, 2006; Culley et al., 2009; Culley, 2012; Hudson and Culley, 2014). 
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Infertility is often experienced as a ‘secret’ and ‘hidden’ stigma (Whiteford and 
Gonzalaz 1995) although its hiddenness is heavily shaped by the contexts in which it 
is experienced (Reismann, 2000; Bharadwaj, 2003; Hudson and Culley, 2014). 
Despite the World Health Organisation’s definition of infertility as a disease of the 
reproductive system, amongst scholars, it is generally accepted that infertility is a 
socially constructed condition shaped by factors such as degrees of pronatalism, 
perceptions of infertility and patriarchy (Greil et al., 2011). Nonetheless, those who 
decide to use ARTs, in particular gamete donation, are reported as feeling stigmatised 
for using this route to reproduction on the grounds that it deviates from the norms of 
natural and non-commercialised reproduction (Stanworth, 1987; Franklin, 1990; 
Macklin, 1991; Stacy, 1992; Strathern, 1992a; Franklin, 1995; Dolgin, 1997; Becker, 
2000; Harrington et al., 2008). In such cases, revealing the use of gamete donation to 
others inherently reveals one’s own infertility. Studies have reported that recipients of 
donor gametes saw a lack of physical resemblance between themselves and their child 
as stigmatised and as a threat to the legitimacy of their family and potentially 
revealing of their ‘spoiled identity’ (Becker et al., 2005).  
 
2.3.6 The Accomplishment of Kinship and Reproduction through the Clinic 
From the 1990s onwards ARTs and have been used as an ethnographic window 
through which to explore kinship discourses and assumptions (McNeil et al., 1990; 
Stacey, 1992; Strathern, 1992a, 1992b, 1992c; Edwards, 1993; Edwards et al., 1997; 
Richards, 1997; Franklin and Ragoné, 1998; Carsten, 2000, 2004; Atkinson et al., 
2001; Franklin and McKinnon, 2001; Konrad, 2005; Thompson, 2005; Bonaccorso, 
2009; Freeman et al., 2014). The main focus of this work has been on recipients 
constructions of kinship although some scholars have also explored clinicians’ 
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constructions of kinship, predominantly in the field of new genetic technologies 
(Finkler, 2000; Atkinson et al., 2001; Featherstone et al., 2006; Cunningham-Burley, 
2008).  
The main questions posed in the literature exploring the impact of ARTs on kinship 
and the family have been: “To what extent are the different family types produced by 
the use of the ARTs supportive of a particular (that is, dominant) ideology of family 
life?” (Haimes, 1992: 164) and ‘How do recipients constructed relatedness with their 
child in the absence of a bio-genetic tie?’ (Strathern, 1992b; Franklin, 1995; Ragoné, 
2000; Thompson, 2005; Harrington et al., 2008).  
On the one hand, scholars have reported how the use of donor gametes challenges the 
normative ideology of the family by separating the triad of sex, marriage and 
procreation (Stanworth, 1987), undermining the legitimacy of genetic parenthood 
(Robertson, 1991) and disrupting the “unity of procreative and conjugal function” 
(Franklin, 1990: 222). In the UK, the Church has historically opposed the use of 
gamete donation on these grounds, arguing that the use of a donor is akin to a form of 
adultery and that children conceived through sperm donation should be regarded as 
illegitimate (Pfeffer, 1993). The increasing use of sperm donation by lesbians and 
single women can also be seen as a direct challenge to the heterosexual, patriarchal 
institution of the family (Franklin, 1990; Haimes, 1992; Stacey, 1992).  
On the other hand, scholars have argued that the use of egg donation reinforces the 
traditional ideology of the family as a heterosexual two parent family unit by seeking 
to reproduce a sense of genetic/biological relatedness (Haimes, 1992; Stacey, 1990; 
Strathern, 1992a; Pfeffer, 1993; Dolgin, 1997; Daniels, 2005; Mamo, 2007). In this 
regard, scholars have argued that legislation and clinical practices have developed 
according to the contours of the traditional family (Robertson, 1991; Haimes, 1992; 
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Fogg-Davis, 2001; Campbell, 2007). The reinforcement of the traditional ideology of 
the family is also evident in individuals’ stratified access to ARTs, where access to 
reproduction has traditionally been granted to heterosexual, married, white middle 
class couples whereas those deemed ‘unsuitable’ to access ARTs have been denied 
access by virtue of their relationships, ethnicity, sexuality, behaviour or disabilities 
(Millns, 1995; Price, 1997; Steinberg, 1997; Roberts, 1999; Malin, 2003; Szkupinski-
Quiroga, 2007).  
One of the major recent themes to arise from recent studies on gamete donation has 
been the importance of ‘resemblances’, more specifically, the use of physical 
resemblances in constructing and displaying relatedness (Becker et al., 2005; Mamo, 
2005; Hargreaves, 2006; Grace et al., 2008; Harrington et al., 2008; Culley and 
Hudson, 2009a; Nordqvist, 2010). These studies have found that recipients of donor 
gametes saw ‘race’ and ethnicity as a central feature of displaying resemblance and 
constructing relatedness with their child (Becker, 2000; Becker et al., 2005; Mamo, 
2005; Thompson, 2005; Culley and Hudson, 2009a; Nordqvist, 2010; Hudson and 
Culley, 2014), as will be explored further below in the literature on matching.  
Outside of the field of ARTs, building on the work of Morgan (1996), Finch (2007) 
has highlighted the importance of ‘displaying’ as well as ‘doing’ families and the 
strategies used by families to gain recognition as a family by others. In their research 
with donor-conceived families Becker et al. (2005) argued that family resemblances 
are used to support a hierarchy of family legitimacy, where clear resemblances are 
regarded as confirming belonging to a ‘blood’ relationship whereas unclear or lack of 
physical resemblances lead to questions about the authenticity of family relationships, 
individual belonging and to stigma (Becker et al., 2005: 1301). One of the ways in 
which notions of blood relatedness are expressed then are through comments and 
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queries about a child’s physical resemblance to its parents and other family members, 
dialogue which Becker et al. (2005) have termed “resemblance talk’’.  
According to Becker e al., (2005), ‘resemblance talk’ constructs a child’s identity 
within the family and legitimises the child as part of the family. Thus for donor-
conceived families, where there is an absence of a bio-genetic tie, scholars argue that 
a lack of physical resemblance between family members is regarded as a threat to 
recipients’ display of normative family. As highlighted by Haimes (1992: 168), 
donor-conceived families face: 
 “The constant potential of being exposed as something other than an ordinary 
family... they can give themselves away or others can make connections which 
suggest there is something not quite right because of a particular mix of eye 
colour, for example, or perhaps blood group.”  
 
Studies looking at donor conceived families’ constructions of relatedness have found 
that parents of donor-conceived children strategically used physical and social 
resemblances as a resource through which to invoke relatedness and as a means of 
‘legitimatising’ kinship ties between the non-genetic parent and their child (Hayden, 
1995; Becker et al., 2005; Thompson, 2005; Hargreaves, 2006, Harrington et al., 
2008; Cadoret, 2009). Thus, while the importance of the bio-genetic tie was 
challenged by these families through the use of a donor it was not completely 
displaced but mobilised in an elastic way, ‘as if’ it were present (Hayden, 1995).  
Looking at how kinship is accomplished in fertility clinics Thompson (2005) 
developed the concept of ‘ontological choreography’ to show how far from being the 
outcome of random arrangements the (re)production of parents and children through 
ARTs is the outcome of “the dynamic coordination of the technical, scientific, 
kinship, gender, emotional, legal, political, and financial aspects of ART clinics […] 
things that are generally considered parts of different ontological orders (part of 
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nature, part of the self, part of society)” (ibid: 8). Such co-ordinations also reveal the 
ontological separation between things and how one type of thing is reduced into 
another. For example, a recipient of donor eggs is at once a patient of biomedical 
procedures, a consumer of biomedical procedures and a potential parent in which her 
fertility is reduced to her age and follicle-stimulating hormone (FSH) levels.  
When choreographies ‘go wrong’, e.g. when a patient can’t afford to access treatment, 
or does not get pregnant, Thompson (2005) argues that this can lead to an ontological 
failure where the patient becomes objectified. However, Thompson (2005) also 
highlights that agency and objectification are not necessarily opposed and that women 
can strategically achieve agency through objectification. Comparing women’s 
experience in the clinical context of egg donation and surrogacy, Thompson (2005: 
149) argues that women exercise agency through a process of “strategic 
naturalization” in which “patients exercise agency and claim or disown bonds of 
ancestry and descent, blood and genes, nation and ethnicity” to suit their individual 
strategies of parenthood; certain elements of kinship differentiation are foregrounded 
and recrafted whilst others are minimised. 
 
2.4 Donor-Recipient Matching in Gamete Donation  
The section below explores the empirical literature on matching, drawing on studies 
which explore the perspectives, practices and roles of clinicians and recipients and 
shows how gaps in this literature informed the research questions for this thesis.  
There are two basic models of matching in gamete donation. One is that of ‘donor 
selection’, where the recipient selects their own donor, often with access to lots of 
information about donors; this model of matching is associated with commercialised 
contexts of egg donation with a relatively high supply of donors (such as the USA). 
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The other model is that of ‘donor allocation’, where fertility providers allocate donors 
to recipients and typically offer varying amounts of information to recipients about 
donors. Sometimes recipients can state their preferences for donor characteristics and 
choose to accept or decline a donor under offer. This model of matching is associated 
with highly regulated contexts of egg donation, with both a high (e.g. Spain) and low 
(e.g. UK) supply of donors. However, the fast-paced changing nature of the field of 
gamete donation means that in practice elements of both models can exist in some 
capacity and that in the UK there has been a move towards a ‘donor selection’ model 
and importing donor eggs from abroad.  
The regulation of matching varies between countries, as will be explored further in 
Chapter 4. However, different models of matching can exist in the same context and 
so the regulation of gamete donation is not the only determinant of which model is 
used. For example, in the USA (not centrally regulated) and UK (highly centrally 
regulated) both models exist, to different degrees. In sperm donation, where there is a 
relatively larger supply of donors (internationally) and where the freezing of donor 
sperm is common practice, models of donor selection are typical and the 
commercialisation of donor sperm is generally accepted (Schmidt and Moore, 1998; 
Barney, 2005; Almeling, 2007; Mamo, 2010; Daniels and Heidt-Forsythe, 2012; 
Glennon, 2012). 
Most of the studies on donor-recipient matching in egg donation have taken place 
outside of the UK in international and transnational context of egg donation. These 
studies have predominantly been undertaken in highly commercialised contexts of egg 
donation in which there is a relatively high supply of donors. This includes studies of 
white American recipients travelling to India (Deomampo, 2015, 2016) and to Mexico 
(Schurr, 2016), Israeli recipients travelling to Romania (Nahman, 2006), Danish 
recipients travelling to Spain (Kroløkke, 2014), Nordic recipients travelling to Finland 
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(Homanen, 2018), German recipients travelling to Spain and Czech Republic 
(Bergmann, 2011), UK recipients travelling abroad for treatment (Hudson, 2017) and 
“foreigners” travelling to Thailand (Whitakker and Speirer, 2010).  
Researchers have generally focused on matching as part of wider studies on egg 
donation and sperm donation, including studies in the USA (Roberts, 1999; Becker, 
2000; Fogg-Davis, 2001; Thompson, 2005; Almeling, 2007; Szkupinski-Quiroga, 
2007; Martin, 2018), Israel (Kahn, 2000; Birenbaum-Carmeli, and Carmeli, 2010), 
Italy (Bonaccorso, 2009), Brazil (Costa, 2007), India (Bharadwaj, 2003) and 
Argentina (Ariza, 2015) and the UK (Price, 1997; Konrad, 2005; Klotz, 2014; 
Braverman and Frith, 2014; Hudson and Culley, 2014; Zadeh, 2016a) 
In the UK, studies of egg donation have explored recipients’ preferences for donor 
characteristics or recipients’ practices of selecting donors outside of the clinical 
context (Ahuja et al., 1997; Hudson and Culley, 2014) and inside (Konrad, 2005; 
Braverman and Frith, 2014; Klotz, 2014; Zadeh et al., 2016a) and have reported 
recipients’ preference for and interaction with donor information (Stuart-Smith et al., 
2012; Rubin et al., 2015). Theorisation of recipients’ preferences for gamete donors 
has received more attention in the arena of sperm donors, particularly with lesbian 
couples (Hayden, 1995; Jones, 2005; Mamo, 2007; Almack, 2008; Nordqvist, 2010). 
Few studies have explored clinicians’ perspectives and practices of matching with any 
primacy in the UK context of donor allocation (Price, 1990; 1997). Some 
ethnographic studies have touched on this as part of their wider focus on egg donation 
in the UK (Konrad, 2005; Klotz, 2014) although these studies did not explore the 
process of matching in egg donation in-depth. More recently, Braverman and Frith 
(2014) and Zadeh (2016a) have reported some preliminary findings on recipient 
preferences for donor characteristics and donor information in the clinical context.  
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Matching in egg and sperm donation has been theorised according to different types 
of ontological orderings. Scholars have theorised matching in relation to anonymity 
and secrecy (Price, 1997; Pennings, 2000), mate selection (Scheib, 1994), 
consumption (Becker, 2000; Mamo, 2010; Nordqvist, 2010), “biomedicalisation” 
(Mamo, 2005), kinship and family legitimacy (Jones, 2005; Thompson, 2005; Mamo, 
2007; Nordqvist, 2010) and processes of ‘othering’ (Schurr, 2016). Most of these 
theories of matching arose outside of the UK context of matching in egg donation. 
Scholars have also theorised matching as a racialising practice, in which ‘race’ is 
reified and reproduced (Roberts, 1999; Fogg-Davis, 2001; Fuscaldo, 2006; 
Szkupinski-Quiroga, 2007; Thompson, 2009; Nordqvist, 2010; Deomampo, 2015; 
Hudson, 2015).  
These researchers have typically theorised matching within a wider framework of 
consumerism and commercialisation. This is because researchers have posited their 
studies in contexts of neo-liberalism, with low state regulation, a high supply of 
donors and privatised access to treatment, where recipients often pay money 
separately to egg donors, fertility clinics, lawyers and mediating egg donation 
agencies. Even in the UK, researchers of gamete donation have highlighted the 
importance of the wider commercial context in which matching takes place (Konrad, 
2005; Nordqvist, 2010). According to Zadeh et al. (2016a) for example: “the 
contemporary climate of assisted reproduction is characterized by commercial 
practice” (Zadeh et al., 2016a: 330; Konrad, 2005; Nordqvist, 2010). However, 
researchers have seldom extrapolated on the nature and implications this.  
Despite the large number of researchers using ethnography to study ARTs in the UK 
in the 1980s and 1990s (Stanworth, 1987; McNeil, 1990; Stacey, 1992; Strathern, 
1992a, 1992b, 1992c; Edwards et al., 1993; Franklin, 1997; Franklin and Ragoné, 
1998), the lack of attention paid specifically to matching is surprising. Despite ‘clinic-
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mediated’ matching being an ‘institutionalised’ practice in the UK (Haimes, 1992), 
this stage in the treatment process with donor gametes has generally been neglected 
by wider literature on the medicalisation of reproduction. The paucity of ethnographic 
studies in the UK context of egg donation is especially surprising, and unfortunate 
given the traditional model of donor allocation in the UK.  
Recognising the limits of current research in this area and building on concepts 
discussed earlier in this chapter, this study sought to explore the organisation of 
matching in UK egg donation. This overarching aim is broken down into 4 sub-
questions which are outlined and contextualised in existing literature on matching in 
the following sub-sections. 
 
2.4.1 Clinicians’ Perceptions and Practices of Matching 
According to a number of authors the main socio-psychological considerations 
underlying donor-recipient matching stem from issues of secrecy and anonymity 
(Haimes, 1992; La Lannou et al., 1997; Pennings, 2000; Pennings, 2001) which have 
been described as the “linchpin” of medical practice using donor gametes (Price 
1997). Donor-recipient matching can be seen as part of a wider “culture of 
concealment” in donor fertility treatment (Price, 1997: 221) and has been attributed to 
a biomedical model of reproduction and a desire to conceal the use of donor gametes 
(Price, 1997; Hudson et al, 2009).  
Unlike in the USA, the distribution of donor gametes (and healthcare more generally) 
in the UK has been based on an ethos of ‘need’ rather than ‘ability to pay’ (Pennings, 
2001, 2005), although ideological and subjective decision making may also influence 
regulation and clinical practice (Warnock, 1984; Malin, 2003). Studies looking at 
clinicians’ practices of donor allocation have found that clinicians seek to match for 
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resemblance, regardless of whether legislation on matching exists, e.g. in Spain and 
Finland where matching is legislated (Bergman, 2015; Homanen, 2018) and in India, 
Israel and Mexico where matching is not regulated (Kahn, 2000; Deomampo, 2016; 
Schurr, 2016).  
Researchers in the UK who have considered the role of clinicians in donor allocation 
have highlighted the subjective nature of clinician’s decision making in this context, 
where clinicians are required to make social judgements that go beyond the purely 
medical (Millns, 1995) based on personal and ideological assumptions about who and 
what makes a family (Campbell, 2007). Although a few researchers have touched on 
the role of clinicians in matching in the UK context of egg donation (Price, 1997; 
Culley, 2005; Konrad, 2005; Campbell, 2007; Klotz, 2014) they have not explored the 
organisation of matching and the perceptions and practices of clinicians and recipients 
in-depth.  
In her ethnographic study of 10 fertility clinics in the UK, Price (1990; 1997) found 
that clinicians raised concerns and uncertainties about their capacity to make 
decisions which went beyond the medical. Clinicians felt uncomfortable with 
engaging and presiding in debates which were less about risks of a technical, safety or 
efficacy nature and more about the perceived ‘social risks’ of gamete donation (Price, 
1990), and were unclear about their role in ‘ethnic matching’ (Price, 1997). 
Furthermore, in the absence of clear guidance or appraisal Price (1997) found that 
clinicians made matches on pragmatic grounds (e.g. availability of donors and 
recipients).  
During the time at which HFEA policy on ‘ethnic and physical matching’ existed (see 
Chapter 4) UK studies reported variability in clinicians’ decision-making, whereby 
some clinicians refused to ‘transracially’ match donors and recipients, citing welfare 
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of the child concerns, whilst others were willing to allow it on pragmatic grounds 
(Millns, 1995; Birdsall and Edwards, 1996; Price, 1997; Culley, 2005; Culley et al., 
2004; Thompson, 2005; Campbell, 2007). According to Millns (1995: 94), such 
pragmatism highlights the subjective and variable nature of clinicians’ decision 
making: “the justification of the decision to implant a black woman with a white 
donor’s egg on the basis of the unavailability of black donor eggs shows the fluidity 
between decision-making on clinical and social grounds.” However, much of these 
commentaries and studies were based on anecdotal evidence rather than systematic 
exploration of matching or were based on quantitative surveys (and so were unable to 
explore matching in any depth).  
In 1996, Birdsall and Edwards (1996) undertook a telephone survey of 46 licensed 
egg donation clinics in the UK and found that the majority of clinicians were not 
willing to offer white donors to BME recipients and that a minority of clinics would 
only do so after recipients underwent counselling. Furthermore, whilst some clinicians 
saw it as acceptable to offer a white donor to a South Asian couple this wasn’t equally 
the case for black couples (ibid). These findings were echoed by Murray and 
Golombok’s (2000) survey. However, the quantitative nature of these surveys 
prohibited in-depth exploration of the meanings that clinicians attached to their 
responses. What is revealed from these surveys however is that although BME 
women may be successful in gaining access to fertility clinics their colour may still be 
a factor in determining whether or not they receive treatment (Millns, 1995). 
Numerous studies have reported that clinicians’ refused to grant recipients’ request 
for a donor of a different ‘race’ (Fogg-Davis, 2001; Culley, 2005; Konrad, 2005; 
Mamo, 2005; Almeling; Campbell, 2007; Costa, 2007; Szkupinski-Quiroga, 2007; 
Thompson, 2009; Klotz, 2014; Deomampo, 2016; Schurr, 2016), often referencing 
welfare of the child considerations (Millns, 1995; Culley, 2005; Thompson, 2005; 
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Campbell, 2007). Clinicians’ refusal to meet recipients’ requests also highlighted how 
clinicians’ and recipients’ view of a ‘good match’ might differ (Hudson, 2015). 
Outside of the UK context of egg donation, scholars have depicted fertility providers 
as businesses that geneticise and commodify donor characteristics, such as ‘race’, 
when marketing donors to recipients (Mamo, 2005; Almeling, 2007).  
The social and subjective nature of clinicians’ decision-making in matching has been 
alluded to in ethnographic studies of gamete donation in the UK. In the 1990s, Konrad 
(2005: 142) found that the most valued skill of the co-ordinator by staff in the clinic 
was their “ability to draw together visually, in the mind’s eye, what future offspring 
would look like when all parties to the conception are blended into one entity as the 
mix of a visible ‘match.’” Klotz (2014) also compared the management of donor 
information in the UK and Germany although like Konrad (2005) she did not observe 
or report on clinicians’ matching practices in egg donation in any depth.  
In contexts of donor allocation outside the UK researchers have also highlighted the 
powerful role of clinicians in defining desirability and acceptability in reproduction 
(Roberts, 1999; Szkupinski-Quiroga, 2007; Deomampo, 2016; Schurr, 2017) and that 
they were “hypervigilant about donor choices to keep boundaries from blurring” 
(Szkupinski-Quiroga, 2007). In India, Deomampo (2015; 2016) showed how 
clinicians labelling women as ‘demanding’ or ‘compliant’ intersected with other 
cleavages of (un)desirability.  
Here, women who were highly educated, had light skin tone and thus were closer to 
Euro-American ideals of beauty, i.e. “Diva donors” were more valued by clinicians as 
egg donors but were seen as too uncompliant to be surrogates. On the other hand, 
women with darker skin tone and no education were regarded as compliant enough to 
be surrogates but not genetically desirable enough to be egg donors (Deomampo, 
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2016). More recent studies have also explored how clinicians distinguished between 
‘types of whiteness’ when matching (Kroløkke, 2014; Schurr, 2016). For example, in 
Spain, clinicians distinguished between women with “lighter” skin tone from northern 
Europe (e.g. UK and Germany) and “darker” southern European women and avoided 
matching donors and recipients on the basis of this distinction (Homanen, 2018: 237; 
Bergmann, 2015).  
Little is known about clinicians’ perceptions and practices of matching in the UK, e.g. 
about what they see as an ‘acceptable’ or ‘unacceptable’ match, their view of 
recipients’ preferences and to what extent they take these into account when 
matching. Reflecting on the UK context of matching, Hudson and Culley (2014: 246) 
highlight that “the role of health professionals in the process of donor-recipient 
matching in the context of identifiable donation is an issue worthy of further 
research”. The current state of the literature and knowledge on ethnic-matching has 
been well summed up Lorraine Culley in her evidence to a Parliamentary Science and 
Technology Committee over a decade ago: 
“Current practice on this [inter-ethnic donation] seems to be variable. It 
appears to be decided by individual clinics or clinicians using the “welfare of 
the child” clause [...] What is the thinking behind this? On what basis is this 
decision made in individual clinics? Whose right is it to decide? Should 
minority ethnic patients who have virtually no possibility of achieving a 
pregnancy because of the shortage of “non-white” eggs be denied treatment? 
[…] In my view further research on this issue is urgently needed.” (Culley, 
2005). 
 
In view of calls for further research in this area and in response to a paucity of 
research exploring the role of clinicians in matching in the UK, the following research 
question was posed: How do clinicians allocate donors to recipients? (Chapter 6) 
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2.4.2 Clinicians’ Classification of Donor Characteristics 
According to the literature on matching, all clinics classify donors according to ‘race’, 
ethnicity and skin tone, although different categories and methods of classification are 
often used in different clinics (Pennings, 2000; Costa, 2009; Thompson, 2009). 
Nonetheless, variability in who classifies these characteristics, how such 
classifications are reached and interpreted can render the outcome subjective, dubious 
and obsolete for the purposes of ‘objective medical’ comparison (Fogg-Davis, 2001; 
Szkupinski-Quiroga, 2007; Fox, 2008; Thompson, 2009). According to Thompson: 
“The central paradox of egg donation, that donor selection is organised 
according to psychological, social and medical qualities […] is contradictory 
to the scepticism expressed about biological heritability of complex social and 
natural traits” (2009: 146). 
 
The classification and use of skin tone in matching has thus been criticised for 
obscuring the difference between the physical expression of genes (phenotype) and 
the inheritance of genes (genotype) (Fogg-Davis, 2001; Szkupinski-Quiroga, 2007; 
Thompson, 2009). While it must be true that phenotypic variation has a genetic basis 
there is no consistent categorisation across characteristics (Sheldon and Parker 1992; 
Aspinall, 2005; Outram and Ellison, 2006; Bhopal, 2007). This has led Thompson 
(2009: 147) to argue that within donor selection “a consideration of skin tone in egg 
donation illustrates active processes of the racialisation of biology and the 
biologisation of race.”  
There have been no studies in UK on how clinicians classify donor characteristics or 
how ‘ethnicity’ is operationalised e.g. whether ‘ethnicity’ is based on donors’ parents’ 
ethnicity or birthplace, that of their grand-parents, on a socio-political identity or on 
skin colour (Sheldon and Parker, 1992). As highlighted by Hudson (2015), there has 
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been a paucity of research on how clinicians operationalise ‘ethnicity’ and “racialised 
markers of heritability” in the context of egg donation:  
“The limited existence of empirical research, which specifically examines the 
ways in which racialised markers of heritability are operationalised within 
clinical practices, is surprising […] Studies which explore in detail the 
operationalisation of racial categories and related decision making of 
clinicians, gamete ‘brokers’ and recipients would significantly advance 
understanding of these processes” (Hudson, 2015: 4). 
Given this evident gap in current research the following research question is posed: 
How do clinicians classify donors and recipients into categories for the purposes of 
matching? (Chapter 5). 
 
2.4.3 Recipients: Matching as a Kinship Practice 
Studies employing quantitative surveys to explore recipients’ preferences for donor 
characteristics, many of which have been undertaken outside of the UK, have focused 
on recipients’ prioritisation of donor characteristics. Studies have found that, on the 
whole, women prioritised egg donors’ ‘health’, then ‘race’/ethnicity and physical 
characteristics (eye colour, hair colour, height and weight), followed by intelligence 
or personality (Le Lannou et al., 1997; Lindheim and Sauer, 1998; Lindheim et al., 
2000; Broderick and Walker, 2001; Flores et al., 2014). On the whole, participants 
wanted to match donors’ characteristics with their own. Some studies have also 
reported that recipients saw donors’ social characteristics, such as their personality, 
education or lifestyle, were described as the most important criteria when selecting a 
donor (Heinemann-Kushinsky et al., 1995; Lindheim et al., 2000). However, 
quantitative nature of these studies meant that little attention was given to why 
recipients prioritised certain characteristics in donor selection, the meanings they 
attach to their choices or the factors shaping their choices. 
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Researchers using a qualitative paradigm to explore recipients’ preferences for donor 
characteristics have often used a kinship studies framework to interpret their findings 
(Haimes, 1992; Konrad, 2005; Thompson, 2005; Nordqvist, 2010; Klotz, 2014). The 
main question posed by these researchers has been ‘how do recipients construct 
kinship with their child in lieu of having a genetic tie with them?’ which has included 
related sub-questions such as ‘how do recipients make their donor-conceived child 
their ‘own’?’ and ‘how do recipients’ process the role of the donor?’. These questions 
have often informed researchers’ contextualisation and interpretation of their findings 
within a wider framework of family and kinship studies.  
As such, researchers have theorised recipients’ preferences for a donor with similar 
characteristics to their own, for resemblance, as a ‘kinship device’, used to construct 
relatedness and connections with their child (Ragoné 2000; Becker et al., 2005; 
Konrad, 2005; Thompson, 2005; Hargreaves, 2006; Harrington et al., 2008; 
Nordqvist, 2010; Hudson and Culley, 2014). According to researchers, recipients seek 
to match donors to themselves on phenotypic grounds so that a potential child will 
resemble the recipient as much as possible. In this respect, the primary aim of 
matching for recipients and clinicians alike has been to select a donor who would be a 
“credible genetic substitute” for themselves (Le Lannou et al., 1997) so that a ‘good 
match’ or an ‘acceptable match’ is one where a child could ‘pass’ as the ‘natural’ 
offspring of its parent, the recipient (Becker, 2000; Konrad, 2005; Campbell, 2007; 
Szkupinski-Quiroga, 2007; Burr, 2009; Thompson, 2009).  
In light of the increasing culture of openness and disclosure around gamete donation, 
some writers have argued that the “secrecy motive” that has been so intertwined with 
matching may make matching for resemblance less important (Scheib, 1994; 
Pennings, 2000: 509). However, researchers have found that resemblances are equally 
important to lesbian and heterosexual couples, who intend to be open about their use 
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of donor gametes (Hayden, 1995; Jones, 2005; Mamo, 2005; Hargreaves, 2006; 
Harrington et al., 2008, Nordqvist, 2010) thus “invalidating the secrecy motive” for 
matching (Pennings, 2000). More recently, researchers have argued that recipients 
match for resemblance in order to secure family legitimacy, to construct kinship 
relatedness with their child and to enable their child to feel a sense of belonging 
within the family (Hayden, 1995; Becker et al., 2005; Becker et al., 2005; Mamo, 
2005; Hargreaves, 2006; Harrington et al., 2008; Cadoret, 2009; Nordqvist, 2010).  
Matching was therefore used as a resource by recipients for “naturalising kinship” 
(Thompson, 2005; Burr, 2009) in “constructing the child as if it was theirs 
biologically” through the use of phenotype as one indicator of (the social recognition 
of) biological relatedness (Nordqvist, 2010: 1135). Looking at lesbian couples 
selection of sperm donors in the USA, Mamo (2005) argues that the choices and 
meanings underlying recipients’ donor selection practices have led to a 
“biomedicalization of kinship” in the context of donor ARTs where “the power of 
genetics is omnipresent as sperm selections are made and futures are imagined” 
(2007: 194). Central to Mamo’s (2005: 258) argument is that donor selection is a 
mechanism for constructing a form of relatedness which she calls “affinity ties”, 
which are mutually constituted through ‘practices of sperm selection, users 
themselves, and sperm bank services’.  
Affinity ties are a kinship device underpinned by the imagining of shared social and 
cultural characteristics between recipients and their offspring, where the donor’s 
characteristics, such as ‘national origin, religious ancestry, cultural interests, hobbies, 
and social characteristics’, are mobilised to be imagined as shared with parents to be 
and treated “as if” they were genetically inheritable by resulting offspring (Mamo, 
2007:205). This is done in order to allow couples to imagine a future child and future 
‘affinities’ with it, referred to by Konrad (2005: 46) as “social connexions”. Mamo 
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(2005) argues that for lesbian couples ‘affinity ties’ are also a way of privileging 
social legitimacy and affirming family connections to those outside of the family: 
“The social and the biological, the natural and the cultural, the genetic and 
the social are negotiated and merged as futures are imagined and legitimacy 
is maximised. That is, this merging is performed not only to share affinities but 
also to secure social legitimacy” (Mamo, 2005: 258). 
 
Thus, whilst acknowledging the role of women’s agency in reinforcing and subverting 
technological scripts of matching (according to their own needs) scholars have 
highlighted how this agency is exercised within wider structural and ideological 
constraints (Franklin, 1997; Mamo, 2007). In other words, recipients’ choices were 
embedded within and reinforced dominant hetero-normative ideas about whom or 
what makes a family (Haimes, 1992). As such, recipients reproduced wider 
ideological conceptualisations of reproduction and kinship through exerting their 
agency (Thompson, 2005). Thus, as highlighted by Mamo (2007: 248), although 
ARTs “provide the institutional and technical practices necessary to bypass social 
conventions of the heterosexual family [...] they do not necessarily bypass cultural 
and social ideals of what and who make a family”.  
Researcher who have focused on the experiences of lesbian couples argue that 
matching carries specific meaning in the context of lesbian reproduction and is used 
instrumentally by women to counteract discrimination in their everyday lives (i.e. 
homophobia) (Mamo, 2005; Nordqvist, 2010). Thus, in addition to being a strategy 
for ‘biogenetic construction’ (or ‘affinity ties’) these scholars argue that for lesbian 
couples matching “highlights the normative importance of looks and physical 
resemblance for the recognition and legitimization of (marginalized) family 
relationships” (Nordqvist, 2010: 1139-1140). However, the importance of physical 
resemblances for providing social legitimacy for heterosexual couples has also been 
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highlighted by researchers, whereby heterosexual couples face a different type of 
stigma in relation to heteronormative expectations of their relationship and fertility 
(Becker et al., 2005; Hargreaves, 2006; Harrington et al., 2008).  
Reflecting a tension within the wider literature on recipients’ conceptualisation of 
donors, Mamo (2005) and Nordqvist (2010) differ in their conclusion of how the 
lesbian couples in their studies processed the role of the donor when constructing 
kinship with their child. On the one hand, Mamo (2005) and others (Klotz, 2014) have 
argued that recipients re-materialise donors with full personalities when imagining 
their donor, which enabled them to imagine future connections with potential 
children. On the other hand, Nordqvist (2010), Konrad (2005) and others (Edwards 
and Strathern, 2000; Murray and Golombok, 2003; Braverman and Frith 2014) report 
that couples’ construction of kinship with their child depended on their “obliteration” 
of their donor so that they were “out of sight out of mind” (Nordqvist, 2010).  
Qualitative studies which have explored recipients’ preferences and practices of 
selecting donors have been able to explore the meaning that recipients attached to 
their selection of egg donors and their prioritisation of ‘race’ and ethnicity. 
Researchers have found that ‘racial’ and ethnic resemblance was used by recipients as 
a means of facilitating the likelihood of physical resemblance (Thompson, 2001; 
Jones, 2005; Mamo, 2005: 258; Hargreaves, 2006; Wade, 2007; Nordqvist, 2010) 
through the “racialization of family resemblances” (Nordqvist, 2010: 1137). ‘Race’ 
and ‘ethnicity’ also invoked the notion of shared cultural and ancestral roots and 
genealogy through the view of ‘race’ as a genetically inherited property (Thompson, 
2001; Jones, 2005; Mamo, 2005).  
Thus recipients saw ‘race’/ethnicity as a primary means of constructing affinity 
between themselves and their (donor-conceived) children, as well between their 
72 
 
children and their wider family and community (Thompson, 2001; Mamo, 2005; 
Hudson and Culley, 2014). In contrast to other attributes, recipients saw shared ‘race’ 
and ethnicity as invoking the promise of an ‘instant familial bond’ (Becker et al., 
2005) More recently, scholars have also drawn attention to the importance of religion 
and nationality as important factors in donor selection (Inhorn, 2006; Nahman, 2006; 
Hudson and Culley, 2014).  
However, given the shortage of donors in the UK, in particular BME donors (Price, 
1997; Golombok et al., 1999; Culley et al. 2004), matching donors and recipients 
according to specific characteristics may be impractical (Pennings, 2000; Konrad, 
2005; HFEA, 2005b). Thus, in order to avoid delays to their treatment, or to have the 
opportunity treatment at all, recipients may be willing to accept gametes from a donor 
of a different ethnicity to themselves (Fogg-Davis, 2001; Pennings, 2001; Jones, 
2005; Hudson and Culley, 2014). However, the acceptance or refusal of recipients’ 
request to forgo ‘ethnic matching’ is typically left to ‘clinical discretion’ (Culley, 
2005; Campbell, 2007).  
A common theme in the literature on gamete donor selection has been the extent to 
which recipients seek to match a donor with their own characteristics (for 
resemblance) versus the extent to which recipients seek to ‘improve’ or ‘exotify’ the 
characteristics of their child (Hanson, 2001; Birenbaum-Carmeli and Carmeli, 2002; 
Mamo, 2005). Here, recipients’ preference for a donor with different characteristics to 
their own has typically been framed as a “consumer” choice (Birenbaum-Carmeli and 
Carmeli, 2002). On the whole, studies have concluded that although recipients want a 
donor who matches their own characteristics they are willing to compromise on this 
when selecting donors with characteristics that they deem to be desirable, i.e. which 
tended towards ideal-type characteristics of Euro-American beauty (Birenbaum-
Carmeli and Carmelli, 2002; Mamo, 2005; Nahman, 2006; Bergman, 2015).  
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2.4.4 Recipients: Matching as a Consumer Practice 
Ideas about ‘designer babies’ or ‘improving’ the characteristics of a children and 
families have been an ongoing concern in the literature on recipients’ selection of 
donors (Pennings, 2000; Hanson, 2001; Birenbaum-Carmeli and Carmeli, 2002; 
Mamo, 2005; Costa, 2007). According to scholars, predominantly researching in 
transnational or US contexts of egg donation with little regulation, matching can be 
seen as a ‘consumer’ or ‘commercialised’ practice (Becker, 2000; Fogg-Davis, 2001; 
Konrad, 2005; Nahman, 2006; Whitakker and Speier, 2010; Kroløkke, 2014; 
Deomampo, 2016; Schurr, 2016; Homanen, 2018).  
Rather than matching donors’ characteristics with themselves, researchers have found 
that some recipients sought a gamete donor with different characteristics (perceived as 
better) to themselves. Such choices were made in relation to ‘race’, ethnicity, skin 
colour (Campbell, 2007; Costa, 2007, Thompson, 2009), height, temperament, 
musical and sports abilities (Mamo, 2005; Pennings, 2000; Hanson, 2001; Nordqvist, 
2010). For example, instead of wanting to ‘match’ the skin colour of donors with 
themselves studies have found that some BME recipients wanted a donor with ‘fairer’ 
skin tone (Fogg-Davis, 2001; Campbell, 2007; Costa 2007; Hudson and Culley, 
2014), which was regarded as an “attractive and/or high-status skin tone” and thus 
intertwined with wider histories of colonialism, imperialism and racism (Almeling, 
2007; Thompson, 2009: 138).  
According to Strathern (1992b: 30) donor selection practices are reflective of nature 
having become ‘enterprised up’ in the context of donor ARTs, where what was once 
seen as left to ‘nature’ (such as the random moment of conception) has now become a 
matter of ‘choice’. Few studies have reported instances of white couples wanting a 
donor with darker skin tone; where such cases have been reported, recipients’ 
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conceptualisation of ‘racial difference’ has been framed by researchers as ‘exotic’ 
rather than ‘enhancing’ (Nahman, 2006; Bergman, 2015; Deomampo, 2016). 
Researchers have also reported that recipients avoided selecting donors whom they 
perceived as having ‘undesirable’ characteristics (Mamo, 2005; Thompson, 2005). 
Interestingly, recipients excluded donors who might have been a phenotypical match 
but were seen as inappropriate for political, religious or historical reasons (Inhorn, 
2006; Thompson, 2009; Whitakker and Speier, 2010; Kroløkke 2014; Hudson and 
Culley, 2014) or because they deviated from normative Euro-American ideals of 
beauty (Nahman, 2006; Schurr, 2016). Studies focusing on transnational reproduction 
have found that white recipients travelling abroad for egg donation distinguished 
between the types of white donors that they saw as acceptable or unacceptable based 
on skin tone and/or culture, e.g. recipients generally sought to exclude white donors 
from Eastern Europe but sought to include donors from Spain, Finland or Romania 
(Nahman, 2006; Kroløkke, 2014; Bergman, 2015; Homanen, 2018).  
In the studies outlined above, researchers have had a tendency to conflate recipients’ 
preferences for donor characteristics, i.e. the characteristics that recipients wanted in a 
donor, with recipients’ practices of selecting donors, i.e. the characteristics that 
recipients accepted in their donor. Few studies have reported on similarities or 
differences between recipients’ preferences and their acceptance of donors in practice 
(Lindheim and Sauer, 1998). Therefore, separate exploration of recipients’ preference 
for donor characteristics and their practices of accepting/selecting donors would 
provide insight into the complex meanings and decisions that shape recipients’ 
negotiations and actions.  
Such exploration may be especially pertinent given the shortage of egg donors in the 
UK, where since “a perfect match can rarely be offered” (Pennings, 2000: 512), 
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pragmatic factors rather than merely ideologies of family construction may shape 
matching practices (van den Akker, 2006: 92). Challenging the perspective of 
recipients as consumers who want more control in the matching process recent studies 
have shown that in contexts of donor allocation many recipients wanted less choice in 
the matching process and less information about their donor (Stuart-Smith et al., 
2012; Rubin et al., 2015). Few studies have distinguished between recipients’ 
preferences for donor characteristics (what they wanted) and their practices (what 
they got). The extent to which matching might be primarily described as a consumer 
practice in the UK context of egg donation is therefore an area worthy of further 
investigation. 
 
2.4.5 Recipients’ Practices of Selecting Egg Donor Selection the UK  
Few studies have explored recipients’ preferences, practices and experiences of 
matching specifically in relation to the UK clinical context of egg donation. Konrad 
(2005) reported that recipients were rarely critical about the matching process or 
fertility providers despite feeling they had a lack of control over the matching process; 
recipients were concerned about appearing “hyper-selective” and ungrateful to 
clinicians and worried that declining donors might jeopardise their place on the 
waiting list for donors. In a more recent study, Klotz (2014) reported that recipients 
were critical of the clinic system and did not just accept the first donor they were 
offered. However, a shortage of donors also meant that the recipients in both of these 
ethnographic studies were unable to state preferences for donor characteristics and so 
these researchers were unable to explore how recipients negotiated the process of 
selecting donors in practice (Konrad, 2005; Klotz, 2014). 
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A recent publication by Zadeh et al. (2016a) which reported preliminary findings 
from an on-going study in UK fertility clinics (using interviews) found that sometimes 
recipients excluded donors for reasons relating to health and fertility but otherwise 
accepted donors they were matched with, reflecting that they were grateful to have 
reached the top of the waiting list for a donor. Other studies, using structured surveys, 
have reported that recipients placed less importance on their donors’ phenotypical 
characteristics after birth (Braverman et al., 2010a) and after counselling (Braverman 
et al., 2010b). Stuart-Smith et al. (2012) reported on the ‘paradox of choice’ (Rubin et 
al., 2015) facing recipients of donor eggs, where recipients faced a tension between 
wanting to know more about donors whilst wanting to retain distance with donors.  
As highlighted by Zadeh et al. (2016a), in the UK context of egg donation, little is 
known about what preferences recipients request with clinics, their practices of 
accepting/declining donors that they are matched with, or indeed how the clinical 
context shapes recipients’ preferences and practices of donor selection. Addressing 
these gaps in the literature, the following research questions are posed in this thesis: 
‘How do recipients express and negotiate their preferences in the context of the 
clinic?’ (Chapter 7) and ‘How do recipients negotiate accepting/declining donors they 
are matched with in practice?’ (Chapter 8). 
 
2.4.6 ‘Race’ and Matching  
The theme of ‘race’ pervades the literature on donor-recipient matching, as will be 
illustrated in the literature reviewed below. The central importance of ‘race’ to donor-
recipient matching in gamete donation necessitates that some attention be given to this 
topic in its own right. 
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According to Szkupinski-Quiroga (2007), the practice of ‘racial matching’ reinforces 
a dominant hetero-normative ideology of the white family whose members resemble 
each other. This view echoes that of Roberts (1999), who maintained that it is not 
uncommon for children in BME families not to resemble their parents, especially 
given the variability and diversity of skin tone in these families. Scholars have argued 
that in matching “resemblance” is used as a neutralised code or proxy for “race” by 
clinicians and recipients (Ariza, 2015; Hudson, 2015; Deomampo, 2016) and that 
‘race’ is reified and reproduced through matching (Fogg-Davies, 2001; Thompson, 
2009; Szkupinski-Quiroga, 2009; Hudson, 2015).  
According to Thompson, scholars should reframe attention from asking “(how) is race 
biological?” to address “how and by whom and for what purposes is race biologised 
and biology racialized?” (2005: 132). Scholars outside of the UK context have argued 
that fertility providers geneticise and commodify ‘race’ when classifying donor 
characteristics and later ‘selling’ them to recipients (Duster, 1990; Campbell, 2007; 
Costa, 2007; Schurr, 2016), particularly in contexts of donor selection where donors 
are advertised to recipients via catalogues (Fogg-Davis, 2001; Scheper-Hughes and 
Wacquant, 2002; Fuscaldo, 2006; Mamo, 2005; Almeling, 2007; Thompson, 2009). 
In the last 5-10 years especially, there has been an increasing literature in matching on 
the “reproduction of whiteness” and its implications for stratified reproduction. The 
main theme to arise out of these transnational and international studies on matching 
has been the “reproduction of whiteness” through clinicians and recipients practices 
of matching (Roberts, 1999; Szkupinski-Quiroga, 2007; Cooper and Waldby, 2014; 
Kroløkke, 2014; Deomampo, 2015; Schurr, 2016; Homanen, 2018). 
These scholars have described egg donation as a “whitening project” (Deomampo, 
2015: 322), a ‘market for whiteness’ (Cooper and Waldby, 2014) and as “protecting 
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the purity of whiteness” (Homanen, 2018). According to these scholars, the aim of 
egg donation is to reproduce white babies. Here, they draw on white recipients being 
the main users of egg donation, primarily white donors being recruited to meet the 
demand by white recipients and clinicians’ expectations of racial matching and the 
reproduction of white fertility. Thus, it is argued that egg donation fundamentally 
supports “a white heteropatriarchal model of the family” (Szkupinski-Quiroga, 2007). 
However, the majority of recipients in the majority of these studies were white and 
there has been little relative exploration of BME recipients’ experiences of travelling 
abroad for a ‘racially matched’ donor (Hudson et al., 2011). Therefore, there is a need 
to explore the experiences, meanings and practices of BME recipients of donor eggs, 
particularly in the UK context (Culley and Hudson, 2006; Culley et al., 2009). 
 
2.5 Research Questions 
This chapter explored some of the key concepts and theories that have framed the 
research questions and findings of this thesis. These include: (bio)medicalisation, 
stratified reproduction, stratified (bio)medicalisation, racialisation and stigma. The 
current state of the literature on donor-recipient matching in gamete donation was 
reviewed with a particular focus on the UK context of egg donation and how the gaps 
in this literature have informed the research questions for this thesis. It was shown 
that to date no ethnographic studies have been undertaken in the UK context of egg 
donation which have focused on the stage of donor-recipient matching (often defined 
as ‘donor selection’). Informed by this review of the literature this research set out to 
explore how donor-recipient matching in egg donation is organised in two UK fertility 
clinics. To recap, the research questions for this thesis are: 
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 How do clinicians classify donors and recipients into categories? 
 How do clinicians allocate donors to recipients? 
 How do recipients express and negotiate their preferences in the 
context of the clinic? 
 How do recipients negotiate accepting/declining donors they are 
matched with? 
 
In the following chapter, the methodological approach and methods employed to 
address these research questions are outlined and discussed.  
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 Chapter 3: Methodology  
 
3.1 Introduction 
This study was designed to be an ethnographic exploration of donor-recipient 
matching in egg donation in the UK clinical context. The aim of this study was to 
understand the organisation, meanings, practices, interactions, and context which 
shape the matching process.  
This chapter discusses the methodology and research methods used in this study and 
will outline the focus of the study, the chosen theoretical orientations, the 
methodological approach selected and research design. This includes outlining the 
recruitment procedures, sampling strategies, sample characteristics, methods of data 
collection and analysis and reflections on my own experience of fieldwork in each 
research setting.  
 
3.2 Theoretical Paradigms and Methodological Frameworks 
Research paradigms refer to the ontology, epistemology and methodology which 
shape our understandings about what reality is (ontology), how something can be 
known (epistemology) and which types of procedures should be employed for finding 
out (methodology) (Guba, 1990). Paradigms therefore reflect a “worldview” in which 
there is “a basic set of beliefs that guide action” (Guba, 1990: 17). It is generally 
agreed, particularly in qualitative research, that one’s choice of research paradigm 
should be conscious, justified and explicit given its importance in shaping the design, 
research strategies, undertaking and analysis of research (Blaikie and Priest, 2017).  
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This study was informed by a constructionist/interpretivist epistemology, which holds 
there is no single reality or truth and that ‘multiple realities’ are socially constructed 
from the perceptions and interactions of individual actors (Berger and Luckmann 
1991). Matching was thus regarded as the outcome of individuals’ perceptions, 
interpretations, meanings, actions, interactions and negotiations, and not as 
embodying a ‘reality’ in and of itself. Ethnography was considered most appropriate 
methodology to explore the organisation of clinic-mediated donor-recipient matching 
and the views of clinicians and recipients within the clinical context. Ethnography is 
used to understand peoples’ experiences and views of everyday social life and to 
locate this understanding within local and/or wider contexts (Hammersley and 
Atkinson, 2007). Ethnographic research within sociology is usually an inductive 
process, beginning with observations about the empirical world, the emergence of 
categories, and finally moving towards the development of concepts and theories 
(Neuman 2013). Participant observation is a defining feature of ethnography, 
alongside the use of multiple methods, such as interviews and documents 
(Hammersley and Atkinson, 2007).  
Ethnography involves exploring not just what people say, but what people do, through 
participating in their daily activities over an extended period of time (O’Reilly, 2012). 
This allows the researcher to explore peoples’ accounts, actions and interactions in the 
context within which they occur. The aim is to gain an ‘emic’ view, i.e. the ‘insider’s 
perspective of reality’ (Hammersley and Atkinson, 2007). Thus research takes place 
‘in the field’, allowing the researcher to document the culture, the perspectives and 
practices, of the people in these settings and to become an instrument of data 
collection (Fielding, 2001).  
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As such, ethnographic researchers are immersed in the context under study, taking 
part in the everyday practices of the research sites, building trust and rapport with 
participants, both participating and observing (Hammersley and Atkinson 2007: 3). 
Researchers are thus required to reflexively consider their own role in the construction 
of everyday life and on the social setting under study. Furthermore, ethnographic 
research involves the triangulation of various methodological approaches within the 
same framework (Flick, 2006; Hammersley and Atkinson, 2007), as it enables the 
exploration of an idea from multiple points of view and uses different research 
methods and investigative tools to do so (O’Reilly, 2012; Neuman, 2013) 
Ethnography has a long history of use in medical sociology/anthropology (Becker et 
al., 1961; Bosk 1979; Strong 1979; Goffman, 1961; Atkinson, 1995) and has been a 
key methodology in the studies of reproductive technologies (Stanworth, 1987; 
Stacey, 1992; Strathern, 1992a, 1992b; Edwards et al., 1993; Ginsburg and Rapp, 
1995a; Franklin, 1997; Franklin and Ragoné 1998; Carsten, 2004; Kahn, 2000; 
Konrad, 2005; Thompson, 2005; Featherstone et al., 2006; Nahman, 2006; Almeling, 
2007; Costa, 2007; Inhorn, 2007; Bonaccorso, 2009; Klotz, 2014; Ariza, 2015). As 
highlighted by Thompson (2005), fertility clinics are “ideal sites” for ethnographic 
enquiry, as they enable researchers to show how ‘external political effects get created 
out of, contested by, and sustained through everyday local practices’ within self-
contained clinical spaces. 
This study was a multi-sited ethnographic study, undertaken across two different 
research sites. In line with ethnographic approaches, this study adopted multiple 
methods to collect data, including participant observation, semi-structured interviews 
with clinicians and recipients and relevant documentation/statistical information from 
both clinics.  
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3.3 Ethical Considerations 
This section outlines the ethical considerations that informed the design, undertaking 
and writing up of this research, including the general conduct of the researcher.  
According to texts on ethical research governance, key elements of good research 
include: valuing the diversity in society; personal and scientific integrity; honesty and 
openness; accountability; and ensuring that the dignity, rights, safety and well-being 
of participants are the primary consideration in any research study (British 
Sociological Association (BSA), 2002; Department of Health, 2005a). When applied 
to qualitative research, the implementation of these ethical principles include reflexive 
consideration of: (a) risk and benefits of participation to research participation, (b) 
participants informed and voluntary consent, and (c) confidentiality and anonymity 
(Beauchamp and Childress, 2001; Silverman, 2001; BSA, 2002; Hammersley and 
Atkinson, 2007).  
Before undertaking this research, ethical approval was applied for and granted by the 
Ethics Committee at the Centre for Criminology and Sociology, Royal Holloway, 
University of London (see Appendix 1). Below I outline some of the most relevant 
ethical issues to this study and discuss the steps undertaken to make this an ethical 
research study.  
 
3.3.1 Informed Consent 
“Informed consent” is predicated on an individual’s right to choose whether to 
participate in a study. It is the fundamental ethical principle of ‘respect for persons’ is 
operationalised (Beauchamp and Childress, 2001; O’Reilly, 2012) and requires that 
participants be informed of the nature and purpose of the study, what participation 
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would involve, and the voluntary nature of this, and the potential risks and benefits of 
participation (BSA 2002; Hammersley and Atkinson, 2007).  
Obtaining informed consent from participants is at “the heart of ethical research” 
(Department of Health, 2005a: 2.2.3) and requires researchers to consider their 
responsibility to research participants in the context of the research setting. However, 
obtaining informed consent from participants can be far from straightforward where 
ethnography is concerned (Drew, Hardman and Hosp, 2007; Murphy and Dingwall, 
2007; Murchison, 2010: 61). Given that ethnography involves spending long periods 
of time undertaking observations of people, activities and interactions, and that in 
healthcare settings different actors may enter the scene at irregular and unexpected 
intervals, obtaining consent can be especially problematic (Murphy and Dingwall, 
2007).  
In this study, where private fertility clinics formed the research context, the majority 
of observations were focused/semi-structured observations which were pre-arranged 
and undertaken in relatively contained settings, such as private consulting rooms, and 
‘back-stage’ spaces, such as clinicians’ private offices. Furthermore, this study was 
conducted overtly, so that the aims of the study, the nature of my presence in the 
clinics, and the voluntary and confidential nature of participation were clearly 
communicated to all participants. 
Firstly, clinicians and clinic staff were informed about this study and my presence in 
the clinic before I entered the field. All patient participants were initially approached 
and invited to partake by a doctor or nurse, on my behalf. For each phase of the 
research, Information Sheets were provided for clinicians (Appendix 2) and recipients 
(Appendix 3). These information sheets outlined the nature of the study, what 
participation involved, and why they were asked to take part and were adapted for use 
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at each respective clinic. These sheets also emphasised that participation was 
voluntary and confidential, and that individuals were free to withdraw from the study 
at any time, without reason or repercussion. The contact details of the researcher, the 
complaints procedure and details of relevant support organisations were also 
provided.  
Although obtaining written consent from participants is generally regarded as ‘best 
practice’, some researchers have also noted that in some contexts obtaining written 
consent may be more intrusive and burdensome on participants than obtaining verbal 
consent (Inhorn, 2004). This issue was highlighted by the clinicians in this study, who 
suggested that for observations of patient consultations obtaining verbal consent 
would be a more appropriate method of gaining consent because of: (a) the time-
limited nature of patient consultations and (b) clinicians discomfort with the formal 
nature of my asking patients, whom they were often meeting for the first time, to sign 
of a consent form. Thus, for observations of patient (donor and recipient) 
consultations verbal consent from donors and recipients was obtained prior to 
observations taking place. Written consent was gained from the clinicians prior to 
observations taking place.  
For the semi-structured interviews, written consent was obtained from all clinicians 
and patients prior to their interview (see Appendix 4 for clinician consent form and 
Appendix 5 for recipient consent form). Potential interviewees were given at least a 
week to consider their participation in the study. Interviews were digitally recorded 
where explicit and informed written consent for this recording was given. When 
participants did not consent to recording the interview, hand-written notes were taken. 
All interviewees were given the opportunity to receive a summary of the findings of 
this study and to discuss this further should they wish to do so (6 recipients asked for 
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a summary, which will be provided to them in due course). Interviewees were offered 
the option of being interviewed at their home, at the clinic, or in a quiet private room 
at Senate House, University of London Library in London.  
 
3.3.2 Confidentiality and Anonymity 
Ensuring the confidentiality and anonymity of participants is paramount to 
undertaking ethical research, and involves the researcher taking measures to maintain 
the privacy and protection of participants’ identity and contribution to the study (BSA 
2002). This was seen as particularly pertinent given to the sensitive nature of 
infertility and egg donation (Renzetti and Lee 1993; Allan, 2006).  
During observations, I unexpectedly had access to identifying and confidential patient 
information, including patient names. Encountering such information was almost 
unavoidable whilst undertaking observations in the clinical setting. This included 
instances where clinicians discussed patients, where I could see patient information on 
computer screens and when I observed patient consultations. To ensure that I retained 
this confidentiality I made sure that I did not write down participant names or 
reference real names in any material. Before entering the field I signed and adhered to 
confidentiality agreements of non-disclosure at each clinic, in which I agreed to keep 
all patient identifying and commercially sensitive information confidential. 
I was reflexive about my conduct throughout this study. I was mindful about the kind 
of information I discussed with my peers and supervisor so that I did not disclose 
potentially identifying information with them. The anonymity and confidentiality of 
participants was considered during the data collection, data cleaning and data 
analysis, where reflexive consideration was given to the removal of potentially 
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identifying information. All participants were assigned a pseudonym (code) and this 
pseudonym was used in the field notes, transcription and writing up of this study. 
Material that could identify individual participants (e.g. consent forms) was kept 
securely and separately from the data, accessible only by the researcher.  
Protecting the anonymity was particularly challenging when describing the 
demographics of clinics and clinicians (because of the relatively small number of 
fertility providers in the region studied). To maintain anonymity, certain information 
was therefore removed and replaced with other characteristics which reflected the 
relative importance of the substituted characteristic. For example, the organisational 
details of clinics were amended. Personal contact details of participants were 
permanently destroyed after interviews had been undertaken, as were interview notes. 
Electronic data and documentation were stored in a password-protected folder on a 
password-protected computer; all data and related material were stored securely and 
privately in accordance with the Data Protection Act (1998). The contact details of 
participants who requested a summary of the research findings will be stored in a 
private and secure place until this has been done.  
 
3.3.3 Managing Risk 
“Risk” in social research refers to the possibility that psychological, physical, legal or 
social harm may occur to participants as a result of research (Eckstein, 2003: 131). 
The interpretative nature of qualitative research in particular could lead to participants 
feeling that their contributions to the study have been misrepresented or taken out of 
context, and so there is a risk of participants losing control over representation of their 
self-identity (Richards and Schwartz, 2002).  
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When observing and interviewing recipients, I tried to be reflexive about how this 
contact might influence participants and about my own responses to what I had 
observed or heard. I tried to be understanding and, where appropriate, sympathetic. 
For example, female recipients sometimes appeared visibly distressed during patient 
consultations and looked to me as a source of gendered support, usually during 
consultations with male doctors. I felt it would be unethical to ignore recipients’ 
feelings, and my own involvement in the consultation, and so in these cases I 
acknowledged recipients’ emotions and responded with eye contact and a sympathetic 
look. All of the recipients who took part in this study were provided with an 
Information Sheet which outlined details of support organisations. Recipients were 
also expressly given the opportunity to stop observations or interviews or to withdraw 
their data from the study (which no recipients took up). 
 
3.4 Sampling and Recruitment 
Purposive sampling was used to select the research settings for this study (Teddlie and 
Yu, 2007), with the selection criteria of: (a) private fertility clinics, (b) based in South 
East England, UK, and(c) which undertake egg donation and recruit egg donors. 
Fertility clinics were chosen for the important information they provide and their 
ability to answer the study’s research questions (Patton, 2002). It is recognised that 
purposive sampling is a non-probability sampling method and that this may limit the 
extent to which findings from this study can be generalised and free from researcher 
bias (Brink et al., 2006). This research seeks to explore the organisation and practices 
of donor-recipient matching in two UK fertility clinics and how these contexts shape 
the views and experiences of the clinicians and recipients involved.  
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Whilst it is hoped that the findings of this study will contribute to an understanding of 
the UK context of ARTs, it is recognised that even in the UK context different clinics, 
clinicians, patient demographics, in different geographical locations, at different 
points in time, will all influence the process and outcomes of matching. Below, the 
sampling and recruitment procedures for fertility clinics, clinicians, recipients and 
focused observations will be presented, alongside the characteristics of each of these 
samples.  
 
3.4.1 Recruitment of Fertility Clinics 
The majority of egg donation treatments (and donor-recipient matching) in the UK are 
undertaken in the private sector (HFEA, 2016). Focusing on private fertility clinics 
also enabled the study to explore assumptions in the literature around matching as a 
commercialised practice by contextualising this study within a commercialised and 
privatised context. Clinics in the South East of England were approached because this 
area has the highest concentration of fertility clinics in the UK (HFEA, 2016).  
Clinics which recruited egg donors ‘in-house’ and provided treatment with donor eggs 
‘in-house’ were purposefully selected for inclusion in this study to enable 
understanding and insight into the different stages involved in donor-recipient 
matching, as a process, and to contextualise the role of matching within the wider 
clinical processes. Clinics that outsourced provision of egg donation to a partner clinic 
abroad were therefore excluded from this study.  
Six fertility clinics which fulfilled these criteria were invited to participate in this 
study. After a face to face meeting, the Directors of three clinics initially agreed to 
participate. However, one clinic dropped out due to a change in senior management. 
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The remaining two clinics proceeded to participate in this study, which have been 
given the pseudonyms: Creative Fertility and The Fertility Centre. The two clinics 
recruited to participate in this study were significantly different in their size, culture, 
demographics and internal processes, as will be described further in the following 
chapter (Chapter 4). These two clinics formed the primary research settings for this 
study. 
Below, the sampling and recruitment strategies for inviting participants to be observed 
and interviews will be discussed. The sample of participants recruited at each clinic 
was shaped by the respective size, organisation, method of recruiting participants and 
demographics of the patient population at each clinic. 
 
3.4.2 Sampling and Recruitment of Clinicians  
For the purposes of this study, ‘clinicians’ were defined as including doctors, nurses, 
directors and counsellors. The inclusion criteria for clinicians to participate in this 
study were for clinicians to (a) be directly or indirectly involved in matching related 
activities and (b) be able to provide informed consent and speak English. 
Administrative staff and clinicians who were not involved with the matching process 
were not eligible for inclusion, although they were observed and encountered during 
ethnographic observations in each clinic (after providing their verbal consent to this). 
I was first introduced to staff members by the Director of each clinic during my 
second visit to the clinic. The Directors personally introduced me to the Nurse Egg 
Donation Co-Ordinators, who quickly became my primary gatekeepers in the field. In 
turn, these nurses inducted my presence in the clinic with clinicians who undertook 
matching activities. On each introduction, I took steps to obtain verbal consent from 
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clinicians and answered any questions that they had. During these introductions, 
clinicians were asked if they were willing to be observed, willing to be interviewed 
and if they were willing to approach recipients on my behalf. Clinicians were given a 
week to consider these aspects of participating in the study, after which, if they were 
willing to participate, written consent was taken. All of the clinicians who were 
approached agreed to take part.  
Clinicians: Interviewee Characteristics 
In total, interviews were undertaken with 9 clinicians. The number of clinicians 
interviewed at each clinic reflected the size of each clinic. At Creative Fertility 6 
clinicians were interviewed. At The Fertility Centre 3 clinicians were interviewed. 
The characteristics of these clinicians and their role in the matching process are 
outlined in Table 3.1 (Creative Fertility) and Table 3.2 (The Fertility Centre) below. 
Although ethnicity was not a variable of interest, it is worth noting that at Creative 
Fertility the majority of clinicians were white and came from “Old Commonwealth” 
and European countries outside of the UK whilst at The Fertility Centre the clinicians 
directly involved in the matching process were from BME backgrounds.  
Table 3.1 Creative Fertility: Clinician Characteristics 
Pseudonym Role Ethnicity Gender Role in 
Matching  
Mrs Redwood Director White Dutch Female 
Indirect: 
Managerial 
Anna 
Head Nurse, 
Egg Donation 
Co-ordinator 
White 
Australian 
Female 
Allocation, 
Offering 
Jemma 
Nurse, Egg 
Donation Co-
ordinator 
White 
American 
Female 
Allocation, 
Offering 
Doctor Ali Doctor British Indian Female 
Classification 
 
Doctor Demetrious Doctor White Turkish Male Classification 
Linda Counsellor White British Female 
Indirect: Point 
of Referral 
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Table 3.2 The Fertility Centre: Clinician Characteristics 
Pseudonym Role Ethnicity Gender Role in  
Matching  
Doctor Rana Director Indian Female 
Managerial, 
Allocation 
Noreen Head Nurse Chinese, Malaysia Female 
Classification, 
Allocation, 
Offering 
Roxanne Embryologist White Spanish Female 
Indirect: Point 
of Referral 
 
3.4.3 Sampling and Recruitment of Patients  
Recipients were invited to participate in 2 aspects of this study: observations and 
interviews. Donors were also invited to participate in the observational phase of this 
study. Details of the ethical conduct by which the recruitment of patients took place 
were outlined in Section 3.3 (above).  
Observations 
At both clinics, matching-related activities took place during patient consultations. 
During the ‘Initial Donor Consultation’ clinicians classified donors’ physical and 
social characteristics and during the ‘Initial Recipient Consultation’ clinicians 
classified the characteristics of recipients’ (and their partners) and recipients’ 
preferences for donor characteristics; these consultations were often the first time that 
patients were attending the clinic. During the ‘Donor Offering Consultations’ a nurse 
offered donors to recipients in a face-face/ telephone consultation and recipients 
accepted or declined the donor(s) under offer.  
Whilst ‘Initial Donor Consultations’ were relatively easy to identify this was less the 
case with ‘Initial Recipient Consultations’, where it was sometimes difficult to single 
out which consultations to attend, particularly when the women themselves did not 
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specify or know their reason for attending. For example, on several occasions I 
observed consultations in which women wanted a ‘fertility check-up’, to use a known 
egg donor or to use their own eggs, and therefore recipients’ characteristics or 
preference for donors were not recorded. After consulting with doctors and 
receptionists at both clinics the inclusion criteria for potential recipient consultations 
was restricted to women in their mid-late 40s, who are the main users of egg donation 
(HFEA, 2014b). The process of inviting donors and recipients to have their 
consultations observed was similar at each clinic. All recipients and donors were 
approached on my behalf by a clinician from the clinic in the first instance (as 
explained in ‘Informed Consent’ in Section 3.3 above).  
Interviews 
The inclusion criteria for recipient interviewees was to (a) have accepted a donor 
during the period of fieldwork at each clinic and (b) be able to provide informed 
consent and speak English or Gujarati (researcher’s spoken languages). The stage of 
having accepted donors was chosen because this allowed recipients’ experiences and 
practices throughout the matching process (albeit retrospectively at times) to be 
captured, e.g. of stating their preferences, of declining donors, of deciding to accept a 
donor and donor information. Given that the majority of recipients in previous studies 
on matching have predominantly explored the views of white, middle-class women 
(Konrad, 2005; Mamo; 2005; Bonaccorso, 2009; Nordqvist, 2010; Klotz, 2014; Rubin 
et al. 2015), the intention in this study was to over-sample BME recipients.  
Recipients of donor eggs were identified and approached with the help of nurses and 
doctors in the clinics. The recruitment of recipients for interview differed at each 
clinic, reflecting the individual perspectives of the nurses at each clinic (themselves 
influenced by other dynamics, such as the size of the clinic). At Creative Fertility, 
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nurses felt uncomfortable with approaching recipients for an interview whilst they 
were still having treatment at the clinic. Therefore, it was agreed that nurses would 
only contact recipients who had agreed to participate in research on their HFEA 
consent forms (all of whom had finished treatment at the clinic). From the 65 
recipient consent forms considered, 14 recipients had agreed to being contacted, 4 
recipients were deemed by nurses as being “too anxious” to approach. This led to 10 
recipients being invited for an interview; two recipients did not respond and one 
recipient originally agreed but then stopped contact. This process resulted in a sample 
of 7 recipients being interviewed, including one couple (i.e. recipient and partner).  
At The Fertility Centre, some recipients were approached for interview after I had 
observed their consultation with a clinician and some were approached by the head 
Nurse (who did feel comfortable approaching recipients on my behalf). All of the 
recipients who were invited for interviews at The Fertility Centre were therefore still 
in the process of having treatment and were regularly attending the clinic, often as a 
couple. Nine recipients were recruited through ethnographic observations (by me) and 
three recipients were approached by my primary gatekeeper. These processes resulted 
in a higher rate of interviews, with 12 recipients in total, including 12 couples.  
All recipients were provided with an Information Sheet prior to having an interview 
and after explaining this information to recipients verbally I obtained written consent 
from all individuals before the interview took place (as explained in the section on 
‘Informed Consent’ above). The difference in partner attendance in interviews at each 
clinic could have been the result of the method of recruitment used at each clinic. That 
is, at Creative Fertility, couples were no longer attending the clinic and so it may have 
been inconvenient for them to attend. At The Fertility Centre on the other hand, the 
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majority of recipients were still having treatment at the clinic, and so this may have 
made it more convenient for recipients’ partners to attend the interview. 
Recipients (and Partners): Interviewee Characteristics 
In total, 19 recipients were interviewed. This comprised 7 recipients at Creative 
Fertility and 12 recipients at The Fertility Centre. The majority of recipients at both 
clinics were using egg donation due to age-related infertility (n=15), and the average 
age of the whole sample of recipients was 44 years. One recipient at each clinic was 
using egg donation due to pre-mature ovarian failure and were each in their mid-
thirties (n=2), and one recipient at each clinic was a male same-sex couple (n=2).  
Twelve recipients identified as white and seven recipients identified as BME. 
However, there was a noteworthy difference in how the ethnicity of recipients was 
distributed across each clinic. At Creative Fertility the vast majority of recipients self-
defined as white (n=6) whilst at The Fertility Centre recipients came from a diverse 
mix of ethnic backgrounds; while 50% of interviewees self-defined as white (n=6) the 
other 50% came from BME backgrounds (n=6). All of the recipients were in a 
relationship. The majority of recipients were in a relationship with a partner from a 
similar ethnic (or rather racial) background to themselves (n=14) whereas 5 recipients 
were in a relationship with a partner of a different ethnicity to themselves. Four BME 
recipients had a white partner and one white British recipient had a black African 
partner. With the exception of one recipient (from France at Creative Fertility) all 
interviewees lived in the UK. 
All but one of the recipients who were interviewed had accepted a donor. At The 
Fertility Centre one couple was interviewed at the stage of stating their preferences in 
the hope of interviewing them again when they had been offered a donor, but delays 
to this couples’ treatment meant that the second interview did not take place. In one 
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case of a male same-sex couple at Creative Fertility (Dirk, see below), the partner of 
the recipient was interviewed but not the recipient himself. Below, Table 3.3 
(Creative Fertility) and Table 3.4 (The Fertility Centre) outline the relevant 
characteristics of the recipients (and their partners) who were interviewed. 
Table 3.3 Creative Fertility: Recipient Characteristics (Interviews) 
Recipient 
Pseudonym 
Recipient 
Age 
Recipient 
Ethnicity 
Partner 
Ethnicity 
Stage in 
Treatment 
Class 
Ayeshah 37 
British 
Pakistani 
White British Pregnant Middle 
Caroline 47 White British 
White South 
African 
Miscarried Working 
Helen 48 White British White British Pregnant Middle 
Wendy 45 White British White British Pregnant Middle 
Brenda & 
Roger 
44 White British White British Pregnant Middle 
Camille 47 White French White British Pregnant Middle 
Dirk [Partner 
of Recipient] 
42 
British 
Chinese 
White 
Norwegian 
Awaiting 
Surrogate 
Middle 
 
Table 3.4 The Fertility Centre: Recipient Characteristics (Interviews) 
Recipient 
Pseudonym 
Recipient 
Age 
Recipient 
Ethnicity 
Ethnicity of 
Recipient's 
Partner 
Stage in 
Treatment 
Class 
Aileen & 
Adrian 
47 
Black 
African 
Black 
African 
Accepted 
Donor 
Working 
Jan & 
Jonathan 
41 Chinese White British 
Accepted 
Donor 
Working 
Dipti 32 British Indian White British 
Accepted 
Donor 
Middle 
Amandeep & 
Inderjit 
49 
Indian 
(Sikh) 
Indian 
(Sikh) 
Accepted 
Donor 
Working 
Rada & Faris 44 Iranian Iranian 
Accepted 
Donor 
Working 
Rabiaa & 
Nadeem 
49 
British 
Pakistani 
Pakistani 
Accepted 
Donor 
Working 
Uzma & Asif 42 
British 
Pakistani 
Pakistani 
Accepted 
Donor 
Working 
Dan & Tina 44 White British White British 
Accepted 
Donor 
Middle 
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Betty & Nick 48 White British White British 
Accepted 
Donor 
Middle 
Linda & Tim 45 
White 
German 
White British Pregnant Middle 
Joanne & 
Kalvin 
47 White British 
Black 
Caribbean 
Accepted 
Donor 
Working 
David & 
Milo 
41 White Italian 
White South 
African 
Awaiting 
Surrogate 
Middle 
 
The social class of recipients were also different. Social class is an ambiguous concept 
and can include a multitude of facets (Nazroo, 1998; Lareau, 2008). In this study, the 
socio-economic background of recipients was determined through their educational 
background, their occupation, the occupation of their partner and the way in which 
recipients talked about their ability to afford treatment. On the whole, recipients who 
came from middle-class backgrounds also had a higher education degree. At Creative 
Fertility the majority of recipients were classed as coming from middle-class 
background (n=6).  
At The Fertility Centre on the other hand, recipients came from a mixture of socio-
economic backgrounds. The majority of recipients came from working-class 
backgrounds (n=7), including 5 recipients from a BME background. On the other 
hand, 5 recipients came from a middle-class background, including 1 recipient from a 
BME background.  
 
3.4.4 Sample of Observations 
Observations were undertaken of a variety of matching related activities, including: 
focused observations of: (a) ‘Matches’ made by clinicians (donor allocation), where 
clinicians made decisions about which donors and recipients to match (backstage), (b) 
‘Initial Donor Consultations’, in which clinicians classified donors’ physical and 
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social characteristics (frontstage), (c) ‘Initial Recipient Consultations’, in which 
clinicians classified recipients’ (and recipients’ partners) characteristics and 
recipients’ preferences for donor characteristics (frontstage), and (d) ‘Donor Offering 
Consultations’, in which a nurse offered donors to recipients in a face-face/ telephone 
consultation and recipients accepted or declined the donor(s) under offer (frontstage). 
Few instances of ‘Donor Offering’ were observed at Creative Fertility because this 
process was usually undertaken virtually, via e-mail. These focused observations are 
summarised in the table below. 
 
Table 3.5  Sample of Focused Observations at Each Clinic 
Summary of Observations Creative Fertility The Fertility Centre 
Total No. Days Attended 80 (over 10 months) 120 (over 14 months) 
Matches by Clinicians 152 35 
Initial Recipient Consultations 14 6 
Initial Donor Consultations 13 5 
Donor Offering Consultations 2 14 
 
At Creative Fertility, I observed 52 matches being made; this comprised the majority 
of matches made at the clinic over the period of observations at the clinic. I observed 
13 ‘Initial Donor Consultations’ and 14 ‘Initial Recipient Consultations’. Two 
telephone ‘Donor Offering’ consultations were observed. The majority of donors and 
recipients observed being matched and in consultation were labelled as white 
British/white other by the clinic (90%). 
At The Fertility Centre, the smaller size of the clinic meant that fewer focused 
observations of matches and ‘Initial Consultations’ for donors and recipients took 
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place. Over a period of 13 months, I observed 35 matches being made. Not all of the 
matches made at the clinic were observed; this is because the small size of the clinic 
often meant matching was done informally. However, I was able to collate 
information about the overall matches made, as will be explained in more detail 
below. I observed 5 ‘Initial Donor Consultations’ and 6 ‘Initial Recipient 
Consultations’. I also observed 15 ‘Donor Offering’ consultations, 13 of which were 
face-face and 2 over the telephone. The ethnicity of donors and recipients observed at 
The Fertility Centre was more mixed than at Creative Fertility, but the majority of 
recipients observed were labelled as BME by the clinic.  
 
3.5 Data Collection 
Fieldwork was undertaken over a period of 23 months, between January 2013 and 
November 2014. The first 12 months of fieldwork were spent at Creative Fertility. 
During this year, I spent 10 months observing matching related activities. Focused 
observations of ‘back-stage’ matching activities took place over the entire ten-month 
period and included observing meetings between doctors and nurses in which 
decisions were made about which donors to offer (or not offer) to which recipients. 
Observations of ‘front-stage’ matching activities, i.e. patient consultations, took place 
between months 6 and 9 of observations. Around 80 days were spent in the field 
during the period of observations at Creative Fertility, with each visit at the clinic 
lasting between 3-6 hours. Semi-structured interviews with clinicians and recipients 
were undertaken between months 8 and 12. Towards the end of my time at Creative 
Fertility, I began fieldwork at The Fertility Centre.  
Fieldwork at The Fertility Centre was undertaken over a 14-month period. Eleven 
months were spent observing ‘back-stage’ matching activities, i.e. the organisation 
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and practice of matching; the practice of matching was observed irregularly during 
this period (as will be explained below). ‘Front-stage’ donor and recipient 
consultations were observed between months 5 and 14 of fieldwork. Around 120 days 
were spent undertaking observations at The Fertility Centre, with each visit lasting 
between 2-8 hours. Semi-structured interviews with clinicians and recipients took 
place between months 10 and 14 months. Fieldwork took longer at the Fertility Centre 
because the clinic undertook a smaller number of matches, over irregular periods of 
time in a more informal way. Table 3.6, below, summarises collection of data over the 
period of fieldwork at each clinic.  
 
Table 3.6  Fieldwork Timeline at Each Clinic 
 
The remainder of this section will outline how the methods chosen for data collection 
were applied to the undertaking fieldwork in this study. 
 
3.5.1 Participant Observation 
At both clinics, I undertook participant observation to explore matching related 
activities. Participant observation involves the researcher taking part, to various 
degrees, in the “daily activities, rituals, interactions and events of a group of people as 
Fieldwork Activity
Month 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12
Creative Fertility
Obs. Donor Allocation
Obs. Patient Consultations
Obs. General
Clinician Interviews
Recipient Interviews
The Fertility Centre
Obs. Donor Allocation
Obs. Patient Consultations
Obs. General
Clinician Interviews
Recipient Interviews
2013 2014
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one of the means of learning about the explicit and tactic aspects of their life routines 
and culture” (DeWalt and DeWalt, 2002: 1). This entails viewing phenomena from 
the perspective of those being studied in their own settings (Bryman, 1988; 
Hammersley and Atkinson, 2007; Silverman, 2001) by looking, listening, watching 
and asking as part of the observational process (Lofland et al., 2006). 
The method of ‘participant observation’ was used to explore the organisation of 
matching within the clinical context in which it takes place, thus enabling insight into 
the contextual factors which shape the different stages of the matching process 
(Denscombe, 2007; Hammersley and Atkinson, 2007). As a participant observer, the 
researcher participates (to varying degrees), observes and records events as they occur 
(Lofland et al, 2006; Hammersley and Atkinson, 2007). In this study, I adopted the 
role of the ‘Moderate Participant’ (Spradley, 1980) and ‘Observer as Participant’ 
(Gould, 1958), where one is identifiable as a researcher, occasionally interacts with 
participants, but generally ‘shadows’ a person rather than actively participating in the 
research setting.  
During observations, I focused on and documented conversations, comments, actions, 
interactions and negotiations between clinicians, donors, recipients, recipients’ 
partners and myself. I tried to note details about the structure of each observation, 
such as where it took place, the duration, the physical location, who was present and 
the general atmosphere. This was to enable me to contextualise my analysis and 
interpretation of the data at a later stage. I primarily undertook what can be classed as 
general/unstructured observations of the egg donation process and organisation of the 
clinics and focused observations of matching activities.  
Early general observations at each clinic included general and broad observations 
about the physical and socio-cultural organisation of the clinics and clinicians roles 
102 
 
and routines. Later general observations included observation of egg-donation related 
activities, including internal clinic ethics committees, biomedical procedures in the 
laboratory, general patient consultations and work-shadowing nurses. ‘Hanging out’ 
in communal areas of the clinics, such as the staff kitchen or staff room also proved 
valuable as this enabled insight into the organisation and culture of the clinic, 
facilitated relationship building with staff and contributed to legitimising my presence 
in the clinic.  
Focused observations of ‘back-stage’ matching activities were centred around the 
practice of matching, but included observation of other matching activities, such as: 
the monitoring and updating of patients records, the un-matching of donors and 
recipients and matched donors and recipients going through treatment cycles. When 
observing matching sessions, I paid particular attention to facets such as: the structure, 
process and tools employed; clinicians’ interpretation and negotiation of patient 
characteristics; and clinicians’ reasoning for matching, or not matching, particular 
donors and recipients. A clear view of clinicians’ matching tools during observations 
allowed me to additionally document the characteristics/information about donors and 
recipients that clinicians drew on when matching.  
Over time, I recorded information about the matches made at each clinic for a large 
number of cases. At Creative Fertility I documented information about 152 matches 
and at The Fertility Centre I documented/collated information about 65 matches. 
However, the collection of this data differed between each clinic.  
At Creative Fertility for each match that I observed I systematically recorded: (a) the 
recorded ethnicity and physical characteristics of matched donors and recipients, (b) 
where relevant, their social characteristics and additional recorded information, (c) 
clinicians’ reasoning for making the match and (d) whether the matches had been 
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accepted or declined by recipients and if a reason had been given by recipients. 
During fieldwork, I collated and input this information onto an excel spreadsheet. 
Near the end of fieldwork, I returned to the clinic to check the accuracy of the 
information that I recorded against the clinic’s own records (which I was given 
supervised access to) and to collect information that I had missed. 
At The Fertility Centre, I also recorded the physical characteristics of matched donors 
and recipients, although it was more difficult to systematically record these. This is 
because the clinic did not always record the characteristics of recipients separately 
from recipients’ preferences and because I did not observe all of the matches in the 
clinic being made (unlike at Creative Fertility). However, my role as ‘data-inputter’ at 
the clinic (explained further below) meant that I could record the ethnicity, height and 
weight of all the donors and recipients who had been matched during the period of 
observations. This enabled me insight into information about matches even I did not 
observe them directly.  
As fieldwork progressed observations were expanded to include front-stage’ matching 
activities, including ‘Initial Donor Consultations’, ‘Initial Recipient Consultations’ 
and ‘Donor Offering Consultations’. During these observations, particular attention 
was paid to the interactions between clinicians, patients and technology and the ways 
in which donor and recipient characteristics were operationalised and mediated.  
Field Notes 
The data gathered from observations took the form of field notes, which form the 
fundamental basis of ethnographic work (Spradley, 1980). Field notes enable 
researchers to capture details of the setting and the context of events, actions and 
meanings; they can serve as aide memoires; and can be a tool for processing and 
clarifying fieldwork experiences (Franklin and Roberts, 2006).  
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The taking of field notes was a process, which involved making ‘condensed’ notes 
during observations with a note-pad and pen, in public view, writing up ‘extended’ 
notes as soon as possible on a computer the same evening, and keeping a reflexive 
diary (Spradley, 1980). ‘Condensed’ field notes included short-hand notes, quotations, 
comments, phrases, descriptions of events, and key words or symbols that could 
trigger memories about events (Lofland et al, 2006; Pope, 2005). Condensed field 
notes were between 6-15 pages, and were written up in fuller form later in the day 
with further details and reflections. It usually took between 4-9 hours to write up 
extended notes for a standard day of observations at the clinic. In my reflections, I 
noted my own thoughts, feelings, responses to and interactions with others. 
At the beginning of fieldwork in each clinic some clinicians appeared slightly 
disconcerted at my writing of notes. These clinicians peered in to see what I was 
writing or asked me what I was writing about. I tried to be as open as possible with 
participants about what I was writing, and the purpose of making notes, and often 
found myself positioning my note-pad so that it was relatively visible to those I was 
observing. Over time, and the development of rapport and trust, clinicians appeared to 
normalise my note taking as part of my presence in the clinic and did not raise any 
further questions or comments.  
As I became more familiar with the research settings and more apt at field-notetaking, 
my field notes became more systematic. I began to document conversations, 
comments, interactions, behaviours, practices and aspects of the clinics culture in 
more detail. I had begun writing verbatim what I had heard, even if I did not 
understand the jargon, with single words triggering a rich reconstruction of observed 
events (Fielding, 2001). I used a coding system to distinguish between individual 
donors and recipients so that I could track which donors had been matched with which 
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recipients over the period of observations (as the majority of donors and recipients 
were matched more than once).  
 
3.5.2 Interviews 
Semi-structured in-depth interviews were undertaken with clinicians and recipients. 
As highlighted by Silverman (2001: 54), although observational work can tell us 
about how people respond in particular settings, it is unable to explain how people 
constitute that setting or the meaning they attached to their actions. Thus, whilst 
observations of donor-recipient matching enabled insight into participants’ practices, 
interviews with these participants allowed insight into the subjective assumptions, 
motivations, values, emotions, experiences, meanings and beliefs which informed and 
shaped their practices (Denscombe, 2007: 174). Therefore interviews were used to 
explore complex and subtle phenomena that had been observed, rather simply for the 
straightforward collection of factual information (ibid). A topic guide was used to 
undertake interviews. The topic guide was informed by issues that had been identified 
in the literature review and from prior ethnographic observations at each clinic. 
The topic guide for clinicians (Appendix 6) explored: clinicians professional 
background; how clinicians operationalised donor/recipient characteristics; clinicians’ 
perceptions of the purpose of matching, of recipient preferences, and of the role of the 
welfare of the child in matching; clinicians’ conceptualisation of ethnicity and ‘ethnic 
matching’, and clinicians perceptions of a ‘good match’ and an ‘unacceptable’ match. 
The topic guide for recipients (Appendix 7) explored recipients’: trajectory towards 
egg donation; experience of the matching process; preferences for donor 
characteristics; and decision to accept or decline donors. Where recipients’ partners 
attended interviews they were also asked about their views of the matching process.  
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Interviews with clinicians were undertaken in a private room in their respective 
clinics, at their request. The location of recipient interviews, at their request, appeared 
to be shaped by recipients’ stage in the treatment process; on the whole, recipients 
who had finished their treatment chose to be interviewed outside of the clinic 
(Creative Fertility) whilst recipients who were still attending the clinic for treatment 
chose to be interviewed inside of the clinic (The Fertility Centre). The location of 
recipient interviews for participants from each clinic is outlined in Table 3.7, below: 
Table: 3.7 Locations of Recipient Interviews  
Clinic Inside Clinic Home/Outside Clinic Telephone 
Creative Fertility 2 2 3 
The Fertility Centre 9 2 1 
  
The majority of interviews lasted between 60-120 minutes and were digitally 
recorded, including all clinician interviews. Digitally recorded interviews were 
transcribed verbatim by me. Two recipient interviews were not recorded because a) of 
a methodological oversight on my part, not realising that I could have recorded my 
first telephone interview and b) the recipient requested that I did not record the 
interview. In both of these cases I took hand-written notes. By this time I had become 
accustomed to writing shorthand notes, which made this process easier.  
The undertaking of individual and joint (couple) interviews had an influence on the 
dynamics of the interviews. On the one hand, interviews with recipients alone enabled 
in-depth insight into their own unmediated perceptions and experiences of their 
infertility and donor selection. On the other hand, interviews with couples enabled 
insight into couples’ negotiation of recipients’ infertility and encouraged spontaneous 
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discussion about matching, whilst also providing an opportunity for couples to 
corroborate or challenge one another’s stories (Valentine, 1999). 
 
3.5.3 Documentation 
A range of documentation was collected during this study, both inside and outside of 
the clinic. Collected documentation within the clinics included paper and electronic 
items such as clinic price-lists, websites, published leaflets, standard e-mails, 
anonymised donor ‘pen-portraits’ (i.e. messages from donors to persons born of their 
donation which recipients were given access to) and standard template forms to record 
donor/recipient characteristics, recipient preferences and to offer donors to recipients. 
These latter forms contained the characteristics (and categories) used by clinicians for 
allocating donors to recipients and to offer donors to recipients. I also used the clinics’ 
databases/patient files to crosscheck and collate information about the characteristics 
of matched donors and recipients. In this respect, the secondary data collected at each 
clinic were regarded as “static” or “immutable things” but as data in their own right 
and as a “key component of dynamic networks” (Prior, 2008). 
I also reviewed government legislation, i.e. the HFE Acts 1990 and 2008, and 
policy/guidance from the HFEA and Department of Health in relation to egg 
donation, with a specific focus on the welfare of the child and donor-recipient 
matching and the implications for the reproduction, clinician autonomy and 
dominance and recipient agency (explored in Chapter 4). 
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3.6 Reflections on the Experience of Fieldwork 
3.6.1 Reflexivity 
The ‘reflexive turn’ in ethnography requires researchers to be self-critical and self-
reflexive, to think about their own impact on the field and the various conditions 
under which research was done (O’Reilly, 2012). Reflexive ethnographers think 
carefully about who has the power to say and do what to whom, about what they read 
and write, are honest about the influences on their work, and take into account the 
context of research and wider structures of power and control (O’Reilly, 2012). 
According to Hammersley and Atkinson (2007: 15), “the concept of reflexivity 
acknowledges that the orientations of social researchers will be shaped by their socio-
historical locations”.  
Following a feminist informed ethnographic approach, I sought to be transparent in 
my interactions, reflexively sensitive to values of reciprocity and emotional 
connection in my interaction with participants, particularly recipients (Stacey, 1988; 
Harrison et al., 2001; Blakely, 2007).  
 
3.6.2 Positionality 
I was aware of managing my ‘presentation of self’ or “impression” at each clinic 
(Hammersley and Atkinson, 2007: 66). This included being aware of and adjusting 
my behaviour, language, actions, dress and general demeanour whilst in the field. I 
tried to be courteous, respectful and friendly at all times. Staff at both clinics often 
referred to me as “smiley” and friendly, which correlated with my own reflections 
some evenings that my cheeks still hurt from smiling so much all day. I think this 
smiley disposition was in part a response to the suspicion that I had initially felt from 
109 
 
clinicians, who were only used to being observed by new members of staff and 
external authorities, and could not understand why I was studying the ‘mundane’ 
process of matching.  
Like the clinicians I observed, I did not generally wear any name badges or lab coats 
(except when in the laboratory), and I dressed smart-casual when attending the clinic 
as the staff in the clinic did. This was done to help me fit into the context I was in. 
Instead, my presence as a researcher was demarcated by my physical location during 
observations (e.g. sitting on a smaller chair or behind clinicians), the presence of my 
note-pad, and introductions in the field.  
I was aware of the impact of my own ethnicity (Indian) and gender (female) on 
particular aspects of fieldwork. On the whole, I think my being a female in a 
predominantly female setting helped my acceptance in the clinic’s culture, especially 
where the majority of patients were female. When interviewing BME recipients it 
became evident that many had agreed to be interviewed, in part, because of my own 
ethnicity and gender, which they felt would allow me to understand their own views 
and experiences of infertility in relation to their central identity of ethnicity. Many of 
these women were particularly concerned about being misrepresented in research and 
their anonymity being compromised. I engaged in conversations with BME women 
around shared cultural values, identity and experiences of racism. However, I also 
emphasised that my primary role was to undertake research, and that I would seek to 
represent their views as honestly and insightfully as possible (as I hoped to do with all 
participants). When interpreting recipients’ views and experiences I tried to locate 
them within wider structures of power.  
At The Fertility Centre, where the Medical Director/founder of the clinic and I shared 
a similar ethnic/religious background (Indian, Hindu), I also felt that my ethnicity 
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facilitated trust between the clinic and myself. This was also the case with Doctor Ali, 
at Creative Fertility. Like BME recipients, BME clinicians often talked to me ‘as an 
Indian woman’, and drew on shared experiences and world-views based on our shared 
ethnic backgrounds. For example, when discussing why some South Asian women 
wanted a donor with lighter skin tone, the Director drew on a range of cultural 
references informed by BME perspectives, including Bollywood, skin-lightening 
products, and the repercussions of colonialism and racism. I felt this ‘ethnic 
connection’ not only shaped the type of relationship I had with BME clinicians but 
also facilitated my unsupervised access to the clinic’s patient data; the trust to access 
this data was also enabled by my extensive integration into the clinic’s culture and my 
role in inputting patient data onto the clinic’s new computer system (see below). To 
address this ethical issue I had on-going discussions with my supervisor whilst in the 
field and I regularly reminded the Director and other clinic staff about the purpose of 
my presence in the clinic and how I intended to use the data I had access to. 
 
3.6.3 Role in the clinics 
Those experienced in undertaking clinical ethnographies in “elite” field sites highlight 
that the clinic is a busy place where “time is always at a premium” and a space which 
can be “an intimidating and confusing” for participant observers (Franklin and 
Roberts, 2006: 84). In this respect, I often felt aware of not having a legitimate 
defined role and not wanting to be obstructive, in a setting in which everyone was 
busy performing tasks. Initially I felt tense and awkward about my role in ‘observing’ 
clinicians, who were only used to being externally observed by regulators and new 
members of staff, and tried hard to position my presence as akin to the latter. 
However, as time progressed, I found myself more familiar with and engaging in the 
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etiquettes of the clinics and felt that my presence had been accepted by participants, 
which helped to legitimise and define my role as a researcher (for both participants 
and myself). 
At Creative Fertility, I was much more of an observer than participant. The formal 
structure and organisation of clinic meant that there were clearly demarcated roles for 
staff, and so it was difficult to ‘participate’ and immerse myself in the clinic. 
However, attending the clinic on a regular basis to undertake general observations 
was more difficult, unless I had a pre-arranged reason to be there (i.e. observations of 
specific events and interviews). At The Fertility Centre, I was more of a participant 
(and observer), as I became more integrated in the clinic’s culture. However, this did 
not always translate into observations of matching related activities. Furthermore, at 
the beginning of fieldwork, my attendance at the clinic was patchy, infrequent and 
dependent on my gatekeeper. At The Fertility Centre, donor allocation was often 
undertaken informally, by clinicians in isolation or during informal meetings, making 
it difficult to pre-arrange observation of these sessions. Trying to observe donor 
allocation in the clinic was difficult, time-consuming, and often an unsuccessful 
process. 
 It wasn’t uncommon for my gatekeeper to contact me the night before arranged 
matching sessions to cancel my going in, or for the sessions to be cancelled on the day 
itself, because the clinic was “too busy” to have these sessions. For several weeks at a 
time my gatekeeper didn’t respond to my e-mails or phone calls and I was unable to 
attend the clinic. Other times, my gatekeeper would telephone me to inform me that 
she was “in the “mood to do some matching”, giving me less than an hour’s notice to 
reach the clinic. In all, my gatekeeper cancelled my going into the clinic or my 
observations of donor allocation for 4-5 months of fieldwork. When I told the Clinic’s 
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Director that I was not observing as many matches as I had hoped, she began 
scheduling matching sessions into the clinic’s diary. However, these were frequently 
cancelled. Although I arranged to work-shadow the nurse undertaking donor 
allocation at The Fertility Centre, this did not result in significantly more observations 
of this practice, as the nurse continued to allocate donors to recipients outside of 
observations.  
For the last 3 months of fieldwork, I decided to ask the nurse about the matches that 
she had made in retrospect, at the end of every week (as advised by my supervisor). 
After spending over a year in the field at The Fertility Centre I felt like I had ‘failed’ 
in finding out how donor allocation was undertaken and that despite my best efforts at 
systematic observation ‘it was all happening elsewhere’ (Hammersley and Atkinson, 
2007). However, near the end of fieldwork I realised The Fertility Centre had its own 
model of matching, and it was this informal model of matching’ that I had 
documented over a long period of note taking. Furthermore, I realised that to a large 
extent ‘matching sessions’ at The Fertility Centre appeared to have taken place for the 
purposes of this study. When I stopped asking to observe these sessions no subsequent 
matching sessions were scheduled in the clinics’ diary (which I had access to).  
Halfway through fieldwork, the director of clinic asked me to undertake a ‘data-
inputting’ role, as the clinic had installed a new database during fieldwork and needed 
to transfer patient information from the existing patient files onto the new system. I 
agreed to input information about donors and recipients who had been matched at the 
clinic, and it was agreed that I could anonymise and use the information I inputted for 
my own research. My role as ‘data-inputter’ legitimised and normalised my presence 
in the clinic and allowed me to undertake general observations.  
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My integration into The Fertility Centre, at different levels over time, was also 
evident in the activities that I undertook at the clinic. I was commonly asked to buy 
milk, make coffees, to escort patients between appointments, to retrieve patient files 
and later to answer ringing telephones and to update patients with non-clinical 
information. I was told I no longer needed to sign the ‘visitor book’ and was invited to 
the staff Christmas party. Having this defined role meant that I could access the clinic 
more frequently, independently and easily. Whilst my access to observing clinicians’ 
practices of matching still depended on my gatekeeper (Noreen) having a regular 
presence in the clinic meant that Noreen often approached me spontaneously to 
observe her undertaking matching activities.  
 
3.6.4 Delays, rapport building and exiting the field 
Originally, I had intended to spend 6 months, not 10-12 months, undertaking 
fieldwork in each clinic. I intended to begin observations of patient consultations 
(‘front-stage) and identifying recipients for interview 2 months into fieldwork at each 
clinic. However, this process took longer than expected for several reasons. Although 
permission for this fieldwork was granted by the clinic’s Directors, in practice, ethical 
access to patients, in particular access to recipients, was a process of continual 
negotiation.  
On the whole, clinicians were fine with my observing their own activities in the 
‘back-end’ of the clinic. However, they were less comfortable with me observing 
patient consultations, recipient consultations in particular, and interviewing recipients. 
The nurses and doctors indicated that they were pessimistic about whether recipients 
would consent to allowing me to observe their consultation, let alone consent to being 
interviewed. This was frustrating given that they had initially granted this access. 
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Clinicians were concerned that recipients might see my research as a potential risk to 
their anonymity and confidentiality, something which the clinic otherwise went to 
lengths to protect.  
Within the privatised setting of clinic, I also appreciated that for both clinicians and 
recipients, consultations were simultaneously a time limited, commercial and medical 
activity. However, over the next few months I gently familiarised clinicians with the 
importance of my research and of understanding recipients’ perspectives. Around 4-5 
months into fieldwork I asked clinicians if I could observe patient consultations again, 
and this time my request was approved. By then I was described as “part of the 
furniture” by staff at both clinics and had developed relationships and trust with staff. 
In turn, clinicians also became more familiar and interested in my research, and were 
therefore keen to help me to meet the aims of my study, including having contact with 
recipients. In hindsight, the longer time spent observing ‘back-stage’ clinic activities 
was a necessary mechanism of building trust and rapport with clinicians and of being 
accepted in the clinical context (O’Reilly, 2012), which I think outweighed clinicians’ 
previous concerns about my contact with recipients.  
The decision to stop fieldwork at both clinics was determined by practical 
considerations and external time constraints (i.e. analysing the data writing-up within 
the PhD time frame). In addition, I had collected more than sufficient data for the 
purposes of the study. I informed staff members and the clinics Directors about my 
intention to leave the field 1 month prior to leaving, again nearer the time and said my 
goodbyes on my last days. The process of ‘leaving the field’ in both clinics was 
difficult. Having spent longer than planned at each clinic as a necessary part of 
fieldwork, it was difficult to know when to stop. In hindsight, I collected too much 
data at each clinic and spent too long in the field at each clinic. I should have 
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considered ending my data collection sooner. However, this immersion over a long 
period of time did enable me to collect a large number of cases and to document 
practices of matching and patterns within these.  
I found that my immersion into the topic of egg donation continued even when I left 
the field. Outside of the clinics, I could not help but hear and see advertisements for 
egg donation on the tube, the radio, national newspapers and on my social media 
pages. I adopted the language used by clinicians in the clinic and took for granted the 
specialist nature of what I had learned (which I only realised through conversations 
with my supervisor, friends and family).  
 
3.7 Data Analysis 
This research was a qualitative ethnographic study seeking to explore the organisation 
of matching in egg donation in two UK fertility clinics. Qualitative research generally 
involves an inductive approach to data analysis in which the process of analysis is 
‘driven’ by the data rather than a pre-existing hypothesis. In ethnographic research the 
process of data analysis is an inherently iterative one and shaped by decisions made at 
all stages in the research process (Hammersley and Atkinson, 2007).  
The process of analysis (along with other stages in the research process) was informed 
by the emergent research questions, by existing literature, by emergent findings in the 
data and by key ‘sensitising concepts’ and theoretical frameworks (Patton, 2015) 
which were explicitly chosen to explore the topic under study. Thus the analysis in 
this thesis reflects the ‘more explicitly analyst-driven’ approach as identified by 
Braun and Clarke (2006), rather than a purely ‘inductive’ or ‘deductive’ approach. 
The sources of data which were analysed comprised: interview transcripts, 
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observational field notes and personal reflections from the period of data collection at 
two field sites.  
 
3.7.1 Method of Data Analysis 
The method of thematic analysis was used to analyse the data collected in this study. 
This involves the researcher searching across datasets to find repeated patterns of 
meaning. There is some debate about the nature and implications of ‘thematic 
analysis’. Some argue that it is an ‘unsophisticated’ method which merely describes 
patterns in data or is merely part of a process within larger analytic traditions, such as 
grounded theory (as highlighted by Braun and Clarke, 2006; Braun et al., 2015). 
Others however, emphasise the value of thematic analysis and argue that it is a 
method of analysis in its own right (Boyatzis, 1998; Joffe and Yardley, 2004; Braun 
and Clarke, 2006).  
Unlike other data analysis methods, which are theoretically committed methodologies, 
thematic analysis is typically described as a “flexible” method (Boyatzis, 1998; Joffe 
and Yardley, 2004). Indeed, Braun et al. (2015: 96) refer to “flexibility” as being the 
“hallmark” of their approach to thematic analysis. As a method, thematic analysis can 
be used with quantitative, qualitative, small and large datasets, it can be used 
inductively or deductively and it does not tie researchers to pre-existing theoretical 
commitments (Guest et al., 2011; Braun et al., 2015), although it is essential that 
researchers are explicit and transparent about their epistemological assumptions 
(Braun and Clarke, 2006). Thematic analysis has also been praised for being a useful 
’contextualist’ method (Braun and Clarke, 2006: 9) which enables insight into the 
meaning that individuals attach to their experiences and for these to be related back to 
the wider social context shaping such meanings (Golafshani, 2003; Braun et al. 2015).  
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Braun and Clarke (2006) outline 6 key stages in this process of thematic analysis, 
which are often drawn upon by scholars using this method. These comprise: (1) 
Become familiar with the data, (2) Generate initial codes, (3) Search for themes, (4) 
Review themes, (5) Define themes and refine and (6) Write-up. As acknowledged by 
Braun et al., (2015), despite the analytical distinction between these phases in reality 
the relationship between them is better described as ‘fluid’ and ‘recursive’ rather than 
linear. This is true of the application of this process to the data in this study.  
In order to organise and manage the large amount of data collected I used NVivo 
qualitative data management software) to organise and code data. However, I 
undertook more in-depth analysis by hand. Familiarisation with the data began whilst 
I was still in the field, where I began to organise and review collected data and 
undertook some preliminary analysis. This included noting down emergent themes, 
points of uncertainty and information that I felt was missing, which enabled me to 
clarify issues and explore particular themes in-depth with participants and check the 
accuracy of my own collated information about matches against the clinics’ own 
recorded information (where this information was recorded in different places). I also 
became more familiar with the data as I wrote up extended field notes and transcribed 
interviews. After leaving the field I read the data I had collected several times to 
familiarise myself with its nature, contents and feel (e.g. allowing myself to be 
immersed in thick description), noting down my reflections about recurrent, 
differentiating, emergent and interesting themes.  
I made the decision to analyse and write-up the perceptions and practices of clinicians 
and recipients separately and discuss similarities and differences between these two 
groups in the conclusion chapter (other decisions made throughout the analytical 
process will be outlined further below). Data were sorted according to ‘codes’ to 
begin organising it in a meaningful way (Braun and Clarke, 2006; Lofland et al., 
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2006). A “code” refers to “a succinct label (a word or short phrase) that captures a key 
analytical idea in the data and conveys this to the researcher” (Braun et al., 2015: 
100). To begin with, ‘open coding’ was used so that codes ‘emerged’ from the data. 
These codes were developed and modified throughout the analytical process. The 
analysis of ‘negative’ cases which departed from dominant accounts were especially 
helpful in providing contrasting interpretations of the data and illuminating and 
refining understanding of dominant cases (Lofland et al., 2006). 
I undertook ‘semantic coding’, where descriptive information from or about 
participants was coded, and ‘latent coding’, which was more interpretative and 
focused on the “underlying ideas, assumptions and conceptualisations –and ideologies 
– that are theorised as shaping or informing the semantic content of the data” (Braun 
and Clarke, 2006: 13). This allowed me to capture descriptive information- such as 
the categories used by the clinics and more interpretative data – such as the meanings 
that clinicians’ and recipients’ attached to these categories. Some codes were 
developed from the language used by participants themselves whilst others were 
‘observer-identified’ codes which reflected the meaning of the data and were 
sometimes borrowed or adapted from existing literature (Lofland et al., 2006; 
Hammersley and Atkinson, 2007). I coded paragraphs, rather than merely sentences 
of interest, within individual data sources to enable contextualisation of the data 
encompassed under codes. Thus, single data excerpts (e.g. a paragraph) and single 
data sources (e.g. an interview transcript) were coded re-coded and reviewed multiple 
times as new relationships in the data were identified. 
The process of deciding which individual codes might combine to form an 
overarching theme took place throughout the process of analysis. The large amount of 
codes generated during coding meant that the process of reviewing and re-organising 
codes and themes could not wait until the end of the coding process (as ideally 
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prescribed by Braun and Clarke (2006)). As I generated a longer list of codes and 
built up the data excerpts under individual codes some codes and themes were re-
conceptualised and re-named, some were merged and some were deleted. I reviewed 
all of the themes, sub-themes, codes and data within them and progressively re-
organised these so that there was ‘internal homogeneity’, i.e. coherence between 
themes, and ‘external heterogeneity’, i.e. clear distinctions between themes (Braun 
and Clarke, 2006) (See Appendix 8 for an example of the recipient coding frame). 
This analytical work took place manually. The themes and my interpretation of them 
were checked across the dataset as was the relationship between individual themes 
and the overall thesis. I paid particular attention to similarities and differences within 
and across themes, exploring how different people and different levels of analysis 
addressed the same theme. The use of different methods and sources of data collection 
were especially helpful in enabling me to contrast and triangulate differing accounts 
of the same phenomena and to understand the nuanced ways in which different 
contexts, situations, tools, people and interactions shaped this. Thick descriptions of 
the settings and phenomena observed were also included as a means to situate 
findings within the context and different circumstances in which data was gathered 
(Geertz, 1973). Such descriptions also helped to ground interpretation of participants’ 
accounts in relation to wider social norm, e.g. situating participants’ perceptions of 
‘race’ within wider historical, political and academic understandings of ‘race’.  
I analysed qualitative data alongside descriptive statistics of the overall matches made 
at each clinic (outlined further below) which enabled comparison of participants’ 
discourses and with their material practices and contextualisation of each of these data 
sets. The identification, reviewing and refining of emergent themes was 
predominantly undertaken by hand. Whilst I found NVivo useful for organising and 
retrieving data I found it less useful for undertaking in-depth analysis and this much 
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of this manually. I used a range of paper materials (from sticky labels to large flip 
charts) and coloured pens to explore links, patterns and variability within and between 
the coded data, themes and sub-themes, to develop key emergent concepts.  
As noted by Braun and Clarke (2006), data cannot be analysed in an epistemological 
vacuum and researchers should make their epistemological assumptions explicit. 
Although themes were derived from the data they were also informed by the 
theoretical frameworks chosen before entering the field. The main theory utilised was 
(bio)medicalisation theory, which informed the use of concepts such as 
‘medicalisation’, ‘consumerism’, ‘stratification’ and (to a lesser extent) ‘racialisation’. 
‘Sensitising concepts’ provide analysts with a general sense of reference and direction 
in which to look, rather than prescriptive guidance on what to see (Patton, 2015). 
These concepts were related to the research questions and included: ‘matching’, 
‘classification’, ‘allocation’, ‘recipient preferences’, ‘recipient selection practices’, 
‘recipient agency’, ‘welfare of the child’ ‘race’ and ‘ethnicity’. The research questions 
framing this thesis too were refined during the research process in order to provide a 
detailed, nuanced and coherent examination of a particular phenomenon, i.e. the 
matching process. 
The writing up of this thesis was an integral part of the analytical process, as 
acknowledged by Braun and Clarke (2006). This process was shaped by constraints of 
space and time, as well as the processes outlined above. Several decisions were made 
in the writing up of this thesis, including: defining the scope of matching-related 
themes, the presentation and organisation of findings and which themes to include or 
exclude. It was tempting to explore the organisation of egg donation more generally in 
the clinics, particularly as I had accumulated a lot of data on this, and to locate 
‘matching’ within this wider framework. However, I felt that this would have diluted 
the specific insights gained by putting matching at the central focus of study. 
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Furthermore, I felt that this is what previous researchers had done and I wanted to 
contribute new understandings to the existing literature. A large array of coding and 
analysis were not used for the purposes of this thesis, including themes and codes 
which did not specifically enhance or relate to understanding of matching, e.g. 
clinicians’ differing constructions of kinship with donors and recipients and 
recruitment and screening of donors and recipients. 
I made the decision to organise the empirical findings chapter according to four 
overarching categories: clinicians’ classification of donors and recipients, clinicians’ 
allocation of donors, recipients’ preferences for donor characteristics and recipients’ 
practices of accepting/declining donors. There were overlapping themes across these 
categories, for example in recipients’ preferences of exclusion and their practices of 
declining donors (see Appendix 8). These decisions were informed by the existing 
literature, the research questions and the endeavour to represent the complex nuances 
in the different stages of matching as a process.  
When writing up the themes I found the need to draw on wider theoretical concepts. 
Sometimes these concepts added to analysis by helping to understand and 
contextualise findings and sometimes my findings also illuminated or developed 
aspects of the pre-existing concepts in different ways. Sometimes, when no specific 
concepts to explain the meaning that participants attached to their actions and 
interactions or the consequences of this were available, I developed some ‘new’ 
concepts based on existing literature and participants’ accounts (e.g. ‘kinship risk’ and 
‘marked whiteness’).  
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3.7.2 Descriptive Statistics 
At both clinics I collated information about the matches that I had observed, although 
this process was undertaken differently at each clinic. This included the ethnicity and 
physical characteristics of matched donors and recipients, whether the matches had 
been accepted or declined by recipients and their reason for declining donors (when 
given). At The Fertility Centre, only the ‘ethnicity’, height and weight of matched 
donors and recipients was obtained (for the reasons outlined earlier in this chapter). 
This information was deductively coded from observational field notes of donor 
allocations (Boyatzis, 1998) and put into a separate excel spreadsheet for each clinic. 
Before undertaking analysis I cleaned the data to make it more manageable and 
consistent. Each donor and recipient was assigned a code, making it possible to 
distinguish individual donors and recipients with similar characteristics, and data were 
checked for accuracy with the clinics’ own records. Each clinic used different 
categories for recording donors and recipients characteristics and so it was necessary 
to re-code data to higher order categories for consistency.  
For example, one clinic used the categories ‘light brown’ and ‘dark brown’ to classify 
hair colour whilst the other clinic merely used ‘brown’, and so these categories were 
all coded under ‘brown’. Another example is the classification of ‘ethnicity’, where 
ethnic categories were haphazardly and inconsistently used between and within 
clinics; thus ‘Indian’, ‘Pakistani’, ‘Bangladeshi’ and ‘Sri Lankan’ were recoded to 
‘Asian’. It is recognised that the racialised category of ‘Asian’ is contentious and that 
it loses the nuances of differences between individuals within this categories. 
However, this category reflected the use of ‘ethnicity’ by clinicians and recipients, 
enabled comparative analysis and where relevant differences within these categories 
are made clear.  
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Microsoft Excel was used to analyse the extent to which the ‘ethnicity’ and physical 
characteristics of donors and recipients matched. Each category (e.g. blue, green, 
brown) within each characteristic (e.g. eye colour) was compared and coded for 
sameness and difference, where the number 1 indicated same and 0 indicated 
difference. To compare height/weight differences, recipients’ height/weight was 
subtracted from their matched donors’ height/weight (with + indicating that recipients 
were bigger than donors and – indicating that recipients were smaller than donors). 
Descriptive statistics, i.e. Average, Median, Mean, Mode and Maximum, were then 
applied to this coded data. These statistics were reported and contextualised within the 
wider data. At Creative Fertility, I additionally documented whether each match had 
been accepted or declined by donors. Using the numerical code assigned to individual 
donors I counted the number of times that donors had been accepted or declined by 
the first recipient they were matched with and the number of times that individual 
donors were declined, enabling insight into donors’ that were most excluded by 
recipients.  
Analysis of this data enabled longitudinal insight into clinicians’ and recipients’ 
material practices and patterns of matching over time and comparison and 
contextualisation with their discourses. That is, this information showed the outcome 
of the material practices of clinicians and recipients (separate from their negotiations 
and discourses). However, some caveats are necessary to note about their use. Firstly, 
this study is primarily a qualitative study, framed by an interpretive paradigm, and so 
the meaning of numbers not as important as the meaning behind them (gained through 
qualitative methods). Secondly, having observed the subjective, contingent and 
socially constructed nature of how clinicians’ classified patients’ characteristics these 
categories are not taken to be objective or valid in and of themselves. However, they 
were included because of their importance in enabling insight into clinicians’ 
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practices (via clinicians’ own recording mechanisms) and contextualising qualitative 
findings from a different level of analysis.  
 
3.8 Research Rigour, Trustworthiness and Quality  
The evaluative criteria of ‘reliability’ and ‘validity’ are central to quantitative 
research. These are seen as protecting the research and its findings from criticisms of 
‘bias’ and as quality assurance measures (Golafshani, 2003). ‘Reliability’ refers to the 
replicability of research findings using the same methodology. Joppe (2000: 1) 
defines reliability as: “The extent to which results are consistent over time and an 
accurate representation of the total population under study”. ‘Validity’ refers to the 
accuracy of the research (Joppe, 2000; Babbie, 2015), including the extent to which 
the research measures what it intended to (construct validity), coherence between data 
and theory (internal validity) and the generalisability of research findings beyond the 
immediate research context (external validity) (Trochim et al., 2015; Bryman, 2016).  
Given the different paradigms which these two approaches subscribe to the question 
of how ‘reliability’ and ‘validity’ should be assessed in qualitative research is the 
source of much debate. Whereas quantitative research is concerned with manipulation 
of phenomena under study, causal relationships between variables, prediction, 
hypothesis, statistics and generalisability, qualitative research is concerned with 
meaning, understanding phenomena in-depth in the settings in which they naturally 
occur. Thus, whereas quantitative analysis takes more of a deductive ‘top-down’ 
approach and seeks to test a pre-existing hypothesis quantitative analysis is more 
inductive, exploratory, ‘bottom-up’ and ‘data driven’, allowing theory to emerge from 
the data itself.  
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Some scholars argue that researchers should endeavour to replicate these principles of 
validity and reliability in qualitative research (Patton, 2001) whilst others have been 
critical of these criteria and argue that they do not apply to qualitative research in the 
same way (Lincoln and Guba, 195; Strauss and Corbin, 1990). This latter group of 
scholars instead propose other criteria to replace these concepts, such as: 
‘trustworthiness’, ‘credibility’, ‘sensitivity’, ‘commitment’, ‘transparency’’ 
‘coherency’ and ‘rigour’ (Lincoln & Guba, 1985; Seal, 1999; Golafshani, 2004; 
Shenton, 2004; Nowell et al., 2017). 
A commonly referenced framework for evaluating qualitative research is that 
proposed by Lincoln and Guba (1985), in which they also proposed techniques for 
achieving these criteria. The four pillars of this framework are: Credibility, 
Confirmability, Dependability and Transferability. ‘Credibility’ refers to the ‘truth 
value’. It is similar to the concept of ‘internal validity’ in positivist terms and refers to 
the coherence between data collected and theory generated. Techniques for achieving 
credibility include: prolonged engagement, persistent observation, triangulation, peer 
debriefing, member checking and negative case analysis. Confirmability in qualitative 
research is less about researchers’ efforts to maintain neutrality and freedom from bias 
(as in quantitative research) than about researchers’ efforts to engage with the 
phenomena under study, ethically and in ‘good faith’. To achieve this, Lincoln and 
Guba (1985) advocate research reflexivity, triangulation and an audit trail (i.e. the 
transparent and explicit description of the steps taken throughout the research 
process). 
Dependability refers to the ‘reliability’ of research. However, in qualitative research, 
this is less about whether research findings can be replicated than whether the 
research process was coherent, transparent and consistent. To the end, Lincoln and 
Guba (1985) suggest providing an “inquiry audit”, i.e. having an external researcher 
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examine the process and findings of the research. Transferability refers to the 
‘applicability’ of research findings to other contexts, and is most similar to ‘external 
validity’ and generalisability in the positivist paradigm. Lincoln and Guba (1985) 
suggest that providing a ‘thick description’ of the so that one can evaluate to what 
extent research conclusions are applicable to other settings, times, situations and 
participants. Below, I will discuss the steps taken to ensure the quality, rigour and 
trustworthiness of this research by addressing Lincoln and Guba’s (1985) 4 criteria.  
One of the benefits of using ethnography is that it enables researchers to use multiple 
methods through which to explore a single topic. The findings and theory generated in 
this thesis were triangulated between data methods, e.g. interviews, observations and 
clinic documentation, between different participants, e.g. clinicians and recipients and 
between 2 field sites. The long-term duration of observations also enabled me to 
verify findings longitudinally, to contextualise phenomena within the wider context of 
the clinic and to build rapport and trust with participants, encouraging them be more 
open and honest in their interactions with me. The systematic recording of 
information about a large number of matches at each clinic also enabled comparison 
of participants’ discourses and with material practices; the accuracy of quantified 
information was checked with clinics’ own recorded before analysis. The findings of 
this thesis are also coherent with the findings of research on donor-recipient matching 
in transnational and international contexts of egg donation. 
The process of designing the research, fieldwork, data analysis and interpretation, 
were discussed confidentially with my supervisor, with scholars in the field and, 
where possible, with clinicians and recipients during fieldwork. Efforts were made to 
undertake all stages in this research process reflexivity, inclusively and ethically. I 
critically engaged with the process of research, noting down personal reflections, 
discussing my experiences, reflections and emergent findings confidentially with my 
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supervisor and peers and shared emergent themes with participants. An audit trail of 
the choices made in different stages of this thesis and the reason for making them has 
been detailed so that they could be traced and re-evaluated. My own interests in the 
research topic, the purpose of the study, and methods used to recruit participants, 
collect data and analyse data were made transparent and explicit, as were the 
inferences made. 
The small size of this study and the rapidly changing field of egg donation through 
techno-scientific, policy and organisational developments limit the applicability of the 
findings of this research to other contexts. For example, since fieldwork was 
undertaken there has been as increase in egg freezing, the importation of donor eggs 
and websites enabling recipients to choose their own donor, all of which shape the 
organisation of matching and did not feature in this study. The different organisational 
dynamics of other fertility clinics in different parts of the UK might also limit the 
extent to which the findings of this study might be applicable elsewhere.  
This study was intended to be in-depth and as such the sacrifice of having limited 
transferability was accepted from the outset. However, the thick description of the 
research settings, participants, methodology used and data gathered enable external 
evaluation of the ways in which the research context shaped the findings and 
conclusions of this study, and the extent to which these conclusions may be 
transferable to other time periods, settings, participants and situations.  
 
3.9 Summary  
This study follows a constructionist approach and used an ethnographic approach to 
explore the organisation of matching and the perceptions and practices of clinic and 
recipients in the context of two private fertility clinics in South East England.  
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To enable this, the research methodology adopted multiple data collection methods 
namely observations of consultations and clinical practices, clinicians interviews, 
recipients interviews as well as available documentation on and about the clinics. 
These methods not only allowed a rich collection of data but also supported 
triangulation and a deeper understanding of the ways in which perspectives and 
practices were linked (and not linked) and related (and not related) to each other. The 
ethical considerations, sampling and recruitment methods, sample characteristics, data 
collection methods and data analysis method pertaining to this study were also 
outlined, as were my own selective reflections on the experience of fieldwork. 
Finally, processes of quality assurance in qualitative research as they applied to this 
study were discussed. The next chapter will provide the background and context to the 
empirical findings of this thesis (presented in Chapters 5-8). 
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Chapter 4: The Regulatory and Clinical Context of 
Matching 
 
4.1 Introduction 
This chapter provides the background to the wider regulatory and immediate clinical 
settings in which this study was undertaken. It provides the context to the findings of 
this study and draws attention to the highly regulated nature of the UK context of egg 
donation, in which it is argued that regulation is a driver of medicalisation and limits 
the commercialisation of egg donation.  
The organisation of egg donation and matching differ significantly across different 
countries, and indeed within individual countries and clinics. This includes 
differences in the public funding of Assisted Reproductive Technologies (ARTs), 
legal definitions of parenthood and the regulation of donor screening, anonymity, 
donor payment, patient access to treatment and the welfare of the child, to name a 
few. The different organisation of egg donation is each country reflects the politico-
economic context and socio-cultural values of that country and illuminates the 
peculiarities of a particular context.  
In some countries, such as Germany and Norway, egg donation is prohibited 
(Bergmann, 2011), whilst in other countries access organised differently. In France, 
the majority of ART cycles are funded by the State but access is limited married 
heterosexual couples (Fournier et al., 2013) whilst in Israel the state funds unlimited 
egg donation cycles irrespective of marital status or sexual orientation (Birenbaum-
Carmeli, 2016). In the USA on the other hand, as in several countries with provisions 
for ARTs, egg donation is organised according to the free-market and access is 
restricted to those who can pay (Barney, 2005; Almeling, 2007; Glennon, 2012). In 
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the UK, there is a mixed picture of private/public funding of ARTs, although the 
majority of egg donation cycles are privately paid for; restrictions to recipients’ access 
to private and NHS funded treatment come from the state, healthcare commissioners 
and the medical profession (as will be shown below).  
Such contrasts are also revealing when considering the macro-level organisation of 
matching in difference countries. For example, in the USA recipients can select their 
own egg donor (Becker, 2000; Almeling, 2007) whilst in Spain and Finland clinicians 
have a mandatory duty to match the ‘ethnicity’ and physical characteristics of donors 
and recipients (Kroløkke, 2013; Bergmann, 2015; Homanen, 2018). The regulation of 
matching in the UK has changed over time, as will be explored below. The USA 
context of egg donation in particular will be drawn upon below because it provides 
such a stark point of comparison with the UK context.  
The chapter will begin by outlining the regulatory context of ARTs and egg donation 
in the UK, where this study took place, and provides a historical overview of 
regulation on donor-recipient matching in gamete donation. This will be followed by 
a description of ‘matching’ – as defined for the purposes of this study and informed 
by ethnographic fieldwork. Finally, the organisation of each clinic and the 
organisation of matching in each clinic will be outlined, with attention to the 
differences between each clinic. 
 
4.2 Regulation of Egg Donation in the UK 
The regulatory context of egg donation is particularly significant in shaping the 
organisation of matching in the UK context and provides some of the background to 
the research questions which emerged in this thesis. The UK context of gamete 
donation is highly regulated, centralised and medicalised. The UK government has 
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taken what has been described as a “communitarian approach” (Glennon, 2012) 
towards fertility treatment in that it has sought to safeguard the interests of society and 
children born from fertility treatment and has developed legislation through numerous 
public consultations and reviews (Pfeffer, 1993; Thompson, 2005; MacInnes and 
Diaz, 2009).  
This approach is in sharp contrast to the organisation of egg donation in the USA, for 
example, where individual autonomy, privacy and commerce are prioritised over the 
state intervention and in which there is a minimalist approach to federal (and 
sometimes state) regulation and no public funding for ARTs (Thompson, 2005; 
Almeling, 2007; Glennon, 2012). Thus, unlike in the USA, where the regulation of 
ARTs is predominantly left to the medical profession and the market, in the UK ARTs 
are regulated by the medical profession and the state (Barney, 2005; Thompson, 2005; 
Sargent, 2007; Glennon, 2012). The size of the market in the US and UK contexts are 
also significantly different. The growing US fertility market is estimated to be worth 
more than $3.5 billion [££2.8 billion] (Harris Williams & Co, 2015) whilst the UK 
fertility market estimates the UK fertility market to be worth around £320 million 
(Risebrow, 2018).  
The main principles underlying the UK’s regulatory framework of ARTs are based on 
the recommendations of the Warnock Committee, who published their findings in 
what is commonly known as ‘Warnock Report’ (Warnock, 1984). The Warnock 
Committee saw regulation as fulfilling a normative function, for the “protection of the 
public”, to safeguard the welfare of children born through ARTs and to ensure the 
‘moral regulation’ of ARTs. The main legislation governing egg donation has been 
the Human Fertilisation and Embryology (HFE) Act (1990), which put into practice 
many of the Warnock Committee’s (1984) recommendations. In mid-late 2000, ART 
legislation and regulation was subject to major reforms which accumulated in the 
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updated HFE Act (2008), introduced to consolidate previous amendments and new 
updates to the HFE Act (1990). Several public consultations and reviews were 
commissioned by the HFEA and the Department of Health (DoH) to inform the 
development of regulation (DoH, 2003, 2005b; HFEA, 2005a; HFEA, 2005b). 
The HFE Acts (1990, 2008) extensively regulate a range of ethical, legal, socio-
cultural, ethical, techno-scientific, biomedical and economic aspects of ARTs. Under 
the provisions of the HFE Act (1990) the responsibility for implementing, overseeing 
and enforcing ART regulation and relevant legislation falls to the Human Fertilisation 
and Embryology Authority (HFEA). The HFEA is the UK’s independent arm’s length 
statutory regulator for fertility treatment which defines one of its primary roles as 
being to balance and protect the “conflicting interests” of clinics, intending parents, 
donors, donor-conceived persons and society.  
The HFEA’s main responsibilities are to license, monitor and inspect fertility clinics 
in the UK, to set standards for good clinical practice and to interpret legislative 
requirements for fertility clinics. By law, all fertility clinics operating within the UK, 
both NHS and private, must have a HFEA license to practice (which the HFEA has 
the power to grant and revoke), for which they must follow HFEA guidance and use 
standardised forms to record and submit information to the HFEA. Together, state 
legislation and the HFEA regulate a range of ethical issues in relation to gamete 
donation, including: informed consent, legal parenthood, donor compensation, donor 
anonymity, disclosure, the welfare of the child, the screening of donors and the 
procurement, handling, storage, transportation and transfer of donor gametes.  
Under UK law, all aspects of the egg donation process are under the jurisdiction of 
licensed fertility clinics and clinicians have state-sanctioned monopoly over the 
procurement, provision and use of donor eggs (Wikler and Wikler, 1991) which has 
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protected them from external market forces. Furthermore, only fertility treatment 
undertaken in HFEA licensed fertility clinics are covered by the provisions of the 
HFE Act (2008) thus making legal definitions of parenthood through gamete donation 
inherently medicalised (Winkler and Winkler, 1991); the legal rights and protections 
afforded to donors, recipients and donor-conceived persons under UK legislation 
would not automatically apply to the exchange of gametes outside of the UK state-
sanctioned clinical context, e.g. to sperm donation at home or egg donation abroad. 
Unlike in the US, where recipients of donor eggs are required to employ external 
lawyers and can pay a mediating egg donation agency thousands of dollars in addition 
payments for donors and treatment costs, in the UK legal paperwork and the ‘supply 
of donors’ are undertaken ‘in-house’ by clinics themselves (although this latter point 
is changing). 
Since the introduction of the HFE Act (1990) it has been a criminal offence in the UK 
to buy or sell human gametes. However, the Act (1990) does allow for donors to be 
“compensated”, and in turn, the HFEA stipulates that egg donors may be remunerated 
£750 or through “benefits in kind” per treatment cycle. This latter option generally 
entails women taking part in ‘egg sharing’ arrangements, where a woman ‘donates’ 
half of her eggs to a recipient and in returning for using the other half in her own 
heavily subsidised treatment. Currently (since 2005) the state mandates that donors 
must be identifiable to persons conceived of their donation from the age of 18 (HFE 
Act, 2008). This is based on ‘welfare of the child’ considerations, which in the current 
era of regulation, are defined by the state as knowing one’s ‘genetic origins’ (DoH, 
2005b). This is contrary to previous legislation in which donors were permanently 
anonymous and the state framed identifiable donors as a threat to the donor-conceived 
families (Warnock, 1984). This is in sharp contrast to the USA, where donors can 
remain anonymous and are reported to have been paid in excess of $50,000 [£37,000], 
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with “premier” donors with ‘desirable’ characteristics commanding higher sums 
(Glennon, 2012).  
It has been argued that the regulatory context of the UK, where legislation limits 
donors’ financial autonomy and their right to privacy, has led to a shortage of egg 
donors, whilst countries in which the free-market determines issues in egg donation, 
where there is no state restriction on the payment to donors and donors remained 
anonymous, have enabled a higher supply of donors (Craft et al., 2005; Pennings, 
2005; Glennon, 2012). In the USA for example, third party commercial ‘egg brokers’ 
have emerged as a niche service to recruit and ‘sell’ donors to recipients (Mamo; 
2005; Almeling, 2011; Glennon, 2012). In the UK on the other hand, regulation over 
the provision of donor gametes (which favours the authority of the medical 
profession) and the limit to donor compensation have discouraged the emergence of 
such third party commercialised agencies. Nonetheless, it is important to note too that 
despite concerns about the impact of regulation on ‘donor supply’ the number of egg 
donors in the UK has increased since 2006, which the HFEA have put down to an 
increase in compensation limits and public awareness of gamete donation (HFEA, 
2014b). 
Access to publicly funded treatment is restricted at different levels. At a macro level, 
Clinical Commissioning Groups (CCGs), which have been responsible for 
commissioning healthcare since 2013, have restricted, reduced or stopped the 
provision of NHS fertility treatment altogether, thus exacerbating the ‘post-code 
lottery’ in healthcare and stratifying (bio)medicalisation. For example, most CCGs 
exclude women over 36 years old, women with existing children and women with a 
high BMI from accessing NHS funded treatment. Bearing in mind that two-thirds of 
recipients of donor eggs in the UK are women over the age of 40 (HFEA, 2014b) this 
has meant that most recipients are forced to use the private sector. Thus in the UK the 
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vast majority of gamete donation treatment cycles in the UK are funded by private 
paying (HFEA, 2014b).  
However, whilst recipients’ ability to pay to access egg donation is necessary it is not 
sufficient. This is because the HFE Act (1990), like the Warnock Report (Warnock, 
1984) before it, focused on a moralised conceptualisation of restricting patient 
eligibility for treatment based on social welfare of the child considerations. This 
translated into meso-level constraints on recipients’ access to fertility treatment, 
which placed a duty on clinicians to make social judgments, not just medical 
judgements, about a person’s access to treatment on the basis of their perceived 
‘suitability to parent’ (Douglas, 1993; Malin, 2003; Campbell, 2007). Set out in 
Section 13(5) of the HFE Act (2008) is a small clause mandating that clinicians take 
into account the welfare of any child born through ARTs before providing intending 
parents with treatment. Currently, the HFE Act (2008) mandates:  
“A woman shall not be provided with treatment services unless account has 
been taken of the welfare of any child who may be born as a result of the 
treatment (including the need of that child for supportive parenting)” (HFE 
Act, 2008: 13(5)). 
 
Previously, the bracketed clause of the need to take into account a child’s need for 
‘supportive parenting’ specified a child’s ‘need for a father’ (HFE Act, 1990: 13(5)). 
Thus, the HFE Act (1990) inherently discriminated against lesbian couples and single 
women from accessing gamete donation. As such, scholars have argued that 
legislative (and therefore state) discourses concerning the ‘welfare of the child’ have 
been an attempt to regulate parenthood and procreation in accordance with wider 
societal and state assumptions about who or what makes a family based on an 
ideology of the family as heterosexual, two parent, white and middle class (Haimes, 
1992; Pfeffer, 1993; Franklin, 1997; Campbell, 2007).  
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Whilst acknowledging clinicians’ legitimate discretion in making “social judgements 
that go beyond the purely medical” (Warnock, 1984: 2.13) the Warnock Committee 
(1984) nonetheless drew attention to the importance of the moral and legal framework 
of reproduction and the need to ensure that clinicians’ autonomy did not lead to a 
radical departure from that framework. According to some, the state’s vested interest 
in reproduction is exerted and visible through its regulation of ARTs which it 
legitimises as being in the interests of the ‘public’ and the ‘welfare of the child’ 
(Robertson, 1991; Pfeffer, 1993; Franklin, 1995; Steinberg, 1997; Roberts, 1999; 
MacInnes and Diaz, 2005; Thompson, 2005; Campbell, 2007; Wade, 2007; Apel, 
2008).  
Although on the one hand clinicians’ mandatory obligation to consider the welfare of 
the child might be interpreted as limiting their professional autonomy by regulating 
their decision-making, on the whole scholars have argued that the ‘welfare of the 
child’ has been used by clinicians to legitimise their discretional decision-making and 
social judgements about reproduction (Steinberg, 1997; Roberts, 1999; Malin, 2003; 
Culley et al., 2004; Campbell, 2007). Thus, as highlighted by Szkupinski-Quiroga 
(2007: 148), in the US context of gamete donation, “because of their mastery of 
biomedicine, physicians in particular have culturally sanctioned authority that extends 
to reproduction”. However, Lee et al. (2014) have argued that although legislated 
welfare of the child considerations have been seen as a prime example of 
medicalisation the gatekeeping role of clinicians has more of a reality in law than in 
practice.  
Whilst the UK context of egg donation shares some aspects of neo-liberal ideology 
(e.g. rolling back of state funding) it does not share them all. In the UK, there is high 
state intervention through regulation, the nature of which limits the free-market, 
prioritises societal and children’s welfare over individual reproductive autonomy and 
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shapes the roles of stakeholders in the egg donation process (Barney; 2005; Glennon, 
2012). Findings from current studies on matching in transnational and international 
contexts cannot therefore be uncritically applied to the UK context, where egg 
donation is highly regulated, there is a shortage of egg donors and medical 
professionals have a mandatory obligation to consider the welfare of the child. In this 
respect, the political-economic context of egg donation in the UK reflects that of the 
British “regulatory state” (Walshe, 2002), in which state expansion and intervention 
increasingly takes place through regulation and less through funding and provision 
(Majone, 1997, Levi-Faur, David, 2011). According to Tanzi (2002: 121), “one could 
almost speak of a regulatory welfare state, since many countries have pursued their 
social objectives not through public spending or tax expenditure but through 
regulation”. 
 
4.3 HFEA Policy on Matching 
The emphasis on the neo-liberal context of matching in previous studies of gamete 
donation warrants some attention to the regulatory and policy context of the UK, 
specifically as it relates to matching. Having explored the general regulation 
surrounding ARTs and egg donation more widely (above), this section provides the 
historical and regulatory context for matching in gamete donation specifically and the 
key rationale behind the development of this research, through which the present 
findings in the following chapters can be framed and understood.  
The Warnock Committee (1984) and the HFE Acts (1990, 2008) both stood silent on 
the topic of donor-recipient matching. Between 1991-2007, the HFEA had two 
policies related to matching in place, ‘Cytomegalovirus (CMV) matching’ and ‘ethnic 
and phenotypical matching’ (HFEA, 2003). Although the nature of HFEA matching 
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policies has changed over time there has been an inherent assumption throughout 
these changes that it is clinicians who will allocate donors to recipients and mediate 
recipients’ selection of donors, i.e. that matching will take place under medical 
jurisdiction. A shortage of egg donors in the UK has necessitated the allocation of 
these donors to recipients by a mediating agency. The two HFEA matching policies 
and their implications for clinicians’ autonomy and recipients’ autonomy will be 
discussed below, with focus given to ‘ethnic matching’.  
It is important to note here that, as shown above, in the UK the wider regulatory 
context of egg donation has thus far precluded the market from significantly 
threatening the dominance of the medical profession over the recruitment – and 
allocation – of donors to recipients (the global organisation of ARTs and cross-border 
reproductive travel aside). Therefore, the main threat to clinical autonomy in 
matching has been from regulation rather than from the market. This is in contrast to 
the USA, for example, where third party commercial agencies have “outhustled” the 
medical profession from this role (Glennon, 2012: 101; Almeling, 2007) and, given 
there is provision for recipients to choose their own donor from an online catalogue of 
donors, have access to a range of in-depth information about donors and pay more for 
donors with ‘desirable’ characteristics (Barney, 2005; Almeling, 2011; Glennon, 
2012). The implications of this regulatory context for matching are discussed below. 
 
4.3.1 Cytomegalovirus Status Matching  
Although it has been given little attention in sociological literature, historically the 
HFEA has required fertility clinics to match donors and recipients by their 
Cytomegalovirus (CMV) status. CMV is a common (predominantly dormant) virus 
and it is estimated that well over 50% of the adult population in the UK are CMV 
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positive (NHS, 2018). If a pregnant woman is CMV negative and is exposed to the 
CMV virus during pregnancy there is a risk that the foetus will become infected and 
develop “congenital CMV”. Whilst most of these babies do not exhibit any problems 
it is estimated that a small number of infants will be symptomatic at birth and face 
some long-term health problems (NHS, 2018).  
It was due to this relatively small risk of foetuses developing congenital CMV that the 
HFEA demanded that egg and sperm donors be matched with recipients according to 
their CMV status. Therefore, this policy was rationalised as being in the welfare of 
children born through egg donation (HFEA, 2003). As with the screening of donors 
more generally, the above policy revealed the state’s aim in ensuring that ARTs 
reproduced particular types of children, i.e. healthy children. In doing so, this policy 
restricted CMV negative recipients’ access to donors. 
  
4.3.2 ‘Ethnic’ Matching  
Historical HFEA Policy on ‘Ethnic’ Matching 
Commentators on the HFEA’s matching policy have predominantly focused on the 
stipulation that clinicians ‘ethnically match’ donors and recipients (Millns, 1995; 
Price, 1997; Culley, 2005; Culley et al., 2004; Campbell, 2007; Wade, 2007; Wade, 
2012). However, the implications of this policy went beyond prescribing how donors 
should be allocated to recipients, as will be shown further below.  
In the 6
th
 Code of Practice (2003-2007), the HFEA stipulated a policy which stated: 
"Centres should strive as far as possible to match the physical characteristics 
and ethnic background of the donor to those of the infertile partner unless 
there are good reasons for departing from this. 
When discussing the selection of potential donors, centres should be sensitive 
to the wishes of those seeking treatment for information, whilst avoiding the 
140 
 
possibility that this information could be used to select a donor possessing 
certain characteristics for reasons that are incompatible with or not relevant 
to the welfare of the child. For example, those seeking treatment should not be 
treated with gametes provided by a donor of a different physical resemblance 
unless there are compelling reasons for doing so.” (HFEA, 2003: 3.18-3.19 
(underline added)) 
 
In the 7
th
 Code of Practice (HFEA, 2007), following the recommendations of a HFEA 
Review (HFEA, 2005b) and as part of a wider overhaul of HFEA policy, the HFEA 
removed its policies on CMV matching and ethnic matching, as will be outlined 
further below on ‘Current HFEA Policy’. First, the development of historical HFEA 
policy on ‘ethnic matching’ will be explored immediately below, including what this 
revealed about the state’s conceptualisation of normative families, and its intention to 
reproduce them, and the implications for the clinical autonomy and patient (recipient) 
agency. 
Normative Reproduction: Clinicians as Gatekeepers of the State 
For the first couple of years since its inception (1991-1993) the HFEA stipulated that 
clinicians should match the physical characteristics of donors and recipients as “good 
clinical practice” (HFEA, 1991). From the 3rd – 5th Code of Practice (1995-2003) the 
HFEA still required clinicians to match the physical characteristics of donors and 
recipients but removed reference to this as ‘good clinical practice’. The 3rd Code of 
Practice also introduced the characteristic of ‘ethnicity’ as an overt consideration in 
matching for the first time, thus beginning the formal legacy of ‘ethnic matching’ in 
egg donation by mandating that clinicians prohibited recipients from choosing a donor 
of a different ‘ethnicity’ to themselves. In the 6th Code of Practice (HFEA, 2003), 
presented just above, the HFEA intertwined clinicians’ role in matching with their 
mandatory responsibility to take into account the social welfare of children born from 
gamete donation for the first time.  
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In doing so, the HFEA re-framed the rationalisation for ‘ethnic matching’ from being 
a scientific standard (“good clinical practice”) to being an ethical standard (‘welfare 
of the child’). Prior to the implementation of this policy, a letter from the HFEA to 
clinics advising them of the update to the 6
th
 Code of Practice originally used the term 
“racial origin” (HFEA, 2002) (see underlined in the excerpt above), which was 
replaced with “physical characteristics” when implemented in the Code of Practice 
(HFEA, 2003). Although this was a small change, it reflected a more general populist 
orientation in conceptualising ethnicity as a physical characteristic whilst moving 
away from the overt use of racial terminology. The use of ethnicity in inverted 
commas in this thesis indicates such ambiguities surrounding its use. In this policy, 
the HFEA defined the welfare of the child as best being met by a normative ideology 
of the family in which parents and children shared the same ‘ethnic’ background and 
physical characteristics.  
As such, a lack of ‘racialised resemblance’ was framed as harmful to the welfare of 
the child and as requiring intervention by medical professionals, thus positing them as 
‘agents of the state’ (Steinberg, 1997) and restricting their clinical autonomy to match 
donors and recipients. However, the HFEA did allow clinicians a degree of discretion 
in their gatekeeping role by permitting them to depart from this practice where they 
saw “good” or “compelling” reasons to do so, although it provided little guidance as 
to what constituted a “good” reason.  
HFEA policy on ‘ethnic matching’ has been criticised by a range of scholars, who 
have argued that this policy was tantamount to reproducing a ‘state sponsored 
racialised ideology of the family’ (Campbell, 2007). According to Szkupinski-
Quiroga (2007), the practice of ‘ethnic matching’ reinforces a dominant hetero-
normative ideology of the (white) family whose members physically resemble each 
other on account of being the genetic offspring of each parent. Scholars have drawn 
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parallels between the imposition of ‘ethnic matching’ at a macro level and historical 
state intervention into reproduction and ‘race’, i.e. American miscegenation laws and 
attempts at maintaining ‘racial purity’ and preventing ‘racial cross-mixing’ (Roberts, 
1999; Fogg-Davis, 2001; Campbell, 2007: 113; Szkupinski-Quiroga, 2007).  
According to Campbell (2007) HFEA ‘ethnic matching’ policy “smacks of eugenics”, 
whereby state-sponsored medicalisation serves to reproduce normative racialised 
boundaries of the family. HFEA policy has also been criticised for reproducing the 
discrimination faced by mixed ethnicity families by explicitly preventing their 
reproduction (Wade, 2012). The main focus in the literature on egg donation has been 
on the above ‘ethnic matching’ policy, which according to Wade (2012), seeks to 
reproduce ‘racially congruent families’.  
Constraining Recipient Agency 
In the early days of policy, the HFEA required clinicians to “take into account” 
recipients’ “preferences” for donor characteristics, thus prescribing a degree of 
agency to recipients (HFEA, 1991). The 3
rd
 Code of Practice (HFEA, 1995) 
introduced the first of a series of constraints on recipient agency in the matching 
process. More specifically, the HFEA prohibited recipients from choosing a donor of 
a different ethnicity to themselves “for social reasons alone” and placed clinicians in 
the gatekeeping role of ensuring this was adhered to. 
 The 6th Code of Practice (HFEA, 2003), outlined above, continued the trend of 
curtailing recipient agency in the matching process, defined here as the ability to 
choose a donor of a different ‘racial origin’ to themselves. In framing ‘ethnic 
matching’ as a welfare of the child concern the HFEA simultaneously framed the 
welfare of the child as in direct opposition to recipient agency and required clinicians 
to make decisions in favour of the latter.  
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This framing of recipient agency as needing to be restricted reflected the view of the 
Warnock Committee (1984: 4.21) which concluded that recipient choice in donor 
selection should be limited “as a matter of principle” and as a welfare of the child 
concern. The 6
th
 Code of Practice (2003) stated that clinicians should merely “be 
sensitive to the wishes” of recipients in relation to “donor information”. This subtle 
change of wording reflected a subsequent shift in the HFEA’s conceptualisation of 
recipients’ agency, diverting attention away from recipients’ active agency in 
choosing the characteristics of their donor towards recipients’ passive agency in 
‘receiving information’ about donors. This shift became solidified in successive 
Codes of Practices. 
After HFEA policy on matching was removed, the HFEA continued with its earlier 
re-conceptualisation of recipient choice from being ‘active’ to being ‘passive’ and 
focused its attention on recipients’ right to receive non-identifying information about 
their donor (HFEA, 2007). Previously, the HFEA had only defined recipients’ access 
to information in relation to informed consent, i.e. in relation to clinicians’ obligations 
to inform recipients about the nature and implications of treatment. However, after 
2007, the HFEA also placed a duty on clinicians to provide recipients with non-
identifying information about their donor, including donors’ ethnicity, basic physical 
characteristics, year and place of birth and hobbies, a ‘good-will message’ and ‘pen-
portrait’ (HFEA, 2009). Although HFEA policy has increased recipient’s potential 
agency through increasing the amount of information that they can receive about 
donors it has also curtailed recipient agency by defining this in relation to their access 
to information rather than the right to choose their donor.  
As illustrated above, the policy of ‘ethnic matching’ was about far more than 
reproducing a racialised ideology of the family, although this was an important facet 
of it. HFEA policy on matching also mandated that clinicians act as ‘agents of the 
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state’ and ‘agents of women’s reproduction’ (Steinberg, 1997) in managing 
recipients’ preferences and ensuring they did not challenge the existing moral order of 
reproduction and kinship (Warnock, 1984). Thus this policy constrained recipient 
agency by restricting their choice of donors according to their ‘ethnicity’ and as a 
consequence stratified their access to treatment (Culley, 2004; Millns, 2005).  
Current HFEA Policy 
In 2014, some 7 years after the removal of HFEA policy on ‘ethnic matching’ and 
CMV matching, the HFEA introduced the general guidance requested by the SEED 
Review (HFEA, 2005b) which has remained in place to the present day. In a stark 
departure from previous policy (before 2007) the HFEA advises clinicians that they 
are no longer expected to ethnically match donors and recipients and that if a recipient 
is willing to accept a donor of a different ethnicity then ‘transracial matching’ would 
be acceptable (HFEA, 2014a). From 2014 to the current time (mid-2018), HFEA 
matching policy states:  
Centres are not expected to match the ethnic background of the recipient to 
that of the donor. Where a prospective recipient is happy to accept a donor 
from a different ethnic background, the centre can offer treatment, subject to 
the normal welfare of the child assessment. (HFEA, 2014a: 11.16)  
  
Unlike previous HFEA policy on matching, which constrained clinicians’ autonomy, 
current HFEA policy re-validates clinicians’ discretional autonomy and dominance in 
matching by stipulating that they no longer have an obligation to ‘ethnically’ match 
donors and recipients. On the surface, the current guidance appears to afford 
recipients a degree of agency in matching by enabling them to accept a donor of a 
different ‘ethnicity’. However, unlike earlier HFEA policy on matching which 
recognised recipients’ ‘active agency’ (in choosing a donor of a different ethnicity), 
albeit whilst trying to constrain it, current HFEA policy appears to frame recipients’ 
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agency in a passive way (recipients’ willingness to accept a donor of a different 
ethnicity because of a shortage of donors). Furthermore, the acceptability of this 
agency is still subject to clinical discretion, as clinicians must be willing to match 
recipients with a donor of a different ‘ethnicity’ in the first place.  
Despite the removal of policy on ‘ethnic matching’ a brief perusal of UK clinic 
websites reveals that fertility clinics match donors and recipients by ‘ethnicity’ and 
physical characteristics. As noted previously, the present study was undertaken during 
the period of policy absence on matching (2013-2014). All clinics in the UK are 
subject to the same national legislation and policy regulations. However, there has 
been little exploration into how different clinics organise matching within this 
regulatory framework. It was seen as important to investigate how clinicians matched 
donors and recipients, entirely at their own discretion, and the impact of the 
regulatory context on clinicians’ and recipients’ practices.  
Having outlined the wider regulatory context and examined how it shapes the 
organisation of matching in the UK, before going on to present the empirical findings 
of this thesis, it is important to additionally contextualise the findings of this thesis in 
the immediate contexts in which they were explored. Below, the nature of matching 
as a process will be defined followed by an overview of the two fertility clinics in this 
study and the organisation of matching within them.  
 
4.4 Overview of the Matching Process and Two Field Sites 
Both of the clinics that took part in this study were subject to the national regulation 
outlined above. However, fieldwork across both clinics revealed nuanced similarities 
and differences in relation to the structure of each clinic and the way in which each 
clinic organised matching, and in particular in relation to the process, procedures, 
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policies and practices of matching. Before going on to outline some of the differences 
between the two clinics in this study and how they each organised matching, the 
concept of matching will be defined. Fundamentally, for the purposes of this study, 
matching is defined as a process.  
 
4.4.1 The Matching Process 
‘Matching’ has commonly been depicted as a single practice, i.e. the selection of 
donors by clinicians or by recipients. However, ethnographic fieldwork for this study 
revealed matching to be a process, which can be broken down into 6 interdependent 
stages. Conceptualising matching as a process enables insight into how different sets 
of aims, activities, decisions, trajectories, roles, tools, constraints, perceptions and 
interactions combine to result in particular outcomes. The organisation of matching is 
thus mediated by and reliant on several stages, which were revealed through the 
course of fieldwork and data analysis.  
These stages, presented in Figure 4.1 below, involve: (1) Classification of donor 
characteristics (2) Classification of recipient characteristics and recipient preferences 
for donor characteristics (3) Management of the recipient waiting list (4) Allocation of 
donors to recipients by clinicians (5) Offering of donors to recipients by clinicians (6) 
Recipients’ acceptance or refusal of offered donor(s). Both of the clinics in this study 
structured the matching process according to these stages. Although other important 
stages in the egg donation process also took place around these stages (e.g. screening 
of donors and recipients) they were excluded from the matching process.  
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Figure 4.1 The Matching Process 
 
 
Although the overall process of matching at each clinic (Figure 4.1) was similar, the 
procedures of matching in each were significantly different, as will be outlined below.  
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Characteristics
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4. Donor Allocation to 
Recipient
5. Donor Offer to Recipient
6. Recipient Accepts/Declines 
Donor
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Recipient Declines 
Donor 
 Low Quality/Quantity 
Egg Collection  
 Donor/Recipient Cancels 
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4.4.2 Organisation of Matching in 2 Fertility Clinics 
Both of the clinics in this study shared similar attributes; they were private clinics 
which undertook egg donation, based in the Southeast of England and were subject to 
the same national regulatory framework (outlined above). However, fieldwork at each 
clinic revealed important differences between the two clinics in this study, including 
in relation to their organisational cultures, structures and demographics. The culture 
of each clinic refers to the shared assumptions, values and beliefs which shape 
individuals’ actions and behaviour and the taken for granted norms of an organisation 
(Parker et al., 2008; McLean, 2013). The organisational structure of each clinic refers 
to size, the materials used, the roles of staff and the procedures employed with clinics 
(McKenna, 2000; Jones, 2013), particularly in relation to the organisation of egg 
donation and matching. The size of each of these clinics refers to the number of staff, 
patients and treatment cycles undertaken at each clinic. 
Despite both of the clinics in this study organising the matching process according to 
the stages outlined above (Figure 1), each did so in distinctly different ways. These 
differences are important for situating the empirical findings in the following 
chapters. The organisational features of each clinic and their respective organisation 
of the matching process are outlined below.  
 
Creative Fertility  
The first clinic at which fieldwork was undertaken was ‘Creative Fertility’, a large, 
stable, and well-established clinic. The clinic was founded and managed by Mrs 
Redwood and a partner, who opened the clinic in the early 1990s. The clinic was 
defined as a “large treatment centre” by the HFEA; in the year of fieldwork (2013), 
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Creative Fertility undertook around 1,500 treatment cycles, about 150 of which 
involved cycles of egg donation, and employed around 35 members of clinical and 
administrative staff, including 3 doctors, 8 nurses and a team of 8 embryologists. 
The stability of the clinic was reflected in its low staff turnover (most staff had been 
with the clinic for over 5 years) and formal/bureaucratic organisation. Because 
Creative Fertility was a large and well-established clinic it had formalised internal 
policies and procedures in place, such as electronic systems for recording and 
managing large sets of patient information. Clinic staff undertook specialised roles, 
e.g. different nurses worked on different stages of the egg donation and matching 
process and clinicians’ roles were clearly demarcated. Therefore, recipients typically 
saw different nurses during their visits to the clinic (as they moved through the egg 
donation process).  
Most of the clinicians who worked on the egg donation programme at Creative 
Fertility were white and came from outside the UK. Anna and Jemma (the nurses 
responsible for matching) were from Australia and Mrs. Redwood (Director) was 
from the Netherlands and used to manage and undertake matching in the past. Doctor 
Demetrious was from Turkey and Doctor Ali was British Indian, and both saw donors 
and recipients for their ‘Initial Consultation’. Reflecting the picture of donors and 
recipients nationally, most of the recipients were white British middle-class women 
over 40. Most of the donors were also white British/white other. Of the 150 matches 
observed at the clinic 90% comprised white British or white other donors and 
recipients whilst 10% of these donors and recipients came from BME backgrounds.  
Matching at Creative Fertility 
The large number of patients at Creative Fertility required matching to be managed in 
a formal, de-centralised and systematic way, which included having defined staff 
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roles, systems and processes. The matching process at Creative Fertility was 
organised using electronic systems. Electronic forms were used to record donors’ and 
recipients’ characteristics and recipients’ preferences for donor characteristics, a 
tailor-made database was used to allocate (‘match’) donors to recipients, and donors 
were offered to recipients remotely via e-mail.  
Decision-making authority was de-centralised and staff had specialised roles. The 
Directors of the clinic, who had a financial investment in the running of the clinic, 
were not directly involved in the matching process. The clinicians who undertook 
matching were salaried employees, within a large clinic, and so did not have a direct 
financial investment in the matching process (i.e. encouraging recipients to accept 
donors). The classification of characteristics was undertaken by doctors (Doctor Ali 
and Doctor Demetrious), the allocation of donors to recipients was nurse-led and 
undertaken by 2 nurses (Anna and Jemma) and a doctor (Doctor Ali), and the offering 
of donors to recipients was undertaken by the above 2 nurses. As the different 
elements of the matching process were undertaken by different clinicians, it was 
typical for donors and recipients to encounter different clinicians at different stages of 
the matching process.  
The practice of donor allocation (‘matching’) took place in regular weekly ‘matching 
sessions’. Clinicians typically made around 4 matches a week and recipients, where 
they matched and offered a single donor at a time to recipients. Recipients waited 
around 6 months to be matched with a donor. Typically, the waiting list for a (white) 
donor was in excess of 25 recipients. However, for donors with certain characteristics, 
i.e. BME donors and white donors with particular characteristics, the number of 
recipients on the waiting list much shorter, often between 3-7 recipients, reflecting the 
number of recipients who were willing to accept donors with those characteristics. 
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The Fertility Centre 
The second clinic at which fieldwork was conducted was ‘The Fertility Centre’, a 
smaller and newer clinic than Creative Fertility. Established in 2011, the clinic was 
founded by Doctor Rana, the Director of the clinic, with support from partners. In the 
year of fieldwork (2014) the clinic undertook fewer than 300 treatment cycles, 50 of 
which were egg donation cycles (a third of egg donation cycles undertaken at Creative 
Fertility). The clinic employed around 7 members of staff, including 1 doctor, 1.5 
nurses and several Health Care Assistants (HCAs), who were employed to undertake 
non-technical care work. 
The small size of the clinic and its relatively recent inception meant that the internal 
organisational structure was not well established and there were few formal policies 
and procedures in place. The clinic primarily relied on paper forms and patient files to 
maintain patient records. The informal structure and culture of the clinic meant that 
staff roles were not clearly defined and a shortage of doctors and nurses meant that 
individuals were often expected to “use initiative” and to undertake duties above their 
pay grade, e.g. HCAs were commonly asked by senior management to undertake 
clinical nursing duties. The instability of the clinic’s culture was also reflected in its 
high staff turnover; during the period of observations 8 new members of staff joined 
the clinic and all 8 left. 
The clinic had a self-defined ethos of providing ‘personalised patient care’ and 
‘continuity of care’ to patients, which clinicians felt was made possible due to the 
small size of the clinic. Typically, Doctor Rana and Noreen dealt with patients 
throughout their egg donation journey. The recently established nature of the clinic 
meant that it was still trying novel ways to market itself in the growing industry of 
fertility clinics in the UK (and globally). The commercial strategies employed by the 
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clinic to promote its services included branded merchandise, such as pens and baby 
grows, discounts for consultations, and advertising in social media orientated towards 
BME women (such as Asian magazines and radio shows).  
The clinicians who worked on the egg donation programme at The Fertility Centre 
were predominantly BME; Noreen was Chinese and from Malaysia and Doctor Rana 
was British Indian. Other staff (e.g. HCAs, managerial and administrative), who were 
not directly involved in matching, came from an equal mix of white ‘other’ (e.g. 
European and Australian) and BME backgrounds. The ethnicity of donors and 
recipients was also more mixed than at Creative Fertility; this feature of the clinic not 
only differentiated it from the other field site, but also from samples of recipients in 
previous studies on egg donation in the UK (Konrad, 2005; Klotz, 2014). From the 65 
matches that were made at the clinic, just over half involved BME recipients (58%) 
followed by white recipients (42%) and just under half involved BME donors (40%) 
compared with white donors (60%).  
Matching at The Fertility Centre 
At The Fertility Centre, the small size of the clinic meant that the organisation of 
matching was based on a more informal approach. The Fertility Centre took a 
“personalised” approach to matching, which relied on a small number of staff, their 
tacit knowledge, and paper forms (contained in patient files). Paper forms were used 
to record donor characteristics and recipient preferences, to allocate donors to 
recipients, and to offer donors to recipients via a face-face consultation. 
The different elements of the matching process were undertaken by a single nurse, 
Noreen. However, decision-making authority was centralised to the extent that donor 
allocation was sometimes undertaken, and always authorised, by Doctor Rana 
(Director). As the only full-time doctor and nurse at the clinic, these clinicians 
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typically saw all of the patients who attended the clinic. As the founder of the clinic, 
the Director had a vested financial interest in the running of the clinic, and in the 
matching process, which was especially apparent given the clinic’s small size.  
On average, the clinic made one match a week, although these matches were 
undertaken sporadically over the period of observations. The small number of 
matches made meant that matching could be undertaken “casually” within the clinic 
and was not given allocated time as a defined task. Although some matches took place 
during a scheduled ‘matching session’, the majority took place outside of any 
formalised sessions, during informal meetings or by the Doctor or Noreen in isolation. 
At The Fertility Centre, recipients were often matched with a donor within 3 months 
of joining the clinic’s waiting list for donors, and sometimes well within a month. 
Despite having a shortage of egg donors relative to recipient demand, on the whole, 
the disparity between the supply and demand of donors and recipients was less than at 
Creative Fertility. The size of the waiting list of recipients was much shorter at The 
Fertility Centre. Typically, there were fewer than 10 recipients on the waiting list for a 
donor at any one time. On some rare occasions, the clinic had donors to match but no 
recipients on the waiting list for those donors. The existence of a ‘frozen egg bank’ at 
The Fertility Centre also contributed to the short waiting time for recipients, as 
recipients could be allocated a donor instantaneously and did not have to spend time 
going through treatment with donors. 
 
4.5 Summary 
This chapter has outlined the wider regulatory background and immediate clinical 
contexts in which this study took place. The UK context of egg donation was shown 
to be highly regulated, in which the welfare of the child is a central organising 
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principle and used to reproduce a normative moral order and model of the family. The 
nature of regulation reinforces medical professional jurisdiction and dominance (and 
sometimes challenges their autonomy) whilst limiting the degree to which egg 
donation is commercialised and arguably has translated into a shortage of egg donors 
and long recipient waiting lists for donors. HFEA policy on ‘ethnic matching’ has 
changed over time, moving from an emphasis on the ‘welfare of the child’ to 
recipients’ access to treatment.  
The conceptualisation of matching as a process, rather than a single practice, was put 
forward, and the stages within this process were outlined. Although both of the clinics 
in this study followed the same high-level matching process each clinic had different 
organisational procedures for undertaking matching. The two clinics in this study each 
had distinct organisational features and matching procedures; Creative Fertility was a 
larger clinic which took a more bureaucratic, arguably paternalistic, approach to the 
organisation of matching whereas The Fertility Centre was a smaller clinic and took a 
more personalised and informal approach to matching.  
In the literature recent studies have explored how the constraints of the UK regulatory 
context as ‘push’ factors leading to recipients going abroad for treatment (Hudson et 
al., 2011). However, few studies have explored the impact of regulatory constraints on 
recipients’ perceptions and practices within the UK clinical context. This study seeks 
to fill this gap by exploring the impact of context on the organisation of matching at a 
meso- and micro-level. The following four empirical chapters will explore the 
different stages that comprise the matching process alongside clinicians’ and 
recipients’ perceptions and practices, beginning with clinicians’ classification of 
donors and recipients into categories (Chapter 5).   
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Chapter 5: Clinicians’ Classification  
of Donors and Recipients 
 
5.1 Introduction 
Classification is a central component of stratification; the categories that individuals 
are ascribed to determine their access to resources and shape their identity and 
experiences. Shim (2014) has highlighted the importance of exploring how the 
‘mechanisms for sorting people become mechanisms for stratifying them’. That is, 
she advocates exploring how difference is made meaningful through classification (as 
will be the focus of the current chapter), and then to explore how we then act on those 
beliefs (the focus of the next chapter). In order to explore how matching is 
undertaken, it is important to understand how clinicians categorise donors and 
recipients beforehand. This is because stratification ‘boils down’ to two powerful 
mechanisms: “the allocation of people to social categories, and the institutionalization 
of practices that allocate resources unequally across these categories” (Massey, 2007; 
5-6).  
Clinicians’ classification of patients has been explored in studies of ‘race’ and 
ethnicity (Miles, 1989; Sheldon and Parker, 1992; Smaje, 1996) and the healthcare 
literature more generally (Bradby, 1995; Nazroo, 1997; Aspinall, 2005; Bhopal, 
2007). However, few scholars have explored how clinicians classified donors’ 
characteristics for the purposes of matching (Fox, 2008; Costa, 2009; Thompson, 
2009; Bergman, 2015; Schurr, 2016) and hardly any have explored the ways in which 
clinicians classified recipients’ preferences for donor characteristics. Some studies 
have reported that clinicians sought to influence recipients’ preferences for donors of 
a different ‘race’ (Roberts, 1999; Jones, 2005; Szkupinski-Quiroga, 2007) although 
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few of these studies explored the ways in which this was undertaken in practice 
(Bergmann, 2015; Deomampo, 2016). 
Classifications or categorisations are spatial and temporal. According to Bowker and 
Star (2000: 10), “a classification is a spatial, temporal or spatial-temporal segment of 
the world”. Classification involves categorising things into “a set of boxes” which 
then do some kind of work. Classification systems are simultaneously conceptual, 
contextual and political and can shift historically. The classification of human beings 
into racial categories is particularly contentious, especially in relation to 
‘race/ethnicity’ and skin tone. Such classifications are entrenched in wider histories of 
colonialism, eugenics, slavery, imperialism and racism where they have been used to 
segregate human beings according to a racial hierarchy of skin tone and justify the 
inferiority of non-white people and the superiority of white people (Miles, 1989; 
Gilroy, 2000b; Thompson, 2009; Hudson, 2015).  
Such classificatory systems are inherently intertwined with the “creation of stigma 
and racialised ideas about people from hot climates” (Rodriquez (2011: 423). In the 
literature on ‘race’ and ethnicity, whiteness has traditionally been posited unmarked, 
invisible and the norm whereas those from minority ethnic backgrounds have been 
posited as marked, visible and other (Jackson, 1998, Tyler, 2007; Frankenberg, 2001; 
Hudson, 2015). As highlighted by Stoler (1995), for example, the categories of 
“Indians” and “whiteness” were created (when) to establish and sustain a particular 
colonial social and political order.  
In this chapter, I will explore how clinicians classified donors’ and recipients’ 
‘ethnicity’, physical characteristics and social characteristics, how clinicians shaped 
the classification of recipients’ preferences for donor characteristics, followed by 
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clinicians more implicit classification of recipients as ‘good’ or ‘demanding’ based on 
recipients’ behaviour and clinicians’ expectations of the recipient role.  
 
5.2 Classification of Physical and Social Characteristics 
Although primarily collected for the purpose of matching donors and recipients, the 
classification of donor information served multiple purposes within the clinic. Firstly, 
anonymised donor information was also provided to recipients to use as a ‘donor 
selection tool’ to decide whether to accept or decline a donor. Secondly, clinics were 
also required to submit donor information to the HFEA so that donor-conceived 
persons could access it in the future.  
At Creative Fertility, electronic template forms were used to record the characteristics 
of donors, recipients and recipients’ partners. These electronic forms contained a list 
of pre-existing characteristics (e.g. eye colour) and tick-box categories (e.g. blue, 
brown). The pre-existing list of categories meant that clinicians and recipients were 
restricted to the characteristics and categories used by the clinic. At The Fertility 
Centre, paper forms were used to record donors’ (and sometimes recipients’) 
characteristics. Although the forms contained pre-existing characteristics (e.g. hair 
colour), the responses were filled in as free-text, by hand, by the nurse.  
Despite the different tools used, both clinics recorded similar information about the 
physical and social characteristics of patients. The characteristics recorded by 
clinicians included: ethnicity, skin tone, eye colour, hair colour, height, weight, 
religion, occupation, education and hobbies/interests. For donors, clinicians also 
recorded their motivation for donation and asked them to fill-out a ‘pen-portrait’ (self-
description) and ‘good-will’ message for persons born from their donation. At both 
clinics, the forms contained a free-text box in which clinicians’ recorded additional 
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information about patients’ characteristics. The characteristics and categories used at 
each clinic were based on the HFEA Donor Information Form (see Appendix 9). 
Despite having the option of categorising donor characteristics as free-text at The 
Fertility Centre, in practice, the categories used by the nurse generally correlated to 
the categories used at Creative Fertility 
Nonetheless, despite the standardised characteristics used for recording patients’ 
(donors’ and recipients’) characteristics, in practice, the process of classification was 
not a straightforward and neutral practice of ascribing objective categories to 
measurable characteristics. Rather, the characteristics recorded were the outcome of: 
clinicians’ perceptions of patients, patients’ perceptions of themselves, how clinicians 
posed questions to patients, how patients responded, and the responses that were 
recorded by clinicians. Thus, this section will show how the classification of donors 
and recipients into different categories highlights the subjective, medicalised and 
racialised nature of classification. In the following chapter, the ways in which these 
classifications determined which donors and recipients could or could not be matched 
together will be explored.  
The classification of donors and recipients into physical and social characteristics is a 
mechanism of differentiation; donors and recipients are reduced into individual 
categories so that they can be re-assembled in medically sanctioned ways (i.e. during 
allocation and offering). In this section, the process by which clinicians’ grafted the 
properties of donors and recipients onto physical and social categories of 
differentiation (Thompson, 2005) will be explored. Below, the problematic nature of 
classifying patients’ physical and social characteristics will be explored, followed by 
clinicians’ classification of patients’ ‘ethnicity’ and skin tone.  
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5.2.1 Physical Characteristics and Hobbies  
On the whole, clinicians described the process of recording patients’ physical and 
social characteristics as “easy” and “straightforward”. When labelling patients’ 
physical and social characteristics, sometimes clinicians posed open-ended, closed-
ended or leading questions to patients and sometimes they simply asked patients for 
confirmation of their own inferences. Sometimes patients responded to clinicians’ 
questions about their own characteristics with confusion and ambiguity, and sought 
clarification from the doctor, their partner, and even from me. 
For example, when asked about their hair/eye colour, some (white) patients replied 
that these characteristics were changeable depending on the lighting of their 
environment/different seasons of the year, and some patients replied with a mixture of 
colours across or outside of the available categories (e.g. strawberry blonde hair 
colour). On one occasion, a donor had one green colour eye and one blue colour eye. 
In such cases, clinicians asked recipients to arbitrarily select a single category (at 
Creative Fertility) or wrote in an amalgamation of multiple categories as free-text (at 
The Fertility Centre), e.g. ‘greeny blue’ eye colour.  
The height and weight of patients was recorded as free-text at both clinics, with BMI 
being worked out electronically. Although it might well be assumed that the height 
and weight of patients were accurately and reliably recorded given the categorical 
nature of these categories and the availability of measuring equipment, sometimes 
clinicians filled in this information by merely asking patients about their current 
height and weight. If patients responded that they did not know, clinicians sometimes 
extrapolated patients’ height from a visual comparison with their own height or 
recorded the outcome of verbal deliberations between the recipient and her partner. 
Clinicians paid little regard to ambiguities around patients’ physical characteristics, 
and instead concentrated on ensuring that the forms were filled in in a timely manner. 
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The classification of donors’ hobbies and interests was also inherently shaped by 
clinicians. When enquiring about patients’ hobbies and skills, clinicians would first 
pose this as an open-ended question to patients, such as ‘what are your hobbies and 
interests?’ The recording of these social characteristics was more laboured for donors 
than for recipients, and if the information disclosed by donors was deemed too little, 
clinicians would ask more closed or leading questions, such as whether the donor 
enjoyed ‘travelling’ or ‘cooking’, or whether they ‘played a musical instrument’. 
Often donors were recorded as playing the ‘recorder’ or ‘piano’, despite them not 
having played in over a decade. 
 
5.2.2 ‘Ethnicity’ and Skin Tone 
Unlike the physical and social characteristics of donors (listed above), the process of 
classifying the ethnicity and skin tone of donors and recipients was more complex and 
involved clinicians differentiating patients into different categories through a process 
of racialisation. This process of ascription was not merely a case of ‘asking patients 
the question and noting down their reply’ (as some clinicians saw it), but was the 
outcome of clinicians’ own beliefs and assumptions about skin tone, ‘race’, and 
genetic inheritance, and their interaction with these and other socio-technological 
categories.  
The ‘race’/ethnicity of donors and recipients are used as primary matching criteria by 
clinics and are therefore recorded in all clinics globally (Costa, 2007; Thompson, 
2009; Ariza, 2015; Hudson, 2015). The classification of ‘ethnicity’ and skin tone by 
fertility clinics has been subject to much criticism from scholars (Pennings, 2000; 
Fogg-Davis, 2001; Szkupinski-Quiroga, 2007; Costa, 2009; Thompson, 2009). As 
highlighted by Gunaratnam (2003: 19): 
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“The conceptual ‘fixing’ of ‘race’ and ethnicity is dangerous… because it can 
serve to produce and reproduce wider forms of essentialism, stereotyping and 
racism.”  
 
Studies have explored how clinicians classify the physical and social characteristics of 
predominantly white donors and recipients in egg donation in Brazil (Costa, 2007), 
Argentina (Ariza, 2015), the USA (Almeling, 2007), India (Deomampo, 2015) and 
Spain (Bergmann, 2015), all of which found that clinicians classified donors and 
recipients ‘ethnicity’ based on their own perceptions of skin tone. For example, 
Bergmann (2015) found that clinicians in Spain generally classified women from 
Northern Europe as ‘white’ but would also classify women as “Mediterranean” if they 
thought they “looked Spanish”. However, there have been no empirical studies of 
clinicians’ practices of classification in the UK context of gamete donation. 
In the following sub-sections the focus will be on how clinicians’ operationalised the 
ethnicity and skin tone of patients and on the material processes and mechanisms by 
which clinicians stratified patients into different ‘ethnic’ and skin tone categories.  
‘Ethnicity’  
During the period of observations, Creative Fertility based its ethnic categories on the 
1991 Census despite the HFEA recommending ethnic categories based on the 2001 
Census at the time of fieldwork. The categories available for recording ethnicity at 
Creative Fertility were: White British; Black African, Black Caribbean, Black other; 
Indian, Pakistani, Bangladeshi; Chinese; and Any other ethnic group. The categories 
of ‘any other white’, ‘any other Asian’ and ‘black’ were also available on the clinic’s 
database, but were seldom used or used with very little consistency in classification. 
Despite the option of recording patients ethnicity as free-text, the nurse at The 
Fertility Centre also relied on the above categories, in addition to using general and 
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specific racial and ethnic categories, such as “Caucasian”, “Black”, “Oriental”, 
“Asian”, “Indian” and “Gujarati”.  
The use of generic categories such as “Caucasian” and “Black” is troublesome 
because of the historically contingent and politicised nature of these categories. 
Whereas the UK Census ethnic categories were intended to measure ethnicity as 
cultural identification, despite the criticisms levelled against them for conflating 
ethnicity, nationality, ‘race’ and skin tone (Ahmad and Sheldon, 1992; Aspinall, 
1997; Modood et al., 1997), both clinics used ethnic categories primarily for the 
purpose of physical differentiation. Clinicians said they felt ‘restricted’ and 
“frustrated” by the availability of ethnic categories, which they saw as unsuitable for 
the purposes and patient population of their clinics. This view is illustrated by Noreen, 
at The Fertility Centre (who ironically classified ethnicity as free-text): 
“I think those are the only categories anyway. Because we are bound by the 
HFEA and those are the only categories that we can give. But there are times, 
sometimes I really get frustrated.” [Noreen, The Fertility Centre] 
 
The increasing trend towards fertility tourism has meant that increasing numbers of 
recipients are seeking fertility treatment, from outside of the UK’s traditional 
immigrant population, in UK fertility clinics. Although most donors were UK based, 
some donors were from abroad and attended the clinic whilst on a UK work or student 
visa. Thus, the 1991 Census categories, designed to reflect the ethnic diversity of the 
UK population (at that time) (Sillitoe and White, 1992), were not always able to 
accommodate the diverse ethnicities and nationalities of patients at each of the clinics. 
Neither clinic used the specific ‘Ethnicity Codes’ recommended by the HFEA at the 
time (although these Codes had also changed during the course of fieldwork).  
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Clinicians found it particularly difficult to classify “white” patients from countries 
outside of the UK. At both clinics, patients from a range of countries, cultures and 
ethnicities were assigned to the generic and homogenous category of “white” based 
on clinicians’ perception of their skin tone. This included women from Afghanistan, 
Algeria, Iran, Brazil, Chile, Columbia, the Middle East, Russia, Saudi Arabia and 
countries in Europe. As illustrated by the quote below from Doctor Ali, clinicians saw 
the category of ‘white’ as so broad that it became almost meaningless: 
“They’re quite restrictive [the ethnic categories]. ‘Cause we were trying to 
work out, ideally, like we’ll get some patients who are from North Africa, and 
they are white or whatever, and if we get somebody who’s Middle Eastern, 
just, everything will be white […] I don’t think the database has anything 
saying mixed race, or middle eastern” [Doctor Ali, Creative Fertility] 
 
In order to differentiate between ‘types’ of white donors, clinicians recorded 
additional information about patients’ ethnicity as free-text, e.g. ‘Bulgarian’. That is, 
clinicians ‘marked’ the ethnicity of white patients from outside of the UK by 
recording additional information about their ethnicity/nationality/skin tone. No 
additional information was generally recorded for white British patients, unless 
additional information was disclosed by patients which clinicians deemed worth 
recording, e.g. about their genetic ancestry (e.g. grandparents’ ethnicity) or place of 
birth. For example, 2 white British donors were ‘marked’ when they disclosed having 
a “Maltese grandmother” and a “half-Tunisian grandmother’.  
This ‘marking’ of ethnicity also took place when there was a disparity between donors 
self-identified ethnicity and clinicians’ perceptions of donors’ skin tone, which they 
saw as a primary indicator of donors’ ethnicity. In this respect, clinicians 
conceptualised ethnic classification as a visual skill, which involved undertaking 
further investigation to discern donors’ “natural” and ‘genetically inheritable’ skin 
tone, as illustrated by the quote below from Doctor Ali: 
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“I saw one donor and she said that she was white British, but then I asked her, 
because I looked at her skin colour, and I said ‘Is that your natural skin 
colour?’, and it was olive. And then she said, ‘Well actually my grandmother 
has done an ancestry chart or something like that and they found out that she 
was from Romany Gypsies’.” [Doctor Ali, Creative Fertility] 
 
In such cases, clinicians would classify patients as ‘white’ and record the outcome of 
their investigations as free-text, e.g. “Romany Gypsy grandmother”. Previous studies 
which have explored clinicians’ categorisation of ‘whiteness’ in transnational contexts 
of egg donation (Costa, 2007; Ariza, 2015; Almeling, 2007; Schurr 2016; Bergmann, 
2015) and of skin tone in South Asian donors in India (Deomampo, 2016) have 
reported that clinicians classified donors according to their own perceptions of skin 
tone. However, none of these studies were undertaken in the UK and so were unable 
to capture the specific nature of classification within this context, such as the 
categories available for classification and the factors influencing the process of 
ascription to these categories.  
Clinicians’ perceptions of skin tone and ‘race’ also impacted how they classified 
patients, as did the availability of ethnic categories that they had access to. For 
example, The 1991 ethnic Census categories did not have a category for ‘Arab’ or for 
‘mixed ethnicity’ and so in the absence of such categories, clinicians allocated 
patients to ethnic categories based on their own perceptions of skin tone.  
Thus, depending on a clinicians’ perception of a recipients’ skin tone, an Arab woman 
could be classified as “black African” or as “white” (from observations). In both 
cases, these classifications were ‘marked’ with additional free-text information to 
qualify the ambiguity of the classification. For example, an Arab recipient who was 
classified as “black African” was additionally described as “light-skinned Arab” and 
an Arab recipient classified as “white” was additionally described as “Arab”. These 
additional ‘markings’ were used to signal to clinicians that the patients were 
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something other than their classification indicated so that they could be could be 
allocated an ‘appropriate’ donor (explored further in Chapter 6). This process of 
categorising patients according to their skin tone also illustrated that minority 
ethnicity could also be marked (to reference the ‘lighter’ skin tone of BME patients), 
which was also evident in clinicians’ categorisation of mixed ethnicity patients.  
When classifying the ‘ethnicity’ of mixed ethnicity patients, clinicians assigned these 
patients to their minority ‘non-white’ ethnicity. This classification would be marked 
by additional comments about patients’ particular ‘racial mix’ e.g. “Indian and 
Caucasian”. This process of classification was undertaken at both clinics. However, 
unlike at Creative Fertility, the nurse at The Fertility Centre additionally described the 
ethnicity of mixed ethnicity individuals as percentages in the free-text box, e.g. one 
donor was labelled as being “50% White British, 25% Caribbean and 25% Indian” 
and was ultimately classified as BME (black Caribbean). Such descriptions gave the 
idea that ethnicity could be broken down and assigned a quantitative value, by 
medical professionals, thus reinforcing ideas about “race” and ‘purity of races’ 
(Duster, 1990; Stoler, 1995; Wade, 2007) and contributing to the medicalisation of 
‘race’ and ethnicity (Witzig, 1996; Santiago-Irizarry, 2001; Morning, 2011).  
Clinicians’ categorisation of mixed ethnicity individuals as non-white (BME) also 
illuminated their underlying conceptualisation of white ethnicity as ‘unmarked’ and 
BME ethnicity as ‘marked’, reflecting more traditional understandings of racialised 
markedness (Frankenberg, 2001). That is, clinicians appeared to conceptualise ‘non-
white’ ethnicity as visible and genetically dominant, and therefore needing to be 
labelled, whilst ‘white’ ethnicity was seen as unmarked, invisible and genetically 
recessive, and therefore was not a ‘risk’ needing to be marked but something needing 
to be protected. Therefore, clinicians sought to categorise mixed ethnicity donors as 
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‘non-white’ rather than ‘white’ so that this could be taken into account during 
matching (i.e. to prevent these donors being allocated to white recipients).  
However, as illustrated above, clinicians also marked the ethnicity of some white 
donors, illustrating that the process of ethnic marking was not restricted to BME 
patients. Clinicians thus marked the skin tone of some white donors through their 
classification of donors and recipients into different categories of skin tone, as will be 
shown below. 
Skin Tone 
Both clinics used pre-existing categories to record patient’s skin tone which were 
based on the HFEA Donor Information Form (Appendix 9). These categories were 
“Light/fair”, “Medium”, “Olive”, “Freckles” and “Dark”. At The Fertility Centre, 
nurses also recorded patients’ skin tone as an amalgamation of different categories or 
using different categories altogether, e.g. “medium-dark” or “light brown”. The role 
of clinicians in categorising patients’ skin tone has been subject to criticism by 
researchers, who have challenged clinicians’ ability and authority to undertake this 
process by virtue of their medical training (Fogg-Davies, 2001; Thompson, 2009: 
132). As with the classification of patients’ ethnicity, the ascription of skin tone 
categories to patients was not a straightforward and objective process but was based 
on clinicians’ racialised perceptions of skin tone.  
Unlike with the labelling of other physical characteristics, clinicians saw the nature of 
ascribing skin tone to patients as “difficult” and “contentious”. However, despite 
acknowledging the inherently “controversial” and subjective nature of classifying 
patients’ skin tone clinicians nevertheless felt that they were best placed to undertake 
this classification. Thus, in practice, clinicians’ perceptions of skin tone took 
precedence over patients’ own self-identification, as illustrated by the quote below 
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from Doctor Demetrious who was responding to my question about how he classifies 
patients’ skin tone. Initially, the doctor responded by asking me to label my own skin 
colour, to which I replied “medium”:  
Doctor Demetrious: “So you think your medium. I think you are more than 
medium. Is medium more than olive? Less than olive? What is olive? So this is 
extremely difficult to understand. Because for someone Swedish you are dark. 
So I have to say it’s very difficult. It’s something controversial. It’s very 
difficult to debate whether you are medium or you are light. No, I usually put 
that in myself, what I think, because I don’t think it makes much sense” 
PD: “If you had asked me as a patient? …”  
Doctor Demetrious: “You wouldn’t know. There is no way. So that particular 
one I put in myself. It’s very ethnically sensitive” [Doctor Demetrious, 
Creative Fertility]  
 
As illustrated by the quote above, clinicians classified patients’ skin tone in relation to 
their ethnicity. South Asian and black African/Caribbean patients were often labelled 
as having ‘medium’ or ‘dark’ skin tone, regardless of their own self-identified skin 
tone, as illustrated by the quote below from Doctor Ali: 
“A lot of Asian women will say they’re light, but they’re medium. So a lot of 
them I’d say were medium, there’s only ever one that I’d say I’d really seen 
who was light skinned but the rest of them I’d say were probably medium.” 
[Doctor Ali, Creative Fertility] 
 
White patients on the other hand were typically labelled as having “light/fair” skin 
tone, which clinicians described as a standard process of enabling some uniformity in 
the matching process (e.g. not differentiating between types of white donors to the 
extent of hindering a match being made). However, when this standard practice was at 
odds with clinicians’ perceptions of patients’ skin tone they sought to determine and 
record patients’ “natural” skin tone, i.e. , i.e. generally inheritable skin tone. For white 
patients clinicians commonly used ‘ability to tan’ as an indicator of their ‘natural skin 
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tone’. This process was more laboured for donors than for recipients, for whom 
clinicians sought to discern their ‘natural’ and genetically inheritable skin tone. 
Here, clinicians’ conceptualisation of ‘natural white skin tone’ was shaped by the UK 
context, and its climate. That is, in the context of the UK clinicians conceptualised 
‘natural’ white skin tone as ‘light’ and ‘untanned’ (and unmarked) due to the colder 
climate, whilst ‘naturally “tanned” or “olive”’ (marked) white skin tone was attributed 
to patients from countries with ‘warm and sunny’ climates such as southern Europe 
and other countries in the southern hemisphere. As such, in the context of the UK, 
clinicians saw ‘light’ skin tone as providing the baseline for ‘natural’/‘normal’ white 
skin tone. Conversely, clinicians saw ‘naturally tanned’ skin tone, or a “forever tan”, 
as needing to be identified and ‘marked’ (rather than classified as ‘light’), as 
illustrated by the quotes below from Anna and Noreen:  
“But with White British it’s quite difficult because we live in the UK and it’s 
not always very warm and sunny, so you don’t see a lot of tanned people. So 
you know, we have to sort of have to gauge that. When we say ‘fair skinned’, 
for white, that’s the majority. But if a patient’s really… then we can ask the 
donor, to what extent…Do you tan easily?” [Anna, Creative Fertility] 
 
“Yeah, because you base it on their ethnicity. If they are Caucasian and dark, 
it means that they tan easily, so sometimes you write ‘Olive’ because they tan 
easily or they have a forever tan and stuff like that […] it’s hard to quantify 
it.” [Noreen, The Fertility Centre] 
 
The ‘marking’ (labelling) of white patients was predominantly focused on patients 
with ‘darker features’. Although there was no ethnic category for ‘Mediterranean’ 
patients, clinicians commonly used this informal category to describe donors and 
recipients from a range of regions, including southern Europe, the Middle East and 
Northern Africa. Clinicians conceptualised ‘Mediterranean type’ patients as sharing 
similar physical characteristics, i.e. ‘olive skin’, ‘dark hair’ and ‘dark eyes’, as 
169 
 
illustrated by the quote below from Mrs. Redwood. In this regard, Mediterranean 
type’ patients can be seen as the archetype of ‘marked white’ patients. 
“So we find donors who are Mediterranean in terms of type, but they come 
from Cyprus, or they come from Iran, Morocco, or Libya, you know, living in 
the UK […] donors who are really Mediterranean looking, olive skin and uh, 
dark hair, and eyes.” [Mrs. Redwood, Creative Fertility] 
 
According to Brekhus (1998: 35), the very act of naming/labelling a category 
simultaneously constructs and foregrounds that category; when something is ‘marked’ 
it is qualified as a specialised form that needs to be distinguished from its more 
“generic” form. Such markings involve a social process whereby certain groups are 
rendered more visible than others, often in negative ways (Snyder, 2015).  
In the remainder of this thesis I will use the term ‘marked whiteness’ to refer to those 
white donors and recipients who had literally been ‘marked’ in the clinic by having 
additional information recorded about their ethnicity, skin tone, wider kin, nationality 
and place of birth and who were thus differentiated from the more generic category of 
whiteness, i.e. white British with light skin tone Such markings were undertaken to 
signal that patients were something other than their ethnic classification indicated. 
This practice of ‘marking’ was not generally undertaken for white British patients 
who fitted clinicians’ perceptions of ‘normal whiteness’ in the context of the UK. 
 
5.3 Classification of Recipient Preferences  
The tools used to classify recipients’ preferences for donor characteristics at each 
clinic were similar to those outlined above at each clinic (e.g. electronic forms and 
paper forms). At both clinics, recipients could state their formal preferences for 
donors’ ethnicity, skin tone, eye colour and hair colour. At The Fertility Centre, 
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recipients could also state their preferences for donors’ height, weight, religion and 
educational/professional level. At both clinics recipients could also state additional 
informal preferences for donor characteristics as free-text. As with the classification 
of donor/recipient characteristics, the recording of recipients’ preferences was 
undertaken by a clinician.  
Clinicians emphasised recipients’ ability to state their preferences for donor 
characteristics and to decline donors as central sources of agency for recipients in the 
egg donation process. According to clinicians, recipients’ ability to have some choice 
in selecting their donor enabled recipients to feel like they had some “control”, 
“comfort” and “reassurance” about their donor in a context within which their donors 
were otherwise anonymous and selected on their behalf by clinicians. This view is 
illustrated by the quotes below from nurses at each clinic: 
“Well, I guess it’s the recipient, they’ve got a bit more control in terms of who 
they can choose, as such, although they don’t have any idea, we’re doing it 
all. But I think it would be quite difficult as a recipient not to have any 
involvement at all, or not have a clue about who this person is. At least they 
have some idea, or, you know, some control over what they may look like, 
what they do, or whatever they’re looking for in a donor” [Jemma, Nurse, 
Creative Fertility] 
 
“I can’t blame them. I can’t judge them as well. I can’t blame them, the way 
that they want to design the baby. Because this is the only control that they 
have” [Noreen, The Fertility Centre] 
 
However, clinicians saw a limit to the agency that recipients should exercise within 
the matching process. They had expectations of the type and amount of agency that 
recipients should exercise and undertook strategies to pathologise and intervene in 
cases where recipients’ behaviour disrupted these expectations. Although clinicians 
saw the aim of matching as being to meet recipients’ preferences for donor 
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characteristics, they had expectations of what these preferences should be and shaped 
recipients’ preferences accordingly, as will be outlined below. 
On the one hand, clinicians expected recipients to have a preference for a “suitable 
donor”, which in the context of egg donation referred to a donor with the same 
characteristics as themselves, as illustrated by the quote below from Doctor Rana:  
“First of all it is the patient’s requirement, what she wants, and then we feel 
happy that we found a donor suitable for her. Like we matched to somebody 
who looks like her and all” [Doctor Rana, The Fertility Centre]  
 
Whilst clinicians were keen to facilitate this preference, as it was concurrent with their 
own priorities in matching, they also expected recipients to be willing to compromise 
on their preference for resemblance due to a shortage of egg donors (and donors with 
a particular mix of characteristics). Therefore, clinicians also expected recipients to be 
willing to accept donors with different characteristics to their own in order to prevent 
having delay to their treatment. The quote below from Noreen from The Fertility 
Centre illustrates this view:  
“I think the more specific you are the harder it is to match. The more broad 
the choices are the more easy to match. You know, the more easier, quicker to 
match a donor with a recipient. If we specify too much then I think it would 
take longer. So you have to be willing to compromise. But otherwise it’s going 
to take a longer process to match” [Noreen, The Fertility Centre]  
 
This expectation was relayed to recipients during their consultations. Despite telling 
recipients they could request whichever donor characteristics they wanted, clinicians 
also encouraged recipients to widen their acceptability criteria for donor 
characteristics to include donors with characteristics which were different to their 
own. Clinicians framed this compromise as ultimately beneficial for recipients, as a 
“reasonable” compromise and ‘choice’, which would reduce recipients waiting time 
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for a donor and actually increase their choice of donors, as illustrated by the excerpt 
below from an observation of a recipient consultation at Creative Fertility, in which 
the doctor told the recipient: 
“Doctor Redwood: You can specify what you want. You can state the physical 
characteristics which will be acceptable to you. But the more you choose, the 
more this will increase the potential donors that are offered to you, it will 
actually widen your choice. You set the limits. But in our experience we’ve 
found that if the characteristics you’ve requested are reasonable, the waiting 
time shouldn’t be too long” [Field notes, Recipient Consultation No. 10, 
Creative Fertility] 
 
Clinicians also advised BME recipients that they should be willing to compromise on 
their preference for a donor of the same ethnicity. For example, during recipient 
consultations clinicians often asked BME (primarily South Asian) recipients whether 
they would be willing to accept a white donor if no BME donors were available, as 
illustrated by the quote below from Anna. If recipients refused, clinicians often 
advised them to go abroad (to India for) treatment, to use a known donor or to be 
prepared to wait for a long time, as indicated by the quote below: 
“It’s less common, we have less donors of other ethnicities [than white] 
coming through. So the reality is they [BME recipients] are going to be 
waiting longer, and I think the majority of patients who … they’re told this at 
their initial consultation, so I think a lot of them will make a decision at that 
point that…they don’t want to wait any longer than necessary” [Anna, 
Creative Fertility] 
 
However, although clinicians expected recipients to accept difference with their donor 
due to a shortage of donors they did not see it as equally acceptable for recipients to 
have a specific consumer preference for a donor with different characteristics to their 
own. Neither were preferences for all types of difference seen as equally acceptable. 
Clinicians questioned recipients’ motivation for not wanting to match their own 
characteristics or to reproduce resemblance with their child. In particular, clinicians 
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pathologised the motivation of recipients who specifically wanted a donor of a 
different “race” to themselves. They framed such a preference as “demanding”, 
“unusual” and as an “ethical” concern; this was particularly the case when referring to 
white recipients requesting a BME donor.  
Echoing previous HFEA policy on ‘ethnic matching’, clinicians depicted recipients as 
having a consumer motivation for wanting ‘racial difference’, which they saw as 
challenging normative familial boundaries (through ‘choosing difference’ and seeking 
to enhance their child’s characteristics) and needing to be curtailed to protect the best 
interests of the child. In such cases, clinicians saw it as their own role to limit the 
degree of whiteness that recipients could access in their donor, as illustrated by the 
quote below from Mrs. Redwood:  
“I think a patient who decides, who is one type, one race, and decides to have 
a child of another race from egg donation, has to be completely aware of the 
consequences, on the child. I think, people do not always have the right idea of 
what’s going to happen, or have misconceptions, and it’s really to protect the 
child […] It’s the same in the African population [as the ‘Indian population’]. 
Some, a lot of these African ladies want a child that’s as light as possible. But 
how far light do you go?” [Mrs. Redwood, Creative Fertility] 
 
Clinicians saw recipients who specifically wanted a donor with different 
characteristics to their own as having a consumer motivation of wanting to ‘improve’ 
or ‘exotify’ the characteristics of their child, particularly in relation to racial 
difference. However, different discourses shaped clinicians’ perspective of the 
acceptability of a white recipient wanting a BME donor vs. a BME recipient wanting 
a white donor. A common theme in clinicians discourses was that lighter skin tone 
and fairer features are regarded as more valuable, desirable and “beautiful” within 
BME communities and so BME recipients therefore wanted to ‘improve’ their child’s 
characteristics by lightening the skin tone of their child, as illustrated by the quote 
below from Noreen:  
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“I think they want a child who is lighter skinned than them, or a mixed child, 
because in their eyes, in their mind, the child would be beautiful and 
everything.” [Noreen, The Fertility Centre]  
 
At The Fertility Centre, the Director, who was South Asian, contextualised BME 
recipients’ preference for a white donor within the wider context of racial 
discrimination, in which lighter skin tone is privileged and darker skin tone is 
stigmatised. The Director therefore conceptualised BME recipients’ preference for a 
white donor, and a child with lighter skin tone, as a protective mechanism employed 
by recipients to protect their child from discrimination and to facilitate their child’s 
life chances. As illustrated by the quote below, Doctor Rana saw BME recipients’ 
preference for a white donor as a strategy for enabling their child to ‘fit in’ to wider 
(British) society, not merely into their family unit: 
“Some of them, they say, ‘well, we are in this country, if our child is fair, it’s a 
good future for the child’, that’s what they say, they want to give a better life 
for the child you know […] We think that is beautiful. So we say that if you 
have a fairer child, the child will fit into this society” [Doctor Rana, The 
Fertility Centre]  
 
When asked whether there were any recipient requests that clinicians would not 
allow, all clinicians said they would not allow a white recipient to request a BME 
donor. Clinicians had concerns about the motivation of white recipients for wanting to 
cross what they saw as ‘natural’ racialised boundaries of the family and saw this 
request as ‘overdoing it’. Clinicians’ opposition to this request is illustrated in the 
quote below from Doctor Ali:  
“I think it probably depends on what the patients want. But you don’t want to 
overdo it. You can’t have white patients demanding ‘I want to have a black 
donor’. I don’t think we can do that, I don’t think anyone has ever done that.” 
[Doctor Ali, Creative Fertility] 
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Recipients’ preferences were recorded by a clinician using the standard forms in each 
clinic. This meant that clinicians were in the powerful position of shaping, allowing 
and disallowing recipients’ preferences for donor characteristics. In ensuring that 
recipients’ preferences were “ethically correct”, clinicians saw it as their role to 
intervene in and constrain recipient choice if they deemed recipients’ preferences 
were ‘abnormal’ or “strange”. In these cases, clinicians used counselling and ethics 
committees as disciplinary mechanisms to manage recipients’ non-compliant 
behaviour before allowing them to proceed with treatment. This ethical and 
disciplinary gatekeeping role was evident in the discourses of clinicians at both 
clinics, as illustrated by the quotes below:  
“If the request is somewhat strange for example, if the recipient wants 
characteristics in a donor which we think are not normal then we always ask 
them to see the counsellor to discuss the implications of all these things. And 
also if we have any concerns, we always discuss in our group meeting, so that 
we make sure that we are not doing anything that isn’t ethically correct.” 
[Doctor Rana, The Fertility Centre]  
 
“I think that’s where counselling comes in useful. Someone who wanted a 
different ethnicity, we’d probably have to advise them against it, or tell them 
they’d have to think about it. If they were really insisting we’d have to tell 
them to go to our ethics committee” [Doctor Ali, Creative Fertility] 
 
Interestingly, without being prompted, all clinicians drew on the acceptability of 
single white women selecting a BME sperm donor (to conceive using their own eggs). 
This example highlighted the stratification of women’s reproduction through egg 
donation compared with the aforementioned group of single women using sperm 
donation. In the commercialised context of sperm donation, recipients typically select 
their own donor from a catalogue of sperm donors. In this context, clinicians 
conceptualised their own intervention in restricting white women’s access to BME 
sperm donors as ‘racial discrimination’.  
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Although clinicians saw single white women’s preference for a BME sperm donor as 
embodying a consumer motivation, they conceptualised these women as exotifying, 
rather than improving, their child’s characteristics (which appeared to be more 
acceptable). Thus in this context, women’s donor selection practices and the crossing 
of racialised reproductive boundaries were framed as a matter of individual and 
consumer choice, rather than as an ethical concern. This view is illustrated by the 
quote below from Mrs Redwood:  
“If it is a single woman, using a sperm donor, you know, all the fantasies are 
up in the air. You would be amazed by the number of single women who want 
a different race donor to themselves. They choose a donor sperm with, I don’t 
know, Indian, African [laughs] because they find it exotic” [Mrs. Redwood, 
Interview, Creative Fertility]  
 
As illustrated above, clinicians actively shaped the preferences for donor 
characteristics that recipients of egg donation could request within the clinics 
according to their own expectations of the recipient role. Their discourses revealed a 
range of nuanced contradictions which were shaped by wider ideals of ‘race’, kinship, 
gender and the market. Clinicians’ expectations of the recipient role also shaped how 
clinicians categorised recipients as ‘good’ recipients and as ‘demanding’, or rather 
‘anxious’, recipients, and the repercussions of this for recipient agency.  
 
5.4 Classification of Recipients: The Good as Deserving and the 
Demanding as Anxious 
According to Clarke et al., (2010: 83), stratified (bio)medicalisation can occur when 
clinicians classify patients as ‘good’/’deserving’ or ‘bad’/’undeserving’ by virtue of 
their “compliance”. Studies which have explored clinicians’ classification of 
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individuals as ‘suitable’ or ‘unsuitable’ patients have predominantly focused on the 
impact of clinicians’ labelling of patients on patients’ access to fertility treatment 
(Doyal, 1987; Haimes, 1992; Pennings, 2001; Price, 1997; Steinberg, 1997; Roberts, 
1999, Malin, 2003; McCormack, 2005; Bergmann, 2015). In this study, clinicians 
labelled recipients as ‘good’ or ‘demanding’ based on recipients’ behaviour in the 
matching process. Interestingly however, one strategy (amongst others) used by 
clinicians to deal with ‘very demanding’ recipients who challenged their authority 
was to re-frame them as being ‘very anxious’ recipients, as will be explored below.  
Clinicians labelled recipients who met their expectations of the recipient role in 
positive terms such as “good” “lovely” and “deserving”. These ‘good’ recipients 
exercised passive and minimal agency in the matching process and accepted 
clinicians’ decision-making without question or challenge. Clinicians saw compliant 
recipients as women who were willing to compromise on their ideal preferences for 
donor characteristics, who were content with the information provided to them about 
their donor and who accepted the first donor that was allocated to them (regardless of 
whether their ideal preferences were met). Clinicians saw recipients’ compliant 
behaviour as reflective of their trust in clinicians to make decisions on their behalf and 
as having ‘come to terms with’ their own infertility and using donor eggs, as 
illustrated by the quotes below from nurses at each clinic: 
“I think it comes down to their whole comfort level with having egg donation. 
I think people who are really comfortable with it are generally less anxious 
about someone being an absolute perfect physical match. They just don’t 
mind. Who just want to have a child and are very comfortable with the fact 
that this is not their egg, so it doesn’t matter to them” [Anna, Nurse, Creative 
Fertility]  
 
“I think at the end of the day, maybe those people who said that they don’t 
mind what the ethnicity is, they don’t mind whatever, what anything is, at the 
end of the day they know what they want, and they want a child. And they are 
trusting us to give them that child” [Noreen, The Fertility Centre] 
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As illustrated by the quotes above, clinicians conceptualised ‘good’ recipients as 
having accepted using donor eggs, and the limits of their own infertility, and so were 
not intent on achieving the ‘exact’ physical resemblance with their child. They were 
seen as trusting clinicians to choose a donor on their behalf, and indeed, as trusting 
clinicians’ medical diagnosis of infertility and its solution (egg donation).  
On the other hand, clinicians’ labelled recipients as non-compliant, or more 
specifically as “demanding” and “difficult”, when they exercised too much agency. 
As illustrated in the sub-section above, clinicians pathologised recipients who exerted 
too much choice or did not make the right kind of choices. Clinicians also labelled 
recipients as ‘demanding’ or ‘difficult’ when they behaved in ways which disrupted 
other expectations that clinicians had about the recipient role, such as recipients who 
regularly contacted the clinic for ‘no reason’, recipients who challenged clinicians’ 
authority by questioning or refusing to comply with their advice or with scheduled 
clinic appointments and recipients who were overtly emotionally distressed (e.g. 
crying).  
In relation to matching, clinicians’ labelled recipients as ‘demanding’ or ‘difficult’ 
when they had lots of specific preferences for donor characteristics, were not willing 
to compromise on their preferences for resemblance, specifically requested a donor of 
a different ‘race’ to themselves, or asked lots of questions about the donors they were 
offered (particularly at Creative Fertility). Despite stressing that it was recipients’ 
“prerogative” to decline donors, the most common behaviour that clinicians attributed 
to ‘demanding’ recipients was the declining of multiple donors. Clinicians reasoned 
that these recipients were “obsessed” with having a donor who was an “absolute 
physical match” with their own characteristics because they were “stuck” on wanting 
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a child who physically resembled themselves and concluded that this was because 
these recipients had not accepted the lack of physical resemblance that was associated 
with not having a genetic connection with their child.  
Clinicians held such a medicalised view of female infertility they reasoned that 
‘demanding’ recipients had not psychologically come to terms with using donor eggs 
(the medical solution) and were ultimately in denial about their own infertility (the 
medical diagnosis), the two being synonymous in these fertility clinicians’ view. The 
quotes below from Anna and Noreen reflect clinicians’ view of recipients who exerted 
too much agency in the matching process: 
“The other ones who are more ridged in the matching process, I think they’re 
still in denial that they can’t use their own eggs. They still want to use their 
own eggs, and this is like their control” [Noreen, The Fertility Centre] 
 
“I think people that are still trying to hang onto the idea that this is their 
genetic child, or that they want this child to physically resemble them as much 
as possible, are going to be more strict and not willing to compromise […] 
The most difficult recipients are the one that are very very caught up on all 
physical aspects of the donor, and are just stuck on their criteria. They want it 
to be them, and we can’t give them enough reassurance I guess, ‘cause they’re 
having to just take our word on this. Some people get to the point where they 
can barely accept anybody because they just grill you about every aspect of 
this person’s appearance” [Anna, Creative Fertility]  
 
During observations of matching sessions, nurses often reflected that some recipients 
were being ‘difficult’ and declined multiple donors because they were ambivalent 
about using donors eggs and wanted to actively delay having their treatment. This 
view is illustrated by the excerpt below from ethnographic observations of a matching 
session at Creative Fertility: 
“The nurses were not fond of this next recipient who showed up on the waiting 
list. Jemma said that she was being difficult. When I asked why, Jemma said 
that she was being difficult because she kept declining donors that she was 
matched with. Jemma said it is because she doesn’t really want to use a 
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donor’s eggs but is going ahead anyway”. [Field notes, Day 31, Creative 
Fertility] 
  
Clinicians reasoned that recipients who declined multiple donors sought to retain a 
degree of control over their own reproduction or were declining donors as a way of 
delaying their own treatment because they were reluctant to use donor eggs. Thus, 
according to clinicians, recipients’ declining of donors was neither a reflection of 
clinicians’ decision making nor of the characteristics possessed by donors. Instead, 
they saw recipients’ declining of donors as stemming from recipients’ own 
‘unresolved underlying issues’ in using donor eggs, and ultimately in accepting their 
own infertility. For clinicians, there was therefore very little they could do to help 
these recipients in the matching process. These recipients were seen as not trusting 
clinicians’ authority and decision-making (in matching and more generally) and 
therefore challenged clinicians’ deep-seated role as medical gatekeepers.  
Recipients who consistently declined multiple donors also disrupted the matching 
process more generally and the financial running of the clinic, both of which relied on 
recipients’ acceptance of donors. In order to manage such disrupts and threats, 
clinicians re-framed recipients’ agency in declining donors from being an active and 
autonomous decision to being symptomatic of a pathological denial about their own 
infertility and their ‘medical need’ to use donor eggs. In this respect, clinicians re-
conceptualised ‘demanding recipients’ (who were a threat to clinicians’ authority) as 
being ‘very anxious recipients’ with underlying issues (who were not a threat to 
clinicians’ authority), as illustrated by the quote below from Mrs. Redwood: 
“People who still have issues and haven’t completely come to terms with the 
fact that they do need egg donation generally raise objections at the time that 
they are matched. This is going to happen. It hits them in the face, and 
suddenly there are all sorts of objections that have nothing to do with the 
donors’ characteristics […] I think it’s more the anxiety of having a child that 
is different, and having a child who has genes that you can’t understand or 
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control, rather than being a highly demanding patient. The very highly 
demanding patients generally are the most anxious ones” [Mrs. Redwood, 
Creative Fertility]  
 
Clinicians thus neutralised the threat of recipients’ behaviour to their own authority 
and re-framed it as an issue that lay with recipients themselves. Thus, whilst clinicians 
saw it as acceptable for recipients to exhibit some agency in the clinical context of 
egg donation, it was not seen as acceptable for recipients to display ‘too much’ 
agency or anxiety, i.e. outside of clinicians’ expectation of the recipient role. At 
Creative Fertility, all of the clinicians who were interviewed spoke about an informal 
clinic policy whereby recipients who declined three or more donors would be referred 
to counselling. This ‘policy’ was also relayed to recipients during their Initial 
Consultation with the clinic. Clinicians were concerned that recipients who were ‘not 
coping’ with egg donation or had underlying issues required intervention on the 
grounds that they: might regret going through egg donation, might reject their child in 
the future, would be likely to pull out of treatment or would be unable to accept a 
donor.  
Clinicians thus saw it as their role to intervene in the treatment of these recipients, in 
the form of counselling, to help them “unknot” their underlying issues and to help 
them to proceed with treatment, i.e. to accept a donor. Thus counselling for recipients 
was conceptualised by clinicians as a disciplinary tool, rather than as a ‘therapeutic’ 
tool (as recommended by the HFEA), to dissuade recipients from persistently 
declining donors and ‘fix’ their non-compliant behaviour. Recipients who were 
labelled as being ‘too anxious’ by clinicians were given little choice about being 
referred to counselling. The quotes below from Jemma and Mrs. Redwood illustrate 
clinicians’ conceptualisation of recipients’ refusal of donors being symptomatic of 
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recipients’ underlying psychological issues and their subsequent need for counselling 
and compliance: 
“If I’m concerned, or I feel they’re not coping with the whole situation, 
because that’s when you’ll pick it up, because they’re not coping with it. 
They’re matched, and they’re declining, declining, even though they’re good 
donors, so there’s obviously some sort of problem there. So yeah, it’ll come up 
then, and that’s when you’ll push for the counselling” [Jemma, Nurse] 
 
“Other recipients will decline 1, 2, 3, by which time I will have said to my co-
ordinating nurses, ‘Could you please send this lady to see the counsellor so 
that the counsellor helps us pinpoint exactly what their expectations are, 
because obviously we’ve had three donors turned down that matched what we 
had recorded as acceptable, and there must be another issue that needs to be 
discussed […] When we feel that someone is particularly anxious, or highly 
strung, or just, is objectionable to any step, then generally we recommend, we 
insist, that they see a counsellor, to sort of help unknot all the issues and 
prepare for a smooth treatment”. [Mrs. Redwood, Director] 
 
However, this policy was not seen being put into practice. For example, numerous 
recipients declined more than 3 donors (as will be explored in Chapter 8) and were 
not referred to counselling. This ‘3 strikes rule’ then appeared to be more a looming 
threat in the matching process. However, this threat was put into action during earlier 
stages of the egg donation process when doctors encountered recipients that they 
found difficult to manage. For example, during observations clinicians referred 
several recipients to counselling before proceeding with treatment because they 
displayed overt signs of (uncontrollable) emotional distress.  
 
5.5 Conclusion 
This chapter showed how clinicians categorised patients’ characteristics and 
recipients’ preferences and behaviour in inherently racialised and medicalised ways. 
When classifying the ‘ethnicity’, physical and social characteristics of donors and 
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recipients, clinicians negotiated pre-existing categories and ascribed patients to these 
categories based on their own perception of skin tone.  
The recorded outcome of these categories was shown to be highly subjective and 
socially constructed process, based on a variety of influencing factors, such as: 
clinicians’ perceptions of patients, patients’ perceptions of themselves, how clinicians 
posed questions to patients, how patients responded and the responses that were 
recorded by clinicians. Clinicians’ ascribed patients to an ‘ethnic’ category based on 
their own perceptions of patients’ skin tone and literally ‘marked’ the ‘ethnicity’ of 
some white patients by recording additional information about their skin tone, 
nationality, geographical ancestry or place of birth. This process of ascription was 
more laboured for donors than for recipients, for whom clinicians sought to discern 
their ‘natural’ and genetically inheritable skin tone.  
Clinicians held multiple expectations of the type of agency that recipients should 
exercise in the clinic and shaped recipients’ preferences accordingly. Whilst they 
expected recipients to want resemblance with their donor they also expected 
recipients to be willing to compromise on this preference and accept difference in 
their donor. However, clinicians did not see it as equally acceptable for recipients to 
specifically request difference, particularly in relation to ‘race’. Nor did they see all 
types of differences as equally acceptable.  
Clinicians’ conceptualisations of BME recipients and white recipients wanting a 
donor of a different ‘race’ also revealed nuanced differences in the motivation they 
attributed to these groups of recipients and their subsequent willingness to meet their 
preferences. Whereas clinicians saw it as acceptable, and even necessary, for BME 
recipients to request a white donor they did not see it as equally acceptable for a white 
recipient to request a BME donor. Conversely, clinicians saw it as altogether 
184 
 
unacceptable for white recipients to request a BME egg donor. Echoing HFEA policy 
legacy, clinicians framed recipients’ specific request for ‘racial difference’ as 
consumerist, going against the welfare of the child and needing to be circumvented.  
The example of single white women requesting a BME sperm donor also highlighted 
how clinicians’ views were specific to female recipients of donor eggs, illustrating 
how racialised conceptualisations of gender, reproduction and kinship also shaped 
clinicians thinking. Clinicians’ discourses around the permissibility of married BME 
women requesting a white egg donor and single white women requesting a BME 
sperm donor also revealed how ‘geographies of desirability’ (Nahman, 2006) shaped 
clinicians’ perspectives. Here, the former group of women were seen as wanting to 
‘improve’ the characteristics of their child whilst the latter group of women were seen 
as ‘exotifying’ the characteristics of their child.  
Clinicians’ expectations of recipient agency also shaped their implicit categorisation 
of donors and recipients. Recipients who were compliant with clinicians’ expectations 
were conceptualised by clinicians as ‘good’ recipients who had come to terms with 
their own infertility and using egg donation whilst recipients who were not compliant, 
e.g. recipients with lots of preferences or recipients who declined multiple donors, 
were seen as ‘demanding’. ‘Demanding’ recipients were a threat to clinicians’ 
authority, which clinicians contained through their re-conceptualisation of 
‘demanding’ recipients (consumers) as inherently ‘anxious’ recipients (patients). As 
such, clinicians reasoned that it was their role to intervene in and manage the anxiety 
of these recipients by referring them to counselling. Counselling was used by 
clinicians as a tool to manage recipients who displayed ‘too much’ agency and who 
challenged clinicians’ expectations of the recipient role and ‘racialised reproduction’.  
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This section has shown how clinicians’ classification of donors and recipients into 
formal and implicit categories was an inherently medicalised and racialised process of 
stratification. In the following chapter, the ways in which clinicians allocated donors 
to recipients based on these categories will be explored.  
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Chapter 6: Clinicians’ Allocation  
of Donors to Recipients  
 
6.1 Introduction 
In the previous chapter, we saw how clinicians’ classified patients’ characteristics, 
shaped recipients’ preferences for donor characteristics and re-interpreted the 
behaviour of ‘demanding’ recipients as being inherently ‘anxious’ and requiring 
intervention. In this chapter, clinicians’ discourses and practices of allocating donors 
to recipients based on their ascribed characteristics and the ways in which clinicians 
prioritised competing matching criteria, will be explored. At the time of fieldwork, 
there was no policy regulating clinicians’ practices of donor-recipient matching. 
Therefore, donor allocation was left entirely to the discretion of clinicians and clinic 
management (e.g. through policies).  
Despite the differences in the organisation of matching between each clinic clinicians 
across both clinics saw matching as having similar aims. These included the need to 
ration egg donors because of a shortage of donors and clinicians’ mandatory 
requirement to take into account the welfare of the child, which they intertwined with 
their role in matching. Clinicians’ discourses and practices of matching revealed that 
clinicians had organised donor allocation around what might be termed ‘primary 
matching criteria’, comprising “medical” characteristics and “race”/ethnicity, and 
‘secondary matching criteria’, comprising the waiting list, recipients’ preferences and 
general physical characteristics. Clinicians did not overtly make this distinction 
themselves, but it provides a useful categorisation to understand their prioritisation 
and negotiation of matching criteria.  
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Below, clinicians’ prioritisation and negotiations of ‘second matching criteria’, 
followed by ‘medical criteria’ and ‘race’ will be explored. The final section of this 
chapter will explore the ways in which clinicians’ informal classifications of 
recipients as ‘demanding’ shaped their practices of matching.  
 
6.2 Secondary Matching Criteria 
In the context of a shortage of donors, clinicians at both clinics saw a central aim of 
matching as being to “ration” the allocation of donors in a “fair” and equitable way. 
The waiting list for donors was a central mechanism to this aspect of donor allocation, 
which was seen by clinicians as ensuring this process was fair. 
Some work has been undertaken on the role of waiting lists in resource allocation in 
areas of public health care (Pope, 1991; Doyle and Bull, 2000; Foote et al., 2002) in 
organ donation (Schmidt, 1998; Sung, 2005), and in the field of ARTs (Stacey, 1992; 
Steinberg, 1997; Malin, 2003). However, few scholars in ARTs have paid attention to 
the distinction between recipients’ access to the clinic and their access to resources 
within the clinic, such as through the clinic waiting list for donors (Millns, 1995; 
Price, 1997; Pennings, 2001). As noted by Pennings (2001), how clinicians rank 
recipients on the waiting list for egg donors and their selection of recipients from the 
waiting list (rather than admission to) has received hardly any attention. Transnational 
studies which have explored clinicians’ allocation of egg donors to recipients rarely 
mention the role of the waiting list in clinicians’ decision-making (Nahman, 2006; 
Whitakker and Speier, 2010; Bergmann, 2011; 2015; Kroløkke, 2014). 
The waiting list involves a 2 step process (Pennings, 2001), including admission to 
the waiting list (and treatment) and ranking of those on the waiting list (which has 
received less attention). Pennings (2001; 2005) suggests a “points system” based 
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allocation system, where clinicians allocate donors to recipients based on 4 primary 
criteria: waiting time, medical urgency, phenotype matching and synchronisation, 
although his suggestions were more theoretically than empirically informed. As yet, 
no previous empirical studies have explored clinicians’ negotiation of the waiting list 
for donors in the context of egg donation in the UK. 
Clinicians framed the allocation of donors to recipients in a moral way, in which 
one’s place on the waiting list was the main determinant of one’s access to donors 
(and treatment). Thus clinicians were keen to stress the ‘fairness’ of the waiting list 
(Pope et al., 1991; Pennings, 2000) and its “simple” and “mechanical” nature, 
whereby the next available donor would be allocated to the recipient at the top of the 
waiting list, who had been waiting the longest. The quote below from Mrs. Redwood, 
the Director at The Fertility Centre, illustrates this view: 
“The matching process is quite fair, as soon as one donor comes up with so 
many characteristics, there is this patient, 1, 2, 3, 4, 5, that match in order of 
waiting. So we would offer to the first patient, and if declined to the second 
one, and if declined to the third, and so on” [Mrs Redwood, Creative Fertility] 
 
The waiting list was referred to as a necessary mechanism for managing donor 
allocation at both clinics, although it was more a central feature of donor allocation at 
Creative Fertility than at The Fertility Centre. This was primarily due to the larger 
number of donors and recipients at the clinic, the long waiting times to be matched 
and the electronic formalisation of the waiting list.  
The list for donors was not determined by ability to pay (although this was a 
perquisite of joining the waiting list) nor by urgency/need (e.g. age or infertility 
history). Instead, the waiting list was ordered by time spent waiting (as mentioned) 
and by recipients’ preferences for donor characteristics, so that recipients who were 
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willing to accept donors with particular characteristics would show up on the waiting 
list for those donors and not for others.  
According to clinicians, recipient choice was another organising criterion of 
matching. Clinicians described the aim of matching, and their own role in matching, 
as being to meet recipients’ preferences for donor characteristics and to ensure that 
recipients were “happy” with the donor that they were matched with, and so would 
accept her. This view is illustrated by the quotes below from nurses at each clinic:  
“I think an ideal match is something that the recipient is absolutely thrilled 
with.” [Anna, Creative Fertility] 
 
“A good match I would say is a 90% match, based on the preferences form 
that we have. It’s subject to the recipient. What’s important to them will be 
important for me when I match.” [Noreen, The Fertility Centre] 
 
As discussed in the previous chapter, clinicians had expectations about the type of 
preferences that recipients could state in the clinic. One such expectation was that 
recipients would want a donor who matched their own physical characteristics. When 
asked about the characteristics by which they matched donors and recipients by, it 
was common for clinicians to respond with a list of physical characteristics which 
were recorded by clinicians (and outlined in the previous chapter), as illustrated by the 
quote below:  
PD: “Which characteristics do you have in mind when matching?” 
Anna: “So, eye and hair colour, height and weight, and sort of general skin 
colouring are the main ones” [Anna, Creative Fertility] 
 
However, in practice, the waiting list, recipients’ preferences and physical 
characteristics shaped, but did not determine, the allocation of donors to recipients at 
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both clinics. It was common, for example, for clinicians to allocate a donor to a 
recipient who was more than halfway down the waiting list, with different physical 
characteristics, and/or to override recipients stated preferences for donor 
characteristics. That is, clinicians allocated donors to recipients based on their own 
perceptions of what constituted an “appropriate” or “good” match, as illustrated by 
the quotes below from Jemma and Doctor Rana at each clinic: 
“But we try and make it fair, so we do try and offer in order of who is on the 
list first, And we basically just compare their physical profiles. Often, a 
difficult one is when there’s no-one’s at the top half of the list who maybe is as 
physically appropriate, whereas someone who just joined the list might be 
[Jemma, Creative Fertility]  
 
“So I called Noreen, and I said ‘look, we got a Muslim donor, who is top of 
the list amongst those 4 recipients?’. Because it’s small clinic, we can just do 
it. Because patients get better service you see, the appropriate donor. So, 4 
patients on the waiting list, I’ll say no. 1, and Noreen will say ‘no no no 
doctor, she looks very much like number 3, that is a better match. So I say 
‘yes, okay, we’ll give it to number 3’” [Doctor Rana, The Fertility Centre] 
 
Therefore, clinicians did not see all types of matches as equally acceptable. In seeking 
to make an “appropriate match” clinicians inherently sought to avoid making an 
inappropriate or “unsuitable” match. Currently, there is no specific policy prescribing 
clinicians’ matching practices. However, at both clinics, clinicians saw a primary aim 
of their role in matching as being to protect the welfare of children born through the 
clinic, as will be explored below. Clinicians thus intertwined their role in matching 
with their mandatory duty to take into account the ‘welfare of the child’. Thus the 
waiting list, recipients’ preferences and matching physical characteristics were all 
secondary to the clinics’ own imposed primary matching criteria of ‘medical 
characteristics’ and ‘ethnicity’, both of which were legitimised as being in the best 
interest of children born through egg donation. These will now be explored in turn 
below. 
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6.3 ‘Medical Matching’ 
 
In seeking to fulfil their duty in protecting the ‘medical welfare of the child’, 
clinicians cited internal policy which imposed “medical” matching criteria intended to 
reproduce ‘healthy’ children and ensure a ‘medically safe’ pregnancy and birth. There 
is little in the social sciences or medical literature on matching donors and recipients 
according to medical criteria. In the past, the HFEA stipulated that clinicians 
matching donors and recipients by Cytomegalovirus (CMV) status, although this was 
removed due to a lack of evidence about CMV transmission in egg donation (as 
explored in Chapter 4).  
Although both clinics medicalised matching and reproduction through their definition 
of some characteristics as a ‘medical risk’ each clinic did so by prioritising different 
‘medical’ matching criteria, thus illuminating the socially constructed nature of these 
medicalised criteria. The ways in which medical criteria were prioritised in each of 
the clinics will now be explored in turn.  
 
Creative Fertility 
At Creative Fertility, clinicians said that they prioritised the height and weight (BMI) 
of donors and recipients when matching. Clinicians’ discourses revealed that they 
conceptualised these characteristics as a ‘medical risk’ in matching which required 
medical intervention to ensure ‘medical (physical) safety’ of children born through 
egg donation and recipients. In particular, clinicians drew on the potential danger of 
matching a large donor with a smaller recipient on the basis that this might lead to a 
recipient gestating a baby that was too big for her to give birth to. According to this 
reasoning, the access of recipients who were considered to be ‘small’ would be 
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restricted to small donors whereas ‘large’ recipients could supposedly be matched 
with any size donor. This view is illustrated by the quote below from Anna:  
“The height and weight will be a difficult one sometimes. Because, physically 
speaking, if there’s a very small recipient, who’s got the same hair and eye 
colour, but it’s a very large donor, you shouldn’t, for the medical safety of 
pregnancy and things like that, we probably shouldn’t be offering someone 
like that. So BMI tends to be a big deciding factor” [Anna, Creative Fertility] 
 
As illustrated by the quote above, clinicians prioritised medical criteria 
(height/weight) over and above the matching of physical characteristics (hair colour 
and eye colour). In medicalising height and weight as a risk, clinicians appeared to be 
drawing on a naturalistic assumption about women’s bodies regulating the size of 
their babies in natural reproduction. Thus, clinicians seemed to conceptualise their 
own role in regulating the height and weight donors and recipients as mimicking 
nature and natural reproduction, which they saw as adhering to their duty to protect 
the medical welfare of recipients and donor-conceived babies. Elsewhere, it also was 
not uncommon to hear doctors tell recipients that IVF was so successful because 
doctors had been perfecting the ability to “mimic nature”. 
At The Fertility Centre, clinicians did not report prioritising height and weight when 
matching. Instead, when questioned, they explicitly discounted height and weight as 
being a primary or medical matching concern. Instead, clinicians drew on the 
imposition of different ‘medical’ matching criteria, as will be shown below.  
 
The Fertility Centre 
At The Fertility Centre, clinicians prioritised the Cytomegalovirus (CMV) status of 
donors and recipients as the primary criterion of matching. The role of CMV 
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matching in egg donation was discussed in Chapter 4, where it was shown that the 
HFEA removed policy on CMV matching in egg donation due to lack of medical 
evidence. However, the Director of The Fertility Centre, who championed this 
internal clinic policy, was unaware of the removal of CMV matching from the HFEA 
Code of Practice in 2007 and drew on this policy and welfare of the child concerns to 
justify this practice, i.e. to prevent a child being born symptomatic at birth due to 
contracting congenital CMV.  
Therefore, the CMV status of donors and recipients was medicalised by the clinic as a 
‘medical risk’ in matching and as needing intervention and management by medical 
professionals. This medicalisation was specific to recipients of egg donation; couples 
undergoing fertility treatment using their own gametes or a known egg donor were not 
subject to such stipulations. In this respect, clinicians appeared to try to ‘improve on 
nature’ (rather than ‘mimic’ nature). As illustrated by the quote below, clinicians 
prioritised matching donors and recipients by CMV status, over and above matching 
for resemblance or physical characteristics:  
“What I’m saying is, how you will match first. First step is, if a recipient is 
CMV negative, then the nurse and myself will say ‘Oh, we have to find a CMV 
negative donor for her’. So, we can’t offer her the donors who are CMV 
positive, even if they had blue eyes like they wanted. So, the first criteria is 
CMV. If somebody is CMV positive, it’s not a problem, they can have positive 
donor or negative it makes no difference. So that is the first thing. And then, 
once we get CMV sorted, then we go for blue eyes and other physical 
characteristics” [Doctor Rana, The Fertility Centre]. 
 
As illustrated by the quote above, CMV negative recipients could only be matched 
with CMV negative donors whereas CMV positive recipients could be matched with 
CMV positive and CMV negative donors (as these recipients had already contracted 
the virus). Despite the emphasis on CMV matching, Noreen, the nurse who was 
required to implement this practice, saw it as “confusing” and “unfair”. For example, 
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whenever I asked Noreen to explain the rationale for CMV matching in egg donation 
she either avoided the conversation or directly asked for the topic to be changed. 
Acknowledging the prevalence of the CMV virus in the general population, Noreen 
described CMV as akin to the “common cold”. Noreen’s particular concern was the 
impact of CMV matching on CMV negative recipients, who had to wait longer to be 
matched with a donor, as illustrated by the quote below: 
 “The only thing that I found difficult in the matching process is the matching 
with CMV. If we do not match the CMV then we won’t have any waiting list. 
CMV positive donors can only be matched to CMV positive recipients, but 
CMV negative donors are very rare.” [Noreen, The Fertility Centre]  
 
However, Noreen also cited the need to manage the risk of congenital CMV for 
donor-conceived children, the nature of which went far beyond the common cold. 
Thus, despite being unsure about CMV matching, and at times questioning it, Noreen 
continued to implement it at the behest of Doctor Rana. Given the ‘rarity’ of CMV 
negative donors, these donors were often more valued by clinicians, who sought to 
‘save’ them for CMV negative recipients.  
Creative Fertility on the other hand stopped matching by CMV status after the 
removal of this HFEA policy in 2007. The Director of the clinic also saw CMV 
matching as severely restricting recipients’ ability to access donors and the clinic’s 
ability to match donors and recipients, and so applauded the HFEA’s change in 
policy, which she had been vocal in criticising for lacking in evidence base, as 
illustrated by the quote below: 
“I’ve stood up and said this story of CMV has to stop. You are penalising all 
the poor recipients who have never been exposed to CMV and that’s not fair 
[…] I’ve had ladies wait 1 year because of their CMV. Oh, there was this 
perfect donor for her, but unfortunately she was CMV negative and the donor 
was positive. It was not medically founded. Finally somebody heard, and 
finally somebody scrapped it from the regulation.” [Mrs Redwood, Creative 
Fertility] 
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The aim of the above internal medicalised matching criteria at each clinic was to 
reproduce ‘healthy children’, an outcome which was valued and encouraged. This aim 
was prioritised over secondary matching criteria such as meeting recipients’ 
preferences for donor characteristics or achieving physical resemblance between 
recipients and their child. Having explored clinicians’ discourses of allocating donors 
to recipients according to medicalised criteria, attention will now be paid to 
clinicians’ practices of matching donors and recipients according to these criteria. The 
ways in which clinicians foregrounded and minimised the importance of these criteria, 
and how they ‘strategically naturalised’ (Thompson, 2005) these criteria to make 
matches, will also be explored.  
 
6.3.1 Clinicians’ Negotiation of Medical Criteria 
Height and Weight 
Given the lack of information in existing literature about matching egg donors and 
recipients by height and weight, it is difficult to contextualise the actual height and 
weight differences matched by clinicians. Therefore, clinicians’ discourses and 
practices will be triangulated to uncover patterns in clinicians’ practices of matching 
donors and recipients by these characteristics. As will be shown below, despite 
clinicians’ emphasis on closely matching height and weight at Creative Fertility, 
descriptive analysis of 152 matches over the period of observations at the clinic (10 
months) revealed that clinicians matched donors and recipients across a wide range of 
height and weight differences and that this was done. 
Of the 152 matches for which information was collated, the height of matched donors 
and/or recipients was missing in 19 cases and the weight was missing in 22 cases (i.e. 
they were missing because they had not been formally recorded by clinicians). 
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Sometimes clinicians matched donors and recipients even when this information was 
missing. In such cases, clinicians commonly relied on their own perceptions of donors 
and recipients height/weight. Of the 133 cases for which the weight of donors and 
recipients was recorded, the average weight difference between matched donors and 
recipients was 8kg and the largest weight difference was 30kg. Of the 130 cases for 
which the height of donors and recipients was recorded, the average height difference 
between matched donors and recipients was 6cm and the largest height difference 
matched was 19cm.  
These differences were slightly smaller than at The Fertility Centre but were not 
significantly difference. At The Fertility Centre, descriptive analysis of 40 matches 
showed the average matched weight difference was 13kg and analysis of 44 matches 
showed the average matched height difference was 7cm. The table below summarises 
height and weight disparities between matched donors and recipients at each clinic. 
 
Table 6.1  Height and Weight Differences between Matched Donors and 
Recipients at Both Clinics over Period of Observations  
 
Weight Difference (kg)  
 
Height Difference (cm) 
 Creative Fertility 
The Fertility 
Centre 
Creative 
Fertility The Fertility Centre 
Average 8 13 6 7 
Median 6 11 5 5 
Mode 6 2 5 4 
Max 30 35 19 25 
Cases 133 40 130 44 
Missing 19 25 22 21 
Total 152 65 152 65 
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Although clinicians at Creative Fertility sought to prohibit the allocation of ‘large’ 
donors to ‘smaller’ recipients, analysis of their matching practices revealed that in the 
majority of cases recipients were actually shorter and weighed less than the donors 
they were allocated. Table 6.2 below outlines the distribution of height and weight 
differences between matched donors and recipients at Creative Fertility.  
 
Table 6.2  Distribution of Height and Weight Differences between Matched 
Donors and Recipients at Creative Fertility  
Creative Fertility Number of Cases (Matches) 
 Weight Height 
Donor Bigger than Recipient 83 70 
Donor Smaller than Recipient 44 51 
Donor and Recipient Same 6 9 
Total Number of Cases 133 130 
 
As illustrated by the above Table, recipients weighed less than the donors they were 
matched with in 83 cases and weighed less in 44 cases at Creative Fertility and 
recipients were shorter than the donors they were matched with in 70 cases and taller 
in 51 cases. Thus contrary to clinicians’ discourses about not matching a ‘bigger 
donor’ with a ‘smaller recipient’ their practices revealed that they did this in the 
majority of matches that they made.  
During observations of matching sessions at Creative Fertility it wasn’t uncommon 
for clinicians to draw on height and weight differences as a risk to kinship 
resemblance, rather than as a medical risk. For example, clinicians raised concerns 
about matching a small recipient with a large donor for resemblance. Furthermore, in 
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cases where recipients were using a gestational surrogate, in addition to an egg donor, 
clinicians typically matched the height/weight of donors to recipients and not to the 
surrogate who would be giving birth to the child.  
CMV 
At The Fertility Centre, the CMV status was recorded for 40 matched donors and 
recipients. Below, Table 6.3 outlines the number of matches made at The Fertility 
Centre according to CMV status. 
 
Table 6.3  CMV status of Matched Donors and Recipients at The Fertility Centre  
Recipient CMV Status Donor CMV Status Number of Matches 
Positive Positive 21 
Positive Negative 3 
Negative Negative 12 
Negative Positive 4 
Total number of Cases 40 
 
As illustrated in the table above, unlike at Creative Fertility, clinicians’ practices 
echoed their discourses of matching donors and recipients according to ‘medical 
characteristics’ at The Fertility Centre. A CMV positive donor was allocated to a 
CMV negative recipient in 4 cases, something which clinicians were adamant they 
would not do. Furthermore, a CMV negative donor was allocated to a CMV positive 
recipient in 3 cases, which was technically permissible, but something which 
clinicians generally avoided (as this would reduce the already limited availability of 
donors for CMV negative recipients).  
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At both clinics, the largest discrepancies in clinicians’ practices of matching by 
‘medical criteria’ were in relation to the matching of BME recipients, as will be 
explored below.  
 
BME Recipients: Stratifications of (Bio)Medicalisation  
As illustrated above, clinicians saw ‘medical criteria’ determining which donors and 
recipients could be matched. However, clinicians did not these criteria as equally 
applying to all types of matches and recipients. As illustrated in the section 
immediately above, clinicians’ practices revealed that they did not always adhere to 
their primary aims of matching according to medical criteria. In particular, the 
‘exception to the rule’ (medical criteria was not imposed) was when clinicians were 
matching BME recipients and BME donors. This exception brings to the fore the 
other primary matching criterion imposed by clinicians at both clinics, i.e. ‘ethnicity’ 
(which will be discussed in more detail in the following sub-section).  
At Creative Fertility, where clinicians saw matching the height/weight of donors and 
recipients as a priority, the small number of matches made between BME recipients 
and BME donors (n=9) had missing information in the majority of cases (n=7). 
Furthermore, the minority of cases for which this information were amongst the 
largest height/weight differences in the whole sample of matched donors and 
recipients at the clinic (n=152). For example, in one case, a BME donor was 25kg and 
18cm bigger than the BME recipient she was matched with. At The Fertility Centre, 
where CMV status was prioritised as a primary matching criterion, the few cases 
where clinicians mismatched the CMV status of donors and recipients were when 
matching BME donors and recipients. Here, 6 out of the 7 cases where the CMV 
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status of donors and recipients did not matched were between BME donors and BME 
recipients. 
Clinicians’ practices of matching by medical characteristics reflected their discourses 
of matching BME donors and recipients and their prioritisation of ‘ethnicity’ over 
medical criteria. The imposition of both medical criteria and ethnicity as primary 
matching criteria, coupled with a shortage of BME donors, meant that clinicians had 
to decide which of these matching criteria to prioritise in order to make a match. In 
such cases, clinicians prioritised matching the ethnicity of donors and recipients over 
their medical characteristics, thus racially stratifying medicalisation (Clarke et al., 
2010). Clinicians rationalised their mitigation of medical matching criteria in these 
cases as being necessary, i.e. in order to prevent delays to BME recipients having 
treatment, and in some cases, to allow them to have treatment at all. The quotes below 
illustrate clinicians’ prioritisation of ethnicity over medical criteria when matching 
BME recipients: 
“Generally they [BME recipients] get a lot less, there’s less donors to choose 
from, so there’s not as much choice. Things like BMI, we just need to offer 
regardless. But if we had somebody where the height and weight were going to 
be really ridiculously unmatched, well, we would probably ask and see what 
they thought.” [Anna, Creative Fertility]  
 
“I mean before CMV, of course, is the ethnic thing […] Especially if they’re 
Afro-Caribbean and Asian recipients, it’s difficult to find. And then CMV 
negative Asian donor, and Gujarati donor, and... forget all those things! So 
many ifs. It becomes difficult. So then in those cases, if the husband is CMV 
positive, then we say, then we explain to them, he is positive, anyway your 
embryo is going to be positive, as long as you don’t mind, and if they accept, 
then we go ahead.” [Doctor Rana, The Fertility Centre].  
 
As illustrated by the quote directly above, at The Fertility Centre rather than merely 
overriding CMV matching with ethnic matching, clinicians extended their clinical 
gaze to the CMV status of recipients’ partners, and sought to match donors’ CMV 
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with that of recipients’ partners. Thus whilst BME recipients who were CMV 
negative were able to access CMV positive BME donors, their access to these BME 
donors was dependent on the CMV status of their partner. At both clinics, clinicians 
imposed medical matching criteria for white recipients and BME recipients in 
different ways.  
Although the cases above illustrated how clinicians prioritised ‘race’ over ‘medical 
matching criteria’ specifically in relation to BME recipients, they also revealed 
clinicians’ prioritisation of these matching criteria more generally. However, for white 
recipients, it was taken for granted by clinicians that both their medical characteristics 
and ‘race’ would be matched with donors. That is, ‘race’ was seen as one of multiple 
Master Statuses for white recipients, alongside their medicalised characteristics. For 
BME recipients on the other hand, ‘race’ was seen as an overriding Master Status 
(Hughes, 1945), i.e. as the dominant label by which they were matched and which 
overrode their medical characteristics.  
Clinicians’ perceptions and practices of matching donors and recipients by ‘race’ and 
ethnicity will be explored below. This will include exploring clinicians’ discourses 
and practices of ‘racial matching’ and ‘transracial matching’.  
 
6.4 Racialised Matching: the Prioritisation of ‘Race’ 
As illustrated in the section above, clinicians saw it as their responsibility to protect 
the medical welfare of the children born through egg donation. Clinicians also saw it 
as their duty to protect the ‘social welfare’ of children, which they also intertwined 
with their role in matching, and with the practice of ‘racial matching’. The practice of 
‘racial matching’, commonly referred to as ‘ethnic matching’, refers to the allocation 
of donors to recipients based on ‘race’, albeit under the guise of ‘ethnic’ categories. 
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The term ‘racial’ matching’ rather than ‘ethnic’ matching has been chosen to describe 
the practices of clinicians (as discussed in Chapter 2) as it most accurately reflected 
the subject of participants’ accounts. In recognising that ‘race’ does not in fact exist as 
a scientific construct ‘race’ and ‘racial’ terminology is kept in inverted commas.  
As shown earlier, clinicians saw the aim of matching as being to facilitate physical 
resemblance between donors and recipients. This aim was intended to enable donor-
conceived children to ‘pass’ as the offspring of their non-genetic parent, to conceal 
the use of donor gametes, in what scholars refer to as the ‘biomedical model’ of 
reproduction (Price, 1997; Braverman and Frith, 2014). This aim was based on the 
assumption that children would genetically inherit the physical characteristics of their 
donor and consequently share this ‘kinship resemblance’ with its mother (the 
recipient). Clinicians thus saw the purpose of matching donors and recipients for 
physical resemblance as a social welfare of the child concern, as illustrated in the 
quote below from Doctor Rana:  
“So we try to find somebody who looks like the recipient. The idea, or the 
logic behind that being so the baby will be like them, so the baby will fit into 
their family, look like the others in the family, so that the child is not the odd 
one out. And then the welfare of the child is taken care of.” [Doctor Rana, The 
Fertility Centre]  
 
Matching was therefore seen as a mechanism by clinicians to reproduce a normative 
ideology of the family in which the physical resemblance is seen as an expression of a 
genetic relationship (Ariza, 2015). Conversely, clinicians saw a lack of resemblance 
between recipients and their child, and therefore between recipients and donors, as a 
potential ‘risk’ to the welfare of the child, and as needing intervention by clinicians 
(Millns, 1995; Culley, 2005; Campbell, 2007). However, not all types of differences 
were regarded as a welfare of the child concern by clinicians, or as needing to be 
managed. That is, most physical differences between recipients and donors, i.e. eye 
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colour, hair colour and size, were not regarded as a social welfare of the child 
concern; they did see ‘racial resemblance’ and ‘racial difference’ as a threat to the 
welfare of the child and as needing intervention by clinicians.  
Contrary to scientific understandings of ‘race’, which have discredited the notion of 
‘race’ as a biological concept (Miles, 1989; Wade, 2015; Caballero and Aspinall, 
2018), clinicians reified, reinforced and reproduced ‘race’ through their 
conceptualisation of “ethnicity” as a primary marker of differentiation and as a 
genetically inheritable physical characteristic (Roberts, 1999; Fogg-Davis, 2001; 
Szkupinski-Quiroga, 2007; Hudson, 2015; Deomampo, 2016). For example, clinicians 
commonly used ‘ethnicity’ as a proxy for skin tone, alongside racial terminology such 
as “Caucasian”, “Oriental” and “black”. That is, clinicians used ‘resemblance’ as a 
code for ‘race’ (Ariza, 2015; Deomampo, 2015; Hudson, 2015). As illustrated by the 
quote below from Anna, clinicians primarily conceptualised ‘ethnicity’ as a proxy for 
physical characteristics: 
“Yeah, it [ethnicity] encompasses a lot of things I think, but generally, where 
they’re born, what country or where their parents were born, because 
obviously physical traits go along with that, like skin colour and things. So 
that’s really the main thing, it’s generally physical.” [Anna, Interview] 
 
All of the clinicians in this study described “ethnic matching” as a “standard” and 
“established” practice within their clinics. Few clinicians cited HFEA policy on 
‘ethnic matching’, although all clinicians drew on ‘ethnic matching’ as an ethical, 
moral and welfare of the child concern. Echoing past HFEA policy, clinicians defined 
the welfare of the child as best being met by a normative model of the family, in 
which children racially resemble their parents. Clinicians thus singled out ‘race’ as the 
single most important marker of normative racialised family boundaries and as “a key 
medium for the transmission (or display) of kinship” (Wade, 2007: 8). As such, ‘racial 
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matching’ was seen by clinicians as a primary mechanism for constructing ‘kinship 
resemblance’ between recipients and their child and as protecting the welfare of the 
child. 
Clinicians therefore saw the aim of matching, and their role in matching, as being to 
reproduce ‘racial resemblance’ between donors and recipients and a racialised 
ideology of the family, which they legitimised as being in the best interests of the 
child. That is, clinicians sought to reproduce “race-kinship congruity” (Wade, 2012: 
79), i.e. the idea that “people who are related by consanguineous kinship should also 
have a ‘racial’ appearance that is congruent with-– explicable in terms of – their 
kinship connections” (ibid). Most clinicians saw it as their responsibility to ensure this 
on the grounds that they were ‘helping’ to create a child and had some control over 
donor-conceived children’s well-being, as illustrated by the quote below from 
Noreen: 
“I think we’re thinking of the welfare of the child here, the resulting child. If 
you can have the control, you know, preventing the child to be bullied. So for 
example, if the child turned out to be Caucasian and the birth parents are 
Indian, there might be a bit of confusion for the child as well. So, first and 
foremost welfare of the child is the reason why we match ethnicity”. [Noreen, 
The Fertility Centre] 
 
Several clinicians also described the aim of ‘racial matching’ as being to protect 
recipients by concealing the use of donor gametes (Price, 1997). Clinicians 
highlighted the potentially stigmatising impact of using egg donation on recipients, 
and on their children. This included recipients and their children being marginalised 
within their wider community, “disinherited” by their immediate families and 
constantly having their legitimacy as a family questioned by others. As such, 
clinicians saw matching for resemblance as enabling recipients to maintain secrecy 
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about their use of donor eggs (and their infertility). This view is illustrated by the 
quote below from Mrs. Redwood: 
“There’s all sorts of stigma about it [egg donation], so for some patients it’s 
very very difficult to talk about it. And we respect that, we can perfectly 
understand that in some families it’s going to be very difficult and in others 
it’s going to be more open. So that’s why we focused on the phenotypes” [Mrs. 
Redwood, Creative Fertility] 
 
Some clinicians also referred to matching for resemblance as enabling recipients to 
maintain secrecy from their own child. A commonly held perception amongst 
clinicians in this study was that BME recipients were less likely than white recipients 
to be ‘open’ about egg donation with their child because of “cultural” reasons, a view 
that was reflective of some of the wider literature on disclosure (Culley and Hudson, 
2006; Nuffield Council, 2013). For example, during observations of BME recipients’ 
consultations it wasn’t uncommon for clinicians to skirt over their mandatory 
requirement to encourage recipients to be open with their child. This view is 
illustrated in the quote below, from Doctor Demetrious, who had just finished 
explaining why it was “reasonable” for recipients to want a ‘racially matched’ donor:  
“Which again is reasonable, because not all couples will tell the child, even if 
they say that they will now. Especially the ethnic minorities, I think that 80-
90% of them will not tell the child, Caucasians a little bit more they will.” 
[Doctor Demetrious, Creative Fertility] 
 
In conceptualising ‘race’ as a key mechanism for constructing kinship resemblance 
clinicians conversely pathologised ‘racial difference’ as an primary ‘kinship risk’. The 
concept of ‘kinship risk’ is introduced here to refer to physical differences between 
recipients and their child that might reveal the lack of a genetic relationship between 
recipients and their child, i.e. an imagined threat to the display of kinship 
resemblance. Clinicians saw it as risky to disrupt normative kinship boundaries and 
intertwined ‘natural’ (normative) racial hierarchies. They saw it as their responsibility 
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manage the crossing of racialised boundaries, with the ultimate aim of reproducing 
and reinforcing them. As such, clinicians sought to avoid reproducing ‘racially 
incongruent’ families (Wade, 2012) and rationalised their reproductive gatekeeping 
role as being in the best interests of the child (Steinberg, 1997; Culley, 2005; 
Szkupinski-Quiroga, 2007; Roberts, 1997; Malin, 2003, Campbell, 2007).  
Here, clinicians typically depicted scenarios in which a lack of racial resemblance 
between recipients and their child would lead to children ‘suffering’, questioning their 
belonging within the family, having their belonging questioned by others and being 
“bullied” in the playground, as illustrated by the quote below from Doctor Rana: 
“Well, we always believe in giving the person from the same ethnic origin. It’s 
so that the baby doesn’t suffer, for the welfare of the child. Because we don’t 
want anybody asking questions or pointing at the baby, so that when the child 
goes to the school, say the Indian couple will bring a white looking child, all 
the other children will make fun of the child and bully it. ‘How come you are 
so white, when your dad and mum are Asian? Everyone in school will ask, 
‘who’s your dad, who’s your mum?’ The child will suffer. But if the child fits 
into the family, then there won’t be many questions. That’s the main purpose 
of matching by the physical characteristics.” [Doctor Rana, The Fertility 
Centre] 
 
As illustrated by the quote above, clinicians commonly conflated ‘physical 
characteristics’, ‘race’ and ‘ethnicity’. The Directors of each clinic (in particular) 
recounted several ‘horror stories’ (Goode and Ben-Yehuda, 2010) to highlight the 
dangers of BME recipients using a white donor, and even a mixed ethnicity donor. 
Such stories were often used to legitimise the reproductive gatekeeping role of 
clinicians as being in the best interests of donor-conceived children and recipients. 
For example, in the quote below, Mrs. Redwood recounts a case of a black recipient 
with a white partner ‘insisting on’, and later regretting, having treatment with a mixed 
ethnicity egg donor:  
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“I remember another lady, she was Black, and she was really pushing for a 
donor who was mixed race, and her husband was Caucasian. And I said to 
her, ‘why do you want a mixed race donor and not a black donor? You’re 
going to have a mixed race baby anyway’. Anyway, she had the baby and the 
first thing she said to me was ‘ahh, this baby is so white’. You know, what can 
you say, ‘I told you so?’ You can’t give it back. So I think, people do not 
always have the right idea of what’s going to happen, or have misconceptions, 
but it’s really about thinking of the welfare of the child” [Mrs. Redwood, 
Creative Fertility] 
 
On the whole, clinicians’ practices of racially matching donors and recipients 
reflected their discourses. That is, the majority of matches made at both clinics were 
between donors and recipients of the same recorded ethnicity. To reiterate, for the 
purposes of this study, a ‘racial match’ was defined as a match between donors and 
recipients from the same overarching ‘ethnic groups’ (i.e. white, South Asian, black 
African/Caribbean and Chinese) and a ‘transracial match’ was defined as the 
matching between donors and recipients from different overarching ‘ethnic groups’. 
At Creative Fertility, of the 152 matches observed at the clinic, 95% were between 
donors and recipients of the same ‘racial’ background and over 90% of the total 
matches made were between white donors and white recipients (n=142). At the 
Fertility Centre on the other hand, from the 65 matches recorded, 79% of donors and 
recipients were ‘racially’ matched, and the ‘ethnicity’ of donors and recipients was 
more diverse.  
These figures need to be interpreted with caution however, for the reasons outlined in 
Chapter 3 and due to the subjective process of classification outlined in Chapter 5. To 
briefly recap some of the issues here, (a) the characteristics and categories used to 
record ‘ethnicity’ were limited, (b) clinicians relied on their own subjective 
perceptions of skin tone to record information, (c) some of the ethnic categories that 
donors and recipients were assigned to by clinicians were re-coded because they were 
haphazardly or sparingly used (e.g. ‘Sri Lankan’ was recoded to ‘South Asian’), (d) 
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inconsistent usage of lower-level ethnic categories made it necessary to use broad 
racialised categories (i.e. white, black, South Asian, Chinese) to present this data and 
(e) it is recognised that these broad ‘ethnic’ categories reflect ‘racial’ categorisation 
more than socio-political identity.  
The category ‘white’, sometimes labelled and referred to as ‘Caucasian’ by clinicians, 
predominantly comprised white British patients, but included donors and recipients 
from a range of countries outside of the UK. The category ‘black African/Caribbean’, 
included donors and recipients who were labelled as black Caribbean and black 
African and the category ‘South Asian’ included recipients from Indian, Pakistani, Sri 
Lankan and Tamil ethnic backgrounds. As discussed in the previous chapter, mixed 
ethnicity individuals were categorised according to their minority (and most marked) 
ethnicity by clinicians. Although these categories have been criticised for 
‘essentialising’ culture and phenotype (Bhopal et al., 1990; Frankenberg, 1994; 
Aspinall, 2001, 2003), they nonetheless reflect clinicians’ overarching categorisation 
of patients and will therefore reflexively be employed.  
The number and percentage of ‘racial matches’ and ‘transracial matches’ made at 
each clinic over the period of observations are illustrated in Table 6.4 (Creative 
Fertility) and 6.5 (The Fertility Centre) below. The cells in green represent ‘racial 
matches’ between donors and recipients whilst the cells in blue represent ‘transracial 
matches’ (as classified for the purposes of this study).  
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Table 6.4: Recorded Ethnicity of 152 Matched Donors and Recipients over 10 
months, Creative Fertility 
 
Creative Fertility Recipient Ethnicity 
White Black South Asian Chinese Total 
D
o
n
o
r 
Et
h
n
ic
it
y 
White 90% (135) 1% (2) 1% (2) 1% (2) 93% (141) 
Black 0% (0) 3% (4) 0% (0) 0% (0) 3% (4) 
South Asian 1% (2) 1% (2) 2% (3) 0% (0) 4% (7) 
Chinese 0% (0) 0% (0) 0% (0) 0% (0) 0% (0) 
TOTAL 91% (137) 5% (8) 3% (5) 1% (2) 100% (152) 
 
 
Table 6.5: Ethnicity of 65 Matched Donors and Recipients over 13 months at The 
Fertility Centre 
 
The Fertility Centre Recipient Ethnicity 
White Black South Asian Chinese Total 
D
o
n
o
r 
Et
h
n
ic
it
y 
White 42% (27) 1% (1) 17% (11) 0% (0) 60% (39) 
Black 0% (0) 14% (9) 0% (0) 0% (0) 14% (9) 
South Asian 0% (0) 3% (2) 22% (14) 0% (0) 25% (16) 
Chinese 0% (0) 0% (0) 0% (0) 1% (1) 1% (1) 
TOTAL 42% (27) 18% (12) 39% (25) 1% (1) 100% (65) 
 
As illustrated by the tables above, at both clinics the majority of transracial matches 
(blue cells) were made between white donors and BME recipients, followed by 
donors and recipients from different minority ethnic backgrounds, and lastly, a 
minority of matches were made between BME donors and white recipients at Creative 
Fertility only. At Creative Fertility, transracial matches accounted for 5% (n=10) of 
152 matches recorded, whilst at The Fertility Centre, transracial matches accounted 
for 21% of the 65 matches recorded (n=14). This difference in the percentage of 
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transracial matches between clinics was shaped by the supply and demand of BME 
donors and recipients at each clinic, by clinicians’ perceptions of skin tone (which 
was related to clinicians’ own ethnicity) and by clinicians beliefs about ‘race’ and 
reproduction. The figures in the tables above will be discussed in more depth below, 
alongside clinicians’ discourses of transracial matching.  
Clinicians’ negotiations of transracial matching illuminated the ways in which 
clinicians mediated the crossing of normative racialised kinship boundaries and the 
nuanced ways in which they acted upon patients’ characteristics in ways that stratified 
and racialised reproduction and medicalisation in new and complex ways. 
 
6.5 ‘Transracial’ Matching: Negotiations of ‘Race’  
‘Transracial matching’ refers to the matching of donors and recipients from different 
‘racial groups’, i.e. white, black African/Caribbean, South Asian and Chinese. This 
includes matching donors and recipients from white and BME backgrounds (e.g. 
white and South Asian) and also matching donors and recipients from different 
minority ethnicities (e.g. South Asian and black African). This section explores the 
context in which clinicians made transracial matches and how clinicians strategically 
naturalised, de-naturalised and re-naturalised donor and recipient characteristics for 
the purposes of making a match.  
As mentioned above, ‘transracial matches’ accounted for 5% of all matches at 
Creative Fertility and 21% of all matches at The Fertility Centre. Of these, the 
majority of matches ‘transracial matches’ made by clinicians were between white 
donors and BME recipients, which accounted for 3% (n=6) of all matches at Creative 
Fertility and 18% of matches at The Fertility Centre. This was followed by matches 
between South Asian donors and black recipients, which accounted for 1% (n=2) of 
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matches at Creative and 3% (n=2) of matches at The Fertility Centre. Finally, a BME 
donor was allocated to a white recipient in 1% (n=2) of matches at Creative Fertility 
and in no cases at The Fertility Centre.  
Clinicians’ navigation of ‘transracial matching’ revealed how reproduction was 
stratified through clinicians’ willingness, and unwillingness, to match donors and 
recipients from different ‘racial’ backgrounds. As will be explored below, the types of 
families that were valued by clinicians and the types of families that were less valued 
by clinicians shaped the types of families they sought to reproduce through egg 
donation and their matching practices. Clinicians’ navigation of ‘racial difference’ in 
matching was especially revealing of the role that clinicians played in reproducing 
racialised hierarchies and regulating the ‘reproduction of whiteness’. 
As will be shown, although clinicians were willing to match white donors to BME 
recipients, albeit with certain caveats, they were unwilling to match BME donors with 
white recipients. Below, clinicians’ perceptions and practices of ‘transracially 
matching’ BME recipients will be explored, followed by their views of ‘transracially’ 
matching white recipients. 
 
6.5.1 BME Recipients: Curtailing Whiteness 
At each clinic, the imposition of ‘race’ as a primary matching criteria had particular 
implications for BME recipients. A shortage of BME donors meant that BME 
recipients waited much longer to be matched than their white counterparts and in 
some cases this meant that some BME recipients might not be matched with a donor 
or receive treatment at all. Although The Fertility Centre had a higher proportion of 
BME donors the demand for these donors (by BME recipients) still outstripped their 
supply. In this context, clinicians re-conceptualised ‘race’ as being negotiable and 
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flexible, to an extent. Thus, despite otherwise framing ‘racial difference’ as a risk to 
the ‘welfare of the child’, all of the clinicians in this study not only saw it as 
“reasonable” to match white donors with BME recipients but framed this as a 
necessary compromise for recipients, i.e. to prevent delays to their treatment, as 
explored in Chapter 5. 
However, despite clinicians’ willingness to allocate white donors to BME recipients, 
this practice was only seen as acceptable with certain caveats (recipients’ motivation 
aside), which will be explored below. The overarching theme in clinicians’ discourses 
and practices appeared to be a motivation to limit the degree of ‘whiteness’ in BME 
recipients’ reproduction, with the implication of further stratified particular BME 
recipients’ access to particular types of donors. Clinicians’ imposed several caveats in 
relation to matching white donors to BME recipients. These included: leaving 
recipients to wait longer to be allocated a white donor; restricting the ‘type’ of white 
donor they could be allocated; and restricting the ‘type’ of BME recipient that could 
be allocated a white donor. These factors will now be discussed in turn, below.  
Before allocating a white donor to a BME recipient it was typical for clinicians to 
leave that recipient waiting longer for such a match. That is, BME recipients who 
were willing to accept a white donor would be left waiting longer than their white 
counterparts to be matched with a white donor, as illustrated by the quote below from 
Anna. This appeared to be done in case a ‘racial match’ could be found for the BME 
recipient.  
“But we would still try primarily to match them [BME ORs] with someone of 
the same ethnic group, and we’ll usually leave them waiting longer, and after, 
you know, a fairly long wait, we’ll approach them with a white donor”[Anna, 
Creative Fertility] 
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During observations of matching sessions at Creative Fertility, when a BME recipient 
showed up at the top of the waiting list for a white donor, clinicians questioned her 
position on the waiting list (because she were not white) and often scrolled past her 
without further consideration, in search of a more “appropriate”, white, recipient. 
Clinicians also distinguished between the ‘type’ of white donors that they saw as 
being acceptable to allocate to BME recipients, particularly at Creative Fertility. BME 
recipients were predominantly allocated ‘marked white’ donors, e.g. from Algeria, 
Iran, Morocco and Portugal, who had previously been declined by white British 
recipients (as will be explored in Chapter 8). BME recipients were seldom matched 
with white British donors.  
During observations, it wasn’t uncommon to clear clinicians comment that a 
particular ‘marked white’ or “Mediterranean” donor “looks Indian” or “looks 
African” before allocating them to BME recipients. Clinicians typically sought to 
allocate ‘marked white’ donors, with ‘darker hair and eye colour and olive skin tone’, 
to BME recipients, as illustrated by the quote below from Anna: 
“Even if someone’s white, again, we would try to make sure they’ve got darker 
colouring, darker hair, skin tone, things like that.” [Anna, Creative Fertility] 
 
Clinicians thus conceptualised BME recipients as being closer in phenotype to 
‘marked white’ donors than to white British recipients, and in some cases, event to 
BME donors, as illustrated by the quote below from Mrs. Redwood: 
“I remember matching an Indian lady with an Iranian origin, Iranian donor, 
because it was closer to her looks than some Indian donors who are much 
darker.” [Mrs. Redwood, Creative Fertility] 
 
Clinicians thus conceptualised ‘marked white ’donors as having a flexible ‘race’ and 
being able to ‘pass’ as BME. However, clinicians did not see it as acceptable to 
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allocate ‘marked white’ donors to all BME recipients equally. Instead, the 
permissibility of this practice further stratified reproduction, and (bio)medicalisation 
(i.e. recipients’ access to donors), based on racialised hierarchies of skin tone.  
When questioned about ‘transracial matching’, clinicians typically replied that they 
saw it as “reasonable” and “acceptable” to match white donors with South Asian and 
Chinese recipients. However, clinicians were hesitant/ambiguous about allocating 
white donors to black African/Caribbean recipients, as reported in previous surveys of 
clinicians (Birdsall and Edwards, 1996; Murray and Golombok, 2000) and when 
asked about this practice they frequently slipped into talking about the acceptability of 
matching white donors to BME recipients more generally or to South Asian and 
Chinese recipients specifically.  
Clinicians often conflated categories of ‘ethnicity’ and skin tone and drew on taken 
for granted racialised hierarchies of skin tone to contextualise their perceptions of 
matching. The quote below, from the counsellor at Creative Fertility, illustrates 
clinicians’ reluctance to match white donors with black recipients because they were 
seen as being at the opposite ends of the ‘racial’ spectrum: 
“So if they had a white donor they wouldn’t say ‘we’ll match her with this 
lovely black lady’, they wouldn’t do that automatically. I don’t think that 
would happen. But there’s lots of in betweens […] So I don’t think necessarily 
it would be black and white matched together, but there’s a shady area in the 
middle.” [Linda, Creative Fertility] 
 
Thus the ‘ethnicity’ and skin tone of BME recipients - or rather clinicians’ 
perceptions and classification of these characteristics - directly stratified their access 
to white donors. However, it was not just the ‘ethnicity’ and skin tone of donors and 
recipients which were taken into account by clinicians when matching. Interesting, the 
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‘ethnicity’ and skin tone ascribed to BME recipients’ partners was also a primary 
determinant of BME recipients’ access to white donors. 
In essence, clinicians saw it as acceptable to allocate a white donor to a BME 
recipient with a BME partner (i.e. to a BME couple), they would not allocate a white 
donor to a BME recipient with a white partner. The quotes below from clinicians at 
each clinic provide an insight into the complexities involved in clinicians’ decision-
making and their navigation of racialised reproduction: 
“So, if the wife is black and the husband is black [figures it out]… in this 
situation, they may not only accept a black, they would accept a white as well. 
And in the other situation, where husband is white and the wife is black, if they 
had a white donor, the child would be completely white, so they would not 
accept that. So in that situation, they would be happy for the child to be black 
black, or mixed, but not completely white” [Doctor Demetrious, Creative 
Fertility] 
 
“For example, when the recipient is Indian and the husband is also Indian, 
they will say ‘I can accept a white donor’. But if the recipient is Indian and the 
husband is white, and she uses an egg donor who is white, that means the 
child will be totally white, so we don’t give them. If the partner is Asian, it is 
different, then we can offer.” [Doctor Rana, The Fertility Centre] 
 
Such negotiations add another layer to stratified reproduction, in which some 
reproductive futures are valued and encouraged whilst other futures are ‘despised’ and 
discouraged (Ginsburg and Rapp, 1995b). That is, whilst clinicians saw it as 
acceptable for a BME recipients (of marked ethnicity) to have a mixed ethnicity child 
(of marked ethnicity), and enabled the reproduction of these families, they did not see 
it as equally acceptable for BME recipients to have a “totally white” child (of 
unmarked ethnicity), and avoided this type of reproduction. During observations, 
sometimes clinicians would comment that the ‘genes’ or ‘sperm’ of the recipient’s 
BME partner would ‘balance out’ the skin tone of the child, i.e. make it darker, so that 
the child would be ethnically marked, like the recipient.  
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Ethnographic observations of clinicians’ practices of matching, as outlined in Tables 
6.4 and 6.5 (above), showed that on the whole, clinicians’ practices of matching BME 
recipients reflected their discourses of matching according to racialised skin tone. At 
Creative Fertility, a small minority of white donors were allocated to black 
African/Caribbean, South Asian and Chinese recipients in an equal number of cases 
(n=2 each). However, even these figures disguise important complexities within each 
case. For example, the 2 matches between a ‘white donor’ and a ‘black 
African/Caribbean’ recipient both involved the same ‘black African’ recipient, who 
was also labelled as being “light skin Arab”. Therefore this ‘black African’ recipient 
was seen as ‘marked’ as possessing a flexible ‘race’, i.e. as something other than 
‘black’, which made it more acceptable to match her with a white donor (which 
clinicians were otherwise hesitant to do).  
At The Fertility Centre on the other hand, where there was a higher number of BME 
recipients, clinicians allocated white donors to South Asian recipients in 17% of cases 
but only allocated a white donor to a black recipient in 1% of cases. Clinicians also 
allocated a South Asian donor to a black recipient in 2 cases at each clinic (n=4). 
However, no matches were made between black donors and South Asian recipients. 
Informal discussions with clinicians revealed that they didn’t match black 
African/Caribbean donors with South Asian recipients because they thought that 
South Asian recipients would refuse these donors based on their dark skin tone. On 
the other hand, clinicians saw black African/Caribbean recipients as being more 
“open” to accepting South Asian donors on the basis that these recipients sought 
donors with donors with darker skin tone and saw “South Asian skin tone” as a more 
acceptable compromise than ‘white skin tone’. 
The findings that clinicians were reluctant to match white donors with BME recipients 
echo the findings of previous quantitative surveys on clinicians’ views in the UK 
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(Birdsall and Edwards, 1996; Murray and Golombok, 2000) and qualitative studies 
which have touched on clinicians’ views (Campbell, 2007; Steinberg, 1997; Price, 
1997; Klotz, 2014). However, as illustrated above, clinicians’ discourses and practices 
were more nuanced than simply answering ‘yes’ or ‘no’ to the question of ‘transracial 
matching’.  
Clinicians’ nuanced negotiations of matching BME recipients illustrate how clinicians 
stratified reproduction through seeking to curtail and contain whiteness for BME by 
restricting the type of white donors they could access and the type of BME women 
who could access them. On the other hand, clinicians’ perceptions of matching white 
recipients revealed a primary concern with maintaining whiteness within white 
families, as will be discussed below.  
 
6.5.2 White Recipients: Maintaining Whiteness 
For white recipients clinicians’ primary concern was to maintain (not curtail) the 
degree of whiteness in their reproduction. When clinicians were asked whether there 
were any types of matches that they would not make, all were adamant that they 
would not be willing to allocate a BME donor to a white couple. Clinicians could not 
envisage making such a match unless it was specifically at the ‘insistence’ of white 
recipients (which they had not previously experienced). Unlike BME recipients and 
‘marked white’ donors, for whom clinicians saw ‘race’ as flexible (albeit it with 
several caveats), for white (British) recipients, ‘race’ was regarded as inflexible and 
bounded.  
Clinicians drew on a different set of values and concerns in relation to matching BME 
donors with white recipients (compared with matching white donors with BME 
recipients). Here, clinicians did not draw on the semantics of ‘supply and demand’. 
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Neither did they merely highlight the negative socio-cultural consequences of a lack 
of resemblance between recipients and their child on the welfare of the child. Instead, 
clinicians drew on naturalistic assumptions about ‘race’ and reproduction and saw it 
as unnatural and unethical for a white couple to have a ‘black’ child, and more 
specifically, for a white woman to give birth to a ‘black’ child in the absence of a 
BME partner. This echoes findings from Deomampo’s (2015) study in India, where 
clinicians were reluctant to match South Asian donors with white recipients, although 
they did make such matches (unlike the clinicians in this study). The quote below 
from Jemma illustrates clinicians’ refusal to allocate BME donors to white recipients 
on the grounds of this going against ‘nature’ and the welfare of the child:  
“I wouldn’t be comfortable myself. Because as a white couple you can’t have 
a natural black baby. Do you know what I mean?! I would just feel 
uncomfortable. Ethically, it wouldn't be good for the child as well, that kind of 
thing. More a welfare of the child issue than anything.” [Jemma, Creative 
Fertility] 
 
“If the child is going to be a completely different race to their parents, you 
know, we wouldn’t do that. So we wouldn’t offer a white recipient a black 
donor, an Asian donor or that sort of thing. Definitely wouldn’t do that. That’s 
the main one, given that the mother is going to be giving birth to the child, I 
think that’s one of the main reasons” [Anna, Creative Fertility] 
 
At The Fertility Centre, no matches were made between BME donors and white 
recipients. At Creative Fertility, clinicians allocated South Asian donors to white 
recipients in 2 cases, as illustrated in Table 6.4, despite being vehemently opposed to 
this in theory. However, in each case, the 2 white recipients concerned were both 
‘marked white’, i.e. Algerian and Moroccan, which appeared to supersede clinicians 
concerns about a lack of ‘racial resemblance’. That is, clinicians foregrounded these 
white recipients’ ‘markedness’ over their ‘whiteness’. The excerpt below is from an 
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informal conversation with Anna, which illustrates her reasoning for allocating a 
South Asian (Pakistani) donor with an Algerian recipient:  
“Anna and I talked about what Algerian peoples’ skin colour looks like. I said 
I didn’t know. Anna said she assumed that it would be like South Asian skin 
tone, hence previously offering this Algerian recipient a Pakistani donor who 
had light skin tone” [Field note, week 19, Creative Fertility] 
 
Interestingly, Anna also appeared to draw on the Pakistani donor as possessing both a 
marked and flexible ‘race’ by describing her skin tone as ‘light’, and something other 
than ‘normal’ Pakistani skin tone, thus making it more acceptable to allocate her to a 
‘white’ recipient. Clinicians’ concerns about maintaining ‘pure white’ racialised 
boundaries (Szkupinski-Quiroga, 2007), and their innovative ways of navigating these 
to make a match, were also apparent in their negotiations of matching ‘marked white’ 
donors with white British recipients, something which they otherwise tried to avoid. 
Clinicians’ hesitancy to match ‘marked white’ donors with white British recipients 
was in part due to their experience of white recipients’ declining ‘marked white’ 
donors when they were offered to them (as will be explored in Chapter 8). However, 
clinicians also displayed some concerns about white British recipients having a child 
who would look ‘too different’ from its parents if it had ‘olive’ skin tone. Such 
concerns did not preclude clinicians from making such matches however, although 
when they did, they strategically naturalised and normalised (Thompson, 2005) the 
‘olive’ skin tone of donors as ‘light/fair’ by foregrounding or minimising the role of 
genes in determining donors’ skin tone. Such strategies enabled clinicians to ‘unmark’ 
the whiteness of these donors so that they could be matched with white British 
recipients, as will be shown below.  
When classifying white donors’ skin tone, clinicians foregrounded white donors’ 
‘ability to tan’ as an indicator of their ‘natural’ and genetic inheritable skin tone (as 
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explored in Chapter 5). However, when seeking to ‘unmark’ white donors, clinicians 
contextualised donors’ ‘tanned’ skin tone as being due to them coming from sunny 
countries (and thus not as being due to their inheritable genetic make-up). As such, 
clinicians reasoned that in the UK, which has less sun than the donors’ countries of 
origin, these donors would have ‘lighter’ (natural) skin tone than they would 
otherwise have, making it acceptable to allocate them to white British recipients, as 
illustrated by the field note excerpt below:  
‘After they matched the donor from Columbia with a white British recipient 
they worried that the donor might be darker in skin tone than the recipient. 
They pulled out a passport photo of the donor and looked at her to deem her 
skin colour. Jemma said the difference in skin colour would be fine. Doctor Ali 
said that in her photograph the donor probably would have been in Columbia 
and so would have had a tan, which she probably wouldn’t have in the UK. [I 
don’t know how they could tell- the passport picture was black and white]’ 
[Field notes, week 17, Creative Fertility] 
 
On another occasion, clinicians were concerned about matching a white British donor 
with a white British recipient because the donor was marked as having “olivey” skin 
tone. As with the above example, clinicians reasoned that the donor had ‘tanned’ skin 
tone because she had been travelling in India that summer. However, here, clinicians 
foregrounded the role of genetics in determining the donor’s ‘natural’ skin tone (not 
the environment), by drawing on the ethnicity of her parents and grandparents, all of 
whom were white British. This strategic naturalisation enabled clinicians to 
normalise, and ‘unmark’ the donor’s “olive” skin tone by reconceptualising it as being 
‘naturally’ (genetically) “fair”.  
As illustrated in this section on ‘racial matching’, clinicians’ perceptions and practices 
of matching were nuanced, complex and contextual. Skin tone rather than ‘ethnicity’ 
was the most prioritised matching criterion by clinicians. Although clinicians were 
willing to negotiate the boundaries of ‘racial difference’, their practices ultimately 
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reinforced and reproduced existing racialised hierarchies and inequalities. Whilst 
clinicians’ negotiations of racialised hierarchies were central to their practice of 
matching for physical resemblance, it is important to note that other (unrelated) 
categories and contextual factors also shaped clinicians’ practices of donor allocation.  
As seen in the previous chapter, clinicians classified recipients as ‘good’ or 
‘demanding’ based on recipients’ compliance with clinicians’ expectations of the 
recipient role. Below, some of the ways in which these classifications impacted 
clinicians’ matching practices will be explored.  
 
6.6 ‘Demanding’ Recipients: Delaying Matching  
Clinicians’ perceptions of recipients as ‘demanding’ and ‘difficult’ sometimes shaped 
decision to matching, or rather not match, particular recipients. Here, clinicians 
avoided matching recipients whom they saw as ‘demanding’ and often left these 
recipients to wait longer to be matched with a donor.  
Sometimes nurses avoided matching recipients whom they constructed as being “too 
difficult” because they wanted to avoid supporting them through their treatment cycle, 
which they would have been required to do after matching them. This was particularly 
the case at Creative Fertility, where a larger supply of recipients meant that nurses 
could afford to be more discerning about which recipients to match and where the 
number of on-going treatment cycles was much larger than at The Fertility Centre. It 
was common to see nurses skip over recipients at the top of the waiting list, reasoning 
that they were “too fussy” or “too picky” and so would not accept or were not 
deserving of the donor under consideration.  
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For example, during one matching session at Creative Fertility one recipient, Julia, 
showed up near the top of the waiting list for a donor. However, the nurses concluded 
that Julia would be ‘too difficult to deal with’ during her treatment and so they 
avoided matching her with a donor in that matching session (and in several 
subsequent sessions), as illustrated by the short excerpt below from observational 
field notes:  
“When Julia, the next recipient, showed up as a potential match for a donor 
the nurses and doctor all chorused ‘Oh no, we’re not going to match to her, 
she would be a nightmare to have to go through treatment with. We’re not 
ready to deal with her yet’. And they carried on searching for another 
recipient” [Field notes, Week 31, Creative Fertility] 
 
Nurses were especially reluctant to match ‘demanding’ recipients when they were 
particularly busy. For example, over one period of observations at Creative Fertility 
the head nurse had gone on holiday for several weeks. The remaining nurse, Jemma, 
was concerned about co-ordinating and supporting matched donor and recipient 
through their treatment cycles alone and sought to minimise any disruption to her 
workload during her colleague’s absence. In one matching session, having hesitantly 
matched one recipient (Suzanne) who was regarded as a “nightmare” because she had 
declined ‘lots of donors’, Jemma avoided matching a second recipient (Carmel), who 
was also regarded as being “difficult” on account of having lots of preferences for 
donor characteristics. This meant that the Jemma would not have to support and 
manage the treatment cycles of too many “difficult” recipients at the same time, 
particularly whilst she was doing this alone.  
This scenario is illustrated by the field note below:  
“When the next recipient, Carmel, showed up as a potential match for this 
donor, the nurse and doctor groaned. On Carmel’s profile it stated that she 
“wants very slim donor, in 20’s”. Jemma [the nurse] complained ‘I can’t deal 
with both Carmel and Suzanne (the ‘difficult’ recipient whom had just been 
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matched a moment ago) at the same time while Anna [the head nurse] is 
away’. Jemma skipped over Carmel’s name and carried on going through the 
list looking for another recipient” [Field notes, week 34, Creative Fertility] 
 
Nurses’ practices of not matching particular ‘difficult’ recipients thus enabled nurses 
to manage their own emotional labour and their busy workloads. However, clinicians 
also saw the practice of not matching recipients, and delaying their allocation of a 
donor, as serving another purpose. A pervading theme in clinicians’ discourses was 
the view that recipients’ preferences for donor characteristics would “soften over 
time”, i.e. that recipients would be more willing to compromise on their preferences 
and accept a donor under offer. There was a general perception amongst clinicians 
that the longer recipients waited to be matched the more likely they were to accept a 
donor. The quote below from Doctor Demetrious illustrates this view: 
“There are more fussy patients than others, but after a while they tend to 
become less fussy because time is of essence” [Doctor Demetrious, Creative 
Fertility] 
 
Thus, sometimes particular ‘demanding’ recipients were not matched for weeks, and 
even months, based on the assumption that these recipients would become more co-
operative and more likely to accept a donor after spending longer on the waiting list. 
Thus making a match for commercial purposes was not always a top priority for 
clinicians. On a couple of occasions recipients who were labelled as ‘demanding’ by 
clinicians at each clinic (on account of declining multiple donors) had left the clinic 
because they felt that clinicians had taken too long to match them with a ‘suitable 
donor’. Thus clinicians also stratified (bio)medicalisation, whereby some types of 
recipients were subject to the disciplinary/exclusionary aspects of (bio)medicalisation 
based on their ‘non-compliant behaviours’ (Clarke et al., 2010: 83) 
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6.7 Conclusion 
This chapter explored clinicians’ conceptualisations, prioritisations and negotiations 
of formal and informal matching criteria. In order of least importance, these the 
matching criteria imposed by clinics and clinicians included the recipient waiting list, 
recipients’ preferences and physical resemblance (‘secondary matching criteria’), 
which were superseded by ‘medical characteristics’ (i.e. height/weight and CMV 
status) and ‘race’ (‘primary matching criteria’). Clinicians’ perceptions of recipients 
as ‘demanding’ and ‘difficult’ also shaped their matching practices, primarily with 
regards to not matching particular recipients.  
The findings presented in this chapter illustrate how clinicians’ discourses and 
practices of matching revealed a medicalisation and racialisation of reproduction and 
the stratification of reproduction and medicalisation according to nuanced racialised 
cleavages. I showed, for example, how clinicians’ prioritisation of matching criteria 
varied when clinicians were matching white recipients or BME recipients, prioritising 
different criteria in different contexts of matching.  
At both clinics, clinicians saw a primary aim of their role in matching as protecting 
the medical and social welfare of children born through egg donation. At both clinics, 
‘medical’ matching characteristics were imposed by clinicians to ensure the safety 
and protection of donor-conceived children and recipients of donor eggs. However, 
the prioritisation of different medical matching criteria at each clinic illuminated the 
socially constructed nature of these medical categories, as did clinicians’ willingness 
to compromise on these criteria when matching BME donors and BME recipients.  
The differential treatment of BME recipients also illuminated clinicians’ prioritisation 
of ‘race’ as the most important matching criterion more generally (as will be shown 
below). However, whereas for BME recipients clinicians saw ‘race’ as an overriding 
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Master Status (over and above their medicalised matching characteristics), for white 
recipients, clinicians took for granted that the ‘race’ of recipients would be matched 
and so ‘race’ was one of multiple Master Statuses (alongside their medicalised 
criteria, their preferences and their physical characteristics).  
Clinicians saw ‘race’ as the most important criterion of matching and as protecting the 
social welfare of children born through egg donation. Fundamentally, clinicians 
singled out ‘race’ as a primary indicator of kinship and ‘racial difference’ as a primary 
kinship risk, i.e. to the display of kinship resemblance. Clinicians’ discourses and 
practices of ‘transracial matching’ were particularly revealing of clinicians’ 
conceptualisations of ‘race’ and reproduction, their role in the reproduction of 
whiteness and the nuanced ways in which matching stratifies reproduction and 
medicalisation.  
Clinicians took intricate steps to navigate ‘transracial matching’ with the aim of 
limiting ‘racial difference’ between donors and recipients, and between recipients and 
their child. In doing so, clinicians sought to curtail BME recipients’ reproduction of 
racialised white features whilst maintaining the reproduction of racialised white 
features of white British recipients. For example, BME recipients’ access to white 
donors was dependent on clinicians’ perceptions of their skin tone, the skin tone of 
their partner and skin tone of white donors. On the other hand, when matching 
‘marked white’ donors with white British recipients clinicians strategically 
‘unmarked’ the whiteness of these donors. Whilst clinicians saw it as acceptable for a 
BME couple to have a mixed ethnicity child they did not see it as equally acceptable 
for a white couple to have a mixed ethnicity child.  
These discourses and practices of ‘transracial matching’ reveal how an analysis of 
matching in the present contexts adds new layers to the stratification of reproduction 
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and (bio)medicalisation. It was illustrated how the reproduction of ‘racially 
congruent’ families (Wade, 2012) were valued and encouraged, whilst the 
reproduction of ‘racially incongruent’ families (ibid) were devalued and discouraged. 
Reflecting the regulatory context in which matching took place, this stratification was 
not based on money but on moralised concerns about the welfare of the child. In this 
context, ‘race’ and ‘ethnicity’ are depicted as a ‘risk’ by clinicians, to be managed, 
and not just as a commodity (as argued in the literature).  
Descriptive statistics of ‘racial matching’ at each clinic enabled insight into the 
patterns and outcomes of clinicians’ matching practices and revealed that clinicians’ 
practices were coherent with their perceptions and that the majority of allocations 
made by clinicians were ‘racially’ matched. This has significant repercussions for the 
types of families that were reproduced in the clinics through egg donation. Finally, 
this chapter illustrated how clinicians’ perceptions of recipients as ‘demanding’ 
shaped their practices of matching whereby they avoided matching ‘non-compliant’ 
recipients as a mechanism of managing their own workload and managing the 
expectations of recipients. The strategy of not matching particular recipients was 
undertaken with the aim of neutralising recipients’ active and non-compliant agency 
(declining donors) into a passive and compliant form of agency (accepting donors).  
Taken together, these findings demonstrate that the ways in which clinician’s 
allocation of donors to recipients illustrate a medicalisation, stratification and 
racialisation of reproduction. Clinicians sought to reproduce a normative model of the 
family through discourses of ‘risk’, ‘racialisation’ and ‘strategic naturalisation’ by 
strategically managing the crossing of normative racialised boundaries.  
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Chapter 7: Recipients’ Preferences  
for Donor Characteristics 
 
7.1 Introduction 
In the current chapter recipients’ own accounts of their preferences for donor 
characteristics will be explored. Recipients’ preferences for donor characteristics 
refers to the characteristics that recipients were willing, or unwilling, to accept in their 
donor. This will include exploring the meanings that recipients attached to 
resemblance, the characteristics that they prioritised when stating their preferences, 
and the characteristics that they sought to exclude from their reproduction. Recipients’ 
preferences for information about donors will also be explored, including recipients’ 
views of the amount of donor information they were provided with.  
As highlighted by Braverman and Frith (2014) and Zadeh et al. (2016a), in the UK 
clinical context of egg donation little is known about the preferences that recipients 
request in practice or how the clinical context shapes recipients’ preferences. 
Ethnographic studies on egg donation in the UK have reported that an extreme 
shortage of donors that recipients were unable to state preferences for donor 
characteristics with the clinics under study (Konrad, 2005; Klotz, 2010). Studies 
which have explored recipients’ preferences for donor characteristics have reported 
that recipients wanted a donor who resembled their own characteristics (Hayden, 
1995; Becker et al., 2005; Konrad, 2005; Mamo, 2005; Thompson, 2005; Hargreaves, 
2006, Harrington et al., 2008; Cadoret, 2009; Nordqvist, 2010) and/or who possessed 
characteristics which reflected euro-American ideals of beauty (Birenbaum-Carmeli 
and Carmeli, 2002; Nahman, 2006; Hudson, 2015). Researchers have also have 
reported that some recipients selected donors with characteristics which were 
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‘different’, and perceived as ‘better’, than their own as a way of “enhancing” their 
“family qualities” (Birenbaum-Carmeli and Carmeli, 2002; Mamo; 2005; Nahman, 
2006; Nordqvist, 2010).  
Recipients’ preference for donor information in this chapter refers to how recipients 
conceptualised donor information (in general) and whether they wanted more 
information (Broderick and Walker, 1995; Stuart-Smith et al., 2002; Rubin et al., 
2015). The findings below reflect interviewees’ retrospective accounts of stating their 
preferences with the clinic. Ethnographic data on recipients’ informal preferences 
(their additional preferences, stated as free-text) and recipients’ formal preferences 
(their stated ‘tick-box’ preferences which specified which specific donor 
characteristics they were willing, and unwilling, to accept) will also be drawn upon.  
 
7.2 Recipients’ ‘Desire’ for Resemblance  
Recipients expressed various attitudes towards egg donation, which in turn appeared 
to shape their preferences for donor characteristics. Many recipients reported 
originally being “strongly against” the idea of using egg donation, having never 
considered it in the past. However, after being recommended to use egg donation by 
multiple healthcare professionals and after hearing success stories through the media 
and their social networks, recipients re-conceptualised egg donation from being a 
“crazy” option to being “the only option” (Franklin, 1997) and the “next logical step” 
in what had by then become recipients’ assisted fertility journey. Recipients thus drew 
on a medicalised discourse in rationalising their need for egg donation, as illustrated 
by the quote below from Tina:  
“At the time when we did our own IVF, we weren’t interested in egg donation 
at all. At the time we were strongly against it. It was somebody else’s, not 
ours, which was my opinion at the time […] Actually, the last clinic suggested 
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egg donation, and I said I’m not going to contemplate that. Then I came to 
The Fertility Centre and they suggested egg donation. So I thought 2 clinics 
can’t be wrong, maybe I need to look into it. After speaking with Doctor Rana 
it didn’t sound like a bad idea at all, it sounded like our only option really.” 
[Tina, The Fertility Centre] 
 
As acknowledged by feminist researchers, in their desperation for a child of their 
‘own’, women felt they had no choice but to try to conceive through egg donation 
(Franklin, 1997), a view that was shaped by wider assumptions and expectations 
about motherhood as natural for women (Russo, 1976). Several recipients described 
“grieving” as part of the process of using donor eggs, which involved recipients 
mourning their inability to have a genetically related child and the physical 
resemblance that might accompany this, as illustrated by the quote below from Betty:  
“There was that process of having to grieve, from my point of view, of not 
being able to have my own genetic child. That you look in the mirror and think 
I’m not going to see anything. So we had to go through that period, myself, 
and then as Nick [partner] says, because we wanted to have a family together, 
so donor eggs were the only option.” [Betty, The Fertility Centre] 
 
Even after deciding to use (anonymous) egg donation, many recipients spoke about 
having to ‘coming to terms with’ using donor eggs as an ongoing process. Some 
recipients said that they were “still not 100% comfortable”, “anxious” and “uncertain” 
about using egg donation and described their role as recipients in a precarious way 
(Franklin, 1997; Becker, 2000). These recipients felt alone and uninformed in 
navigating the meaning and consequences of egg donation, and described feeling like 
they were left with a “can of worms” in relation to the psychological impact of using 
donor eggs. In the context of donor anonymity, some recipients had anxieties about 
their donor being a stranger whom they would be unable to meet or see (despite not 
actually wanting to meet or see her).  
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Recipients wondered what their donor would contribute to their child, what biological 
contribution they would have in gestating their child and what this meant for their 
relationship to their child, as illustrated by the quote below from Joanne: 
“There’s a whole other can of worms, emotionally and mentally, the fact that 
it’s egg donation. What’s not considered enough is the attachment thing, 
‘cause it’s like, I know he’s my child in every sense of the word, but 
genetically he’s not […] You’re kind of left going, I wonder what it means, in 
the sense of that genetic thing […] What does the egg, in terms of the 
development of the child, physically, and mentally, emotionally and 
spiritually, how does it affect the child, or how much do I affect the child?” 
[Joanne, The Fertility Centre] 
 
Echoing findings from past studies, the majority of recipients in this study 
conceptualised egg donors as being a genetic and reproductive “substitute” for their 
own ‘genetic material’ in reproduction, which would otherwise have been passed 
down to their child through their own eggs (Konrad, 2005; Szkupinski-Quiroga, 2007; 
Thompson, 2009). Recipients assumed that the physical characteristics they shared 
with their donor would be genetically inherited by their child and consequently shared 
between themselves and their child. They therefore wanted a donor who would be a 
“credible genetic substitute” (Konrad, 2005) in the form of a close physical match to 
themselves:  
“It was about choosing a donor within certain parameters that were close 
enough. It was about being close enough to me. Because, you know, it’s 
instead of my genetic make-up.” [Brenda, Creative Fertility] 
 
Whilst recognising their own socialisation into accepting the use of donor eggs, 
recipients still felt stigmatised by wider society because they were infertile 
(involuntarily childless) and were using egg donation to reproduce (Becker, 2000, 
Murray and Golombok, 2003; Golombok et al., 2006). Recipients felt that egg 
donation deviated from normative models of natural reproduction, biological 
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motherhood and genetic kinship and as such was a “taboo” subject. Some recipients 
described adoption and sperm donation as being less stigmatised in society because 
they were more established routes to alternative family building, and did not 
challenge pre-existing conceptualisations of motherhood, as illustrated by the quote 
below from Betty: 
“Adoption is more talked about now, it’s not so taboo. But I think egg 
donation is, and people don’t really understand it. If they’ve seen you as a 
woman having that pregnant belly it’s more difficult to actually say ‘this isn’t 
mine biologically’ […] It [egg donation] shouldn’t be different from adopting 
a child or using a sperm donor. But I feel at this moment in time it kind of is. 
Because it is so newish” [Betty, The Fertility Centre] 
 
Recipients were particularly concerned about deviating from the normative model of 
kinship resemblance, and the consequences of this for their child’s sense of belonging 
within the family, for the legitimacy of their family and their own identity as parents 
(Becker et al., 2005; Hargreaves, 2006, Harrington et al., 2008; Mamo, 2005; 
Nordqvist, 2010; Hudson and Culley, 2014). Drawing on a normative discourse of 
kinship resemblance – in which physical resemblance is seen as an indicator and 
reflection of a genetic and kinship relationship- recipients sought to construct 
resemblance with their child to enable their child to pass as ‘as if’ it were their own 
‘natural’ and ‘genetic’ offspring (Ragoné, 1998; Finkler, 2000; Broderick and Walker, 
2001; Becker et al., 2005; Mamo, 2005; Richards, 2006; Finch, 2007; Szkupinski-
Quiroga, 2007; Mason, 2008; Marre and Bestard 2009; Nordqvist, 2010), as 
illustrated by the quote below:  
“Because I wanted it to look as much of a natural baby for us as possible […]. 
Because if the genetic thing was different looking, then there’s more of a thing 
for people looking twice” [Joanne, Creative Fertility]  
 
232 
 
Recipients saw a lack of resemblance between parents and children, in the context of 
non-genetic reproduction, as stigmatised and a risk to their display of kinship 
resemblance (Becker et al., 2005). They were concerned about encountering 
‘resemblance talk’ through which others would question the belonging of their child 
and the legitimacy of their family by questioning the origins of their child’s difference 
with themselves (ibid). They saw having a child with characteristics that were “too 
different” from their own as “advertising” the use of a third party in their reproduction 
and as a kinship risk’, i.e. as a threat to their display of kinship resemblance. In order 
to manage this anticipated felt stigma (Scambler, 2004) recipients wanted their child 
to ‘pass’ as their own genetic offspring:  
“So looking as though it could be a genetically natural part of our family. 
Well, why is that important? So I know [white British] friends with Chinese 
children who have adopted children from China and everything. All I can say 
is that I don’t want to be having the supermarket conversation all of the time. 
The kid might just want to be like ‘you know I’m just a normal kid, I don’t 
want to make a big deal of it.’” [Helen, Creative Fertility] 
 
Recipients’ preference for resemblance was thus shaped by wider ideological 
constraints in which children are expected to resemble their parents (as a reflection of 
the supposedly defining genetic relationship between them). In this regard, recipients’ 
preference for resemblance might be interpreted as a form of self-surveillance (Clarke 
et al., 2010) in which they sought to minimise risk and reproduce a normative 
ideology of the family. Thus recipients felt they had little choice but to reproduce 
resemblance with their child as a way of managing the ‘felt stigma’ associated with 
their own infertility and the use of an egg donor.  
By contrast, the white same-sex male couples (n=2) in this study displayed a different 
trajectory towards egg donation compared with the female heterosexual recipients 
discussed above. These same-sex male couples did not see infertility and egg donation 
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as stigmatised (neither of the couples had been diagnosed as medically infertile) and 
did not seek to match donors to the non-genetic father. Though only a small number 
of same sex male couples were interviewed in this study, the absence of their views in 
the literature and their different expectations of the matching process deserve some 
attention, particularly since their differing views contrasted with and illuminated the 
views of the female heterosexual recipients in this study.  
The male couples in this study did not expect to reproduce naturally or even to 
become parents. They displayed little anxiety about using the donor eggs, which they 
framed as a biological, rather than medical, necessity. These couples were not referred 
to egg donation via healthcare professionals (instead relying on queer social 
networks) and did not feel compelled to use ARTs in the same way as female 
recipients, e.g. they spoke about egg donation as a “luxury” and lifestyle choice rather 
than as a necessity. They spoke about donors as a “tissue donor”, e.g. as a potential 
organ or tissue donor for their child in the future, rather than as a ‘genetic substitute’.  
These couples did not seek to match the characteristics of their donor with the non-
genetic parent because they did not seek ‘family legitimacy’ through kinship 
resemblance. Instead, they saw ‘kinship resemblance’ as part of a wider 
heteronormative framework which they did not have access to and did not seek to 
reproduce. Unlike the lesbian couples in Mamo’s (2005) and Nordqvist’s (2010) 
studies, but like the male same-sex recipients in Deomampo’s (2015) study, the same-
sex male couples in this study did not seek to reproduce ‘racial resemblance’. Indeed, 
one couple conceptualised having a ‘black child’ (mixed ethnicity) as acceptable, and 
even desirable. This indicates how gender, not just sexuality, can influence recipients’ 
preferences (although the number of same-sex couples was very small in this study).  
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These couples saw having a child who looked different to themselves as consistent 
with their principles of valuing difference, a view which was informed by their own 
marginalised positions as a gay couple in a heteronormative society. Below is a quote 
from Milo and Dean which illustrates their view of “embracing difference”. The quote 
begins with Milo’s response to my question about whether the couple would have 
considered using a BME donor: 
Milo: “To have a black donor? Of course! I don’t want to have the same as 
the rest. The heterosexual couples they are used to play with the normality, 
they don’t have to go against so many things. When we came out as gay 
people you have to confront so many issues about the society and you have to 
accept to have all the courage to accept yourself, and then to go outside, and 
you’ll be different. We don’t mind difference. I respect that what is normal for 
me, is not normal for you, all of us, we are different. We have to accept and 
respect the difference of each other. This is the main thing”  
David: “So we embrace difference, because essentially we are considered 
different” [David and Milo, The Fertility Centre] 
 
7.3 Preferred characteristics 
Recipients discussed a variety of ideal preferences for donor characteristics and varied 
in relation to which characteristics they saw as important in their donor. In practice, 
recipients’ ability to state their preferences for donor characteristics was limited by 
the available categories in each clinic, the information collected about donors and 
clinicians’ willingness to allow them (as explored in Chapter 5). The focus in the 
current section will be on recipients’ retrospective accounts of stating their 
preferences for donor characteristics within the clinic (rather than merely their ideal-
type preferences). Firstly, recipients’ preference in relation to donors’ health will be 
explored, followed by recipients’ preferences for ‘ethnicity’/“race” and general 
physical resemblance (eye colour, hair colour, height, weight) and lastly recipients’ 
preferences for socio-cultural resemblance.  
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Because of a shortage of donors most recipients were willing to negotiate their 
preference for resemblance and considered accepting donors with different 
characteristics to their own. Such negotiations will not be the focus of this chapter (as 
they will be discussed in the following chapter) but are mentioned here to reflect 
recipients’ experience of stating their preferences and to contextualise recipients’ 
preferences in practice.  
 
7.3.1 Health 
A primary aim for all of the recipients in this study was to have a healthy child 
through egg donation. In this respect, echoing the findings from previous studies 
(Lindheim et al., 2000; Mamo; 2005; Nahman, 2006), recipients saw the health of 
donors as the most important characteristic in their donor. “As long as it’s a healthy 
baby” was one of the most commonly used phrases by the recipients in this study 
(albeit in different contexts), and this aim was prioritised over and above matching 
donors for resemblance, in theory, as illustrated by the quote below from Uzma: 
“It doesn’t matter, as long as it’s a healthy baby, it could be any donor. We 
just want a positive result that is it […] A healthy donor. Don’t matter what it 
is.” [Uzma, The Fertility Centre] 
 
Recipients’ preferences in relation to donors’ health were less about their preferences 
of inclusion than their preferences of exclusion. Recipients sought to exclude donors 
whom they deemed as physically, mentally or genetically ‘ill’ or ‘unhealthy’, 
including donors who had medical history of “Downs Syndrome”, “schizophrenia” 
“depression”, or who were “obese” (‘overweight’). Recipients saw these conditions as 
genetically inheritable and as a risk to the health and well-being of their child, as 
illustrated by the quote below from David (one half of a same-sex couple): 
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“It was really straightforward for us. The only thing for us, which they do for 
all donors, is that she had to be healthy, and that she wasn’t to be obese. And 
mental health too, like schizophrenia in the family, things like that […] We 
mentioned that to Noreen [the nurse], but she said when they screened the 
patients they wouldn’t take on a donor that had any of those issues, otherwise 
that would have been the other concern.” [David, The Fertility Centre] 
 
As illustrated by the quote above, recipients reasoned that having a ‘healthy’ donor 
was the responsibility of clinicians, who, unlike themselves, had the medical expertise 
screen donors and had access to donors’ medical information. Therefore, although the 
health of donors was an important consideration for recipients it nonetheless remained 
a theoretical concern. David’s quote (immediately above) also illustrates another 
pervading preference in recipients’ discourses, one which all recipients subscribed to: 
not having a donor who was ‘overweight’. When detailing their preferences for 
donors’ weight, recipients seldom discussed their preference for weight in terms of 
kinship resemblance. Instead, recipients conceptualised weight as a primary indicator 
of donors’ health and strategically drew on a discourse of health to exclude 
‘overweight’ donors. Recipients foregrounded ‘overweight donors’ as a risk to their 
reproduction by posing a risk to the success of their treatment, as illustrated by the 
quote below from Brenda: 
“There were concerns about the weight, in terms of what that meant for 
health, and even just the health going through the process.” [Brenda, Creative 
Fertility] 
 
Recipients justified their exclusion of overweight donors by foregrounding their 
parental responsibility towards their child’s health and social well-being. Here, 
recipients emphasised the genetic inheritability of weight and described ‘overweight’ 
donors as a risk to their child’s health. Recipients simultaneously depicted donors’ 
weight as both due to genes –‘geneticisation’ (Lippman, 1991) - and individual 
responsibility – ‘healthcization’ (Conrad, 1987: 267) - in which they drew on 
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stereotypes about clinically overweight individuals being ‘unfit’, ‘lazy’, ‘unreliable’ 
and ‘lacking in self-discipline’, thus turning the moral into the medical (Conrad, 
1992). In both of these conceptualisations ‘overweight’ donors were conceptualised as 
being genetically or culturally deviant and undesirable. Some recipients also 
described ‘overweight’ individuals as being subject to stigma and wanted to protect 
their child from inheriting a ‘weight problem’ and facing the social problems 
associated with this, as illustrated by the quote below from Aileen, who was referring 
to ‘overweight’ donors: 
“You people have got to take responsibility in your own actions. Because at 
the end of the day you cannot stuff yourself. I hear a lot of cases of people 
saying ‘when I’m depressed then I eat’. If that’s the issue, you need to find out 
what it is that is making you depressed […] It’s important for me because 
when you’re overweight it affects your health. And it affects you from doing so 
many things, physically. It will affect how you perform in real life. Because 
children go to school and get embarrassed and teased. Because it’s that child 
who has to go out and face the public.” [Aileen, The Fertility Centre] 
 
7.3.2 Physical Resemblance  
Recipients varied in the range of preferences they stated for donors’ physical and 
social characteristics. All of the female recipients who were interviewed and observed 
prioritised having a donor with the same ‘ethnicity’ and skin tone as their own. Many 
recipients also wanted a donor who matched their own general physical characteristics 
(hair, eye and skin colour, height and weight) and some recipients wanted a donor 
who matched their social characteristics (education and religion). Recipients’ 
prioritisation of their preferences, and their foregrounding of ‘race’/ethnicity, are 
illustrated by the quotes below from Betty and Amandeep:  
“There’s a sliding scale of importance if you look at it. Between eye colour, 
hair colour, height and things; Overriding all of that, you’ve got to start with 
race, well, ethnicity, is a better way of putting it.” [Betty, The Fertility Centre] 
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“We weren’t really like into education, well we were, but it wasn’t the main 
category, a priority. The main criteria that we were looking for was being 
Indian. Punjabi if we could.” [Amandeep The Fertility Centre] 
 
Recipients’ prioritisation of donor characteristics echoes the findings of previous 
studies (Klock et al., 1994; Le Lannou et al., 1997; Baker et al., 1998; Lindheim and 
Sauer, 1998; Lindheim et al., 2000; Broderick and Walker, 2001). Below, recipients’ 
meanings and negotiations of their preferences will be explored, starting with their 
preferences’ for ‘race’ and skin tone, followed by hair colour and eye colour and then 
‘social characteristics’.  
 
‘Race’ and Skin Tone 
The samples of participants in previous European studies on matching have 
predominantly been comprised of white, middle-class female interviewees (Konrad, 
2005; Bonaccorso, 2009; Nordqvist, 2010; Klotz, 2014). Therefore, there has been 
little insight into BME recipients’ preferences for gamete donors (Hudson and Culley, 
2014) and little understanding of how these may differ from those of white recipients 
(Hudson, 2015). The interviewee accounts drawn upon in this current and following 
chapters include recipients who self-defined as white British, white European, South 
Asian (Indian and Pakistani), Chinese and black African. The ethnic diversity of this 
sample enabled insight into how recipients from different ethnic backgrounds 
conceptualised ‘race’ and ethnicity and the implications of this for their willingness, 
and unwillingness, to accept donors from a different ‘racial’/ethnic background.  
All of the recipients who were interviewed spoke about ‘ethnicity’ as a genetically 
inheritable characteristic and as a proxy for skin tone and other physical 
characteristics, i.e. as ‘race’. They saw using an egg donor with the same ‘race’ as 
themselves as facilitating physical resemblance between themselves and their child 
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and enabling their child to ‘fit into’ their family, as illustrated by the quote below 
from Linda, a white recipient who had moved to the UK from Germany:  
“Of course, it couldn’t be a black donor. We said we would only accept a 
white donor. But only for one reason, to fit into family. Not to be standing out 
from the beginning, at least to fit into the family. We are not a mixed couple.” 
[Linda, The Fertility Centre] 
 
Recipients saw ‘race’ as a primary indicator of kinship resemblance (Becker, 2000; 
Thompson, 2001; Fuscaldo, 2006; Mamo, 2005; Hargreaves, 2006; Wade, 2007; 
Nordqvist, 2010) and expressed concern that a lack of ‘racial resemblance’ between 
themselves and their child would lead to their child ‘standing out’ from their family. 
This view was shared by recipients across ‘ethnic’ backgrounds, as illustrated by the 
quotes below from Aileen, a black African recipient, and Amandeep, an Indian 
recipient, below: 
“We made it specific to them, you cannot give someone to us who is white 
race. You can’t give a donor egg from the white race to the black race. As 
long as it’s black, I don’t mind. I am black, my husband is black, and if it’s a 
white baby people would say ‘how did that happen?’” [Aileen, The Fertility 
Centre] 
“And we said we wanted an Asian donor […] We wanted an Indian donor, 
just in terms of physical characteristics, Punjabi if possible […]that’s the only 
reason that we didn’t want to go on the white side either, because you don’t 
want to make it too obvious.” [Amandeep, The Fertility Centre] 
 
As illustrated by the quote above from Amandeep, most South Asian recipients 
wanted a donor from their own specific ethnic backgrounds, e.g. Indian Gujarati, 
Indian Punjabi or Pakistani, which they saw as being more reflective of their own 
physical characteristics. Although recipients from all ethnic groups saw having a 
donor of the same ‘race’ as a priority, they differed in their conceptualisation of this 
attribute and their willingness to accept a donor from a different ‘race’, as will be 
explored below.  
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White recipients were particularly concerned about their own reproductive legitimacy, 
and that of their partner when discussing the use of a BME donor. Some white 
recipients saw it as ‘crazy’ that they, as part of a white couple, could give birth to a 
‘black child’. Here, like clinicians, white recipients conceptualised mixed ethnicity as 
‘black’, rather than as white or mixed. Possibly, as women of ‘unmarked’ ethnicity 
(invisible and the ‘norm’), these white recipients could not conceive of ‘naturally’ 
giving birth to a ‘black child’ of ‘marked’ ethnicity (visible and ‘other’). Furthermore, 
white recipients were particularly concerned that if they had a ‘black child’ it would 
be their partner’s paternity and their own infidelity that would be questioned by 
others, rather than their own status as a genetic mother (Szkupinski-Quiroga, 2007), 
as illustrated by the quote below from Camille, a white recipient:  
“Giving birth to a black child for me would be crazy. Because everyone would 
tell my husband, so you’re not the father, I had my child with another man. So 
no, it couldn’t have been a black donor basically.” [Camille, Creative 
Fertility] 
 
Several white recipients (unprompted) said that they had wanted to adopt a ‘black 
child’ before using egg donation. There were a number of reasons underlying this 
decision, but of importance here is that recipients did not see an adopted child as their 
‘own’ or intend to give birth to that child. Neither did recipients intend for an adoptive 
child to ‘pass’ as their own genetic offspring, as illustrated by the quote below from 
Camille (mentioned above):  
“We also had an adoption project and we were ready to have a black child 
basically, because from the beginning, that child knows that it’s not 
genetically connected to us. So I wouldn’t have minded that.” [Camille, 
Creative Fertility] 
 
BME recipients also wanted a donor from the same ‘racial’/ethnic background as 
themselves, although they help a more flexible conceptualisation of ‘race’, to varying 
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degrees. Because of a particular shortage of donors from individual BME 
backgrounds some of the BME recipients in this study had considered using a donor 
of a different ‘race’ and ethnicity to themselves (Szkupinski-Quiroga, 2007; Hudson 
and Culley, 2014).  
During observations, some black African/Caribbean recipients were willing to accept 
white donors, although this was not very common. The main distinction between 
black African/Caribbean recipients was their willingness to consider South Asian 
donors, which seemed to depend on their conceptualisation of ‘race’, or ‘blackness’. 
Whilst some black African/Caribbean recipients were not willing to consider 
accepting South Asian donors because they did not see them as black, others took a 
more politicised, or one might argue ‘racialised’, view of blackness and said that they 
were willing to accept South Asian donors because they did see them as black. This 
latter view is illustrated by the quote below from Aileen, a black African recipient, 
who had rejected the possibility of using a white donor:  
 PD: “So would you be willing to accept an Asian donor?” 
Aileen: “Come on, it’s black […] I wouldn’t mind. The only thing that matters 
to me is that it’s not 100% English white. It doesn’t matter whether it’s Asian, 
Caribbean, as long as its black. I don’t mind. Black is black.” [Aileen, The 
Fertility Centre] 
 
For the South Asian recipients in this study, skin tone held particular significance as 
both an indicator of kinship and as embedded in social norms of desirability and 
stigma. Most of the South Asian recipients in this study had “thought about” using a 
white donor. These recipients acknowledged the desirability of having a child with 
lighter skin tone (Thompson, 2001; Campbell, 2007; Braverman and Frith, 2014), 
although their main motivation for considering a white donor was to reduce delays to 
their treatment (Fogg-Davis, 2001; Pennings, 2001; Hudson and Culley, 2014).  
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Echoing findings from Hudson and Culley’s (2014) study, the South Asian recipients 
in the current study distinguished between the ‘type’ of white donor that they were 
willing to accept. Although South Asian recipients were willing to accept donors with 
“olive skin tone”, “dark eyes” and “dark hair”, i.e. ‘marked white’ donors, they were 
less willing to accept white donors with ‘racialised white features’ such as light skin, 
blonde hair and blue eyes (Hudson and Culley, 2014: 239). South Asian recipients 
with a BME partner saw having a mixed ethnicity child, conceived using a ‘marked 
white’ donor, as being able to ‘pass’ as their own genetic offspring, as illustrated in 
the quote below from Amandeep, an Indian recipient:  
“We were thinking about the British side of it, going for a white donor with 
dark hair and olive skin tone. Cause my niece she’s got really fair skin. Her 
mum is Indian, and her dad, but she has a very fair complexion and green 
eyes. And if you saw my niece you wouldn’t think she was Indian at all, she’s 
just like English. You know because of the dark hair. We thought, what’s 
wrong with that? […] but then we thought no, deep down we do want Indian 
characteristics, skin colour and things.” [Amandeep, The Fertility Centre] 
 
Thus, despite otherwise acknowledging the desirability of having a child with lighter 
skin tone recipients sought to limit the degree of this in their donor, and child. This 
aim was also apparent from observations of recipients’ informal preferences at each 
clinic. The below, just one of many similar informal statements of preference that 
South Asian recipients were observed to express in clinic, illustrates the ways in 
which South Asian recipients differentiated between the types of white donor they 
were willing, and unwilling, to accept, based on qualifications about donors’ 
nationality and skin tone: 
“Will accept Bangladeshi donor if light, Caucasian donor if dark, and 
Mediterranean, Egyptian, Middle Eastern, Turkish, Mexican and south 
American donor with dark/medium skin tone.” [Field notes, week 20, Indian 
Couple’s Informal Statement of Preference at Creative Fertility] 
The above preference illustrates a more general theme amongst some South Asian 
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recipients, where the inclusion of white donors with darker skin tone (e.g. Mexican) 
was prioritised over and above the inclusion of South Asian donors with darker skin 
tone (e.g. Bangladeshi). Thus, in addition to distinguishing between types of white 
donors, South Asian recipients also distinguished between the types of ‘South Asian’ 
recipients that they were willing, or unwilling, to accept. Such distinctions between 
‘racially matched’ donors were not limited to South Asian recipients. White British 
recipients also distinguished between the types of white donors they were willing to 
accept based on assumptions about their skin tone.  
Of note here is that these white and South Asian recipients described their own skin 
tone as being “light” or “medium”; none described their own skin tone as ‘dark’. 
Although recipients were willing to accept donors whom they presumed to have 
‘lighter’ or ‘similar’ skin tone to themselves then, they were less willing to accept a 
donor with ‘darker’ skin tone, as will be illustrated below. 
Stigmatised Skin Tone: ‘Difference within Sameness’ 
Despite their emphasis on having a ‘racially matched’ donor, the white and South 
Asian recipients in this study distinguished between the types of ‘racially matched’ 
donors that they were willing or unwilling to accept. Whereas ‘racially matched’ 
donors with lighter skin tone than themselves were generally considered as acceptable 
by recipients racially matched donors with darker skin tone themselves were not. 
More specifically, these recipients sought to exclude donors from particular ‘racial 
backgrounds’ and nationalities which they associated with having darker skin tone. 
Such exclusions were evident in interviewees’ discourses and during ethnographic 
observations, as will be shown below. 
White British interviewees often requested to be specifically matched with a ‘white 
British’ donor. Recognising that a shortage of donors might prevent this, some white 
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British recipients were willing to accept white donors from outside of the UK. 
However, this inclusion tended to be limited to donors from northern Europe on the 
basis that recipients presumed these donors would share their racialised fair racialised 
white features. This view is illustrated in the quote below from Brenda, a white 
British recipient:  
“It was more about similarity to me. I’ve got a Celtic background, so it was 
the idea of pale skin, lighter eyes, that sort of thing. And again it was just to 
get a similarity. So if we had found out that they [donors] were from another 
country that shared some of those similarities, if they were from Denmark or 
something, that wouldn’t be a problem.” [Brenda, Creative Fertility] 
 
On the other hand, many white British recipients were not willing to accept donors 
from Southern Europe or donors with “olive skin tone” and ‘darker features’, i.e. 
‘marked white’ donors. These recipients perceived ‘marked white’ donors as having 
characteristics which they perceived as being ‘too different’ from their own and as a 
potential kinship risk. This view is illustrated by the quote below from Nick, the 
partner of Betty (both of whom were white British). Like most white British recipients 
who sought to exclude ‘marked white’ donors, Betty and Nick described themselves 
as having ‘fair skin tone’ and “blue eyes”: 
“At the beginning when we were looking at donor eggs other doctors said go 
to Spain, where it’s done quite a lot. But we thought actually olive skin and 
brown eyes would be very different. And that might seem selfish in a way, 
when you put it like that, but it’s a substitute here, and so the matching 
process is important on that scale.” [Nick, The Fertility Centre] 
 
Previous studies have also reported that white recipients travelling to other countries 
for egg donation distinguished between types of white donors (Nahman, 2006; 
Whitakker and Speier, 2010; Bergmann, 2011; Kroløkke, 2014; Homanen, 2018), 
although such distinctions of whiteness have been inherently shaped by the contexts 
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in which matching was explored. In this UK based study, recipients distinguished 
between types of donors based on their perceptions of donors from Southern and 
Eastern Europe as ‘other’ and donors from Northern Europe as ‘similar’.  
Like white recipients, the South Asian recipients in this study used nationality and 
geographical ancestry as indicators of donors’ skin tone. As such, some South Asian 
(mainly Indian) recipients sought to exclude South Asian donors with geographical 
ancestry that they associated with having darker skin tone, including donors who 
came from Bangladesh, Kerala and South India. These recipients did not display 
similar concerns about having a South Asian donor with lighter skin tone, which was 
often depicted as desirable. It was not uncommon to see the informal preferences of 
Indian recipients, state: “Will accept Bangladeshi donor if light” or “No Bangladeshis 
or darker skin” [both from Indian recipients at Creative Fertility]. No Bangladeshi 
recipients were matched at either clinic during the period of observations, perhaps in 
part reflecting barriers relating to their lower socio-economic status compared with 
other South Asian ethnic groups (Modood et al., 1997). 
In addition to conceptualising skin tone as a key indicator of kinship resemblance, 
South Asian recipients also saw skin tone as embedded in wider social norms of 
desirability and stigma, which held particular significance for their preferences. Here, 
South Asian recipients spoke about the social importance attached to skin tone in 
South Asian communities, and in society more generally, where lighter skin tone is 
regarded as more socially desirable and privileged and darker skin tone is seen as an 
undesirable difference, associated with stigma, marginalisation and discrimination.  
Thus, unlike having a South Asian donor with lighter skin tone, these recipients saw 
having a South Asian donor with stigmatised darker skin as a kinship risk and as a 
risk to their child’s well-being, as illustrated by the quote below from Rabiaa, a 
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Pakistani recipient:  
“In our Asian community, skin colour is important. Dark people don't do well, 
they get abused, treated badly […] We might accept Indian, but not people 
from Bangladesh, South India, Kerala and Punjab, they are blacker people. 
We want the baby to be familiar with me and my husband and the family, to 
have the same colour, light skin, not a black baby, that would be too different. 
People in our community would see the difference.” [Rabiaa, The Fertility 
Centre] 
 
The exclusion of Bangladeshi donors by some Indian and Pakistani recipients was 
particularly evident from observations of recipients’ formal preferences at Creative 
Fertility (where this information was quantifiable). Only a small number of recipients 
showed up on the waiting list for a Bangladeshi donor (n=3). On the other hand, there 
were over three times as many recipients on the waiting list for an Indian donor 
(n=>10). Despite acknowledging the undesirability of darker skin tone in South Asian 
communities, South Asian recipients with a white partner generally stated that the 
skin tone of their South Asian donor was not a primary concern. This is because these 
recipients assumed that their white husband’s genes would lighten the skin tone of 
their child, as illustrated by the quote below from Ayeshah, a Pakistani recipient with 
a white husband:  
“For us you see things like complexion, that’s just trivial to us really. Though 
also yes, my husband’s English, I’m Asian, so it would probably balance out. 
We knew that, that wasn’t a concern at all.” [Ayeshah, Creative Fertility] 
 
Eye Colour and Hair Colour 
Many of the white recipients in this study had a preference for a donor with the same 
hair colour and eye colour as themselves, although these characteristics were more a 
prominent feature of white recipients’ discourses. This was particularly the case for 
white recipients with ‘lighter’ eye colours (e.g. green or blue eyes), who often 
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reflected on the recessive nature of their eye colour. These recipients saw eye colour 
as a defining aspect of their self-identity and therefore as a central component of the 
physical resemblance that they wanted to replicate in their child. As such, recipients 
with blue/green eyes ideally sought to exclude donors with ‘brown eyes’, as 
illustrated by the interview quote below from Betty, a white recipient with blue eyes: 
“You don’t necessarily want to have an extreme, ginger haired brown eyed 
child born to us which would be a complete mis-match, and the opposite way. 
‘How did they have a child that looks nothing like them’ […] We are both blue 
[eyes], and I know blue is the recessive gene, but I think if we had a brown 
eyed child, that would be really different. Green, not a problem or whatever. 
But to have that would be so different.” [Betty, The Fertility Clinic] 
 
However, because of a shortage of donors, on the whole, these recipients were willing 
to compromise on this preference and consider accepting donors with a different eye 
colour and hair colour to themselves (and their partner). Nonetheless, all of the white 
(female) recipients who were interviewed (and most those that were observed) singled 
out red hair as a characteristic that they were not willing to accept in a donor. That is, 
whilst these recipients were willing to accept donors with blond hair or brown hair, 
regardless of their own hair colour (often one of the two), they were unwilling to 
accept a donor with red hair, as illustrated by the quote below from Helen: 
“Eye Colour, we said any colour. Hair colour, any, although we ruled out 
red.” [Helen, Creative Fertility] 
 
Recipients’ exclusion of donors with red hair was echoed by observations of recipient 
consultations and observations of the operation of the recipient waiting list. For 
example, at Creative Fertility, only 7 recipients were willing to accept a white donor 
with red hair. This was compared with more than 30 white recipients on the waiting 
list for a white donor with blond hair or brown hair. Sometimes recipients reinforced 
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this exclusionary criterion in their informal statements of preferences, e.g. ‘No red 
hair’. Interviewees’ accounts revealed that they saw red hair as both a kinship risk 
and, to a lesser extent, as a risk to the social well-being of their child. They therefore 
sought to exclude this characteristic from their reproduction.  
Most recipients described their own hair colour as being “normal” and saw red hair as 
falling outside of this conceptualisation, e.g. as a deviant characteristic. None of the 
recipients who were interviewed had red hair themselves. Thus, although recipients 
did not see hair colour in general as a primary indicator of kinship resemblance, they 
did see red hair in particular as being a ‘kinship risk’. Unlike other hair colours, 
recipients stressed that having a child with red hair would “stand out” from their 
family, leading to others questioning the origins of its hair colour. This view is 
illustrated by the quote below from Helen: 
“So I had ruled out ginger hair, because it’s too different from our 
family look […] my daughter is very blond and it would just be those 
conversations of ‘who does she take after’. Just didn’t want to have 
them all of the time.” [Helen, Creative Fertility] 
 
Several recipients drew on the example of Prince Harry in the UK having red hair, 
whilst neither of his parents, Prince Charles or (the late) Princess Diana (his parents), 
had red hair, which led to his paternity being questioned by the media and general 
public. In addition to conceptualising red hair as a minority characteristic (which 
‘stands out’) some recipients also saw red hair as a stigmatised characteristic and as a 
risk to their child’s social well-being. Several recipients drew on instances of people 
with red hair being singled out for negative attention or being bullied on the basis of 
their hair colour. Thus, despite recipients’ conceptualisation of red hair as an indicator 
of whiteness they did not see this characteristic as reflecting the right kind of 
whiteness, as illustrated by the quote below from Caroline: 
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“I don’t know why they [people with red hair] are seen negatively, maybe it’s 
because of some association with the Scots. It’s strange really, because being 
ginger shows that you are definitely on the inside, that you are British, but it 
also means that your child will definitely be bullied at school.” [Caroline, 
Creative Fertility] 
 
Unlike for white recipients, the importance of eye colour and hair colour rarely 
featured in BME recipients’ discourses and practices of stating their preferences for 
BME donors. Instead, BME recipients took the homogeneity of eye colour and hair 
colour amongst BME communities for granted and therefore did not see these 
racialised characteristics as an important part of their preferences. In addition to 
seeing donors’ ethnicity as a proxy for their skin tone, BME recipients also saw 
‘ethnicity’ as a primary indicator of donors’ eye colour and hair colour, as illustrated 
below by the quote from Dipti, an Indian recipient:  
“To be honest, when it comes to ethnicities of Asian people, you pretty much 
get your brown hair, black hair, brown eyes. So that was a given for us.” 
[Dipti, The Fertility Centre] 
 
Thus, recipients also conceptualised hair colour and eye colour as ‘ethno-racialised 
markers’ (Hudson and Culley, 2014; Homanen, 2018) which were intertwined with 
recipients’ conceptualisations of ‘racialised resemblance’.  
 
7.3.3 Socio-Cultural Resemblance  
 Some recipients also had preferences for donors’ social characteristics, such as their 
hobbies, attractiveness, and social class. Both clinics allowed recipients to specify 
their preferences for donors’ social characteristics in their informal preferences. 
Rarely did recipients specify that they wanted a ‘musical’ donor or an ‘attractive’ 
donor, as reported in previous studies on egg donation (Nahman, 2006) and sperm 
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donation (Mamo, 2005; Nordqvist, 2010). On the whole, recipients’ preferences for 
donors’ social characteristics related to donors’ religion and educational level, which 
will be explored below. 
However, first, it is important to note here that unlike recipients from other ethnic 
backgrounds, the South Asian recipients (and the Chinese recipient) in this study 
emphasised the importance of ethnicity as ‘cultural heritage’. These South Asian 
recipients emphasised the importance of their ethnicity to their self-identity in the 
context of the UK (in which their culture is in the minority). South Asian recipients 
also conceptualised ethnicity as an important source of socio-cultural resemblance 
with their donor, and their child (Becker, 2000; Mamo, 2005; Thompson, 2005; 
Hudson and Culley, 2014). These recipients saw donors’ ethnicity as allowing them 
insight into and familiarity with donors’ social backgrounds. This included sharing a 
similar “Asian element”, including upbringing and environment, life values, religion, 
food, cooking, language, clothes and strong family values (Hudson and Culley, 2014). 
This view held particular significance for South Asian recipients with a white partner, 
who didn’t share this socio-cultural resemblance with their partner. The quote below 
from Ayeshah, who had a white husband, illustrates this importance placed on 
ethnicity as socio-cultural resemblance by Asian recipients: 
“For me, the Asian element, it just is my heritage, you know […] it’s a heritage 
aspect, it’s my heritage and therefore I would like my child to know about my 
heritage […] so it’s those sort of elements. For me, it’s just getting a flavour, it’s 
to be aware. That is important. Because the clothes and the food and the culture, 
it’s in our lives, so carrying on that tradition.” [Ayeshah, Creative Fertility] 
 
 
In general, it was not common for recipients to state a preference in relation to the 
religion of donors, regardless of their own religious identification. Those that did all 
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identified as being religious themselves and wanted a donor from the same religious 
background. This was particularly the case for Indian and Pakistani recipients who 
saw religion as intertwined with their ethnic identity (Culley and Hudson, 2006; 
Hudson and Culley, 2014). The quote below from Rabiaa, a Pakistani Christian 
recipient, illustrates this view: 
“I wanted a Christian donor, because Christian people are like us. We are 
Christians. They are not dangerous, they are peaceful, and the donor will be 
the same.” [Rabiaa, Pakistani Christian, The Fertility Centre] 
 
By far the most common theme to arise from recipients’ preferences for donors’ 
religion at both clinics was the exclusion of Muslim donors by recipients who were 
not Muslim themselves. For example, some, mostly Indian Hindu, recipients stated in 
their written informal preferences: “Not accepting Muslims in any way”. Only 1 
couple discussed their exclusion of Muslim donors in any depth. The quote below is 
from an interview with Amandeep and Inderjit, an Indian Sikh couple, who had 
declined a donor who was Muslim at a previous clinic. 
This couple drew on a range of cultural, genetic and health discourses when justifying 
their discriminatory exclusion of Muslim donors, including cultural and historical 
‘differences’ between ‘Sikhs’ and ‘Muslims’ (Hudson and Culley, 2014) and 
medicalised and geneticised discourses of the risk of consanguinity in Islamic 
communities (i.e. reproduction through cousin marriages). Although they did not 
think a Muslim donor would lead to a visual difference between themselves and their 
child, they nonetheless strategically depicted Muslim donors as being genetically 
deviant (Hudson and Culley, 2014) and as a threat to the well-being and health of 
their child. As illustrated by the quote from this couple below, it was not uncommon 
for recipients to conflate religion and ‘ethnicity’:  
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Inderjit: “I think it’s more the way of life, that habits side of it, Muslims and 
Indians, the background, the far far background, the way we’re led to believe. 
How we’re brought up. It’s just what you hear, and what you see going on in 
the world, you don’t want to be associated with it. It’s not that anybody would 
know, but it’s in the roots somehow, in the genetics”. 
Amandeep: “You can’t help but being a bit prejudice. I think it’s to do with 
our psyche almost […] and the other thing with Muslim donors is that in some 
families they have like marrying of the cousins and things like that […] So it’s 
not to do with them per se, it’s more that genetic aspect, maybe. I know they 
[clinicians] check for it, but we had to make sure.” [The Fertility Centre] 
 
Another social characteristic that was raised as important by recipients was the 
education/occupation of donors. In the literature on matching, recipients’ preference 
for an ‘educated donor’ has commonly been depicted as a ‘consumer preference’ of 
wanting to ‘improve familial qualities (Mamo, 2005). However, in this study, having 
an ‘educated’ donor (university degree and above) was raised as an ideal and 
important preference by 10 interviewees, most of whom had a university degree 
themselves. The majority of these recipients and their partners described education as 
an indicator of genetically inheritable intelligence and saw having an educated donor 
as increasing their chances of having an intelligent child. However, they also saw 
education as an indicator of social opportunity (environment and nurture), which was 
also regarded as a desirable attribute. 
Recipients and their partners were keen to stress that they did not seek to improve the 
characteristics of their child by having an educated donor. Instead, they stressed the 
importance of education as an important form of socio-cultural resemblance which 
helped them to identify with their donor in an otherwise anonymised context. This 
view is illustrated by the quote below from Betty and Nick: 
Betty: “Because we’re both educated and we both went to university we 
wanted to have somebody that had that same type of journey in their life, 
because we want that for our child to be able to possibly have”  
Nick: “It wasn’t about selecting someone that had higher education because 
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of the education. It was about having someone that matches us. We’re both 
university educated, so that would lead us towards it. Now other couples 
might say they were selecting based on what they want to be, not what they 
are; but that’s not true of us. I want that to be clear. It was about who is most 
near to you [Betty].” [The Fertility Centre] 
 
7.4 Preference for Donor Information 
Having explored recipients’ retrospective preferences for donor characteristics, 
attention will now be paid to recipients’ preference for donor information. Clinicians 
provided recipients with anonymised information about their donor after matching 
them. The organisation of ‘Donor Offering’ at each clinic was significantly different, 
which meant that recipients from each clinic varied in relation to the amount of 
information they received about their donors (as will be discussed further in Chapter 
8). However, regardless of how much donor information recipients were given, most 
were conflicted about whether they would have liked to have received more 
information about the donors they were matched with.  
On the one hand, recipients saw having some information about their donor as 
important because it enabled them to decide whether or not to accept donors they 
were matched with. Some recipients also saw having donor information as 
“reassuring” because it enabled them to feel a sense of connection with their donor 
(Becker, 2000). Recipients who wanted more donor information saw this as a source 
of control, and would have ideally liked more detailed information about their donors’ 
physical appearance and social characteristics, such as a photograph and information 
about their personality and family upbringing (Becker, 2000). However, these 
recipients felt conflicted about wanting more information, as illustrated by the quote 
below from Linda:  
“On the one hand I would like to know everything about that person [the 
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donor], but on the other hand I don’t want to know anything!” [Linda, The 
Fertility Centre] 
 
Indeed, the majority of recipients who were interviewed concluded that they would 
not have liked more information about their donor because they saw this as a ‘risk’ to 
the distance they wanted to maintain with their donor. Here, recipients described 
having more donor information as “uncomfortable”, “disturbing” and a “burden” 
(Rubin et al. 2015). Although some recipients described the amount of donor 
information they received as “minimal” and “limited” they also concluded that it was 
“enough”.  
Recipients saw having “too much” or identifying donor information as a risk to their 
distance with donors and stressed that they did not want to have “too much 
connection” or an “intimate relationship” with their donor. In this respect, recipients 
saw having limited donor as enabling them to manage their own anxieties in the egg 
donation process and prevent their anonymous donor from becoming “too real”. This 
view is illustrated by the quote below from Dipti: 
“They [clinicians] said she’s [donor] really nice and lovely and chatty. But 
then you can’t ask for too much. I think that with egg donation you don’t want 
to have too much of a connection, because it’s always going to be in your head 
that I did end up having eggs donated to me. And that’s something that I can 
deal with, but the more and more you find out about the person the more it 
becomes real to you. Because at the moment it is real to you, but you don’t 
know the person, all they are is on a piece of paper.” [Dipti, The Fertility 
Centre] 
 
The male partners of recipients were particularly keen to emphasise that they did not 
want more information about donors. These partners raised their own concerns about 
their role in the egg donation process, and in particular, in reproducing with an 
anonymous stranger whom they had not met, as illustrated by the quote below from 
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Roger: 
“There’s another angle on this, from my perspective. I think that in a way 
having less to know about the person, for me, was better. Because you know, 
I’ve gone through the process now, and touch wood, everything will be fine, 
we’ll have a lovely baby. But it’s still a big thing for me to get my head around 
what I’ve actually done. You know, I’ve created a life. I’ve done the most 
intimate thing you can do with somebody and I’ve got no idea who they are. 
And in a way I don’t really want to know that much more about them. For me, 
it’s easier to deal with.” [Roger, Creative Fertility] 
 
Although the majority of recipients and their partners did not want more donor 
information for themselves, couples who intended to disclose to their child made a 
distinction between having access to more donor information for themselves and for 
their child. These interviewees recognised that their child might have curiosity about 
their donor and want access to information about their “genetic origins”. In this 
respect, they saw providing their child with more information about their donor as 
part of their parental duty towards their child, even though they did not want more 
donor information for themselves. This view is illustrated by the quote below from 
Nick: 
“It’s important to know the general characteristics, information, enough to 
feel that that match is correct. But individual specific information would be 
uncomfortable. There probably should be a legal right for the child to find out 
about their origins in later life, and that’s good and proper, but I’m not sure 
that same right should be extended to us at this point in the process. I would 
be uncomfortable with it.” [Nick, The Fertility Centre] 
 
Regardless of their intention to disclose to their child, recipients were also concerned 
that having more donor information would make them too critical when selecting 
donors and therefore lead to delays to their treatment. Recipients were also concerned 
that if they had more donor information then their desire for more information would 
be unappeasable (i.e. they would just want more and more). Therefore, most 
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recipients concluded that whilst more donor information might be appealing, 
ultimately it was “safer not to know”, as illustrated by the quote below from Inderjit:  
“It can help you to have more information about everything, but sometimes 
the less you know can be better for you as well. Because the more you dig 
about somebody, their background, and stuff, something will always keep 
putting you off […] so sometimes it’s better the less you know, rather than the 
more you know, because the more you know, the more you’ll want to know. 
And then you’ll start doubting yourself because you’ve got more to think 
about.” [Inderjit, The Fertility Centre] 
 
7.5 Conclusion 
This chapter focused on recipients’ discourses and practices of stating their 
preferences for donor characteristics and their perception of donor information within 
the clinical context of egg donation. Recipients’ accounts revealed that they 
experienced their infertility and egg donation as stigmatised in society due to going 
against norms of ‘natural’ and genetic reproduction. As such, recipients sought to 
reproduce resemblance with their child by selecting a donor who matched their own 
characteristics with the expectation that these characteristics would be genetically 
inheritable by their child (and consequently shared with themselves). When 
conceptualising their preferences for donors’ physical characteristics, recipients 
foregrounded the role of genetic inheritance and the relationship between resemblance 
and kinship.  
Recipients saw resemblance as a primary indicator of kinship and conceptualised a 
lack of resemblance as stigmatised and as a ‘kinship risk’, i.e. as a threat to their 
display of family, potentially revealing of their infertility and as leading to 
‘resemblance talk’ (Becker et al., 2005). Recipients were not merely seeking to 
manage their feeling of stigma ‘by association’ (Neuberg et al. 1994; Goldstein and 
Johnson, 1997).  
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Instead, recipients’ discourses specifically reflected a ‘relational stigma’, similar to 
that experienced by couples in ‘inter-racial’ (Storrs, 1999; Romano, 2009) and same 
sex (Frost, 2011) relationships. Here, recipients felt ‘relational stigma’ by virtue of 
their relationship with their child rather than because of a direct association with a 
stigmatised attribute. Recipients sought to manage this stigma by matching a donor 
with their own characteristics so that their child could ‘pass as if’ it was their own 
genetic offspring. In this regard, recipients’ preference for resemblance can be 
interpreted as a form of self-surveillance, in which recipients had little choice but to 
match for resemblance and replicate a normative ideology of the family. This 
ideologically constrained preference was further illuminated by the discourses of male 
same-sex interviewees, who actively chose not to subscribe to heteronormative ideals 
of reproduction and kinship.  
Recipients conceptualised ‘ethnicity’ as a physical and genetically inheritable 
characteristic, i.e. as ‘race’, and as a primary indicator of kinship. Conversely, 
recipients’ conceptualised ‘racial difference’ as a primary ‘kinship risk’. However, 
recipients differed in their conceptualisation of ‘racial’ and physical difference and in 
their willingness to accept donors with different characteristics to their own. Whilst 
white recipients were unwilling to consider accepting a BME donor, a shortage of 
BME donors meant that most BME recipients had considered accepting a donor from 
a different ‘racial’ background to their own. However, what was most revealing about 
these differences was recipients’ conceptualisation of ‘race’ in relation to 
reproduction. Whilst white recipients saw ‘racial difference’ as a ‘discredited stigma’ 
(visible and overt) BME recipients saw ‘racial difference’ as a ‘discreditable stigma’ 
(not immediately obvious), to a degree (Goffman, 1963).  
White recipients conceptualised ‘race’ as inflexible, bounded, and immutable, and 
could not conceive giving birth to a mixed ethnicity child. These recipients were 
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concerned about their reproductive legitimacy (e.g. their partner’s paternity). Some 
white British recipients were also unwilling to consider donors from southern 
European (i.e. ‘marked white’ donors) because they saw having a child with darker 
skin tone to themselves as a ‘kinship risk’. BME recipients on the other hand could 
conceive of using a donor from a different ‘racial’ background and conceptualised 
‘race’ as flexible and could be transgressed, to an extent.  
BME recipients could conceptualise having a mixed ethnicity child, although the 
acceptability of this outcome also reinforced and reproduced a racialised hierarchy of 
skin tone in which recipients were willing to accept a donor with lighter skin tone 
than themselves but were unwilling to accept a donor with darker skin tone than 
themselves. Some black African/Caribbean recipients were more willing to accept a 
South Asian donor than a white donor. South Asian recipients in particular 
conceptualised skin tone as both an indicator of kinship and embedded in social 
norms of desirability and stigma. Although South Asian recipients had considered 
using a white donor they limited this inclusion to ‘marked white’ donors, whom they 
saw as having the potential to ‘pass’ as Asian. Furthermore, some South Asian 
recipients were more willing to accept a (marked) white donor with darker skin tone 
than a South Asian donor with darker skin tone. South Asian recipients’ preferences 
were also shaped by the ‘race’ of their partner.  
Recipients strategically drew on discourses of geneticisation and risk to single out and 
exclude donors with minority and stigmatised characteristics. Recipients described 
their own characteristics as being “normal”, “average” and socially desirable and 
framed donors with particular characteristics as falling outside of this 
conceptualisation. Thus recipients’ conceptualisations of ‘resemblance’ and their 
conceptualisations of social desirability and stigma were intertwined. Recipients 
singled out donors with dark skin tone, red hair, a high BMI and who identified as 
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Muslim for exclusion from their preferences. These characteristics were framed by 
recipients as being a ‘kinship risk’ and/or a risk to the health and well-being of their 
child. Thus, the recipients in this study did not directly seek to ‘improve’ the 
characteristics of their child by selecting donors with desirable characteristics (Mamo, 
2005, Burr, 2009) but rather sought to exclude donors who they saw as posing a risk 
to their child and their family legitimacy.  
Despite their emphasis on having a ‘racially matched’ donor, in practice, white 
recipients and South Asian recipients sought to exclude ‘racially matched’ donors 
with particular nationalities or geographical ancestry as a way of excluding donors 
with darker skin tone. This finding echoes previous studies which have reported that 
recipients sought to exclude donors with darker skin tone from their preferences 
(Birenbaum-Carmeli and Carmeli, 2002; Nahman, 2006; Schurr, 2016). This chapter 
also illustrates the ways in which other axis of stigma and discrimination, such as red 
hair, being ‘overweight’ and identifying as Muslim, are reproduced and reified 
through recipients’ discriminatory preferences of exclusion.  
A recent debate in the literature on gamete donation has been the extent to which 
recipients would like more information about their donors in the matching process. 
Typically, access to donor information has been framed in the literature as 
consumerist and enabling recipients more control, particularly in contexts of donor 
selection (Becker, 2000, Pennings, 2000). The findings of this study however echo 
more recent studies in contexts of donor allocation which have highlighted recipients’ 
desire not to know more information about their donor for themselves (Stuart-Smith et 
al., 2002; Konrad, 2005; Rubin et al., 2015; Zadeh et al., 2016b) whilst having a 
desire to know more on behalf of their child.  
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For example, in a recent study exploring recipients’ preference for donor information 
Rubin et al. (2015) referred to the negative consequences of providing recipients with 
more information as a ‘paradox of choice’ whereby more information was seen as a 
source of more control and as a burden, and reflects “the ways in which having 
options undermined, rather than enhanced, the process of choosing” (314). In this 
study, recipients appeared to face a paradox of conflicting identities. On the one hand, 
reflecting a consumer identity, recipients wanted more information about their donors 
to use as a donor selection tool (for control). On the other hand, recipients saw having 
“too much” donor information as a risk to their own identity as parents and the 
distance they wanted to maintain with anonymous donors. However, recipients saw 
having more and identifying donor information as their child’s ‘right’, and in this 
respect, saw having access to more donor information in the future as part of their 
parental obligation towards their child. 
Konrad (2005: 183) described recipients’ desire not to know more as “active not-
knowing”, which she argued was a mechanism for recipients to construct relatedness 
with their child by displacing the role of the donor. This reflects another tension in the 
literature, whereby some researchers have argued that recipients “obliterated” the role 
of their donor when seeking to construct kinship and resemblance with their child 
(Edwards and Strathern, 2000; Murray and Golombok, 2003; Konrad, 205; Nordqvist, 
2010; Braverman and Frith 2014) whilst other researchers have argued that recipients 
“re-materialized” their donor and in order to construct kinship with their child 
(Mamo, 2005: 246; Klotz, 2014). In the context of sperm donation, Grace et al. (2008) 
have also highlighted how recipients can hold multiple and ambiguous 
conceptualisations of donors, as both ‘present’ and ‘absent’ (Grace et al., 2008).  
Neither of these extremes represented the experience of recipients in this study. 
Instead, interviewees in this study appeared to conceptualise donors in a liminal role, 
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where on the one hand they sought to maintain distance between themselves and their 
donor (i.e. avoid their donor becoming ‘too real’) whilst on the other hand they did 
not want to completely deny the existence of their donor as a person. Having 
presented recipients’ preferences for donor characteristics and recipients’ perceptions 
of donor information, the following chapter will explore recipients’ practices of 
selecting donors that they were matched with. This will include exploring how 
recipients’ preferences, amongst other factors, shaped their practices of accepting and 
declining donors. 
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Chapter 8: Recipients’ Practices of Accepting and 
Declining Donors  
 
8.1 Introduction 
In the previous chapter recipients’ preferences for donor characteristics were 
explored, illustrating how they foregrounded notions of genetic inheritance and 
resemblance as an indicator of kinship. In this chapter, recipients’ practices of 
accepting and declining donor they were allocated be explored, including how 
recipients interpreted and utilised the donor information they received. This will 
include exploring the impact of contextual constraints, such as the organisation of the 
matching process in each clinic and recipients’ perceptions of clinicians, as well as 
examining the discourses recipients drew on when discussing their acceptance or 
refusal of donors.  
Previous studies which have explored recipients’ preferences for donor characteristics 
and practices of selecting donors have often conflated the two, or have not reported on 
these two stages separately (Birenbaum-Carmeli and Carmeli, 2002; Mamo, 2005; 
Nahman, 2006, Nordqvist, 2010; Whitaker and Speirer 2010, Homanen, 2018). This 
is particularly the case for studies which have taken place in contexts of sperm donor 
selection, where researchers have emphasised recipients’ agency in selecting donors. 
Few studies have explored the constraints shaping recipients’ practices of 
accepting/declining donors in contexts of donor allocation or to what extent recipients 
were willing to compromise on their original preferences for donor characteristics.  
In the USA, Lindheim and Sauer (1998) reported quantitative findings in which they 
compared recipients’ preferences for donor characteristics with their practices of 
selecting donors. The researchers’ post-hoc reviewed 80 matches over a period of 16 
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months and found that 71% of recipients had accepted the first donor offered to them 
and 29% declined. Whilst studies in the UK context have alluded to constraints 
shaping recipients’ practices they have not explored recipients’ perceptions and 
negotiations of these in any depth (Konrad, 2005; Braverman and Frith, 2014; Klotz, 
2014; Zadeh et al., 2016a). The focus of this chapter will not be on how recipients 
construct kinship with their child but on recipients’ material practices of accepting 
and declining the donors they were offered, which is part of a larger matching process 
(e.g. stating preferences and being allocated a donor). However, recipients’ 
conceptualisations of kinship will be explored in so far as this influenced their 
preferences and practices of donor selection. 
To begin with, recipients’ practices of declining donors will be presented with a focus 
on the most common characteristics by which donors were declined. Attention will 
then be given to recipients’ practices of accepting donors, and in particular donors 
with different characteristics to their own. Finally, the different rates at which 
recipients accepted and declined donors at the two clinics in this study will be 
explored, followed by recipients’ perceptions of clinicians and the matching process 
at each clinic. 
 
8.2 Declining Donors: Marginalised and Stigmatised Characteristics 
In the previous chapter on recipients’ preferences the characteristics that recipients 
did not want in their donor were explored. In this section attention will specifically be 
given to the donors that recipients were matched with and declined, and the 
characteristics by which donors were most commonly declined.  
In the literature on donor selection, some researchers have reported the characteristics 
that recipients did not want to accept in their donor (Nahman, 2006; Kroløkke 2014; 
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Berman, 2015), but few have reported recipients’ practices of declining donors 
(Lindheim and Sauer, 1998; Thompson, 2009). Lindheim and Sauer (1998) reported 
that recipients were just as likely to accept a donor regardless of how long they had 
been waiting for a match and that, consistent with their original preferences, 
recipients’ declined donors on the basis of a range of characteristics, including weight, 
height, skin tone, education and health. However, no more than 2 recipients declined 
(presumably different) donors on the basis of possessing these characteristics.  
The data drawn upon in this section are predominantly taken from Creative Fertility, 
where the majority of recipients declined donors; this includes observations of 152 
matches at Creative Fertility, including 81 recipients and 65 donors, observations of 
‘Donor Offering Consultations’ at The Fertility Centre and interviews with recipients 
who excluded donors at both clinics. At The Fertility Centre it was less common for 
recipients to decline donors than at Creative Fertility, although when choosing 
between multiple offered donors recipients exclusion of donors with particular 
characteristics was clear. Importantly, although recipients declined donors at different 
rates at each clinic (as will be explored further below) their reasons for declining 
donors were similar across both clinics.  
It is useful to note here that the donors that recipients were matched with should 
already have been filtered through the preferences that they stated at their clinic. 
However, this was not always the case, e.g. as explored in Chapter 6 clinicians 
prioritised their own matching criteria over recipients’ preferences. Furthermore, 
although recipients may have been willing to accept donors with certain 
characteristics in theory (in their preferences) they may have not been unwilling to 
accept them in practice (when offered a donor).  
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Recipients declined donors for a range of reasons and on the basis of a variety of (and 
often multiple) characteristics. For example, sometimes recipients declined donors 
because: they thought a donor was ‘too old’; the donor was a carrier of a genetic 
condition; they wanted a donor who was a “closer match” in physical characteristics; 
or they were not ready to start treatment. More commonly, recipients declined donors 
on the basis of possessing particular characteristics, which were usually different to 
recipients’ own. The meaning that recipients attached to these characteristics were 
explored in the previous chapter and so will not be explored here. Here, the main aim 
is to illustrate the systematic nature by which donors with particular characteristics 
were excluded from donating by multiple recipients.  
The main characteristics by which interviewees declined donors will be outlined 
below. It is important to note here that in practice many recipients declined donors on 
the basis of possessing multiple ‘undesirable’ characteristics. However, these 
characteristics have been separated for heuristic purposes. Firstly quantitative data 
gathered from observations will be reported followed by data from interviewees. 
Descriptive analysis of 152 matches at Creative Fertility revealed that the majority of 
donors (74%, n=48 out of 65) were declined by at least once. However, some donors 
were declined more than others (between 1-6 times by different recipients). Whilst the 
majority of donors were declined by one or two recipients (82%, n=39 donors), 9 
donors (18%) were declined by at three recipients or more; that is, they were the most 
declined donors in the clinic. The characteristics by which recipients most commonly 
declined donors were: being ‘overweight’, having red hair, identifying as a lesbian 
and having no higher education degree.  
The number of times that these 9 individual donors were declined and the reasons 
recipients often gave for declining them are outlined in Table 8.1 below.  
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Table 8.1  Donors Declined 3 Times or More by Recipients at Creative Fertility 
over 10 Months Period of Observations from 152 Matches 
 
As illustrated by the table above, the single most frequently declined donor at 
Creative Fertility was a donor with red hair. This donor was declined by 6 different 
recipients before being accepted (over a 4 month period of observations). One might 
recall from Chapter 7 that only seven recipients were willing to accept this donor in 
their stated preferences. The most commonly declined characteristic in donors was 
weight, or rather being ‘overweight’. Two donors were declined by 5 recipients each 
and 1 donor was declined by 4 recipients because they had a high BMI; these 3 donors 
alone thus made up for 14 of the declined matches in the clinic. Each of these donors 
had a high BMI (28-30) and would have been classed as clinically obese (although 
they met the clinic’s screening criteria for donors).  
Five donors were declined by 3 recipients each. Recipients gave multiple reasons for 
declining these donors. For example, one donor was declined by multiple recipients 
because she identified as a lesbian and had no university degree, one donor was 
declined because she was Bulgarian (‘marked white’) and had a high BMI, and 
Number of Times 
Donor Declined 
Number of 
Donors 
Recipients’ Reason(s) for Declining 
Donors 
6 1 Red Hair 
5 2 ‘Overweight’ 
4 1 ‘Overweight’ 
3 5 
Multiple Reasons per Donor: 
Lesbian, Marked White, 
‘Overweight’, No University Degree 
 Total=9  
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another white British donor was declined because she was ‘marked’ as being ‘born in 
Mexico’ and had no university degree.  
Although not apparent from the table above, the declining of ‘marked white’ donors 
was not an uncommon occurrence, particularly by white British recipients. At least 2 
recipients declined donors, at least in part, because they were Portuguese, Columbian, 
Latvian or Romanian. Several white British recipients also declined ‘marked white’ 
British donors on the basis of their ‘markedness’ (i.e. additionally labelled 
characteristics); one donor had a “Maltese grandmother” and the other donor was 
“born in Mexico” (as stated on their profiles). In the former case, recipients appeared 
to foreground the donor’s genetic ancestry over her white British nationality whilst in 
the latter case recipients appeared to prioritise the donor’s place of birth over her 
white British genetic ancestry. In each case, recipients strategically naturalised 
different aspects of donors’ identity in defining them as not being the ‘right kind’ of 
white donor, as found in transnational studies of egg donation (Bergmann, 2015; 
Schurr, 2016; Homanen, 2018). 
Data from interviewees’ accounts of declining donors echoed the findings from 
observational data. Interviewees also declined donors for a range of reasons, including 
eye colour, health and age. Table 8.2 below outlines the main characteristics by which 
interviewees declined donors and the number of recipients who declined donors on 
the basis of possessing these characteristics.  
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Table 8.2 Interviewees Main Reasons for Declining Donors Across Both Clinics  
Main Characteristics by which 
Donors were Declined 
Number of 
Recipients 
Clinic 
‘Overweight’ 4 Creative Fertility 
Red Hair 2 Creative Fertility 
Lack of Education/Occupation 2 Creative Fertility 
Lesbian 2 The Fertility Centre 
 
Most of these characteristics were coherent with the characteristics that recipients 
sought to exclude in donors when stating their preferences for donor characteristics 
(as explored in Chapter 7). Although recipients seldom specified a preference for 
donors’ sexuality some recipients declined donors for this reason. When discussing 
their reason for refusing lesbian donors couples often drew on similar discriminatory 
discourses couples who sought to exclude Muslim donors from their preferences (as 
explored in Chapter 7).  
What was especially illuminating about interviewees’ accounts of excluding lesbian 
donors was their re-negotiation of their original preferences and their apparent 
prioritisation of social characteristics over ‘race’. That is, two interviewees declined 
lesbian donors even though these were the only donors available who met their ‘racial 
preferences’; one recipient was Indian and declined an Indian donor and the other 
recipient was Iranian and declined a white British donor. When declining donors, 
recipients foregrounded donors’ ‘undesirable characteristics’ (e.g. sexuality) over 
their ‘desirable’ characteristics (e.g. ‘race’). They also foregrounded the criteria they 
wanted to exclude in their donor (from their preferences) over delays to their 
treatment, as illustrated by the quote below from Betty, who declined a donor based 
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on eye colour. In this respect, the characteristics by which donors were declined 
became their ‘Master Status’ (Hughes, 1945) in recipients’ eyes.  
“We’re not just going to take any person. We would love to have a family, but 
we are not just going to take anything. That was the whole point of why we’re 
going through this […] So we took the hard choice to say ‘no’ we’re going to 
wait.” [Betty, The Fertility Centre] 
 
Recipients’ motivation for excluding donors with red hair, a high BMI, no education 
and marked white ethnicity/skin tone were explored in Chapter 7 and so will not be 
repeated here. Of note here is that recipients excluded donors with these 
characteristics from both their preferences and practices of selecting donors. This 
meant that donors with these characteristics could only be offered to a small number 
of recipients (who were willing to accept them) and that those recipients who they 
were offered to often declined them. Furthermore, donors who possessed multiple 
‘undesirable’ characteristics were less likely to be accepted by recipients. 
In previous studies, researchers have generally framed the exclusion of donors with 
undesirable characteristics as isolated incidents (Lindheim and Sauer, 1998; Klotz, 
2014). However, the collection of data through multiple methods and analysis through 
angles of enquiry enabled insight into recipients’ patterns of excluding donors and 
revealed that the exclusion of donors with particular stigmatised/marginalised 
characteristics was systematic i.e. they were excluded from recipients’ preferences 
and were declined by at least 3 recipients. This included donors with red hair, a high 
BMI, dark skin tone, and who identified as Muslim or lesbian. 
Despite having been accepted by the clinic, donors with these characteristics waited 
much longer to donate than other donors (as they were offered to different recipients 
over a period of several months). On some occasions they were prevented from 
donating at all. For example, at Creative Fertility a donor with red hair was declined 
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so many times that she left the clinic before donating and on another occasion a donor 
from Bulgaria left the clinic because she had been declined by multiple recipients and 
her student visa ran out. At The Fertility Centre, recipients’ exclusion of ‘overweight’ 
donors led to the clinic freezing the eggs of these donors (before they left the clinic 
without donating) and screening out donors with a high (but ‘acceptable’) BMI range 
from the outset. Thus the reproduction of donors with marginalised/stigmatised 
characteristics was stratified, whereby it was devalued and avoided by recipients and 
discouraged from being reproduced.  
As shown above, recipients were unwilling to compromise on their preferences of 
exclusion and accept donors with different (and marginalised) characteristics to their 
own. However, this was not the case for all types of differences. When accepting 
donors recipients drew on a different set of discourses to legitimise accepting donors 
with different characteristics to their own.  
 
8.3 Accepting Donors: Accepting Difference 
In previous studies on recipients’ selection of gamete donors it has generally been 
assumed that recipients selected donors according to their preferences for donor 
characteristics and that this selection is a consumer practice (Becker, 2000; Fogg-
Davis, 2001; Pennings, 2000; Birenbaum-Carmeli and Carmeli, 2002; Konrad, 2005; 
Mamo, 2005; Nahman, 2006; Costa, 2007; Nordqvist, 2010; Whitakker and Speier, 
2010; Kroløkke, 2014; Deomampo, 2016, Schurr, 2016; Homanen, 2018). 
Researchers have also focused on how recipients constructed resemblance with the 
donors they selected as a mechanism to construct kinship relatedness with their child 
(Becker 2000; Konrad, 2005; Thompson, 2005; Klotz, 2014; Bergman, 2015). 
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As such, these studies have argued that recipients’ selection of donors is a consumer 
practice and a kinship practice, embedded in discourses of genetic inheritance (Becker 
2000; Mamo, 2005; Szkupinski-Quiroga, 2007). However, most of these studies have 
conflated recipients’ preferences for donor characteristics and their practices of 
selecting donors, particularly in contexts of donor selection, and have seldom 
explored whether recipients’ practices were coherent with their preferences – and how 
recipients negotiated any gaps between them. Whilst these studies have alluded to the 
constraints on recipients’ practices of selecting donors there has been little in-depth 
exploration of recipients’ perceptions of these constraints and how they negotiated 
them. In particular, missing from previous studies is how recipients rationalised 
accepting donors with different characteristics to their own.  
In this study, all the recipients who were interviewed (eventually) accepted a donor 
that they were matched with (n=18). These recipients accepted a donor who matched 
their own ethnic/‘racial’ background (apart from one Indian recipient). However, the 
majority of recipients felt that their other preferences for donor characteristics were 
not met in the donor they accepted. Despite recipients’ emphasis on having physical 
resemblance with their donor, in practice, recipients spoke more about the physical 
differences between themselves and the donor they accepted than the physical 
resemblance they shared. Thus, the process of accepting a donor, for the recipients in 
this study, appeared to be more about negotiating and rationalising physical difference 
between themselves and their donor/child than it was about constructing physical 
resemblance. 
Central to recipients’ discourses of accepting difference in their donor was the 
constraints shaping their practices. The theme of ‘compromise’ was central to 
recipients’ discourses of accepting donors, as illustrated by the quote below from 
Nick, the partner of a female recipient:  
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“The whole process is about compromise, and how far are you willing to 
compromise. So for each couple I’m sure the different characteristics are 
weighed in different ways. So certain aspects will be more or less important to 
them.” [Nick, The Fertility Centre] 
 
When rationalising the difference they accepted in their donor, recipients’ discourses 
revealed the constraints shaping their practices as well as nuanced forms of recipient 
agency. Recipients foregrounded the importance of contextual constraints in 
rationalising their compromises but they also employed rationalising discourses to 
strategically minimise, legitimise, naturalise and override difference with their 
donor/child in order to accept their donor. This included foregrounding the 
importance of time and donor shortages and drawing on: fatalistic discourses, the 
presence and absence of resemblance within families and the construction of socio-
cultural resemblance. Interestingly, at The Fertility Centre, recipients also 
foregrounded their trust in clinicians when discussing why they accepted difference 
with their donor (explored further below in Section 8.4). 
 
8.3.1 Foregrounding Contextual Constraints 
All of the recipients in this study reported that time and a shortage of donors were 
strong determining factors in their acceptance of donors, and in particular, their 
acceptance of difference in their donors. Recipients foregrounded these constraints as 
necessitating that they compromise on their preferences and accept donors with 
different characteristics to their own. Many recipients had been trying to conceive for 
a long time before deciding to use egg donation and emphasised that they didn’t want 
to delay having a child any longer. Several recipients commented that if they felt they 
had more time they would have been more discerning about the characteristics they 
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accepted in their donor. The quote below from Tina illustrates how recipients 
compromised on the characteristics they accepted in their donor because of time: 
 “First I was adamant, green eyes or blue eyes, but it’s got to the stage that the 
donor that we are using has hazel eyes. Because we could’ve gone on for 
months and months waiting, until someone else came along, and we don’t 
have time on our side […] So you become a little bit more relaxed about the 
process, about your criteria.” [Tina, The Fertility Centre] 
 
The age of recipients was also a factor in recipients’ perception of time. The majority 
of interviewees were over the age of 40 and had social and medical concerns in 
relation to being an “older mother”. These recipients were especially concerned about 
their ‘treatment clock’ in that after the age of 50 they would be excluded from having 
treatment in the clinics. The quote below from Camille illustrates recipients’ concerns 
about their age in shaping their acceptance of their donor:  
“I couldn’t wait ages, you know. It was already 8/9 months and I was going to 
become 47, for me this is the limit, I already struggled and hesitated a lot 
about my age, and giving birth at my age and so on. So I thought a lot about 
it. So I decided to do it. But I know I’m an old mother. I don’t want to push 
that anymore. So it had to happen.” [Camille, Creative Fertility] 
 
Of note here is that whilst time was an important feature in recipients’ discourses of 
accepting donors at both clinics, it was raised as the main reason for accepting donors 
at Creative Fertility. Recipients at Creative Fertility waited longer to be matched with 
a donor than recipients at The Fertility Centre and typically declined donors before 
accepting a donor, thus leading to further delays to their treatment. Having declined 
one or more donors already, recipients felt that there were only so many donors that 
they could decline without affecting their position on the waiting list, as illustrated by 
the quote below from Brenda who had declined a donor before accepting her donor:  
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“I just felt like there’s only so many times you’re gonna be presented with 
someone and say no without feeling like, am I just going further down the list 
or is it going to be months and months.” [Brenda, Creative Fertility] 
 
Inherent in recipients’ discourses of accepting donors because of time was the 
relatively low supply of donors at each clinic, which meant that they had to wait to be 
matched with a donor. All of the recipients spoke about a shortage of donors as 
necessitating that they compromised on their preferences for donor characteristics. 
Recipients were also aware that a shortage of donors entailed a shortage of donors 
with a particular mix of characteristics, such as the recipients’ own. Thus recipients 
saw a shortage of donors as constraining their choice of a donor, as described by 
Betty: 
“I’d like to have more choice, but I know there’s not that many donors who 
come along. But it would be nice to pick more characteristics that are 
completely what we want. But we know we’re not necessarily going to have 
that.” [Betty, The Fertility Centre] 
 
A shortage of donors was particularly evident in BME recipients’ discourses of 
accepting donors. Unlike the white recipients who were interviewed BME recipients 
often cited the ethnicity of their donor as their main reason for accepting her. This 
reason was given regardless of whether the donor matched the recipients’ own 
specific ethnic background. Central to BME recipients’ discourse was that a shortage 
of BME donors meant they had little choice but to accept the BME donor that they 
were offered. BME recipients thus saw their agency in donor selection as being 
inherently constrained by their own ethnicity, as illustrated by the quote below from 
Jonathan, the (white) partner of a Chinese recipient, who accepted a Chinese donor: 
“It’s difficult, as I say, you’ve got a choice of one or two really, and physical 
height and weight don’t come into it. So that was really the choice we had. As 
far as choosing an egg donor, it’s very much not a lot of choice. There’s not a 
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lot of free choice in it at the moment. So we really take what we can get.” 
[Jonathan, The Fertility Centre] 
 
8.3.2 Fatalistic Discourses 
When rationalising why they compromised on their preference for resemblance, 
recipients commonly drew on fatalistic discourses to rationalise accepting a donor 
with different characteristics to their own. As depicted in the healthcare literature on 
patients’ healthcare behaviour, recipients used this phrase as a way of managing their 
uncertainty, recognising their lack of control, and to re-negotiate their preferences for 
resemblance (Keeley et al., 2009). Some recipients drew on notions of ‘fate’ or 
‘destiny’ to justify why they accepted their donor. More commonly, recipients utilised 
the fatalistic phrase, ‘at the end of the day’, accompanied by a rationalisation for the 
compromises made. For example, recipients qualified differences with their donor by 
emphasising that ‘at the end of the day’ all that all that mattered was having a ‘healthy 
baby’, as illustrated by the quote below: 
 “The one thing I can tell you is I’m quite tall and my husband’s quite tall […] 
And then, I’ll be honest with you, we saw her height and she’s just above 5 
foot, so for a few days we were like ‘oh no’, and I was like ‘oh no’ […] Like I 
said, it was just the height, will it look, you know… in terms of our children`. 
And then we thought that doesn’t matter, at the end of the day as long as our 
child is healthy and happy that’s our child.” [Ayeshah, Creative Fertility] 
 
Recipients used a range of such rationalisations to accept difference with their donor, 
including describing their donors’ characteristics as “close enough” to their own; 
concluding that their donors ‘good characteristics outweighed the bad’ or reasoning 
that they ‘could not control everything’, as illustrated by the quote below from 
Camille: 
“She had brown eyes, not what I would’ve liked. But you have to compromise. 
It was not the ideal thing in all terms, but overall, the good characteristics for 
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me much more outweighed the not so perfect ones. And overall I felt it was 
fine. I could live with a child with brown eyes, and taller than me. She’s 10cm 
taller, so she’s really tall. So yeah, I would’ve preferred smaller somehow, but 
this is all so material and conjectural somehow, in the end, it doesn’t really 
matter I think. You cannot control everything […] you have to give up on 
everything being fine.” [Camille, Creative Fertility] 
 
It was also common for recipients to accept donors with different characteristics by 
reasoning that they had to “let go” of their child resembling them and accept that their 
child will be ‘whoever they turn out to be’. In this respect, recipients might be 
interpreted as de-emphasising the role of the donor by highlighting the role of fate in 
determining the characteristics of their child: 
“I think at some point you’d need to let go and just go ‘this will be, our baby 
will be our baby, and our baby will be who they are’” [Brenda, Creative 
Fertility]  
 
8.3.3 The Presence and Absence of Kinship Resemblance 
Another rationalisation that was drawn upon by recipients to legitimise accepting 
donors with different characteristics to their own was to strategically draw on a 
discourse of either the presence or absence of resemblance within their own 
immediate and wider families. This also involved recipients drawing on different 
genetic discourses to rationalise their decision-making.  
When drawing the absence of resemblance between members of their immediate 
family recipients disentangled the normative relationship between kinship and 
resemblance by drawing on a lack of resemblance between genetically related family 
members. Here, recipients drew on a discourse of ‘genetic unpredictability’ to 
legitimise difference between themselves and their child (and between themselves and 
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their donor) by drawing on a range of differences, such as eye colour, hair colour, 
personality and educational attainment, between members of their family. For 
example, Uzma, a recipient with 3 existing children from a previous relationship, 
expressed this as follows:  
“My daughter looks like me, but my sons don’t look like me. ‘Cause I’ve got a 
son, 2 sons, one’s really chubby, and one’s really tall and skinny. So there’s a 
lot of difference between them two. So, you can’t say that you want a donor 
that’s going to look like me. You can’t say if that child’s gonna look like you 
or not. That’s what I believe in. Not that the donor has to look exactly like me” 
[Uzma, The Fertility Centre] 
 
Conversely, recipients also strategically drew on the presence of particular 
characteristics (possessed by their donor but different to their own) within their wider 
family. Unlike the previous strategy, where recipients emphasised the absence of 
resemblance between genetically related family members, here recipients sought to 
normalise difference by overtly relying on the relationship between kinship and 
resemblance, and the genes mediating this relationship (Szkupinski-Quiroga, 2007). 
For example, one recipient with blue eyes accepted a donor with brown eyes, 
reasoning that her sister had brown eyes. Another recipient accepted a donor who was 
taller than her on the basis that her own mother was taller than her.  
This strategy enabled recipients to provide some justification for their child having 
different characteristics to their own. In doing so, recipients could lay claim to 
possessing the genes for different characteristics (albeit in latent form) by virtue of 
sharing a similar gene pool to their family members with these characteristics. This 
strategy relied on a discourse of ‘latent geneticisation’ as opposed to ‘genetic 
unpredictability’. Unlike white and black recipients, the South Asian recipients in this 
study also used this rationalisation when accepting a donor with a different ‘race’ to 
themselves.  
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In the previous chapter on recipients’ preferences, we saw how Amandeep had 
considered using a white donor on the reasoning that her Indian niece “looked white”. 
In practice, Amandeep was offered and hesitantly accepted a Sri Lankan donor, 
despite her concerns about the donor having dark skin tone (which she associated with 
the donor’s ethnicity). In justifying why it was reasonable to have a child and accept a 
donor with darker skin tone than herself Amandeep drew on the presence of dark skin, 
or rather a “dark gene”, in her wider genetic family:  
“But even then, because one of my cousins, he’s got 3 daughters and the 
middle one is very very dark. But she is definitely his daughter […] The 
reason is, we think, she’s got some sort of black gene […] Because on my 
dad’s side there is a dark gene there. So it doesn’t matter, even if it [the child] 
was darker, in the bigger scheme of things we’d just accept it. It’s not the end 
of the world.” [Amandeep, The Fertility Centre] 
 
Interestingly, such rationalising discourses were not equally applied by recipients to 
legitimise accepting all types of differences. For example, several recipients referred 
to members of their family, or their partner, being overweight or having red hair. 
However, these characteristics were seen by recipients as posing a risk to their child’s 
well-being or to their display of kinship and so could not be mediated. That is, they 
were seen as being “too different” to themselves, as illustrated by the quote below 
from Brenda:  
“I mean I’ve got members of the family with red hair, so it’s feasible that we 
could have a red haired baby anyway. But we just thought stick to as close to 
me without being too restrictive.” [Brenda, Creative Fertility] 
 
Recipients also drew on a particular discourse of unilateral genetic inheritance (i.e. 
through one parent, the father), rather than on scientific notions of bilateral descent, to 
accept difference in their donor. Here, couples foregrounded the role of recipients’ 
partners’ genes in determining the characteristics that their child might inherit. This 
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discourse allowed recipients to negate the role of their donor, including difference 
with their donor, by foregrounding the genes of their partner (the baby’s father), as 
illustrated by the quote below: 
“I’m thinking 50% at least surely. I know it’s not always, some of the time 
they look just like their mum, but a lot of the time you do get the paternal side 
stronger.” [Amandeep, The Fertility Centre] 
 
Couples frequently emphasised the “strong”, “dominant” and “defining” physical 
characteristic of recipients’ partners, such as a particular shaped nose or chin, being 
“tall” or having “blue eyes”, which they described as being symbolic of a wider 
“family look” (e.g. shared by his parents and siblings). This conceptualisation allowed 
couples to imagine recipients’ partners having ‘strong and dominant genes’ which 
they hoped would be inherited by their child over and above donors’ characteristics 
(especially where these were different from the recipient). The quote below illustrates 
how couples foregrounded the genes of the father over their donor in determining 
their child’s physical appearance:  
“I think with me, looking at my family, going back up to my granddad, there 
are very strong characteristics, There’s like a Johnson nose that myself, my 
brother and sister have. We all have dad’s eyes. We don’t have my mum’s eyes 
[...] There’s the Johnson chin. So I can imagine, probably, those would be 
quite strong characteristics that come through in our baby.” [Roger Johnson, 
Creative Fertility] 
 
Couples did not use this discourse to directly negate difference between recipients and 
their child. Rather, it allowed them to imagine their donors’ different characteristics 
(and genes) as being recessive compared with those of recipients’ partners. In a 
minority of cases at each clinic recipients sought to match donors’ characteristics to 
their husband instead of themselves (where these were different). This strategy 
seemed to be employed by recipients to facilitate the likelihood that their child would 
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resemble at least one parent (i.e. the father) and to minimise the risk that their child 
would inherit different characteristics not possessed by either parent (i.e. ‘resembling 
the donor’).  
Thus some recipients sought to match donors’ characteristics with those of their 
partner, over their own, as a strategy for containing difference within the family. This 
practice allowed recipients to theoretically hide their donor’s genetic contribution to 
their child, or rather, to make it theoretically indistinguishable from their husbands’ 
genetic contribution. In turn, this allowed recipients to legitimise physical difference 
between themselves and their child (and to rationalise accepting a donor with different 
characteristics to themselves). 
 
8.3.4 Constructing Socio-Cultural Resemblance  
Another strategy that recipients used for accepting their donor was to construct socio-
cultural resemblance between themselves and their donor based on the donor 
information they were given about donors (verbally and in written form). 
 Unlike the strategic discourses of rationalisation outlined above, which were used to 
specifically negate physical difference between recipients and their child, here 
recipients strategically constructed socio-cultural connections with their donor as a 
mechanism of identifying with her and making her less of a “stranger”. For some 
recipients, this process of identification was an important element of accepting a 
donor. Not all of the recipients who compromised on their preferences drew socio-
cultural connections with their donor. However, all of the recipients who constructed 
these cultural connections had compromised on their preferences. Furthermore, only 
the middle-class recipients (from all ethnic backgrounds) constructed these social 
connections.  
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These recipients described their donors as being “familiar”, sharing a “connection”, 
coming from the “same surroundings”, sharing a “similar world” and doing the “same 
kind of stuff” as themselves. Recipients typically drew on shared hobbies (travelling, 
painting, photography, hiking, cycling and acting), occupation, lifestyle, upbringing, 
socio-economic background, country of origin, education and ethnicity (for BME 
recipients). Recipients not only drew these connections with themselves, but also 
between donors and their partner. Several recipients described the socio-cultural 
resemblance they shared with donors as being the “cherry on the cake”, a “bonus” and 
“reassuring” when selecting their donor, rather than the primary reason for accepting 
her. Recipients’ construction of socio-cultural resemblance with their donor is 
illustrated by the quote below from Camille:  
“Well the nurse did tell us a bit about her background. She quite liked nature, 
and it's the case for us too. She loved bicycles, and my husband, he loves 
cycling and repairing and things. It was the cherry on the cake, not the thing 
that made you decide. But I was feeling it […] I think she doesn’t come from 
too far surroundings, the type of social and cultural … where she comes from, 
the background, so in the end she doesn’t seem too far from where me and my 
husband come from. It seems quite close.” [Camille, Creative Fertility]  
 
In this context, religion and ethnicity were also seen as an important source of 
connection for most BME recipients, who saw donors with these same characteristics 
as themselves as being ‘trustworthy’ and ‘familiar’ (as seen in Chapter 7 on 
recipients’ preferences for donors’ social characteristics). Most recipients also drew 
on cultural connections between themselves and their donors’ country of origin 
(where this was outside of the UK), as illustrated by the quote below from Linda, a 
white German recipient, who accepted a donor from Estonia. 
“She’s [donor] from Estonia. And just this year we went to Latvia, which is 
just outside of Estonia. Because we’ve got friends who live there, so I can kind 
of associate myself with that area as well, very strong minded. There’s lots of 
German influence up there as well. And the way her personality was 
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described, I could identity myself more with it. I think that made it an even 
easier decision.” [Linda, The Fertility Centre] 
 
Thus recipients’ construction of socio-cultural resemblance enabled them to identify 
with their donor which was a step in the process of accepting their donor. Previous 
studies have also highlighted the ways in which recipients of gamete donation use 
donor information to construct socio-cultural resemblance. Drawing on a framework 
of kinship studies researchers have argued that recipients constructed socio-cultural 
resemblance with their donor as a “kinship device”, to construct kinship “connexions” 
(Konrad, 2005: 46) and “affinity ties” (Mamo, 2005: 248) with their child. These 
researchers have argued that recipients geneticised their donors’ social characteristics 
and treated them “as if” they were genetically inheritable by their child and shared 
with the recipient.  
In this study, the primary question of interest was how recipients accepted the donors 
that they were matched with. In this context, recipients’ construction of socio-cultural 
resemblance with their donor appeared to be a mechanism by which recipients could 
identify with their donors so that they could accept them. In the context of 
(temporary) donor anonymity such social connections made donors less strange and 
more familiar to recipients thus helping them to overcome the differences between 
them.  
 
8.4 The Impact of Context on Recipients’ Practices  
As discussed above, although all of the recipients in this study accepted a donor they 
were matched with before doing so some recipients declined donors. A key finding 
here was the difference between in recipients’ rates of declining donors at each clinic, 
which was evident from interviewees’ accounts and ethnographic observations. At 
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Creative Fertility, the majority of recipients declined the first donor they were offered 
whilst at The Fertility Centre the majority of recipients accepted the first donor they 
were offered.  
Below, data on recipients’ rates of accepting and declining donors at each clinic will 
be presented. In order to provide some explanation for this difference, recipients’ 
perceptions of clinicians and the matching process at each clinic will be presented 
alongside ethnographic data relating to the organisation of matching in each clinic 
 
8.4.1 Rates of Accepting and Declining Donors 
At Creative Fertility, where recipients were offered a single donor at a time, the 
majority of recipients who were interviewed declined donors that they were matched 
with; 5 out of 7 interviewees declined at least one donor (between 1-4 donors) and 
only 2 interviewees accepted the first donor who was offered to them. At The Fertility 
Centre, where recipients could be offered multiple donors at a time, the majority of 
recipients accepted (one of) the first donor(s) they were offered; here, 9 out of 11 
interviewees accepted a donor without declining and only 2 recipient declined donors. 
Table 8.3 below summarises the number of donors declined at each clinic 
: 
Table 8.3  Number of Interviewees who Accepted or Declined First Donor 
Offered at Both Clinics 
 Creative Fertility The Fertility Centre 
Accepted First Donor 2 9 
Declined at least one Donor 5 2 
Total Number Interviewees 7 11 
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Interviewees’ patterns of accepting and declining donors were echoed by 
ethnographic observations of recipients’ practices. At Creative Fertility, 152 matches 
were made by clinicians over the 10 month period of observations which comprised 
81 recipients and 65 donors, many of whom were matched more than once. Of the 81 
recipients who were matched, 74% (n=60) declined at least one donor whilst only 
26% (n=21) accepted the first donor they were allocated, as illustrated by Table 8.4 
below. Conversely, this meant that of the 65 donors who were matched at Creative 
Fertility, 74% (n=48) were declined at least once. The characteristics by which these 
donors were most commonly declined were discussed at the beginning of this chapter 
(Section 8.2). 
 
Table 8.4  Number and Percentage of Recipients Who Declined or Accepted a 
Donor at Creative Fertility over 10 Months of Observations  
 Number Percentage 
Accepted First Donor 21 26% 
Declined at Least One Donor 60 74% 
Total Number of Recipients Matched 81 100% 
 
At The Fertility Centre, it was not possible to systematically record the number of 
recipients who declined donors (as this information was not recorded by the clinic). 
However, ethnographic observations generally echoed interviewees’ practices, where 
the majority of recipients accepted one of the first donors they were offered. For 
example, of the 15 ‘Donor Offering’ consultations which were observed only 2 
recipients declined a donor over a telephone consultation. It is important to note here 
that whilst the rate at which recipients declined donors was different at each clinic, on 
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the whole, recipients’ reasons for declining donors across both clinics were similar 
(and will be explored in the last section of this chapter). 
 
8.4.2 Recipients’ Perceptions of Clinicians and the Matching Process 
Researchers have reported that the role of context is of central importance to 
medicalisation and stratification (Singer, 1989; Massey, 2007; Kaplan et al., 2010) 
and have stressed the importance of “trust” in patient decision-making in ARTs and 
healthcare more generally (Mechanic, 1996; Lupton, 1997; Lee and Yin, 2011; Hall et 
al., 2001; Mechanic and Meyer, 2000) few studies have touched on the impact of 
recipients’ trust, or lack of trust, on their practices of selecting donors. In the UK 
context of egg donation, Klotz (2014) reported that sometimes recipients challenged 
clinicians’ authority in matching by declining donors.  
On the other hand, Konrad (2005) reported that the recipients in her study were rarely 
critical about clinicians or the matching process and did not decline donors for fear of 
seeming ‘too demanding’, ‘ungrateful’ or ‘jeopardising’ their place in the long 
waiting list for donors. In this respect, Konrad (2005) argued that although “the 
American system exacts a price, and can be criticised for its market-driven 
profiteering, these examples from Britain show how ‘hidden costs’ are built into the 
system as polite fictions” (ibid: 150). However, none of these UK ethnographies 
considered the impact of recipients’ trust in clinicians on their practices of selecting 
donors. Nor did they explore recipients’ practices of accepting and declining donors 
in any depth. 
In this study, recipients’ discourses revealed that donors’ characteristics were not the 
only factor shaping their decision to accept or decline donors. Instead, context 
appeared to be a significant factor in recipients’ decision-making, in particular, 
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recipients’ trust in clinicians and, relatedly, their perception of the matching process. 
More specifically, at Creative Fertility, where the majority of recipients declined the 
first donor they were matched with, a lack of trust in clinicians and questioning of the 
matching were dominant features of recipients’ discourses of declining donors. At 
The Fertility Centre on the other hand, where the majority of recipients accepted the 
first donor they were matched with, recipients’ trust in clinicians was a central feature 
of their discourses of accepting donors. These factors will now be explored in relation 
to each clinic individually. 
 
Creative Fertility 
At Creative Fertility, where the majority of recipients declined donors, recipient 
agency was restricted by the organisation of the matching process. Recipients were 
offered a single donor at a time, waited between 6-12 months to be matched with a 
donor and were provided with little information about their donor via e-mail. The 
large size of the clinic meant that recipients seldom saw the same nurse for their 
appointments. Underlying recipients’ discourses of declining donors were concerns 
that went beyond the actual characteristics possessed by donors (which were explored 
at the beginning of this chapter). Rather, recipients’ discourses of declining donors 
were intertwined with their negative perception of clinicians and the matching 
process.  
Recipients recognised that Creative Fertility was a large fertility clinic with a lot of 
staff. They described having a lack of a consistent relationship with any one 
individual clinician on the egg donation programme and referred to their contact and 
communication with clinicians as being “minimal”, “impersonal” and 
‘unsympathetic’ and “disappointing”. These recipients seldom spoke about trusting 
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clinicians. Recipients’ critical view of clinicians, nurses in particular, is illustrated by 
the quote below from Helen:  
“It seemed like minimal contact. Because the relationship, that’s what you 
have with the nurses, it was minimal, it was a bit confusing, and yeah, I 
needed more hand holding. I was swapped from nurse to nurse, there was no 
real relationship there […] By the end of the process I didn’t like them. I 
didn’t feel like they had a genuine understanding of my situation and what I 
was going through.” [Helen, Creative Fertility] 
 
This lack of a “real relationship” appeared to influence recipients’ satisfaction with 
the process of matching and the donors that they were offered. Recipients felt like 
they had a lack of information about and a lack of control over the donor allocation 
process, reflecting that, in retrospect, they were unhappy with their experience of 
matching at the clinic. These recipients questioned the role and decision-making of 
clinicians within the matching process and described the matching process as being 
“non-transparent”, “impersonal” and undertaken “behind closed doors”. They 
questioned the fairness of the waiting list and felt that clinicians were unwilling to be 
“open” and “transparent” about their own role in matching, as illustrated by the quote 
below from Helen (mentioned above): 
 “I didn’t feel it was accountable at all, because it was so un-transparent, it 
seems like oh there’s a whole other process behind this that I’m not aware of 
[…] You have no way of knowing. They weren’t prepared to be any more open 
about the process it seemed.” 
 
When stating their preferences for donor characteristics recipients reported feeling 
“rushed” and “confused” about the available pre-existing characteristics and 
categories. Several recipients described this process as akin to scribbling down’ their 
preferences on ‘the back of an envelope’ and questioned to what extent clinicians took 
them into account when matching, as shown by the quote below from Caroline:  
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“I think the matching process at Creative Fertility is inadequate. The 
characteristics that I could specify were too broad and too limited. It’s like 
they scribble them down on the back of an envelope and then go away and try 
and do something with it.” [Caroline, Creative Fertility]  
 
Most recipients waited at least 6 months to be matched with a donor, which appeared 
to compound their feelings of a lack of control. During this time, recipients received 
little contact from the clinic. Many recipients described the period of waiting to be 
matched with a donor as being “anxious”, “difficult” and “uncertain”. Some recipients 
questioned whether clinicians allowed other recipients to ‘queue jump’ or whether 
they might be “forgotten” because of the large size of the clinic, as illustrated by 
Caroline: 
“The waiting I found it psychologically difficult as well, kind of like being in 
limbo […] I think it’s a control thing. Because it’s like a big queue, where you 
don’t know where you are. And my paranoia is that I’m being either forgotten, 
or that, is it that somebody does a bit of queue jumping.” [Caroline, Creative 
Fertility] 
 
Although it may seem counter-intuitive that recipients declined donors after waiting 
for such a long time (given the extra delay to their treatment), for the recipients in this 
study the long time spent waiting for a donor also made them more critical of the 
matching process. The notion that ‘we have waited so long we might as well wait a bit 
longer’ was common in recipients’ accounts of declining donors. The most common 
reason for recipients’ refusal of donors at Creative Fertility was donors’ weight (as 
explored earlier in this chapter). Recipients reported being “scared” about the weight 
difference between themselves and the donors they declined on account of their donor 
being bigger.  
289 
 
Recipients questioned whether the donors they had declined were offered to them “by 
mistake” or because they had been declined by other recipients. The quote below from 
Brenda, who declined a donor who was 28kg heavier than her, illustrates recipients’ 
lack of trust in clinicians and their disappointment with the donors that they were 
matched with: 
“She was sort of, I remember 88kg and 5’4, whereas I am 5’10 and 60kg. so I 
was quite surprised. I actually phoned up and said is that a mistake? I think it 
was Jemma [nurse] who I spoke to who said she is the upper end. I was quite 
surprised about that. So then I thought right, maybe we had got that offer 
because everyone else had turned her down.” [Brenda, Creative Fertility] 
 
Several recipients felt that the donors they declined did not meet their stated 
preferences of exclusion. For example, two recipients reported being “shocked” when 
they were allocated a donor with red hair because they thought they had excluded 
donors with red hair when stating their preferences with clinicians. What was 
particularly disconcerting to these recipients was that clinicians had not taken into 
account their original request, which made them question the matching process and 
further reduced their trust in clinicians.  
For example, Helen had told clinicians that she wanted to “rule out” donors with red 
hair. Having declined one donor because she had endometriosis, Helen was then 
offered another donor with red hair. This led to a breakdown in trust for Helen, who 
felt she had gotten “lost in the system” and subsequently questioned the matching 
process and the role of clinicians within it. The lack of a personalised relationship to 
mediate Helen’s disappointment is illustrated by the quote below in which she 
recounts this event:  
“And then we waited, I think 2-3 months, and then we were offered another 
donor. But actually she didn’t fit the criteria that we had specified […] it was 
a real mess. We had specified certain physical characteristics that we 
wouldn’t accept, like red hair. And the donor they had offered me was a lady 
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with red hair! That was a real shock […] That’s a fairly big omission on the 
part of the clinic. So it began to crack my confidence in them. I think, I’m 
trying to remember, did the nurses introduce themselves before they had 
anything to tell me?” [Helen, Creative Fertility] 
 
Another barrier to recipients’ acceptance of donors was the amount of information 
that recipients received about donors from nurses. Most recipients at Creative Fertility 
described the information they were given about donors as “de-personalised” and 
“limited”. Some recipients spoke about trying to “extract” additional information 
about their donor from nurses, but reported that their requests were often refused, as 
illustrated by the quote below from Ayeshah:  
“We assumed because it is anonymous that the information that they can give 
you is really limited […] I tried to find out more about her height, her family, 
or anything, but they really wouldn’t […] I mean we got some information 
extracted from them.” [Ayeshah, Creative Fertility] 
 
Recipients felt that the clinic’s method of e-mailing donors’ characteristics when 
offering donors was impersonal and that they were rushed into making a decision, as 
shown in the quote below from Caroline: 
“They just e-mailed me the characteristics of a donor and asked me to let them 
know in 2-3 days.” [Caroline, Creative Fertility] 
 
Recipients questioned nurses’ descriptions of donors being a “good match”, including 
their motivation for such a description and the criteria on which this was based. For 
example, recipients questioned whether nurses’ descriptions were a “sales technique” 
to encourage them to accept donors and whether clinicians told them the truth about 
the donors they were offered. Here recipients highlighted the commercial context of 
the clinic over the medical professionalism. When donors did not meet recipients’ 
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expectations of a ‘good match’, recipients questioned clinicians’ authority and wanted 
more control and information, as illustrated by the quote below:  
“I felt this big thing of ‘it’s a good match for you’ and then without 
elaboration, and I was like ‘what? What does that even mean? That’s my 
decision!’…So I got very frustrated with them.” [Helen, Creative Fertility] 
 
Because recipients were given such little information about their donors they felt that 
they had little choice other than to “read into” the little information they did receive. 
For example, two recipients declined donors, in part, on the basis of their lack of 
education and occupation, e.g. being a hairdresser or carer. Both recipients recognised 
that they were making assumptions about donors’ level of intelligence based on their 
educational level (up to NVQ) and occupation, but felt they had little other 
information from clinicians to mediate these assumptions. This view is illustrated by 
the quote below:  
“I needed a picture of the donor as a person, not just that she’s a hairdresser. 
There’s so little information about them that you read more into it. But if I 
knew more about the donor as a person, or her circumstances, for example, if 
she didn’t do her PhD because she was caring for her mum, then I could 
understand it a bit more. But you read too much into it if there is too little,” 
[Caroline, Creative Fertility]  
 
In the context of lacking information and control over the matching process, 
recipients at Creative Fertility often spoke about declining donors as a source of 
agency. Here, recipients highlighted the importance of following their “gut feeling” 
and raising concerns in an otherwise highly technological and medicalised context. 
Thus some recipients saw declining of donors as a way of retaining a degree of 
control over the matching process, as illustrated by the quote below from Camille: 
“I did say that I refused someone. Somehow it’s a bit stupid, but it was a 
conjunction of things, a combination of things, and overall, I didn’t feel it. On 
the one hand, it’s a very medical process. On the other hand it’s not at all. The 
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control is not total for everybody at every step. But for me, the fact that I 
didn’t feel it, I was inclined to follow my feelings […] I wasn't sure she would 
be a good donor somehow. I had doubts. It's not that everything is based on 
very rational arguments.” [Camille, Creative Fertility] 
 
The majority of recipients felt that the donors they were offered were “unsuitable” 
and so challenged clinicians decision-making by declining these donors. Recipients’ 
lack of information and lack of a personalised relationship with clinicians meant that 
there was little to mediate disruptions to recipients’ expectations and ambiguity about 
the donors they declined. Thus, recipients adopted an ‘active patient/consumer’ role 
when declining donors (Lupton, 1997).  
Because recipients provided retrospective accounts of their experience of the 
matching process, it is not possible to know at what point recipients began to lack 
trust in clinicians (e.g. before or after being matched with donors). However, it was 
clear from recipients’ discourses that a lack of trust in clinicians and their experience 
of the matching process shaped their practices of declining donors.  
Recipients’ perceptions of clinicians rarely featured in their discourses of accepting 
donors at Creative Fertility. Rather, recipients emphasised the contextual constraints 
of time and a shortage of donors as shaping their decision to accept donors, as 
explored earlier. This is in sharp contrast to discourses of recipients at The Fertility 
Centre, where recipients’ perceptions of clinicians were central to their discourses of 
accepting donors but rarely featured in their accounts of declining donors, as will be 
explored below.  
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The Fertility Centre 
Recipients were afforded more agency in the matching process at The Fertility Centre, 
where the majority of recipients accepted (one of) the first donor(s) that they were 
offered. Recipients could be offered multiple donors to choose between, were often 
matched in less than a month of joining the clinic and were offered donors during a 
face to face consultation in which a nurse provided in-depth and detailed information 
about donors to recipients. Furthermore, recipients typically saw Noreen and Doctor 
Rana, who were the only full-time clinicians, when they attended the clinic. 
The discourses of recipients at The Fertility Centre were markedly different from 
recipients at Creative Fertility. At The Fertility Centre, recipients were generally 
satisfied with all stages of the matching process, which appeared to be based on their 
positive relationship and interactions with clinicians. Recipients seldom questioned 
clinicians’ authority or the matching process. Instead, the theme of ‘trust’ was 
prevalent in recipients’ discourses, particularly when discussing why they accepted 
their donor and accepted difference with their donor. Unlike at Creative Fertility the 
role of clinicians rarely featured in recipients’ accounts of declining donors at The 
Fertility Centre.  
Recipients frequently declared their love, praise and appreciation for Doctor Rana and 
Noreen, whom they described as “sympathetic”, “friendly”, “honest” and “warm” 
people. Recipients emphasised the “close relationship” and “great connection” that 
they shared with these clinicians and the subsequent “trust” that they had in them to 
make decision on their behalf. Several recipients had been having treatment at the 
clinic for several years and had developed a long-standing relationship with Doctor 
Rana and Noreen. Recipients recognised that The Fertility Centre was a relatively 
small clinic and felt this was part of the reason that staff could give them such 
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personalised attention and have inter-personal knowledge of them, as illustrated by 
the quote below from Dipti: 
“Oh my gosh we love them, they know me inside out […] it’s just nice, and 
this is what they do so well as a clinic. And I hope that don’t change and 
perhaps they might do because as it gets busier, and more patients and more 
demand, but they are just a friendly team.” [Dipti, The Fertility Centre] 
 
Relative to recipients at Creative Fertility, the recipients at The Fertility Centre 
described having a positive experience of the matching process, including stating their 
preferences, of the donors they were offered and the amount of information they 
received about donors. Most recipients said they were matched “quickly” and reported 
few anxieties about waiting for a match. They were grateful for clinicians’ guidance 
on accepting donors and felt that their questions about donors were answered 
satisfactorily by clinicians during their face to face consultations with a nurse.  
Recipients described having both ‘inter-personal trust’ and ‘social trust’ (Mechanic, 
1996) in clinicians to match them with a donor and this feeling of trust was central to 
recipients discourses of accepting a donor. In this regard, recipients’ discourses and 
practices reflected that of ‘passive patients’, as they trusted clinicians moral integrity 
and medical competency and did not challenge their authority (Lupton, 1997). 
Recipients described clinicians as being “medical experts” and as having the 
“professional experience” and competence to undertake matching on their behalf:  
“You trust the medical professional to make the correct decision there based 
on their experience. That’s what you’re asking them for.” [Aileen, The 
Fertility Centre] 
 
“She’s the expert, she’s been doing it, matching people for years and years, so 
I have to trust in her that she’s making the right decision for me.” [Tina, The 
Fertility Centre] 
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Recipients framed clinicians as having their best interests at heart and recited 
clinicians’ rhetoric of giving them the donor they “deserve”. They described trusting 
clinicians to provide them with the “best” or “right” donor for them and valued 
clinicians role in matching. Recipients felt that clinicians had personalised knowledge 
of their characteristics and preferences for donor characteristics and trusted their 
descriptions of donors being a ‘good match’, as illustrated by the quote below from 
Dipti: 
“The trust that I had in Doctor Rana and in Noreen, who was in charge of 
finding the egg donors, she was the one that said ‘this is the person for you’, 
because I know you, you’ve been here for a year, and this is who I think that 
you should go for. Having trust in the professionals, in Doctor Rana to say, 
I’ve met this girl, I know this girl [the donor]. And I believe her when she says 
‘we will find the best donor for you, we will not just have any donor for you, I 
will make sure that the donor you have is the donor that you deserve’. And I 
believe that.” [Dipti, The Fertility Centre] 
 
Recipients (particularly CMV negative recipients) were aware of the clinic’s policy of 
matching donors and recipients according to CMV status and drew on this medical 
matching criterion as a reason for trusting clinician’s to make a ‘medically safe’ 
match. These recipients were aware of a shortage of CMV negative donors in the 
clinic and saw this policy as restricting their choice of donor and constraining their 
preferences.  
Despite being aware that other fertility clinics did not match by CMV status, 
recipients often internalised this ‘medical’ criterion and viewed their restricted access 
to CMV positive donors as being due to a ‘medical problem’ within themselves. The 
quote below from Tina, a CMV negative recipient who wanted a compensated donor 
with blue/green eyes, illustrates the constrained choice experienced by these 
recipients and their foregrounding of the clinic’s medical criteria over their own 
preferences for donor characteristics:  
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“The biggest problem with me is that I’m CMV negative. So if they had 10 
donors that fitted the characteristics, they would’ve all been CMV positive. So 
trying to find the characteristics and a CMV negative donor is obviously a bit 
like a needle in a haystack. So they [clinicians] suggested that rather than 
waiting for months and months for a CMV negative donor with my 
characteristics to come along, that we go for the egg sharer with hazel eyes.” 
[Tina, The Fertility Centre] 
 
In trusting clinicians as best placed to undertake matching on medical grounds, many 
recipients also spoke about their own role as being to “manage” their “emotions” and 
their “anxieties” in the matching process and to allow ‘the professionals’ to ‘do their 
job’. This could help explain why fewer recipients declined donors than at Creative 
Fertility, i.e. by accepting clinicians’ choice of donor and not challenging this, as 
illustrated by the quote below from Kalvin, the partner of a recipient:  
“But there’s other considerations, like if that person is medically a safe match 
for you, there’s so many different factors. Things like the CMV, the blood type, 
any historical factors in that person’s family that may contribute to success or 
failure, so they’re the things that have given me confidence in the process […] 
What’s relevant is the health factors, and their CMV and stuff to make it 
successful, and that that child has a decent life without being born with 
hereditary stuff that we weren’t aware of. So it’s about us managing our 
anxiety and trusting the professionals to do their job.” [Kalvin, The Fertility 
Centre] 
 
Although recipients appeared to occupy a passive role when accepting donors, their 
practices might also be interpreted as form of agency through objectification 
(Thompson, 2005) in which recipients foregrounded their trust in clinicians in order to 
meet their primary aims of having a medically safe match, timely treatment and a 
healthy child (over and above their preferences and resemblance). However, 
observations of donor offering sessions at The Fertility Centre also revealed the ways 
in which clinicians shaped recipients’ decision-making and encouraged them to accept 
donors during ‘Donor Offering’ consultations. Here, it was common for clinicians to 
provide recipients with detailed and subjective impressions about donors, including 
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about their personality, facial features, accent, hobbies, future aspirations, family 
relationships and immigration history.  
However, although clinicians provided recipients with more information, this 
information was carefully managed to encourage recipients to accept a donor under 
offer. Often, Noreen, the head nurse, sought to encourage recipients to accept (one of) 
the donor(s) under offer by highlighting donors’ positive attributes, by constructing 
resemblance between donors and recipients and quantifying resemblance between 
donors and recipients. For example, it was typical for Noreen, and other clinicians, to 
describe donors to recipients in positive terms, including “attractive”, “beautiful”, 
“intelligent”, “cheerful”, “family-orientated”, “outgoing”, and “selfless”, sometimes 
without prompt from recipients. The excerpt below from observational field notes of a 
‘Donor Offering’ consultation illustrates how clinicians foregrounded the desirable 
attributes of donors: 
This donor is beautiful, I remember that. Oh, and she had big eyes, like you 
[the recipient]. And she is a flight attendant, so she’s certainly be pretty 
enough for BA [British Airways] standards.” [Field notes, week 20, The 
Fertility Centre] 
 
Noreen also constructed more personalised forms of resemblance between donors and 
recipients when offering donors, which involved telling recipients that they shared a 
similar shade of skin tone, hair texture/style, personality, facial features, religion or 
accent as the donor they were matched with. Such resemblances were constructed by 
Noreen in spite of a range of differences between the recorded characteristics of 
donors and recipients. The excerpts below from observations of ‘Donor Offering’ 
consultations illustrate the ways in which Noreen ‘sold’ resemblance to recipients. In 
all of the cases below the donors that were being offered to recipients did not match 
all of the recipients’ original preferences:  
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“She has similar features to you, and has a soft voice, just like you” 
“She has the same hair colour as you naturally, but she dyes it.” 
“She has curly hair, just like you.”  
“She looks just like you, your face shape and features.” 
 “She is British, and has a proper cockney accent, just like you.” 
(Field notes, Observations of Donor Offering Sessions: Day 1; Day 6; Day 1; 
Day 9; Day 14)  
 
It was also common for Noreen to quantify resemblance between donors and 
recipients by informing recipients that their donor was a “95%” or “99%” “match” 
with recipients own characteristics or their preferences. Such high percentages would 
be given to the majority of recipients in spite of multiple differences between donors 
and recipients. For example, in one case, Noreen described a match as being “95%” 
despite the donor weighing 18kg more than the recipient and not meeting their 
preference for eye colour and education. In the context of donor anonymity, where 
recipients relied on clinicians for access to information about their donors, the 
contradictory nature of such subjective and statistical descriptions were difficult for 
recipients to question or verify.  
When offering multiple donors to recipients, clinicians also labelled donors in 
chronological order of physical match, with the number 1 being the “closest”. Despite 
otherwise telling recipients to go with their “gut feeling” when deciding which donor 
to accept, clinicians often highlighted the ‘pros and cons’ of each donor and often 
guided recipients towards choosing one. During observations of consultations where 
recipients were offered multiple donors to choose between there appeared to be an 
inherent assumption in the room that recipients were expected to choose one of the 
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donors they were offered. Because recipients were offered donors during a face to 
face consultation, they may also have felt pressured to accept a donor in the presence 
of clinicians (unlike at Creative Fertility, where this exchange was done remotely via 
e-mail).  
When rationalising why they accepted a donor with different characteristics to their 
own recipients commonly reiterated clinicians’ description of their donor being a high 
percentage match, as illustrated by the quote below:  
“And the one that she [Noreen] saw is like a 90-95% match of what we 
original told her so why would we want to look further.” [Aileen, The Fertility 
Centre] 
 
Recipients also drew on clinicians’ rhetoric of donors being a ‘close match’ and 
possessing desirable characteristics to alleviate their concerns about donors having 
different characteristics to their own. For example, Amandeep, an Indian recipient, 
raised her apprehension about accepting a Sri Lankan donor with Noreen. As 
illustrated by the quote below, Amandeep foregrounded Noreen’s description of her 
donor being an ‘exception to the rule’ (of people from Sri Lanka having darker skin 
tone) and resembling herself:  
“Because Sri Lankans are generally of a darker skin tone, so we did ask that 
question, but we were told that she is definitely not of a darker skin tone. We 
don’t mean like, your skin tone [interviewer] and ours [recipient and her 
partner], but really really dark. But Noreen [nurse] said no, because you do 
get certain areas where they are lighter, that was the only thing. We just don’t 
want them to look very different […] She said that it’s [the donor] like a 
medium complexion, with a long face, similar to mine, similar body weight 
and stuff like that.” [Amandeep, The Fertility Centre] 
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8.5 Conclusion 
This chapter has explored how recipients negotiated accepting and declining donors 
that they were matched with and how they navigated the differences they were and 
were not willing to accept. Recipients strategically drew on discourses of contextual 
constraints, genetic inheritances, kinship and resemblance, desirability and stigma, 
trust and control, and inclusion and exclusion, to rationalise their decision making 
when declining and accepting donors and negotiating difference. 
Although recipients were willing to accept donors with different characteristics to 
their own this wasn’t the case for all types of differences. Recipients declined donors 
with marginalised and stigmatised characteristics, a practice which was coherent with 
their preferences of exclusion. Thus donors with red hair, a high BMI, dark skin tone 
and who identified as Muslim or lesbian were systematically excluded by recipients. 
When declining donors, recipients foregrounded the criteria they wanted to exclude in 
their donor, and child, over the importance of time and over any desirable 
characteristics that the donor possessed.  
The characteristics outlined above to varying degrees are all associated with “societal 
deviance”, i.e. they are widely perceived as being deviant and hence stigmatised 
(Falk, 2001). Numerous studies have reported on the stigmatisation, marginalisation, 
discrimination and prejudice against red hair (Cooper, 1971; Feinman and Gill, 1978; 
Clayson and Maughn, 1986; Heckert and Best, 1997), ‘obesity’ (Cahnman, 1968; 
Puhl and Brownwell, 2002), Islam (Nahman, 2006; Razack, 2008; Inhorn et al., 
2009), homosexuality (Israel, 2002; Nordqvist, 2010) and dark skin tone (Nahman, 
2006; Hunter, 2007; Thompson, 2009; Schurr, 2016) in ARTs and society more 
generally. Although discrimination against educational background has not generally 
been a prime focus of studies, associations between low educational levels and the 
301 
 
marginalised characteristics of low class and lower intelligence have been reported 
(Hernstein and Murray, 1994).  
This study has illustrated that donors with marginalised characteristics were less 
likely to be accepted by recipients. Unlike other differences, which recipients saw as a 
‘discreditable kinship risk’ that could be mediated, recipients saw having a child with 
stigmatised characteristics as a ‘discredited kinship risk’, which they felt unable to 
mediate. Although recipients ability to decline donors reflected an important source of 
recipient agency, in exercising this particular agency recipients reified and reproduced 
inequalities in wider society in their reproductive choices and stratified reproduction 
by excluding donors with stigmatised (and devalued) characteristics.  
In doing so, donors’ access to genetic reproduction was discouraged as was the 
reproduction of stigmatised characteristics in recipients’ own family. For egg sharing 
donors in particular, such exclusions also stratified access to their own reproduction 
as their subsidised access to fertility treatment was dependent upon being accepted by 
a recipient. Although recipients were not willing to compromise on their exclusionary 
preferences for donor characteristics they were willing to compromise on their 
preferences of inclusion. 
The majority of recipients spoke about accepting a donor with different characteristics 
to their own. When rationalising why they accepted donors with different 
characteristics recipients foregrounded contextual constraints of a shortage of donors 
and a perceived shortage of time. Contrary to Lindheim and Sauer’s (1998) findings 
then, the passage of time did impact recipients’ practices and led them towards 
accepting a donor. Thus, for the recipients in this study the process of accepting a 
donor was about rationalising and accepting difference rather than merely 
constructing resemblance. 
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Recipients’ discourses of rationalisation revealed nuanced forms of recipient agency 
in which they strategically rationalised differences with their donor in order to 
rationalise accepting them. Recipients foregrounded the role of ‘fate’, drew on the 
presence and absence of resemblance within families and alternative genetic 
discourses of inheritance and constructed social-cultural connections between 
themselves and the donors they accepted based. These social connections enabled 
recipients to identify with their donor in an otherwise anonymised context. Recipients 
saw the differences they accepted in their donor as ‘discreditable stigma’ (Goffman, 
1963), or ‘discreditable kinship risk’, in that they could be mediated and rationalised.  
The context of the clinic was shown to be a key factor in influencing recipients’ 
practices of accepting and declining donors at each clinic. Recipients’ trust in 
clinicians and the organisation of the matching process were central features of this 
context. At Creative Fertility recipient choice and access to information was 
restricted, recipients had a poor relationship with clinicians and lacked trust in them 
and they questioned all aspects of the matching process. In this context, recipients saw 
declining donors as a source of agency. In the absence of trust and information, 
recipients found it difficult to mediate difference with their donor and blamed 
clinicians for providing them with an unsuitable match. For these recipients, a central 
part of the process of accepting a donor appeared to be declining donors beforehand.  
At The Fertility Centre recipient choice and access to information was encouraged, 
recipients had a good relationship with clinicians and trusted them, they were satisfied 
with the matching process and saw it as their own role to manage their behaviour by 
accepting donors. Recipients foregrounded clinicians’ medical expertise and 
clinicians’ descriptions of donors when mediating difference with the donor they 
accepted and so did not decline donors as much.   
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Chapter 9: Conclusions 
 
9.1 Introduction  
This study was prompted by two external impetuses: the (changed) policy 
environment in the UK on ‘ethnic matching’ in gamete donation and a gap in the 
existing literature on fertility treatments. 
The end of HFEA policy on matching in gamete donation in 2007 marked the end of 
formal and (arms-length) state-mandated 'racial matching' of donors and recipients. 
Whilst the existence of this policy sparked my initial interest in the topic of matching, 
I later began to question how matching in egg donation is organised in the UK in the 
absence of policy guidance. How did clinicians match donors to recipients and how 
did recipients negotiate the selection of donors in the clinical context? How did 
clinicians conceptualise ‘ethnic matching’ and what factors shaped their practices of 
matching? What was the role of recipients in matching and how did they experience 
this?  
This study was also prompted by the limitations of the current academic literature on 
the subject of matching. Despite its importance in fertility treatment with donor 
gametes, the intricacies and complexities of the matching process have typically been 
taken for granted in the UK. Previous studies have only alluded to matching as part of 
a wider focus on gamete donation or have situated matching as a consumer practice 
within neo-liberal contexts of egg donation. Unlike previous studies, this study 
contributes an in-depth study on matching in the UK by putting matching at the focus 
of analysis. In this concluding chapter I will begin by recapping the research 
questions, and their answers, and summarise the central empirical findings of this 
thesis. This will be followed by a discussion of the implications of these findings and 
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the main theoretical contributions of this study. I will end with consideration of the 
limitations of this study and some recommendations for further research. 
Research Questions:  
The overarching research objective of this study was to explore the organisation of 
donor-recipient matching in egg donation in the context of 2 fertility clinics in the 
UK. The main conclusions of this thesis are that matching is a process and that this 
process contributes to a medicalisation, racialisation and stratification of reproduction. 
These conclusions are situated within the wider regulatory and immediate clinical 
contexts of egg donation and matching.  
The empirical chapters presented in this thesis were based on 4 research questions, 
informed by the literature: 
 How do clinicians classify donors and recipients into categories? 
 How do clinicians allocate donors to recipients? 
 How do recipients express and negotiate their preferences in the 
context of the clinic? 
 How do recipients negotiate accepting/declining donors they are 
matched with? 
In this concluding chapter I am going to first summarise my central empirical findings 
according to the sub-research questions above. This will be followed by a discussion 
of the main theoretical contributions and implications of these findings. I will end by 
outlining the limitations of this study and recommendations for further research. 
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9.2 Key Findings 
9.2.1 How Do Clinicians Classify Donors and Recipients into Categories? 
In Chapter 5, the ways in which clinicians classified donors and recipients into 
formal, informal and implicit categories were explored to show how the process of 
classification reproduced and reinforced wider system of stratification, including 
medical paternalism, normative reproduction and racialised hierarchies. This involved 
examining how clinicians classified donors’ and recipients’ ‘race’/‘ethnicity’, 
physical and social characteristics, how clinicians shaped recipients’ preferences for 
donor characteristics and how clinicians classified recipients as compliant (‘good’) 
and non-compliant (‘demanding’) based on their matching practices. This chapter 
showed how clinicians decided on which types of differences were made meaningful 
and recorded and which were not. 
Clinicians’ reduction of donors and recipients into different physical and social 
characteristics revealed the arbitrary and socially constructed nature of seemingly 
objective and discreet categories. Although clinicians decided on which types of 
differences were made meaningful, their practices were shaped by a wider regulatory 
framework which determined the characteristics and categories that they had to 
collect about donors. The outcome of such classifications were often a complex 
interplay between: the categories available for recording characteristics, how 
clinicians posed questions to donors and recipients and the information they disclosed, 
donors and recipients perceptions of their own characteristics and the categorisation 
recorded by clinicians. Clinicians classified donors and recipients through a process of 
‘racialisation’ (Miles, 1989) and categorised individuals as ‘white’ or ‘BME’ 
depending on their own perceptions of skin tone. Thus clinicians reified and 
reproduced ‘race’ as a physical and genetically inheritable characteristic.  
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When classifying recipients’ preferences for donor characteristics clinicians shaped 
recipient agency according to their own expectations of the recipient role. Crucially, 
while clinicians considered it acceptable, even necessary, for recipients to accept 
difference because of a shortage of egg donors they did not see it as acceptable for 
recipients to actively choose difference, especially in relation to ‘racial’ difference. 
Clinicians saw it as their role to ensure that “abnormal” recipient preferences were 
disallowed and framed such preferences as in direct conflict with the welfare of the 
child (echoing previous HFEA policy). Clinicians’ perception of ‘racial difference’ 
for white recipient as ‘exotifying’ and BME recipients as ‘improving’ the 
characteristics of their child also reflected the complex power dynamics of racialised 
hierarchies. 
Clinicians’ expectations of recipient agency also shaped their stratification of 
recipients as ‘good’ or ‘demanding’. Clinicians saw recipients who exerted ‘too much 
agency’ in the matching process as ‘demanding’ and as a threat to their own authority. 
They medicalised the behaviour of ‘demanding recipients’ as being due to unresolved 
anxiety rather than autonomous decision-making or their choice of donor. As such, 
they reasoned that recipients who were not compliant with their expectation of 
recipients were inherently uncomfortably with using donor eggs (the medical 
solution) and in ‘denial’ about their own infertility (the medical diagnosis). Thus, 
‘demanding’ recipients were seen as not trusting clinicians’ decision-making in 
matching and more generally. Clinicians used counselling as a tool to manage the 
behaviour of these recipients and to encourage them to become more compliant, i.e. to 
have ‘suitable’ preferences and to accept donors.  
9.2.2 How do Clinicians Allocate Donors to Recipients? 
Having explored how clinicians categorised the characteristics of donors and 
recipients in the previous chapter, in Chapter 6 the ways in which clinicians 
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subsequently allocated donors to recipients based on these categories were explored. 
This chapter looked at clinicians’ negotiation of clinical matching criteria, which 
comprised ‘secondary matching criteria’, i.e. the waiting list, recipients’ preferences 
and general physical resemblance, and ‘primary matching criteria’, i.e. height/weight 
or CMV status and ‘race’/skin tone. Clinicians’ allocation of donors based on their 
perception of recipients was also explored.  
The findings presented in this chapter illustrated how clinicians’ discourses and 
practices of matching revealed a medicalisation and racialisation of reproduction and 
the stratification of reproduction and medicalisation according to nuanced racialised 
cleavages. It was shown, for example, how clinicians’ prioritisation of matching 
criteria varied when clinicians were matching white recipients or BME recipients, 
prioritising different criteria in each case.  
Clinicians saw a primary aim of their role in matching as protecting the medical 
welfare of children born through egg donation and to ensure the medical safety of 
recipients of donor eggs. However, the prioritisation of different ‘medical’ matching 
criteria at each clinic illuminated the socially constructed nature of these imposed 
medical categories, as did clinicians’ willingness to compromise on this criteria when 
matching BME donors and recipients.. The differential treatment of BME recipients 
in this respect revealed clinicians’ prioritisation of ‘race’ and skin tone as the most 
important matching criteria. 
Clinicians saw ‘racially matching’ donors and recipients as the most important aim of 
matching and as protecting the social welfare of ‘children’ born through egg donation. 
Fundamentally, clinicians singled out ‘race’ as a primary indicator of kinship and 
‘racial difference’ as a primary ‘kinship risk’, i.e. a risk to the display of kinship 
resemblance. Clinicians’ discourses and practices of ‘transracial matching’ were 
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particularly revealing of clinicians’ conceptualisations and practices of ‘racial 
matching’ revealed the nuanced ways in which donor allocation stratified, 
medicalised and racialised reproduction and how ‘whiteness’ was reproduced in the 
clinical context. 
Clinicians took intricate steps to navigate ‘transracial matching’ with the aim of 
limiting ‘racial difference’ between donors and recipients and between recipients and 
their child. In doing so, clinicians sought to curtail BME recipients’ reproduction of 
racialised white features whilst maintaining the reproduction of racialised white 
features of white British recipients. For example, BME recipients’ access to white 
donors was dependent on clinicians’ perceptions of their skin tone, the skin tone of 
their partner and skin tone of white donors. On the other hand, when matching 
‘marked white’ donors with white British recipients then clinicians strategically 
‘unmarked’ the whiteness of these donors.  
Whilst clinicians saw it as acceptable for a BME couple to have a mixed ethnicity 
child they did not see it as equally acceptable for a white couple to have a mixed 
ethnicity child. These discourses and practices of ‘transracial matching’ reveal how an 
analysis of matching in the present contexts adds novel layers to the stratification of 
reproduction and (bio)medicalisation. It was illustrated how the reproduction of 
‘racially congruent’ families (Wade, 2012) were valued and encouraged whilst the 
reproduction of ‘racially incongruent’ families (ibid) were devalued and discouraged. 
Reflecting the regulatory context in which matching took place, this stratification was 
not based on money but on moralised concerns about the welfare of the child. In this 
context, ‘race’ and ‘ethnicity’ are depicted as a ‘risk’ by clinicians, to be managed, 
and not just as a commodity. Such practices also stratified recipients’ access to egg 
donors on the basis ‘race’ and skin tone.  
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Descriptive statistics of ‘racial matching’ at each clinic enabled insight into the 
patterns and outcomes of clinicians’ matching practices and revealed that clinicians’ 
practices of matching were coherent their perceptions and that the majority of 
allocations made by clinicians were ‘racially’ matched. This has significant 
repercussions for the types of families that were reproduced in the clinics through egg 
donation. Finally, this chapter illustrated how clinicians’ perceptions of recipients as 
‘demanding’ shaped their practices of matching whereby they avoided matching ‘non-
compliant’ recipients as a mechanism of managing their own workload and managing 
the expectations of recipients. The strategy of not matching particular recipients was 
undertaken with the aim of neutralising recipients’ active and non-compliant agency 
(declining donors) into a passive and compliant form of agency (accepting donors).  
Taken together, these findings demonstrate that the ways in which clinician’s 
allocation of donors to recipients illustrate a medicalisation, stratification and 
racialisation of reproduction. Clinicians sought to reproduce a normative model of the 
family through discourses of ‘risk’, ‘racialisation’ and ‘strategic naturalisation’ by 
strategically managing the crossing of normative racialised boundaries. 
 
9.2.3 How do recipients express and negotiate their preferences in the context of 
the clinic? 
In Chapter 7, recipients’ preferences of inclusion and exclusion for donor 
characteristics and their preference for donor information were explored. Recipients 
felt stigmatised as recipients of donor eggs, both in relation to their own infertility and 
because they would not share a genetic relationship with their child. Recipients were 
concerned that a lack of resemblance between themselves and their child would reveal 
this ‘spoiled identity’ (Goffman, 1963) and lead to ‘relational stigma’. Recipients thus 
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wanted a donor who matched their own characteristics in the hope of having a child 
who would ‘pass as if’ it were their genetic offspring. In this regard, recipients’ 
preference for resemblance can be interpreted as a form of self-surveillance, in which 
recipients had little choice but to match for resemblance and replicate a normative 
ideology of the family. The ideologically constrained nature of this preference was 
further illuminated by the discourses of male same-sex interviewees, who actively 
chose not to subscribe to heteronormative ideals of reproduction and kinship through 
matching for resemblance.  
When discussing their preferences for donor characteristics recipient foregrounded the 
importance of genetic inheritance and of resemblance as a primary indicator of 
kinship. Recipients conceptualised ‘ethnicity’ as a physical and genetically inheritable 
characteristic, i.e. as ‘race’. Like clinicians, recipients conceptualised ‘race’ as a 
primary indicator of kinship and ‘racial difference’ as a kinship risk, i.e. to the display 
of kinship resemblance and leading to ‘resemblance talk’ (Becker et al., 2005). 
However, recipients differed in their conceptualisations of resemblance and difference 
and in their willingness to accept donors from a different ‘racial’ origin.  
Whilst white recipients were unwilling to consider a donor from a different ‘race’ and 
saw ‘racial difference’ as a ‘discredited kinship risk’ BME recipients had considered 
using a donor from a different ‘race’ and, to an extent, saw ‘racial difference’ as a 
‘discreditable kinship risk’. White recipients saw ‘race’ as inflexible, bounded and 
immutable and were concerned about the reproductive legitimacy of their partner. On 
the whole, BME recipients saw racialised boundaries as flexible and able to be 
transgressed, although these transgressions also followed a racialised hierarchy of 
skin tone. Recipients distinguished between types of white donors and South Asian 
donors, so that white British recipients excluded ‘marked white’ donors whereas 
South Asian recipients actively sought them out. On the whole, recipients were 
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willing to accept a donor with lighter skin tone than themselves but not darker skin 
tone.  
Recipients strategically drew on discourses of geneticisation and risk to exclude 
donors with minority and stigmatised characteristics, which recipients framed as 
being ‘too different’ from their own, “normal” characteristics. In particular, recipients 
singled out donors’ with red hair, dark skin tone, a high BMI and who identified as 
Muslim as falling outside of the ‘norm’ and thus sought to exclude them from their 
preferences. Recipients’ conceptualisations of ‘resemblance’ and social desirability 
and stigma therefore were intertwined. 
Recipients’ preference for the amount of donor information they would have liked to 
have received revealed that recipients faced a paradox of conflicting identities which 
recipients sought to strike a balance between. On the one hand, reflecting a consumer 
identity, some recipients wanted more information about their donors to use as a 
donor selection tool and because they saw this as empowering. On the other hand, the 
vast majority of recipients saw having “too much” donor information as a risk to their 
parental identity and the distance they wanted to maintain with anonymous donors. 
However, recipients who intended to disclose to their child saw having more and 
identifying donor information as their child’s ‘right’. This finding echoes more recent 
studies on recipients’ preferences for donor information in contexts of donor 
allocation (Stuart-Smith et al., 2012; Rubin et al., 2015; Zadeh et al., 2016b) and is 
contrary to studies which have posited recipients’ consumption of donor information 
as merely a consumer choice (Becker, 2000; Pennings, 2000).  
Unlike previous studies, which have argued that recipients erased (Konrad, 2005) or 
re-materialised (Klotz, 2014) the role of their egg donor the interviewees in this study 
appeared to conceptualise donors in a liminal role. On the one hand they sought to 
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maintain distance between themselves and their donor (i.e. avoid their donor 
becoming ‘too real’) whilst on the other hand they did not want to completely deny 
the existence of their donor as a person (and wanted some information about them).  
 
9.2.4 How do recipients negotiate accepting/declining donors they are matched 
with?  
In Chapter 8, recipients’ practices of accepting and declining the donors they were 
matched with were explored, revealing the complex meanings and negotiations that 
shaped their perceptions and practices. Recipients’ discourses and practices of 
selecting donors revealed that their exclusion of donors with stigmatised/marginalised 
characteristics was systematic, e.g. 3 or more recipients declined donors with such 
characteristics. Echoing recipients’ preferences of exclusion, recipients most 
commonly declined donors on the basis of: having red hair, being ‘overweight’, being 
‘marked white’, identifying as a ‘lesbian' and having no higher education degree. 
Donors with multiple ‘undesirable’ characteristics were less likely to be accepted by 
recipients. As discussed in Chapter 7, recipients conceptualised donors with these 
stigmatised characteristics as a ‘kinship risk’ and a risk to their child’s health and 
well-being. Thus, for recipients, these characteristics could not be mediated, or 
accepted, even though they could potentially be rationalised (e.g. the presence of red 
hair).  
When declining donors recipients foregrounded donors’ marginalised characteristics, 
i.e. the criteria they wanted to exclude in their donor, and child, over the importance 
of time and over any desirable characteristics that the donor possessed. Thus, 
recipients conceptualised the marginalised characteristics of the donors they declined 
as their Master Status (Hughes, 1945) which overrode any meaning attached to 
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donors’ other attributes. In exercising their agency to decline donors recipients’ 
reified and reproduced inequalities in wider society and stratified reproduction in new 
ways. That is, recipients delayed or prevented these donors from genetic reproduction 
and simultaneously avoided the reproduction of donors’ marginalised characteristics 
in their own family. These exclusionary practices also had particular consequences for 
egg sharing donors whose subsidised and stratified access to their own reproduction 
through the clinic was dependent on being accepted by a recipient.  
Recipients’ discourses of accepting donors revealed that this process was more about 
the negotiation and rationalisation of accepting difference than the construction of 
resemblance. When rationalising why they accepted donors with different 
characteristics to their own recipients foregrounded contextual constraints of a 
shortage of donors and time and minimised the importance attached to their original 
preference for resemblance. Recipients’ discourses of rationalisation revealed 
nuanced forms of agency in which recipients strategically naturalised (Thompson, 
2005) and rationalised differences with their donor in order to accept them. Recipients 
drew on fatalistic discourses, the presence and absence of resemblance within their 
wider families and constructed socio-cultural connections between themselves and 
their donor.  
In contrast to when stating their preferences for donor characteristics, where recipients 
foregrounded the importance of resemblance as a primary indicator of kinship and 
notions of geneticisation, when accepting donors recipients strategically utilised 
alternative discourses of genetic inheritance and disentangled the relationship between 
kinship and resemblance. Recipients thus saw the differences they accepted in their 
donor as ‘discreditable kinship risk’ in that they could be mediated, concealed and 
legitimised through discourses of rationalisation. Therefore, although recipients were 
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willing to compromise on their preferences of inclusion for donor characteristics they 
were less willing to compromise on their preferences of exclusion.  
The impact of context was also shown to shape recipients’ perceptions and practices 
of selecting donors. Recipients’ trust in clinicians and the organisation of the 
matching process were shown to be key determinants of recipients’ selection of 
donors, illustrated through the different rates at which recipients’ declined donors at 
each clinic. At Creative Fertility, where recipient agency was more constrained and 
recipients questioned clinicians’ authority, the majority of recipients declined the first 
donor they were matched with, whilst at The Fertility Centre, where recipient choice 
was more encouraged and recipients trusted clinicians’ decision-making, the majority 
of recipients accepted the first donor they were matched with.  
 
9.3 Contributions to the literature 
 This study makes theoretical contributions to four main bodies of literature: 
(bio)medicalisation theory, reproduction and kinship, stratified reproduction and 
‘race’/ethnicity. Contributions to the latter three areas literatures will be discussed in 
relation to (bio)medicalisation theory which was chosen as the overarching theoretical 
framework for this study. In contrast to prevailing discourse in the field of ARTs, 
which have focused on the commodification of reproduction, I have shown that 
reproduction is medicalised, stratified and racialised and that commercialisation is 
limited in the UK context of egg donation, specifically through donor-recipient 
matching. The contributions made to these fields will be outlined below.  
9.3.1 (Bio)Medicalisation Theory 
This research responds to Clarke et al.’s (2010) call for more case studies of 
(bio)medicalisation in international contexts outside of the USA through the exploring 
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of matching in the UK context of egg donation. A central contention of 
(bio)medicalisation theory is that there has been a decline in medical jurisdiction over 
the last 30 years (Clarke et al., 2010). According to Clarke et al., (2010), the 
increasing commodification of healthcare, the rise of biotechnologies, changes in the 
production and distribution of information, a focus on health rather than illness, the 
rise of risk society and self-surveillance and a decline in trust in experts have led to 
the need to reconsider the applicability of medicalisation thesis (Clarke et al., 2010).  
Conrad (2013) too has emphasised that the rise in ‘consumerism’, ‘managed care’ and 
‘biotechnology’ have challenged clinicians’ dominance and autonomy but unlike 
proponents of the (bio)medicalisation thesis he argues that these changes have been 
the main drivers of the expansion of medicalisation in recent decades rather than 
challenges to. Whilst scholars agree that the medical profession have become more 
peripheral in driving medicalisation and that ‘active consumers’ and other market 
players pose direct threats to professional medical power there is less agreement about 
the implications of these threats for medicalisation at a conceptual level (Ballard and 
Elston, 2005; Conrad, 2005; Clarke et al, 2010; Busfield, 2017). 
 It is useful to note here that frameworks of medicalisation and commercialisation 
have predominantly originated and been developed in the US context of healthcare. 
Notions of the ‘medical-industrial complex’, ‘managed care’, ‘corporatization of 
healthcare’ and neo-liberalism so intertwined with conceptualisations of healthcare 
and ARTs in the US and (bio)medicalisation theory (Clarke et al., 2010) do not apply 
so straightforwardly to the UK context, in which healthcare and ARTs have a mixture 
of public and private funding and are highly regulated by the state (Moran, 1999; 
Tanzi, 2002; Walshe, 2002; Glennon, 2012). The relationship between the state, the 
medical profession, patients and the market in the UK therefore has its own 
peculiarities. In this context, scholars have highlighted how levels of trust in the 
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medical profession are not as low as in the USA and the importance of not conflating 
trust in doctors at an individual level and a social level (Mechanic, 1996; Lupton, 
1997; Calnan and Sanford, 2004). 
Throughout this thesis the term “Biomedicalization” was used in an adapted way: the 
term ‘bio’ was pre-fixed in brackets (Bell and Figert, 2015) and the UK-English 
spelling, i.e. the use of “s” rather than “z”, were explicitly chosen to highlight the 
importance of considering how (bio)medicalisation theory might be applied to the UK 
context. In using this edited version of (bio)medicalisation I have intended to indicate 
more than merely the theory’s limitations (Bell and Figert, 2015) and a personal 
grammatical preference. The use of this amended term also indicates some of the 
limitations of medicalisation theory and the potential value of (bio)medicalisation 
theory in moving beyond these limitations (hence employing the term in this thesis).  
In this study medicalisation theory was less well suited for grasping the specific 
reproductive, consumer, genetic, techno-scientific, heterogeneous and uneven natures 
of ARTs. On the other hand, (bio)medicalisation theory was less well suited for 
explaining the expanding role of the medical profession, the role of the state and 
regulation and the specific nature of constrained consumerism, all of which were 
integral aspects to the findings of this study. The findings of this study challenge a 
number of assumptions in (bio)medicalisation theory, including that there has been a 
decline in medical jurisdiction and state intervention (Clarke et al., 2010; Conrad, 
2013) and that recipients of ARTs are primarily consumers (Becker, 2000; Mamo, 
2005). This study contributes to medicalisation theory by illustrating how the 
expansion of medical jurisdiction can still be a key driver of medicalisation, how 
‘race’ is reified through biomedicine (explored below) and how medicalisation is 
uneven in its processes and effects.  
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Consumerism and medicalisation are two central features of (bio)medicalisation 
theory. However, Clarke et al., (2010) have predominantly emphasised the 
commercialised nature of (bio)medicalisation and been criticised for diluting 
medicalisation and taking it for granted (Conrad, 2013). It is recognised that 
commodification and medicalisation are not antithetical, particularly in the partially 
privatised arena of ARTs. However, my findings showed a strong persistence of 
medicalisation and a limit to commercialisation at a number of levels, namely the 
macro-level of regulation, the meso-level of clinical decision-making and the micro-
level of clinician-patient interactions (Conrad, 1980b).  
Current theorisations in the literature of matching as a ‘commercialised’ and/or a 
‘kinship’ practice did not fully explain the findings of this study. As noted by 
Breitkopf and Rubin (2015: 46) “more recent scholarship tends to bypass questions of 
exploitation versus agency and instead examines the broader social and contextual 
issues at stake in the buying and selling of reproductive matter”. Instead, 
medicalisation, in spite of its limitations, provided a useful framework for 
understanding the power relations shaping the interactions between clinicians and 
recipients. Thus, whilst the wider context within which matching took place was 
privatised and commercialised the dynamics and organisation of matching within this 
arena were less framed by consumerist concerns than medicalised ones. 
Normalisation (medicalisation) not optimisation (biomedicalisation) was seen as the 
ultimate goal of matching, albeit through optimised techno-scientific means. 
Following Conrad (2013), consumerism appeared to be more of a driver of 
medicalisation than a threat to its expansion in this context (Becker and Nachitgall, 
1992). 
As shown in Chapter 4, in the UK the state is a major stakeholder in fertility treatment 
and there is a much smaller market for ARTs than in the USA, which is both privately 
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and publicly funded in the UK. Whilst the funding and provision of healthcare and 
fertility biomedicine are becoming increasingly privatised, the nature of this 
privatisation, within a highly regulated context, demands critical and reflexive 
application of (bio)medicalisation theory to the UK context. The nature of ART 
regulation sanctions clinicians’ dominance and constrains commercialisation by: 
limiting donor payments, mandating the identifiability of donors and protecting 
welfare of the child interests. According to Daniels et al., (2016) the mandated nature 
of welfare of the child considerations inherently intertwines the state, medical 
professionals and parents, leaving little room for the market in this conceptualisation. 
The altruistic context of donation more generally in the UK also shapes the 
relationship between commercialisation and medicalisation (Titmuss, 1997; Glennon, 
2012). The expansion in medical jurisdiction and limit to commercialisation were also 
apparent at meso- and micro- levels of clinicians’ and recipients’ perceptions, 
interactions and practices of matching.  
The perceptions and practices of recipients in this study did not reflect that of the 
autonomous, rational and objective ‘healthcare consumer’, which Henderson and 
Petersen (2002: 4) argue is an artefact of culture, policy, expertise and marketing in 
the UK context of healthcare. Although recipients’ exclusion of donors with 
undesirable characteristics did commodify donors’ characteristics, their discourses of 
declining donors revealed that their practices were shaped by wider concerns about 
the welfare of their child, kinship resemblance and trust in clinicians. Discourses of 
constraints, compromise and trust in clinicians were central to recipients’ accounts of 
selecting donors. Contrary to the view of recipients as merely as consumers of donor 
information (Becker, 2000; Pennings, 2000; Kroløkke, 2009, 2014) this study found 
that recipients saw having more donor information as a burden and as a risk to their 
reproductive agency (Stuart-Smith et al., 2012; Braverman and Frith, 2014; Rubin et 
319 
 
al., 2015). As such, recipients saw the clinical context of anonymous egg donation as 
protective (Allan, 2007).  
In this study, clinicians controlled all aspects of the matching process, including the 
classification of donor/recipient characteristics, the preferences that recipients could 
specify, the allocation of donors to recipients and the amount and type of donor 
information recipients could access. Both clinics imposed their own medicalised 
matching criteria, rationalised as being in place to manage medical risks to the welfare 
of the child and the safety of recipients. Clinicians strategically re-conceptualised 
‘demanding’ recipients (i.e. consumers), who challenged their medical authority, as 
‘very anxious recipients’ (i.e. patients) who had not come to terms with using egg 
donation, or their own infertility, and as a threat to the welfare of the child. They thus 
concluded that these ‘non-compliant’ recipients required intervention in the form of 
counselling before allowing them to proceed with treatment with the intention that 
recipients would become more compliant.  
In their study of how fertility clinic staff applied Section 13(5) of the Human, 
Fertilisation and Embryology Act (2008) Lee et al. (2014), argue that medicalisation 
theory provides a “blunt tool” for understanding the complex realities of service 
provision in ARTs. One of the reasons they put forward for this argument is that the 
responsibility for taking into account the welfare of the child was also taken on by 
non-medical staff, particularly counsellors. Whilst I agree with Lee et al., (2014) that 
medicalisation theory has its limitations, in this study, I argue that the role of 
counsellors was co-opted and encompassed within medicalisation so that they were 
used as a mechanism within medicalisation and contributed to rather than retracted the 
expansion of medical jurisdiction.  
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Therefore my adapted use of (bio)medicalisation is intended to reflect the particular 
findings of this study within the UK context of egg donation in which there was an 
expansion of medicalisation and a limit to the commodification of reproduction. 
Below, the contributions of this conceptualisation of (bio)medicalisation as applied to 
wider areas of sociological literature will be explored, including the implications for 
kinship, stratifications of reproduction and (bio)medicine and ‘race’ and ethnicity.  
 
9.3.2 (Bio)Medicalisation of Reproduction and Kinship 
Since the 1990s, the emergence of ARTs has revitalised sociological interest in 
kinship studies. According to Schneider (1992: 308) kinship has stayed the same for 
such a long time “that these cultural definitions have not changed one iota as a result 
of the new reproductive technologies, nor will these technologies alone cause them to 
change in the immediate future.” Others, however, have emphasised the numerous 
ways in which ARTs have opened up new ways of thinking about the interrelated 
concepts of family, reproduction and kinship and have used ARTs as an ethnographic 
window through which to explore kinship discourses and practices (Stacy, 1992; 
Strathern, 1992a, 1992b, 1992c; Ragoné, 1994; Edwards et al., 1997; Franklin, 1997; 
Franklin and Ragoné, 1998; Kahn, 2000; Franklin and McKinnon, 2001; Carsten, 
2004; Thompson, 2005; Featherstone et al., 2006; Wade, 2007; Bonaccorso, 2009).  
According to Finkler (2000) the deterministic nature of new genetic technologies has 
led to a ‘medicalisation of the family’ where the role of choice in constructing 
relatedness is subverted and determined by genetic relations. This is contrary to 
theorising of kinship and the family as ‘choice’ (Weston, 1991). However, this thesis 
has been criticised by Featherstone et al. (2006) who have argued that Finkler’s 
(2000) ‘medicalisation of kinship’ appears to be more about the ‘geneticisation of 
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medicine’. Other scholars have also shown how the use of Prenatal Genetic Diagnosis 
(PGD) and the ‘new genetics’ has led to a “geneticization of reproductive choice” 
(Franklin, 2013: 299) where the decision to procreate is determined by genetic 
considerations rather than socio-cultural ones. 
In relation to ARTs, Mamo (2005) has argued that the selection of sperm donors by 
lesbian couples constitutes a “biomedicalization of kinship” in which she stresses 
commercialised, geneticised and tech-scientific nature of reproduction and the ability 
to choose donors according ideals’ of health, desirability and power. Noticeably 
absent from this conceptualisation of the “biomedicalisation of kinship” as applied to 
this study are medicalisation, the role of the state and the constraints associated with 
these.  
In this study, it might be argued that the organisation of matching in egg donation 
constitutes a ‘(bio)medicalisation of kinship’ which takes place through the complex 
and dynamic ontological choreography of making families. Rather than reflecting an 
attempt to ‘optimise’ familial characteristics (Clarke et al., 2010; Mamo, 2010) 
clinicians and recipients perceptions and practices of matching revealed an attempt to 
reproduce normative families (Spallone, 1989; Steinberg, 1997; Atkinson et al., 2001; 
Thompson, 2005). Central to such a conceptualisation are two key concepts which 
were utilised in this study to understand and explain clinicians’ and recipients’ 
discourses and practices of matching: ‘kinship risks’ and ‘strategic rationalisation’, 
both of which will be outlined below.  
Kinship Risks 
Building on Goffman’s (1963) concepts of ‘courtesy stigma’ and ‘discredited’ and 
‘discreditable’ stigmas I introduced the concept of ‘kinship risk’ to explain clinicians’ 
and recipients’ conceptualisation and negotiations of acceptable and unacceptable 
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differences. The concept of ‘kinship risk’ refers to physical differences between 
recipients and their child that might reveal the lack of a genetic relationship between 
recipients and their child and consequently the child’s genetic relationship with 
another party (‘relational stigma’). ‘Kinship risks’ can lead to ‘resemblance talk’ 
(Becker et al., 2005), where physical differences between recipients and their child 
were seen as a threat to recipients parental identity, to children’s belonging within the 
family and to family legitimacy, i.e. to displaying family.  
Not all types of differences were construed as a kinship risk. In practice, clinicians 
and recipients appeared to conceptualise some ‘kinship risks’ (i.e. differences) as 
more acceptable than others. For example, just as ‘racial resemblance’ was regarded 
as a primary indicator of kinship resemblance and relatedness (Becker 2000; Marre 
and Bestard, 2007; Szkupinski-Quiroga, 2009; Thompson, 2009; Nordqvist, 2010; 
Hudson, 2015), ‘racial difference’ was simultaneously construed as a primary ‘kinship 
risk’ by all recipients. Whilst BME recipients did not see hair colour and eye colour as 
an essential part of their preferences for a ‘racially matched’ donor some white 
recipients did; furthermore whilst white recipients did not see hair colour in general as 
an indicator of kinship they singled out red hair as a ‘kinship risk’.  
Goffman’s (1963) concepts of ‘discreditable’ and ‘discredited’ stigmas were 
elaborated upon here to explain how recipients navigated their selection of donors. 
Recipients saw some differences in their donor as acceptable, i.e. as a ‘discreditable 
kinship risk’, in that they could be mediated, concealed or rationalised, but saw other 
differences as unacceptable, i.e. ‘discredited kinship risks’, because they were obvious 
and could not be concealed. When accepting donors with different characteristics to 
their own, i.e. ‘discreditable kinship risks’, recipients used a range of rationalising 
discourses to mediate, minimise, legitimise and accept differences. However, 
recipients saw donors with particular marginalised characteristics as a ‘discredited 
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kinship risk’ which they could not mediate and so systematically excluded from their 
preferences and practices of donor selection through a discourse of risk.  
In this study clinicians’ and recipients’ views of ‘racial difference’ were coherent; in 
different circumstances, both clinicians and recipients saw ‘race’ as both an 
immutable and flexible category. However, this coherency was unpinned by an 
underlying logic of a racial hierarchy of skin tone. That is, for white recipients, ‘racial 
boundaries’ were regarded as an immutable and fixed category grounded in 
naturalistic assumptions whilst for BME recipients ‘racial boundaries’ were regarded 
as a flexible and contingent category, to different degrees. Thus for white recipients 
‘racial difference’ was conceived of as a ‘discredited kinship risk’ which could not be 
mediated whilst for BME recipients ‘racial difference’ was construed as a 
‘discreditable kinship risk’, which could be rationalised and mediated.  
Where clinicians and recipients did differ was in their conceptualisation of the 
characteristics that construed a ‘kinship risk’. For clinicians, ‘race’ was seen as the 
only characteristic which posed a risk to the welfare of the child. For recipients on the 
other hand, stigmatised characteristics, i.e. red hair and dark skin tone, were seen as a 
primary ‘discredited kinship risk’, showing how recipients’ conceptualisations of 
undesirability and difference were intertwined.  
Strategic Naturalisation  
Thompson (2001) concept of “strategic naturalisation” was built upon to explain the 
nuanced and complex ways in which both clinicians and recipients negotiated 
articulations of resemblance and difference to meet their own context-specific aims. 
“Strategic naturalisation” refers to the ways in which women exercise agency in the 
clinical context of egg donation by ‘claiming or disowning bonds of ancestry and 
descent, blood and genes, nation and ethnicity’ to suit their individual strategies of 
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parenthood; certain basis of kinship differentiation are foregrounded and recrafted 
whilst others are minimised (Thompson 2001; 2005: 149). The term ‘strategic 
rationalisation’ was employed to highlight the varied discourses that recipients 
strategically drew on the meet their aims, in which they foregrounded, minimised, 
naturalised, de-naturalised and re-naturalised the importance attached to different 
elements of the matching process.  
In this study, recipients strategically rationalised the importance they attached to 
genetic inheritance, resemblance as an indicator of kinship, difference as a ‘kinship 
risk’, the welfare and well-being of the child, contextual constraints, the need to 
compromise and trust when seeking to make ‘acceptable’ families through matching 
(socially acceptable and acceptable to themselves). The ‘dynamic co-ordination’ of 
these various elements of the social, political, self, kinship, techno-scientific, 
regulatory, moral and medicalised aspects of matching illustrate the ‘ontological 
choreography’ (Thompson, 2005) of matching, which seeks to reproduce particular 
types of families (not just ‘suitable’ children and parents).  
Recipients had to manage multiple identities when negotiating their access to donors, 
including that of a consumer, patient and parent (Thompson, 2005). When stating 
their preferences for donor characteristics recipients foregrounded the importance of 
resemblance as an indicator of kinship and the role of genetic inheritances. When 
accepting donors with different characteristics to their own recipients minimised the 
role of resemblance and foregrounded the importance time and a shortage of donors. 
Recipients strategically used a range of discourses to accept these donors, including 
drawing on: fatalistic discourses; the presence and absence of resemblance in 
families; alternative discourses of genetic inheritance; and trust in clinicians. When 
declining donors, recipients foregrounded donors’ marginalised characteristics as their 
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Master Status and minimised the importance of time or the desirability of donors’ 
other attributes.  
Like recipients, clinicians embodied multiple identities including that of a medical 
professional and an employee in a privatised context, meaning that they had a 
mandatory duty to provide patient information, obtain informed consent and ensure 
patient safety, show appropriate customer service and ensure that recipients accepted 
donors so that the egg donation programme could keep running. When matching 
donors and recipients clinicians strategically drew on different discourses to 
rationalise the types of matches they wanted to make. Clinicians’ classification of 
patients’ characteristics illustrated how clinicians foregrounded their own perceptions 
of skin tone and genetic inheritance to categorise individuals into different ‘ethnic’ 
categories and to ‘mark’ the ethnic classification of some patients (particularly white 
and mixed ethnicity patients).  
When allocating donors to recipients clinicians foregrounded medicalised 
characteristics and ‘race’ as protecting the medical and social welfare of the child. 
However, a shortage of BME donors (in particular) meant that both of these primary 
matching criteria were seen as negotiable for BME recipients and not seen as an 
overriding welfare of the child concern. Furthermore, such strategic rationalisations 
followed a racialised hierarchy of skin tone whereby clinicians were more likely to 
allocate ‘marked white’ donors to BME recipients – thus foregrounding their 
‘markedness’ over their ‘whiteness’ and to match these donors with South Asian 
recipients over black African/Caribbean recipients. However, clinicians ideally 
wanted to avoid allocating ‘marked white’ donors to white British recipients and took 
steps to strategically ‘unmark’ donors’ ‘whiteness’ in order to make such matches.  
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9.3.3 Stratified (Bio)Medicalisation and Stratified Reproduction  
The concept of stratified (bio)medicalisation is still in its infancy compared to the 
concept of stratified reproduction (which is itself still being continually 
(re)developed). As highlighted by Herzig (2015: 83), “the concept of “stratified 
biomedicalization” on its own does not offer much in terms of delineating the 
processes of mechanisms of stratification”. This critique has also been recognised by 
Clarke et al., (2010) themselves, who acknowledge that the process of racialisation 
and its relationship to (bio)medicalisation and stratification has not been well-
developed in their own theorisation (hence presenting the contribution to ‘racial’ 
inequalities here). Furthermore, despite Clarke et al., (2010) intention for the concept 
of ‘stratified (bio)medicalisation’ to go beyond ‘inability to pay’ the authors primarily 
shape this concept around neo-liberal consumerism and access to healthcare.  
The concept of ‘stratified reproduction’ refers to the power relations by which 
individual categories of peoples’ reproductive futures are valued and empowered or 
despised and disempowered (Ginsburg and Rapp, 1995b: 3). In common applications 
of ‘stratified reproduction’ to egg donation the main focuses in the literature have 
been on the class and ‘racial’ divisions shaping women’s differential access to 
reproduction through ARTs (Roberts, 1999; Culley et al., 2009; Greil et al., 2011; 
Bell, 2016) and in determining who benefit from egg donation (recipients) and who 
provide the means for those benefits (donors) and their respective experiences of 
reproduction, particularly in contexts of transnational reproduction (Nahman, 2006; 
Deomampo, 2016; Whittaker and Speier, 2010; Twine, 2015). Typically, scholars of 
stratified reproduction in ARTS have emphasised women’s differential access to 
ARTs based on wider axis of inequality, e.g. class, sexuality and racialised divisions 
(Ginsburg and Rapp, 1955; Roberts, 1999; Mamo, 2007; Inhorn et al., 2009; Greil et 
al., 2011).  
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Whilst the concept of ‘stratified reproduction’ has been applied to areas of genetic, 
social, natural and assisted reproduction, the concept of stratified (bio)medicalisation 
is specifically intended for contexts of healthcare. These concepts converge in the 
context of ARTs, where the stratification of one’s access to treatment is synonymous 
with the stratification of one’s access to reproduction. Both concepts highlight 
biomedicine as a site for the reproduction and intensification of wider inequalities in 
society according to divisions of ‘race’, class, gender (Ginsburg and Rapp, 1995b; 
Clarke et al., 2010). In this respect, ARTs have been described as a “prime example” 
of each of these concepts (Ginsburg and Rapp, 1995b; Inhorn and Fakih, 2006; Inhorn 
and Birenbaum-Carmeli, 2008; Clarke et al., 2010). Previous studies which have 
employed these concepts in ARTs have predominantly focused on neo-liberal 
commercialised contexts of ARTs and explored the ways in which stratification takes 
place through the commodification of reproduction (Colen, 1986; Clarke et al., 2010).  
This study contributes to the development of the concept of ‘stratified 
(bio)medicalisation’ in a number of ways. In contrast to existing scholarship this 
study did not focus on the type of women that are seen as legitimate beneficiaries of 
donor eggs and the type of women who are conceptualised as and reduced to being a 
‘bioavailable’ resource for the reproduction of others (Cohen, 2005). Instead, this 
study focused on the systemic differences were found amongst recipients and amongst 
donors according to historic and social patterns of stratification, e.g. class, ‘race’ and 
other divisions of marginalisation, stigmatisation, inequality and discrimination.  
Unlike previous studies on stratified reproduction which have predominantly taken 
place in transnational and international contexts of ARTs (Colen, 1986; Whitakker 
and Speier, 2010; Bergmann, 2011; Nahman, 2011; Daniels and Heidt-Forsythe, 
2012; Kroløkke 2014; Deomampo, 2016; Schurr, 2016) and/or have focused on the 
experiences of middle-class white women as users of gamete donation (Konrad, 2005; 
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Mamo; 2005; Bonaccorso, 2009; Nordqvist, 2010; Klotz, 2014; Rubin et al. 2015), 
this study is situated in the UK and contributes to growing literature on the 
experiences of BME women from working-class backgrounds (Roberts, 1999; Inhorn 
and Fakih, 2006; Inhorn et al., 2009; Culley and Hudson, 2009b; Szkupinski-Quiroga, 
2007). This study explored on how stratification takes place within a predominantly 
medicalised context of reproduction, rather than merely a commercialised context, 
and showed how stratification can take place at the level of the individual and family. 
Unlike current literature on stratified reproduction and (bio)medicalisation this study 
concentrated on recipients’ access to reproduction by virtue of their access to donors, 
rather than their access the clinic, which was predominantly commercialised. Thus 
attention was paid to how recipients’ access to donors was shaped by ideological, 
structural and contextual constraints, not just economic constraints. 
According to Clarke et al., (2010), “stratified biomedicalization” can occur when 
clinicians classify patients as ‘good/deserving’ or ‘bad/undeserving’. Echoing 
previous studies this study found that clinicians’ classification of patients as ‘good’ or 
‘bad’ shaped recipients access to treatment (Doyal, 1987, Pennings, 2001 Haimes, 
1992; Price, 1997; Steinberg, 1997; Roberts, 1999, Malin, 2003) by virtue of their 
access to donors. In this study, clinicians undertook strategies to ‘normalise’ the 
behaviour of ‘demanding’ recipients who posed a threat to their own authority, e.g. 
they avoided matched these recipients or referred them to counselling before allowing 
them to proceed with treatment, thus delaying their access to treatment and 
encouraging them to be more compliant in the future. 
Focusing on epidemiological classifications of heart disease, Shim (2010: 225) argued 
that “biomedicalization is stratified because of the specific inclusion of racial 
difference (from the normative “white” category”) as an object requiring biomedical 
attention”. She argues that stratified (bio)medicalisation occurs when ‘race’ becomes 
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rearticulated as a marker of risk, as something potentially pathological, thus needing 
to be targeted for intervention. This study illustrated how in the context of matching 
in egg donation clinicians conceptualised ‘race’ as a primary marker of risk, i.e. risk 
to kinship resemblance and the welfare of the child and as needing intervention by 
clinicians. Welfare of the child discourse was central to clinicians’ legitimisation of 
their role in matching and in protecting normative racialised kinship boundaries.  
According to Rapp (2004: 311), ‘stratified reproduction is reproducing far more than 
individual babies: It is a lens through which we can see how representations of 
parenting, gender relations, and collective and familial aspirations for the next 
generation are also being reproduced’. For example, in their study on BME women’s 
Inhorn et al. (2009: 182) show how a wider prejudice towards the ‘unwantedness of 
more black and brown babies’ is part of the barriers faced by BME recipients in 
accessing fertility services. Drawing on Rapp’s (2004) attention to “collective and 
familial” reproductive futures this study contributes to the concept of ‘stratified 
reproduction’ by showing that stratification can take place according to collective and 
relational categories of reproductive futures, i.e. of families, not just individual 
categories, i.e. children and parents.  
In this respect, it wasn’t the reproduction of particular individuals that was ‘valued’ or 
‘despised’ through perceptions and practices of matching but the reproduction of 
particular types of families. That is, ‘racially congruent’ families were ‘valued’ and 
empowered for reproduction whilst racially incongruent families (Wade, 2012) were 
‘devalued’ and discouraged from being reproduced and subject to 
disciplinary/exclusionary (bio)medicalisation. For example, recipients who 
specifically requested a donor of a different ‘race’ were pathologised as ‘anxious 
patients’ and would be subject to disciplinary measures (e.g. counselling).  
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The imposition of ‘racial matching’ had particular consequences for BME recipients’ 
access to donors, whereby a shortage of BME donors meant that these recipients often 
waited longer than their white counterparts for a ‘racial match’ and were expected to 
compromise on their preference for an ‘ethically matched’ donor and be willing to 
accept a white donor. Whilst ‘racial matching’ epitomised ‘stratified 
(bio)medicalisation’ and ‘stratified reproduction’ far more revealing was the nuanced 
ways in which stratification took place through discourses and practices of ‘transracial 
matching’, which revealed the nuances of recipients’ heterogonous access to donors 
based on racialised skin tone.  
Firstly, whilst clinicians saw it as acceptable for BME recipients to access a different 
‘race’ they saw it as unacceptable for white recipients to access a BME donor. 
Secondly, the reproduction and (bio)medicalisation of BME recipients was stratified 
differently amongst recipients from different minority ethnic groups; whilst it was 
seen as acceptable for a South Asian recipients to access a white donor this was not 
equally the case for black African/Caribbean recipients. Even then, clinicians’ 
typically left South Asian recipients waiting longer for a white donor than their white 
counterparts (e.g. by ignoring their position on the waiting list).  
Furthermore, the acceptability of matching a white donor with a South Asian recipient 
depended on recipients’ skin tone, the skin tone of their partner and the skin tone of 
that white donor making their access to such donors was stratified in multiple ways. 
Although on the whole clinicians and recipients shared similar views about the types 
of matches that should or should not be made it is important to bear in mind that the 
imposition of such matching criteria by clinicians imposed restrictions on recipients’ 
access to donors. Thus whilst on the surface ‘transracial matching’ appeared to 
challenge a racialised ideology of the family these racialised boundaries were still 
negotiated according to existing racialised hierarchies of skin tone.  
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Unlike previous studies, which have argued that there is a “reproduction of 
whiteness” through egg donation by predominantly focusing on the reproduction of 
white recipients and white donors (Roberts, 1999; Szkupinski-Quiroga, 2007; Cooper 
and Waldby 2014; Kroløkke, 2014; Deomampo, 2015; Schurr, 2016; Homanen, 
2018), this study has shown how whiteness was reproduced through clinicians’ 
nuanced discourses and practices of ‘transracial matching’ with recipients from 
diverse ‘racial’ backgrounds. That is, for white British recipients, clinicians saw it as 
their responsibility to maintain and reproduce ‘whiteness’ through ‘racial matching’ 
whilst for BME recipients clinicians sought to restrict ‘whiteness’ by matching 
recipients according to a racialised hierarchy of skin tone and limiting their access to 
‘marked white’ donors. This contribution extends the ‘reproduction of whiteness’ to 
go beyond the reproduction of white babies and non-reproduction of BME babies 
(Inhorn et al., 2009) to show the complexities of how whiteness was protected rather 
than merely reproduced.  
This study also showed how other patterns prejudices and axis of inequality in wider 
society were reproduced in the clinic (aside from racialisation) and their implications 
for stratified the reproduction of donors. Recipients’ systematic exclusion of donors 
with marginalised characteristics reproduced wider inequalities in society within the 
clinic and stratified reproduction in multi-layered ways. Whilst recipients’ exclusion 
of donors with darker skin tone than themselves has been documented (Nahman, 
2006) this study also showed how the genetic reproduction of donors with other 
marginalised attributes, i.e. red hair, a high BMI and who identified as Muslim or 
lesbian, was also devalued and discouraged.  
The systematic nature of such stratifications was revealed from recipients’ preferences 
and practices of exclusion and took place through discourses of risk and strategic 
rationalisation. The exclusion of egg sharing donors in particular translated into 
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another layer of stratified reproduction in which their access to their own reproduction 
(through ARTs) was dependent upon being accepted by a recipient.  
Studies in some contexts of egg donation, such as the USA and India, have 
highlighted the stratification of reproduction through the differential valuation and 
payment to donors according to a hierarchy of desirable characteristics (Almeling, 
2011; Deomampo, 2016). In the UK however, the payment of donors is regulated and 
restricted. Thus although clinicians and recipients valued and de-valued different 
types of donors in different ways this was not reflected in the payment to donors but 
through their practices of inclusion and exclusion. Recipients did have consumerist 
preferences and display consumerist practices in declining donors. However, the 
nature of this consumption was different to that of the rational autonomous consumer 
(Lupton, 1997) and was embedded in constraints.  
The recipients in this study did not specifically select donors with socially desirable 
characteristics, as they did in other studies, as there was limited scope to do so in their 
preferences and their choices were constrained by the donors they were allocated. 
Rather, they excluded donors with socially marginalised/stigmatised characteristics 
from their reproduction. Recipients did not draw on discourses of desirability and 
consumerism to legitimise excluding donors but on discourses medicalisation, risk 
and trust. Although a nuanced distinction this difference reflects the nature of 
consumerism as it might apply to the UK compared with some other countries.  
 
9.3.4 (Bio)Medicalisation and The Reification of ‘Race’ 
This study contributes to medical sociology’s understanding of the ways in which 
‘race’ and ethnicity are conceptualised and operationalised in the predominantly 
privatised biomedical context of egg donation, including how medical professionals 
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classified ‘ethnicity’ and skin tone, the meanings that clinicians and recipients 
attached to ‘ethnicity’ and how resources were allocated differentially according to 
racialised categories of ethnicity. These contributions will be outlined below. The 
intersections between ‘race’, ethnicity and stratification were explored above. 
According to Gilroy (2000a) the ‘old’ reproduction of ‘race’ and the nature of 
identities have been transformed by scientific and technological developments, such 
as molecular biology and body imaging. Gilroy (2000a: 43) argues that such 
developments are a “compelling sign that we have begun to let the old visual 
signatures of “race” go”. Contrary to Gilroy’s thesis, the findings of this study echo 
those of scholars who argue that ‘race’ has become reified and reproduced through 
techno-scientific developments, through which sophisticated technologies are 
employed based on old classificatory regimes (Collins, 1999; Duster, 1990; 2005; 
Rabinow and Rose, 2006; M’Charek, 2008), including in gamete donation (Roberts, 
1999; Fogg-Davis, 2001; Fuscaldo, 2006; Szkupinski-Quiroga, 2007; Thompson, 
2009; Nordqvist, 2010; Deomampo, 2015; Hudson, 2015).  
This study showed how ‘race’ was reified and reproduced through the different stages 
of the matching process and through the everyday perceptions, tools, interactions and 
material practices of clinicians and recipients (Thompson, 2009; Nahman, 2006; 
Deomampo, 2016). Ethnicity was typically conflated with ‘race’ by recipients and 
clinicians and treated as if it was a proxy for physical characteristics (particularly skin 
tone) and a genetically inheritable characteristic. Clinicians’ definition and 
classification of ethnicity took precedence over patients’ self-identified ethnicity and 
their classification of ethnicity was inherently related to clinicians’ perceptions of 
recipients’ skin tone. Clinicians’ practices of classification revealed inconsistencies in 
the process classification as well as the conceptual conflation of “race” and 
“ethnicity” (Sheldon and Parker 1992; Smaje 1996; Hall 2006).  
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‘Race’ was also reified through clinicians’ and recipients’ nuanced discourses and 
practices of ‘racial matching’ and navigations of ‘transracial matching’ in which 
‘ethnicity’ was regarded as a genetically inheritable a proxy for skin tone, i.e. as 
‘race’. In different contexts, ‘ethnicity’, or rather ‘race’, was conceptualised as both a 
flexible and immutable category. On the whole, ‘race’ was conceptualised as an 
immutable and ridged category for white British recipients’ reproduction but was seen 
as flexible and able to be transgressed for BME recipients’ reproduction, to an extent. 
‘Racial geographies of desirability’ (Nahman, 2006) were apparent in recipients’ 
preferences for donor characteristics, whereby recipients to exclude ‘racially matched’ 
donors according to Euro-American ideals of beauty, i.e. with darker skin tone, red 
hair and a high BMI.  
However, unlike scholars who have argued that ‘race’ is geneticised through matching 
and turned into a “commodity” in egg donation and marketed to recipients by fertility 
providers (Duster, 1990; Campbell, 2007; Costa, 2007; Schurr, 2016) the findings of 
this study illustrated the ways in which ‘race’ was predominantly conceptualised as a 
‘kinship risk’ and as a threat to the welfare of the child. Thus racialised hierarchies 
were reproduced through discourses of medicalisation, risk, self-surveillance, 
morality and naturalness, rather than just the market.  
Clinicians’ view of recipients wanting a donor from a different ‘racial’ background 
also revealed the nuanced ways in which racialised ideologies intersected with 
cultural ideologies of beauty, power and desirability whereby white recipients’ 
preference for a BME donor was conceptualised as ‘exotifying’ whilst BME 
recipients preference for a white donor was seen as ‘enhancing’ (Nahman, 2006; 
Bergman, 2015; Deomampo, 2016). The different concerns of white recipients and 
BME recipients in having a mixed race child also reflected the intersections between 
gender, ‘race’ and reproduction, where white women were more concerned about the 
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risk to perceptions of their partner’s paternity and their own infidelity than their status 
as mothers.  
Marked Whiteness 
In the literature, ‘whiteness’ has traditionally been posited as an invisible, unmarked 
category and as representing the ‘norm’ (Frankenberg, 2001) whilst ‘non-white’ and 
BME groups have been posited as visible, stigmatised and marked (Frankenberg, 
1994; Jackson, 1998, Tyler, 2007; Hudson, 2015). Scholars who have argued that 
‘whiteness’ is also marked have typically emphasised the foregrounding of whiteness 
as a cultural identity and the social location from which it is perceived (Erikson, 1995; 
Frankenberg, 2001; Snyder, 2015). The findings of this study revealed that whiteness 
can also be phenotypically ‘marked’ and ‘unmarked’ at different times and the 
consequences of this for the types of matches that could be made.  
This phenotypical distinction between types of white donors echoes the findings of 
studies undertaken outside of the UK context, typically in transnational contexts of 
egg donation (Nahman, 2006; Bergmann, 2011, 2015; Kroløkke 2014; Schurr, 2016; 
Homanen, 2018); however, none of these have employed the term ‘marked whiteness’ 
in their analysis. As highlighted by Bergmann (2015: 236): “Whiteness is not such a 
stable form, it is rather a performative category alternating between different shades 
of whiteness as pale, sun-tanned, Caucasian or even Mediterranean”.  
Utilising the concept of ‘marked whiteness’, this study showed how at different stages 
of the matching process both clinicians and recipients distinguished between ‘types’ 
of white donors and consequently some white donors were seen as more suitable than 
others for ‘racial matching’ or ‘transracial matching’. This finding was situated in the 
UK context of egg donation in which the majority of recipients and donors are white 
British. In this context clinicians conceptualised ‘natural’ white skin tone as light/fair 
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and saw darker white skin tone as needing to be marked. ‘Mediterranean type 
patients’ (white patients with darker skin tone) epitomised the concept of ‘marked 
whiteness’ and were labelled – and literally marked- with additional information 
about their ‘ethnicity’, skin tone, nationality, ancestry or place of birth. This 
‘marking’ was a mechanism for differentiating between types of white donors and 
recipients and was shaped by clinicians’ perceptions of ‘natural white’ skin tone in the 
context of the UK and the categories available for classification.  
The use of ‘marked white’ donors in donor allocation also revealed the flexibility of 
this racialised category and the different circumstances in which clinicians and 
recipients foregrounded the ‘marked’ or ‘whiteness’ of these donors to meet their own 
needs. When matching ‘marked white’ donors to BME recipients clinicians 
foregrounded donors’ ‘marked’ attributes in making this match acceptable but when 
matching ‘marked white’ donors with white British recipients clinicians foregrounded 
donors’ ‘whiteness’ and strategically unmarked the ‘whiteness’ of donors. Recipients 
also distinguished between types of white donors that they saw as acceptable. Some 
white British recipients excluded ‘marked white’ donors whilst South Asian recipients 
limited their inclusion of white donors to ‘marked white’ donors with darker features. 
The concept of ‘marked whiteness’ therefore shows how ‘race’ might be 
conceptualised as a flexible category whilst still being enacted according to a wider 
racialised logic. 
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9.4 Research Implications for Policy, Practice, Future Research and 
Study Limitations 
 9.4.1 Recommendations for Policy 
This study was undertaken during a period of absence of HFEA policy on matching. 
After fieldwork had finished the HFEA introduced general guidance advising 
clinicians that they were not required to match the ‘ethnicity’ of donors and recipients. 
Whilst this general guidance is preferably to the previous prescriptive guidance the 
HFEA should consider the how this policy shapes clinicians’ practices and whether 
recipients are satisfied with the matching process.  
Clinicians, recipients, donor-conceived persons, the HFEA and the State should 
respectively and collectively consider the meaning and values that each party attaches 
to the ‘welfare of the child’ and its relationship with matching. Whilst it is recognised 
that prescriptive guidance is perhaps not the way forward, especially given the 
culmination of previous HFEA policy on matching into what has been described as 
‘state sponsored racism’ (Campbell, 2007), there is also a danger in leaving matching 
solely to the discretion of clinicians and to their own subjective moral codes. 
The HFEA currently does not publish figures on the ‘ethnicity’ of patients and 
recipients as a standard reporting characteristic although it has published some data on 
the ‘ethnicity’ of donors (HFEA, 2014b). For example, when reporting statistics for 
ARTs the HFEA includes the age, partner status, sexuality and funding method of 
patients but not ‘ethnicity’ (e.g. HFEA, 2014b, 2018). This lack of nationally 
collected data on the usage of ARTs by ‘ethnicity’ is unfortunate as it means that 
evidence of the disparities in access to ARTs are only reflected in the academic works 
which address the ‘research lacuna’ of studies on ‘ethnicity’ and ARTs in the UK 
(Culley et al., 2009; Hudson and Culley, 2014).  
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The HFEA provides clinics with a list of ethnic codes and skin tone categories by 
which to classify patients (in their prescribed Donor Information Form and guidance 
on how to complete this form). However, it might also be useful for the HFEA to 
provide clinics with some guidance on the nature of their use or on navigating the 
complexities of their operationalisation. Although information about donors’ skin tone 
was valued by both clinicians and recipients the ways in which its use reinforced 
racialised hierarchies and prejudice warrants consideration about how useful it is in 
practice, especially given the contentious and dubious nature of skin tone inheritance. 
Although the HFEA mandates that clinicians consider how the Equalities Act (2010) 
might affect conditions that donors may put on their donation, it does not mandate 
that clinicians take these protected, and other stigmatised, characteristics into account 
in relation to recipients’ practices of selecting donors or their own practices of 
allocating donors to recipients. Recipients’ discriminatory exclusion of donors with 
marginalised characteristics contravened the Equalities Act (2010), in both letter and 
spirit and replicated inequalities in wider society within the clinic. Given that 
recipients’ exclusion of donors was based on ingrained prejudices in wider society it 
is difficult to recommend how their perceptions might be modified directly in relation 
to this behaviour, particularly in this privatised context of reproduction.  
Educating recipients about the complexities of genetic inheritability and the altruistic 
nature of donation might mediate some of their anxieties about accepting donors with 
socially marginalised characteristics. Counselling might play a role in this regards 
although it should not be used in a disciplinary way. The HFEA Code of Practice 
requires clinicians to inform recipients about “genetic inheritance and, in particular, 
the likelihood of inheriting physical characteristics from the donor” (HFEA, 2014a: 
20.1(b)) which could be elaborated to address recipients’ prejudices. The HFEA could 
also remind clinicians of their legal responsibilities in this area by linking the 
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Equalities Act (2010) with clinicians’ role in sanctioning recipients’ preferences. 
Clinicians might also be more aware of the type of information that they record about 
donors and how they relay this to recipients. Perhaps training in unconscious bias for 
clinicians might better equip them to recognise and address recipients’ discriminatory 
behaviour. 
 
9.4.2 Recommendations for Practice  
Reflexivity in ‘ethnic’ classification 
The problematic history of classifying ‘race’ in science and medicine, particularly in 
relation to the political history of reproduction (Roberts, 1999; Thompson, 2006, 
2009; Szkupinski-Quiroga, 2007; Hudson, 2015) necessitates that clinicians continue 
to be vigilant and reflexive about the use of ‘race’ and ‘racial categories’ within the 
context of matching in egg donation (Fogg-Davis, 2001, Fox, 2008). 
In this study clinicians’ classification of ‘ethnicity’ revealed an inherent racialised 
bias whereby patients were ascribed to ‘ethnic’ categories based on clinicians’ 
perceptions of their skin tone. Although the need for clinics to have the ability to 
classify patients from a diverse range of ethnic backgrounds is essential they should 
be aware of the contentious nature of these categories and how unreflexively using 
them inherently perpetuates stereotypes, stigma and discrimination. For example, 
categories ascribed to patients by clinicians such as ‘Asian’, ‘black’ and ‘Oriental’ 
have little bearing to ethnicity and reinforce racialised classifications, as does the 
classification of mixed ethnicity individuals to their BME ethnicity.  
Despite the HFEA recommending that clinics use the ethnic categories available in 
the 2001 Census the clinics in this study still used the categories listed in the 1991 
Census which had a restricted number of options and did not include a category for 
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‘mixed ethnicity’. In light of clinicians’ inconsistent use of ethnic categories and it is 
recommended that clinicians use the HFEA recommended ethnic codes to classify 
‘ethnicity’ for consistency and validity.  
Perhaps another method of classification would be to enable donors and recipients to 
self-identify their ‘ethnicity’ and physical characteristics as free text thus enabling 
recipients to receive information directly from donors without the mediation of 
clinicians. This is recommended practice for ethnic classification, would remove 
clinicians’ bias in categorisation and enable donors more agency. However, this 
method might make it difficult for clinicians to match donors and recipients 
(according to a large array of categories).  
The contradictions and conflations around ‘racial’ and ‘ethnic’ categories and 
terminology in clinical practice are not isolated; they exist across the political, public 
and private spectrum, including academia. The ambiguity in navigating these 
contentious concepts is also illustrated in this thesis where it was sometimes difficult 
to walk the fine line between representing participants’ views, locating these within a 
wider historical and socio-political context and using language, which did not 
reinforce the construct of ‘race’ whilst trying to grasp its very real consequences.  
This difficulty is symptomatic of underlying confusion and contradictions in the 
nature of these categories more generally. Nonetheless, such contradictions need to be 
unravelled and addressed, a first step towards which would be the acknowledgement 
of their existence. Perhaps in the clinical context a starting point would be to educate 
clinicians about the historical and political nature of ‘race’ and racialised categories, 
the nature of ethnic diversity and inequalities and about genetic heritability and 
population genetics.  
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Responsiveness to recipients’ need for donor information 
Following recent studies (Stuart-Smith et al., 2012; Rubin et al., 2015; Zadeh et al., 
2016b), it is important for clinicians to consider the amount and type of donor 
information that individual recipients may or may not want. Whilst many recipients 
felt that the amount of donor information they were given was not enough they also 
had concerns about having more. Clinicians should perhaps approach this on a case-
by-case basis, and be aware of some recipients’ need for more, or less, information 
than provided on the standard clinic forms.  
Clinicians should be reflexive about the information they record about donors, how it 
is relayed to recipients and the implications of this information for recipients, donor-
conceived persons and their own matching practices. In this study, recipients were 
more satisfied with donors being offered in a face-to-face consultation than via e-
mail, and this method appeared to help their process of acceptance.  
Awareness of the importance of trust  
Trust was illustrated as being central to recipients’ decision to accept or decline 
donors at each clinic. Recipients’ relationship with clinicians was a central feature of 
their degree of trust in clinicians. Clinicians should be aware of how their relationship 
with recipients might impact recipients’ behaviours and should not assume that 
recipients who decline donors are overly anxious and need to be managed. Instead, 
they could focus on the role of trust in recipients’ decision-making and accept that 
recipients may simply be unhappy with their choice of donor. 
Recipients trust in clinicians was associated with a higher rate of acceptance whilst a 
lack of trust in clinicians was associated with a higher rate of declining. Clinicians 
should take time to understand the nature of recipients’ ‘non-compliant’ behaviour 
and see how they might help to address recipients’ concerns. They should consider the 
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role of counselling in the clinic and whether it is the always the best intervention for 
recipients who do not comply with clinicians’ expectations. Rather, clinicians’ could 
be more reflective about their own expectations and the assumptions that inform 
them.  
Clinicians’ role in matching 
Clinicians intertwined their mandatory responsibility to consider the ‘welfare’ of 
children born through the clinic with their role in matching. In this respect, clinicians 
saw ‘racial difference’ and ‘racially incongruent’ families as a threat to the social 
welfare of the child and drew on medicalised criteria as harmful to the medical 
welfare of the child. Whilst clinicians’ commitment to the welfare of the child is 
commendable (especially in the context of the UK, in which this notion is given 
primacy in law), there is no evidence base for matching by height/weight or CMV 
status in egg donation. Neither is there an evidence base for ‘racial matching’. 
Clinicians drew on their own moralised concerns about ‘transracial matching’ and 
these concerns played out in their practices.  
That is, only certain types of matches were being made in the clinic, with the 
consequence that only certain types of families were being reproduced. When 
allocating donors to recipients it was typical for clinicians to override recipients’ 
preferences for certain donor characteristics with their own imposed matching criteria. 
Perhaps if clinicians were aware of the importance that some recipients attached to 
their preferences, or their difficulty in coming to terms with the compromises they 
made (albeit in innovative ways), they might re-consider their matching priorities. 
Recipients’ declining of donors was a prime example of the difference in how 
clinicians and recipients perceive a ‘good match’.  
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The HFEA currently advises clinicians to relay information about the ‘nature of 
genetic inheritance’ to recipients in relation to donors’ characteristics. However, it 
provides little elaboration of this advice. It seems that making recipients aware of the 
scientific evidence on genetic inheritability might help mediate their concerns and 
expectations when selecting donors. However, given that clinicians are specialists in 
fertility medicine, not genetics, it seems perhaps unrealistic to ask them to take up this 
role. To help clinicians navigate their multiple roles in matching and egg donation 
they might receive training or expand their understanding of the difference between 
‘race’ and ‘ethnicity’, ethnic inequalities, genetic inheritability of physical and social 
characteristics and on recipients’ experiences of having treatment. 
 
9.4.3 Limitations  
The focus of this study was narrow and concentrated on a small stage in the egg 
donation process, within 2 specific contexts and concentrated on the views and 
experiences of clinicians and recipients. As with all in-depth ethnographic studies the 
findings of this study were shaped by the particular context in which they took place. 
Therefore, they are not representative and generalisable to different contexts within 
and outside of the UK.  
This study was based on 2 private clinics in the South East of England with particular 
characteristics. Thus, other clinics, in other locations, with different organisational, 
structural and cultural features in different locations at different times might well 
shape the organisation of matching in different ways and warrants further research. 
For example, the size, patient demographics, region of the UK, use of technology and 
private/NHS nature of clinics could shape how matching is organised and practiced. 
Because this study was a clinic-based ethnography, the experiences of recipients who 
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recruited their own identifiable donors outside of the clinic context were not included. 
In limiting the inclusion of clinics to those that recruited donors’ ‘in-house’, this study 
also did not explore the organisation of matching in clinics which imported donor 
eggs or which partnered with other clinics in Europe.  
In the time since this study began, there have been significant changes in the field. 
HFEA policy has changed, the state of the literature has progressed, egg freezing and 
the import of donor eggs from abroad has increased, many UK clinics are 
‘outsourcing’ their egg donation programmes to clinics abroad and recipients are 
increasingly travelling abroad for fertility treatment. A minority of websites 
advertising anonymous egg donors have also emerged in the UK, although these are 
affiliated with individual licensed fertility clinics – not third party commercial 
agencies – and ultimately these clinics still sanction recipients’ choices. In light of 
these fast-paced changes the findings of this study might provide insight into a 
snapshot in time of the organisation of matching rather than an indicator of the future 
of matching. 
When designing this study I had considered including the perceptions and practices of 
donors in relation to matching, in addition to clinicians and recipients. However, 
although I recognised the central importance of donors to the egg donation process the 
decision was made to exclude donors for several reasons. Informed by the literature, I 
saw matching as predominantly undertaken by clinicians and recipients. Informed by 
discussions with my supervisor, I was aware of the need to limit the scope of this 
study to make it manageable (especially as I intended to explore multiple field sites). 
In light of these reasons, I thought that including donors as participants might have 
diluted the focus on clinicians and recipients (which was identified as gap in the 
existing literature) and would not have significantly contributed to an understanding 
of ‘donor selection’ (as matching was defined in the literature).  
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In not including donors as interviewees it is recognised that the opportunity to take a 
holistic approach to exploring the organisation of matching through the triad of 
clinicians, recipients and donors was missed and that this would have enabled 
important insights into the matching process and how donors were made 
‘bioavailable’ (Cohen, 2005). Therefore the meanings that donors attached to their 
eggs and resemblance, how they wanted their eggs be distributed, the nature of any 
conditions they wanted to put on their donation, questions and concerns that they had 
and whether some types of recipients were seen as more acceptable than others were 
not included in this study (amongst other valuable insights).  
My own role as a researcher could also have posed a limitation to this study. 
Participants’ responses, actions and behaviours could have been affected by my 
presence, and by the presence of my own socio-demographic characteristics, e.g. age, 
skin tone, gender, ethnicity, sexuality, educational background. For example, several 
recipients presumed that I did not have fertility problems related to my age and so did 
not seek to make a connection with me in relation to age. However, most female 
recipients appeared to respond positively to my gender. My ethnicity (Indian) enabled 
a sense of connection with some of the BME participants in this study, including 
clinicians, but may also have hindered the openness of responses given by some 
Indian recipients (e.g. in case I knew members of their community).  
 
9.4.4 Recommendations for future research 
The large emphasis on the nature and implications of commodification and the role of 
the market in ARTs appear to have been at the cost of more traditional sociological 
analysis about medical power and how the state continues to shape reproduction in 
new ways. 
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The question of whether the UK context of egg and sperm donation can be described 
as a ‘medical market in donor gametes’ (Conrad and Leiter, 2004; Almeling, 2007) is 
an interesting one, and warrants further consideration. Particularly in the UK context, 
scholars researching ARTs could consider looking beyond neo-liberalism as the main 
backdrop for studies or draw out some of the nuances of neo-liberalism as applied to 
the UK. For example, consideration could be given to the specific nature of the UK 
politico-economic context of ARTs, in which there is a high level of state regulation, 
and a low – but not absent- level of state funding. Researchers might also explore how 
medical jurisdiction might expand in taken for granted pockets of ARTs, like the 
organisation of matching.  
Further analysis of the relationship between consumerism and medicalisation in the 
UK context of ARTs would be especially welcome. The tension, relationship and 
connections between these two concepts has not been well theorised in the UK 
context of healthcare and would benefit from being explored across different sites of 
(bio)medicine. It would also be interesting to explore which aspects of 
(bio)medicalisation theory are useful for exploring the UK specific context of ARTs 
and which aspects of the theory might be adapted to better reflect this context. 
Given the paucity of research in ARTs with BME women, researchers might consider 
taking a more inclusive approach when designing research and recruiting participants. 
In this study, the proportion of BME recipients recruited at each clinic was heavily 
shaped by the patient demographics at each clinic, but a concerted effort was made to 
recruit BME recipients (e.g. with the help of gate keepers and through building 
rapport). It might be helpful for researchers to be aware of, and sensitive to, specific 
concerns that BME women might have when participating in research in medical 
ART settings (e.g. given the historical relationship between medicine and ‘race’ and 
the highly stigmatised nature of infertility in highly pronatalist cultures).  
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Although individual recipients were encountered at different stages of the matching 
process in this study it was not possible to interview them throughout these different 
stages. As recipients were interviewed after having accepted a donor, they were asked 
about their retrospective preferences for donor characteristics. A fruitful study in the 
future might interview recipients at the time of stating their preferences and then 
again when they were matched with a donor or ‘trace’ recipients’ trajectory through 
the matching process. Future research which collects and contextualises statistics on 
the types of matches made by clinicians and recipients’ practices of accepting and 
declining donors (alongside qualitative methods) would also provide much needed 
insight into the patterns of matching practices. 
 
Specific areas for future research:  
 The recent emergence of clinic-based websites that advertise egg donors 
to recipients in the UK and the ways in which clinicians and recipients 
interact with these websites. Studies might explore how the roles of 
clinicians, recipients and the HFEA interact with, shape, and are shaped by 
these emerging website and their implications for reproduction. Currently, 
these websites are attached to licensed fertility clinics and so occupy a 
different place to those in unregulated contexts of egg donation, in which such 
websites have been explored.  
 
 The increasing rise in male same-sex couples and single men using egg 
donation  
 
 The inclusion of donors as participants in addition to clinicians and 
recipients 
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 The impact of context on recipients’ matching practices and negotiations 
of difference, in addition to the current more obvious focus on recipients’ 
negotiations of resemblance and kinship. This might include exploring how 
a shortage of donors, recipients’ gender/sexuality and recipients’ trust in 
clinicians shape their matching practices. It might also involve exploring 
recipients’ experiences of managing different types of ontological identities 
within the matching process, i.e. being a parent, being a patient and being a 
consumer. 
 
 Comparison of the organisation of matching, and the roles of clinicians, 
donors and recipients, across different contexts or matching models, 
whether transnationally or regionally. Studies exploring these comparisons 
would be useful to uncover the nuances of how context shapes the 
organisation of matching and what matching reveals about the peculiarities of 
different contexts. Future studies might also compare matching across egg and 
sperm donation, in which matching would be a site upon which to illuminate 
the specific gendered, sexualised, racialised, commodified, medicalised, 
technological, economic, political and stratified nature of reproduction through 
gamete donation.  
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Appendix 2: Clinician Information Sheet 
 
 
 
Exploring the Practice of Donor-Recipient Matching in UK Fertility 
Clinics 
Participant Information Sheet for Clinicians 
You are invited to participate in a research study which focuses on practices of matching egg 
and sperm donors with recipients in UK fertility clinics.  This Information Sheet will outline 
the research study, the nature of your involvement and who to contact should you have any 
further questions.   
The Researcher 
My name is Priya Davda, and I am a PhD student at Royal Holloway, University of London. 
Purpose of study 
The aim of this study is to describe how egg and sperm donors are selected and matched 
with recipients, and to explore the views and experiences of patients and clinicians within 
this process. Despite the practice of matching being a central consideration in the treatment 
of patients needing fertility treatment with donor eggs and sperm, little is known about the 
ways in which this practice is carried out, or about the views and experiences that inform it. 
Why has my clinic been chosen for this study? 
Your clinic has been chosen to participate in this study because it offers fertility treatment to 
patients in need of donor gametes, and consequently undertakes the practice of donor-
recipient matching.   This study will take place in 2 fertility clinics, your clinic and one other, 
and will be undertaken in a similar fashion in each.       
Why have I been chosen to take part in this study? 
You have been chosen to participate in this study because of your role in matching egg, 
sperm, and embryo donors and recipients, or in managing these practices.   
What does participation in this study involve? 
This study will involve a range of data collection methods, such as observation of matching-
related activities within your clinic, and undertaking interviews with clinicians and patients. 
For observations, the researcher will spend 2-3 days a week in your clinic, for around 6 
months. This will include the researcher observing day to day clinician activities pertaining to 
matching, attending staff meetings and observing relevant patient-clinician consultations in 
order to understand how donor characteristics are selected. 
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Interviews will last for approximately 1 hour, and will be used to explore: your views and 
experiences of the matching process; some of the difficulties faced; the use and importance 
of social and physical characteristics; and how you think the processes associated with 
matching could be improved.  With your permission, the interview will digitally recorded and 
transcribed, otherwise hand-written notes will be made during the interview. Interviews will 
be undertaken at your convenience. 
Is Participation Voluntary? 
Yes, participation in this study is entirely voluntary.  If, for any reason, you object to being 
observed and/or interviewed, the researcher will cease any observations pertaining to you 
and will refrain from interviewing you.  The decision not to participate in this study can be 
taken at any point before, during and after data collection, without any further 
consequence. If you withdraw from this study, data collected from your participation up 
until that point will be erased. You will be asked to sign a written consent sheet by the 
researcher to show that you have understood the nature of this study and your role in it, 
and that you are happy to participate.  
If you decide that you would not like to be included in this study, or have any concerns about 
the way this study is being carried out, please either contact the researcher or the clinic’s 
Manager (see below for details). 
What are the potential risks/benefits of taking part? 
There are little anticipated risks to participants taking part in this study. It is hoped that the 
findings of this study will contribute to an understanding of how donor-recipient matching 
practices are undertaken in fertility clinics in the UK, and enable understanding of the views 
and experiences of those who deliver, receive and regulate this practice. 
Will data collected from my participation be kept confidential? 
Yes. Any notes taken from observations or conversations with members of staff will be kept 
strictly confidential, and any comments that you or your colleagues share will remain 
anonymous.  Your name and any details which could potentially identify you will be removed 
or changed in the data collection, analysis and reporting of this study.    
All of the data collected will be stored securely and privately; paper materials will be locked 
in a cupboard at a safe location, and electronic materials will be stored in a password 
protected file on a secure computer at a safe location.   
What will happen to the results of this study? 
The results of this study will be disseminated amongst participating clinics, academic and 
professional conferences, and in academic journals.  All individual participants will also be 
given the opportunity to receive a summary of the findings of this study, and to discuss 
these further. 
Funding of this study 
This study is funded by the South West Academic Network, an alliance between St. Georges 
University, Royal Holloway University and Kingston University.  
Ethical Approval 
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Consent to undertake this study has been granted by the clinic’s Manager and the Ethics 
Committee at Royal Holloway, University of London. The researcher has also signed a form 
of non-disclosure at each clinic. 
Contact for further information 
For further information or if you have any concerns about the way this study is carried out, 
please contact either: 
Researcher: Priya Davda, Dept. of Criminology and Sociology, Royal Holloway University, 
Egham Hill, Egham, Surrey, TW20 0EX.  E-mail: p.davda@rhul.ac.uk, or Telephone: 01784 
443156 
Study Supervisor: Professor Jonathan Gabe. E-mail: g.gabe@rhul.ac.uk, or Telephone: 0 
1784 276614 
Clinical Manager:  [Name and contact details of clinic’s Manager] 
 
Thank you for your time 
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Appendix 3: Recipient Information Sheet 
 
 
 
Exploring the Practice of Donor-Recipient Matching in UK Fertility 
Clinics 
 
Participant Information Sheet for Patients 
You are invited to take part in a research study, which will explore how egg and sperm 
donors are matched with recipients in UK fertility clinics. This Information Sheet will outline 
the research study, the nature of your involvement and who to contact should you have any 
further questions.   
The Researcher 
My name is Priya Davda, and I am a PhD student at Royal Holloway, University of London. 
Purpose of study 
The aim of this study is to describe how egg and sperm donors are selected and matched 
with potential recipients, and to explore the views and experiences of patients and clinicians 
within this process. Despite the practice of matching being a central consideration for 
patients needing fertility treatment with donor eggs and sperm, little is known about the 
ways in which this practice is carried out, or about the views and experiences that inform it. 
Why have I been invited to participate in this study? 
You have been invited to take part in this study because you are in the beginning stages of 
your fertility treatment, and because you have a consultation booked at the clinic where you 
will discuss your choice of donor characteristics. 
What does participation in this study involve? 
Taking part in this study will involve allowing the researcher to observe your consultation 
with the clinic in which your preferences for a donor will be discussed. The researcher will 
not intervene in your consultation at any stage, and may make some handwritten notes.  
After your consultation you will be invited to take part in an interview, lasting approximately 
one hour. This time will be used to discuss your views and experiences in relation to 
selecting a donor, which donor characteristics are important to you, and how you think the 
process of selecting a donor could be improved. With your permission, the interview will be 
digitally recorded and transcribed, otherwise hand-written notes will be made. You will be 
given the option of having an interview alone, or as a couple. If your clinician matches you 
with a potential donor within the 6 months that this study is being undertaken at your clinic, 
with your permission, you will also be invited for a second interview after you have decided 
whether to accept or decline this offer. 
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Is Participation Voluntary? 
Yes, your participation in the study is entirely voluntary. The decision not to participate in 
this study can be taken at any point before, during and after data collection, without reason, 
and without affecting your treatment at the clinic in any way. This Information Sheet will be 
sent to you in advance of your consultation at the clinic. When you arrive at the clinic, you 
will be asked whether you are interested in taking part in this study. If you decide not to take 
part, you will not be contacted again.  
If you decide to take part, the researcher will answer any questions that you have and 
request that you sign a written consent form to show that you understand the information 
provided to you and that you are happy to participate. If you withdraw from this study, data 
collected from your participation up until that point will be erased. 
What are the potential risks/benefits of taking part? 
There are little anticipated risks to taking part in this study. Given the sensitive nature of 
issues surrounding donor fertility treatment, it is recognised that infertility and undergoing 
fertility treatment can have significant emotional, psychological and physical consequences 
for those affected.  If you find that you are upset or troubled by some of the issues arising 
from this study, contact details for some sources of support are provided at the bottom of 
this Information Sheet.  If you have any concerns about this study or would like to refrain 
from participating, please contact either the researcher or the clinic’s Manager (see below 
for contact details). It is hoped that the findings of this study will contribute to an 
understanding of how donor-recipient matching practices are undertaken in fertility clinics 
in the UK, and enable understanding of the views and experiences of those who deliver, 
receive and regulate this practice.  The researcher will not access your personal records at 
any time. 
Will data collected from my participation be kept confidential? 
Yes. Any notes taken during this study will be kept strictly confidential, and any comments 
that you or your clinician make will remain confidential and anonymous.  Your name and any 
details which could potentially identify you will be removed or changed in the collection, 
analysis and dissemination of this study. 
All of the data collected will be stored securely and privately; paper materials will be stored 
in a locked cupboard at Royal Holloway University, and electronic materials will be stored in 
a password protected file in a safe location.  
What will happen to the results of this study? 
The results of this study will be disseminated amongst participating clinics, academic and 
professional conferences, and in academic journals.  All individual participants will also be 
given the opportunity to receive a summary of the findings of this study, and to discuss 
these further.  
Funding of this study 
This study is funded by the South West Academic Network, an alliance between St. Georges 
University, Royal Holloway University and Kingston University.  
Ethical Approval 
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Consent to undertake this study has been granted by the clinic’s Manager and the Ethics 
Committee at Royal Holloway, University of London. The researcher has also signed a form 
of non-disclosure at each clinic. 
Contact for further information 
For further information or if you have any concerns about the way this study is carried out, 
please contact either: 
Researcher: Priya Davda, Dept. of Criminology and Sociology, Royal Holloway University, 
Egham Hill, Egham, Surrey, TW20 0EX.  E-mail: p.davda@rhul.ac.uk. Or Telephone: 01784 
443156 
Study Supervisor: Professor Jonathan Gabe. E-mail: g.gabe@rhul.ac.uk, or Telephone: 0 
1784 276614 
Clinical Manager:  [Name and contact details of clinic’s Manager] 
 
Further Sources of Support 
Infertility Network UK: website:  www.infertilitynetwork.com or Telephone: 0800 008 7464 
Fertility Friends: website: www.fertilityfriends.co.uk   
Donor Conception Network: website: www.donor-conception-network.org or Telephone 
0208 245 4369 
 
Thank you for your time 
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Appendix 4: Clinician Consent Form 
 
 
Study Title: Exploring the Meanings and Practices of Donor-Recipient Matching in UK 
Fertility Clinics 
Participant Consent Form for Clinicians 
Name of Researcher:  Priya Davda  
Contact details: p.davda@rhul.ac.uk or 07946 739894 
 
I confirm that I have read and understand the information sheet for the above study, and 
that I have had the opportunity to consider the information, ask questions and had these 
answered satisfactorily 
I understand that my participation is entirely voluntary, and that I am free to withdraw from 
this study at any time, without reason or repercussion 
I agree to take part in this study by being observed by the researcher  
 
I agree to take part in this study by being interviewed by the researcher 
 
I agree to have my interview recorded and transcribed anonymously by the researcher  
I understand that my identity and any information that I share will remain confidential and 
anonymous throughout the data collection, analysis and reporting of this study  
If you would like to receive a summary of the research findings, please provide your contact 
details for feedback (your contact details will only be used for this purpose) 
 
Contact Details:_____________________________________________________________ 
 
______________________________        _____________     ____________________ 
Name of Participant     Date  Signature of Participant 
______________________________        _____________ ________________________
  
Name of Researcher    Date  Signature of Researcher 
When completed, 1 consent form will be given to the participant, and 1 form will be stored 
securely by the researcher 
Please mark boxes 
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Appendix 5: Recipient Consent Form 
 
 
Study Title: Exploring the Meanings and Practices of Donor-Recipient Matching in UK 
Fertility Clinics 
Participant Consent Form for Patients  
Name of Researcher:  Priya Davda  
Contact details: p.davda@rhul.ac.uk or 07946 739894 
 
I confirm that I have read and understand the information sheet for the above study, and 
that I have had the opportunity to consider the information, ask questions and have these 
answered satisfactorily 
I understand that my participation is entirely voluntary, and that I am free to withdraw from 
this study at any time, without reason or repercussion 
I agree to take part in this study by being interviewed by the researcher 
I agree to have my interview recorded and transcribed anonymously by the researcher  
I understand that my identity and any information that I share will remain confidential and 
anonymous  throughout the data collection, analysis and reporting of this study  
If you would like to receive a summary of the research findings, please provide your contact 
details for feedback (your contact details will only be used for this purpose) 
 
Contact Details:____________________________________________________________ 
 
______________________________        _____________ ________________________ 
Name of Participant     Date  Signature of Participant 
 
______________________________        _____________ ________________________ 
Name of Researcher    Date  Signature of Researcher 
When completed, 1 consent form will be given to the participant, and 1 form will be stored 
securely by the researcher 
Please mark boxes 
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Appendix 6: Topic Guide for Clinicians 
 
Core Topics: Organisation of Clinic, Roles in Matching Process, Organisation of 
Matching Process, Aims of Matching, Ethnic Matching, Classification of 
Characteristics, View of Recipients and Recipient Choice, View of Matching Process, 
View of Donor Information,     
[Ask as relevant to role]   
Background/Role 
 Can you tell me a bit about your role in the clinic? What do you do? 
Responsibilities? What don’t you do? Role in the matching process 
 How long have you been here? What did you do before?  
 [demographic info- ethnicity, nationality, age, gender] 
 
General 
 What type of recipients are typical at the clinic? And less typical? 
 What types of donors do you have in the clinic? Have you refused any 
potential donors? 
 Why do you think donors donate? 
 Why do you think recipients seek treatment with donor eggs? 
 Are there any types of recipients you would not accept for treatment 
 What is the role of counselling in the clinic? 
 
Recipients Agency 
 What do recipients want in their donor? What preferences can they state in 
the clinic? 
 Are there are preferences that you would not allow? Why? 
 What unusual requests have you come across? Have you refused any 
recipient requests? 
 Do all recipients accept donors? 
 What do you think shapes recipients preferences? Variability between them? 
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 Do recipients decline donors? Why do you think this is? What characteristics 
do recipients decline donors on the basis of? 
 What do you think about recipients having more choice in the matching 
process? (e.g. select own donors have more information)    
 What do recipients want to know about their donor? What type of donor 
information are you willing/unwilling to give? 
 What do you think about the amount of information that recipients get about 
their donors? Do you think they should get more/less?  
 What information do you record about donors and recipients? 
 How is the process of classification undertaken? Who does it? Categories? 
Tools?  
 What happens if there is a disparity in opinion?  
 How do you classify ethnicity? 
 How do you classify skin tone? 
 
Matching Process 
 How is the matching process organised in the clinic? Talk me through 
process step by step? Decision-making stages and processes? 
 What is your role in the matching process? 
 What is the purpose of matching? 
 What criteria do you match by? 
  What criteria do you prioritise when matching? Same for all recipients?  
 Are there any welfare of the child concerns in matching? 
 What is the role of ethnicity in matching? 
 What are your views on ethnic matching? Is this something you try to do? 
 What is ethnicity? 
 Is there a relationship between Welfare of the Child considerations and ethic 
matching? 
 What are the barriers and constraints to matching?  
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 What is an ideal match? 
 What is the role of hobbies and social characteristics in the matching 
process? 
  Are there any types of donors/recipients that you find easier to match than 
others? 
 Are there any types of donors/recipients that you find more difficult to match 
than others? 
 Are they any types of matches that you would not make?  What would be 
regarded as an unacceptable match? 
 What characteristics are you willing to compromise on when matching? 
 Is there any policy on matching ? Inside clinic? Regulation? 
 How could the matching process be improved? 
 What do you think of the American context of egg donation and matching? 
[briefly explain little regulation, free market, highly prized individual choice] 
 What do you think about the UK system of matching? (donor allocation) 
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Appendix 7: Topic Guide for Recipients 
Core Topics:  background and trajectory towards egg donation, preferences for 
donor characteristics, donor information, view of matching process, view of clinic, 
view of donors offered, practices of declining and/or accepting donors   
Background Information  
 What led you to choosing egg donation in your fertility treatment? How do 
you feel about it? 
 Have you had fertility treatment in the past? With donor eggs? Been to any 
other clinics? 
 Why did you decide to have fertility treatment with donor eggs? 
 When did you join this clinic? How long did you wait for a donor? Why this 
clinic?  
 Why the UK? 
 How was your overall experience of matching at this clinic? 
  [other details: ethnicity, gender, age, educational background, occupation, 
existing children] 
 Donor Preferences  
 What did you want in your donor? 
 What were your preferences for donor characteristics, before you were 
matched? 
 What preferences did you state in the clinic? Were there any others that you 
couldn’t state in the clinic?  [see reference list below] 
  Why were these characteristics important to you? 
 How was your experience of stating your preferences at the clinic? 
 Are there any characteristics that you wouldn’t accept in a donor? Why not? 
 What would an ideal match be? 
 Did the father’s characteristics matter? 
[Reference list for characteristics: ethnicity, hair colour, eye colour, height, weight, 
skin tone, occupation, education, hobbies, religion, attractiveness, personality, 
intelligence, health, fertility, donor type- altruistic, sharer]  
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View of Donors 
 When comes to mind when you visualise/think of the donor?   image? 
 Are there any characteristics that you would like your child to have? 
 Is it important that the donor matches your characteristics? 
 Do you have any thoughts about the genetic inheritability of your donors’ 
characteristics? 
 Did the motivation of your donor matter? 
 How do you feeling about the removal of donor anonymity? 
 
Clinical Context and Matching Process  
 What was your experience of having treatment at this clinic like? 
 What did you think of the matching process at this clinic? Was it a good 
experience? Anything that could have been done better? 
 How long did you wait to be matched with a donor? What was that period 
like? 
 Would you have liked to have more control over the matching process? 
would you have liked to have more choice in selecting a donor? (i.e. choosing 
between multiple or choosing own), State more preferences? Have more 
information?  How would you feel about choosing your own donor? 
 How did you feeling about the nurses selecting your donor on your behalf? 
 How could the matching process be improved? 
Offered Donors 
 What did you think about the donor that you had just accepted? What were 
you most pleased about? Unsure or concerned about?  
 Why did you accept your donor? 
 Did the donor you accept meet your preferences? 
 How much information were you given about your donor? What did you 
think about this amount? Did you want more? Was it enough? Was there any 
other information you would have liked, or not liked? 
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 Do you think your expectation of choosing a donor have changed over time … 
your experience of treatment? 
 Had you previously declined any donors that you were matched with? How 
many? Why? 
Wider Context 
 Did the change in donor anonymity have any impact on your thoughts about 
choosing egg donation and choosing a donor? 
 Have you told others about your use of egg donation? Who? What? Any 
persons not told? Don’t want to know? Why? 
 Do you intend to disclose to your child? Why? 
 What do you think of the American context of egg donation and matching? 
[briefly explain little regulation, free market, highly prized individual choice] 
 What do you think about the UK system of matching? (donor allocation) 
Partners  
 Same themes as above.  
 How has your experience of the egg donation process been? 
 Did you have any additional or other preferences for donor characteristics? 
Did you agree with your partner’s preferences? 
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Appendix 8: Sample Recipient Coding Frame 
 
Experience of (Infertility) and Egg Donation 
- History 
- Diagnosis 
- Infertility as Surprise/Painful 
- Infertility and Egg Donation as Stigmatised  
- Impact of wider networks/media 
- Decision to use anonymous egg donation 
o Crazy to Necessity 
o Anonymous over Known 
- Concerns and Questions about Egg Donation 
o Relationship to Child 
o Resemblance with Child 
o Family Legitimacy  
o Role/Rights of Donor 
o Counsellor not helpful 
o Counsellor helpful  
- Disclosure 
o To others 
o To child 
- Gay Couples  
o Expected non-reproduction  
o Egg Donation as “luxury” 
o Other concerns 
 
Perception of Donor 
- Substitute for Self 
- ‘Tissue’ Donor 
- Stranger 
- Good Donors 
- Bad Donors 
- Type of Donor 
o Egg Sharers 
o Compensated Donors 
- Concerns about Donor 
o Motivation 
o Exploitation 
o Honesty 
o Health 
Resemblance 
- Perception of Self 
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- Purpose of resemblance 
o To Pass 
o Bonding 
- Consequences of no resemblance 
o Risk to Welfare of the Child 
o Risk to Family Legitimacy 
o Risk to Belonging to Wider Community 
Preferences for Donor Characteristics 
- Priorities 
o Health / Fertility 
 Clinic Screening of 
o Resemblance 
 To Self 
 To Partner 
o Race’ / skin tone 
o Weight/height 
o Hair Colour 
o Eye Colour 
 Important 
 Not Important 
o Social characteristics 
 Ethnicity 
 Religion 
 Education 
 Attractiveness 
- Gay Couples – no preference 
- RACE: Inclusion and Exclusion: Difference and Sameness 
o White Recipients 
 No BME Donors 
 Unacceptable White Donors 
o Asian 
 Acceptable White Donors 
 White Donors Unacceptable 
 Unacceptable Asian Donors 
o Black African/Caribbean 
 Unacceptable White 
 Acceptable Asian  
 Unacceptable Asian 
- Characteristics Unwilling to Accept/Declined  
o Dark Skin tone 
o Poor Health/Lifestyle 
o Red Hair 
o Overweight 
o Muslim 
o Poor/Criminal/Uneducated 
o Poor Health/Fertility  
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Conceptualisation of Race/ethnicity 
- Physical features/Skin Tone 
- Cultural connection 
- Religion conflation 
- Discrimination 
- Desirability 
- Indicator of kinship  
- Risk to kinship  
  
Declining Donors 
- Circumstance 
- ‘Undesirable’ Characteristics  
- Donor Characteristic 
o Lack of general resemblance 
o Overweight 
o Red Hair 
o Dark Skin Tone 
o Lesbian 
o Education/Occupation 
o Health/Fertility/Age 
o Lack of Trust in Clinicians 
- View of Declining Donors 
o Immoral 
o Natural 
o Delays to Treatment 
Reasons for Excluding and DECLINING 
o Risk to Welfare of the child 
o Risk to Kinship Resemblance 
o Risk to reproduction of Self 
 
Strategies for Accepting Difference 
- Contextual Constraints 
o Shortage of Donors 
 Ethnicity 
o Time 
 After pregnant 
o Trust in Clinicians 
o Clinic matching criteria 
o Clinicians Guidance 
- @ end of the day 
- Dominance of Partners’ Genes 
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- Displacing Role of Donor 
- Alternative Generic Discourses 
- Social Connections with Donor  
- Disentangling Resemblance and Kinship 
o Differences between immediate family 
o Differences within wider family 
 
Use of Genetic Discourses 
- Geneticisation  
- Nurture over Nature 
o But … 
- Unilateral Inheritance 
- Recessive Inheritance  
- Uncertainty  
View of Clinicians and Matching Process 
- Stages in Process 
o Happy 
o Lack of Control 
o Waiting time for Donor 
- Relationship with Clinicians 
o Trust 
o Questioning 
o Breakdowns in Trust  
- View of Matches Offered 
o Happy 
o Unhappy 
o Unhappy but Compromised  
- View of Donor Information 
o Amount of Info given 
o Purpose of Information 
o Accuracy of Information 
o Wanted more 
o Not want more 
o Recipients’ Partners’ view 
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Appendix 9: HFEA Donor Information Form 
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